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Abstract	
Persisters	 have	 been	 identified	 in	 almost	 all	 free-living	 bacteria	 and	 many	obligate	 intracellular	pathogens.	Bacterial	 persisters	 are	 transiently	 tolerant	 to	multiple	 antibiotics	 and	 are	 thought	 to	be	 responsible	 for	 recurrent	 infections.	The	formation	of	non-growing	persisters	relies	on	Toxin-Antitoxin	(TA)	modules.	These	 are	 ubiquitous	 molecular	 switches	 controlling	 bacterial	 growth	 via	 the	release	 of	 a	 toxin	 component,	 which	 reversibly	 interferes	 with	 an	 essential	cellular	 process.	 Salmonella	 enterica	 serovar	 Typhimurium	 is	 an	 intracellular	pathogen	 that	 forms	 persisters	 to	 high	 levels	 upon	 internalization	 by	macrophages	and	relies	for	that	on	at	least	14	TA	modules.	Of	these,	3	constitute	a	poorly	characterized	TA	family	where	the	toxin	contains	a	predicted	GCN5	N-acetyltransferase	 domain	 (GNAT).	 In	 this	 work,	 I	 have	 shown	 that	 two	 of	 the	GNAT	TA	modules,	TA6	and	TA8,	are	bona	fide	TA	modules.	Both	toxins	require	the	predicted	Acetyl	Coenzyme	A	domain	to	function.	T8	acetylates	the	Nα	amine	group	 of	 the	 amino	 acid	 charged	 to	 tRNA	molecules.	 This	 results	 in	N-blocked	translationally	 incompetent	 aatRNA	 leading	 to	 inhibition	 of	 protein	 synthesis	and	 growth	 arrest.	 T8	 is	 a	 novel	 acetyltransferase	 that	 dimerizes	 allowing	 for	positive	patches	on	the	surface	of	the	dimer	to	facilitate	tRNA	binding.		Peptidyl	tRNA	 hydrolase	 (Pth),	 recognises	 and	 hydrolyses	 T8-acetylated	 aatRNAs,	allowing	for	the	detoxification	of	cells	producing	T8	and	thereby	resumption	of	growth	marking	exit	from	a	persister	state.	
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Chapter	One	
Introduction	
1.1	Taxonomy	of	Salmonella		Members	of	 the	Salmonella	genus	are	rod-shaped,	gram-negative,	motile	facultative	 anaerobes	 belonging	 to	 the	 enterobacteriaceae	 family.	 The	 first	member	of	the	genus	to	be	isolated	was	Salmonella	Cholerasius	by	D.	Salmon	and	T.	 Smith	 in	 1884.	 Initially	 Salmonella	 were	 classified	 into	 serovars	 using	 the	kauffman-white	system,	which	uses	surface	antigens:	O-antigens	associated	with	lipopolysaccharide	 (LPS)	 structures	 in	 the	 cell	 wall	 and	 H-antigens	 associated	variations	 within	 the	 flagellin.	 The	 concept	 proposed	 by	 Kauffman	 was	 one	serovar	 -	one	species,	which,	 if	 still	used	currently,	would	result	 in	upwards	of	2,400	species.	However,	subsequent	studies	using	DNA	hybridisation	and	multi-locus	 enzyme	 electrophoresis	 (MLEE)	 have	 shown	 that	 all	 but	 one	 of	 these	serovars	are	related	at	the	species	level	(Crosa	et	al.,	1973;	Lan	et	al.,	2009;	Boyd	
et	al.,	1996).	Hence,	Salmonella	have	been	classified	into	two	species,	Salmonella	
enterica:	 containing	 the	 subgroups	 enterica	 (I),	 salmae	 (II),	 arizonae	 (IIIa),	
diarizonae	 (IIIb),	 houtane	 (IV),	 and	 indica	 (VI),	 and	 Salmonella	 bongori	(previously	 subgroup	 V).	 Based	 on	 the	 MLEE	 data	 an	 eighth	 subgroup	 was	described	by	Boyd	et	al	(Boyd	et	al.,	1996).	This	group,	now	known	as	subgroup	VII	 and	 yet	 to	 be	 named,	 contains	 4	 strains	 that	 were	 previously	 assigned	 to	subgroup	IV.		
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Salmonella	enterica	subsp.	enterica	(hereafter	referred	to	as	Salmonella	or	
S.	 enterica)	 is	 the	 largest	 of	 the	 subspecies	 groups,	 containing	 approximately	60%	of	all	known	serovars.	S.	enterica	also	contains	the	vast	majority	of	serovars	associated	 with	 diseases	 in	 humans	 and	 warm-blooded	 animals.	 Serovars	belonging	to	all	other	subspecies	and	S.	bongori	are	most	often	associated	with	infection	of	cold-blooded	animals	or	 isolated	from	the	environment	(Brenner	&	Villar,	2000).	S.	enterica	serovars	have	evolved	to	infect	a	variety	of	hosts.	Some	are	described	as	being	host-restricted,	 such	as	S.	enterica	 serovar	Typhi	 and	S.	
enterica	 serovar	Gallinarium,	which	are	only	able	colonise	humans	and	poultry	respectively	 (Lan	et	al.,	 2009).	Others	 that	 have	 adapted	 to	 the	 colonisation	 of	specific	 hosts	 but	 retain	 the	 ability	 to	 infect	 a	 wider	 variety	 of	 organisms	 are	described	 as	 host-adapted.	 These	 include	 S.	 enterica	 serovar	 Dublin	 and	 S.	
enterica	 serovar	Cholerasius,	which	are	most	often	associated	with	 infection	of	cattle	 and	 pigs,	 respectively,	 though	 have	 been	 isolated	 from	 the	 blood	 of	humans	 (Kingsley	 &	 Bäumler,	 2000).	 Finally,	 there	 are	 more	 promiscuous	serovars	such	as	S.	enterica	serovar	Typhimurium,	which	are	frequently	isolated	from	hosts	including	cattle,	pigs,	sheep,	poultry,	rodents	and	humans	(Kingsley	&	Bäumler,	2000;	Ohl	&	Miller,	2001).			
1.2	Diseases	in	humans	 	Diseases	 caused	 by	 Salmonella	 can	 be	 broadly	 categorised	 into	 three	groups	 based	 on	 their	 clinical	 manifestations	 and	 the	 causative	 serovars.	Typhoid	fever,	caused	by	S.	Typhi	and	S.	Paratyphi,	is	a	life	threatening	systemic	infection	common	in	developing	countries.	 In	2000,	 it	was	estimated	that	there	
	 	 Chapter	one:	Introduction	
	 18	
were	 21.7	million	 cases	 of	 typhoid	 fever,	 resulting	 in	 217,000	 deaths,	 and	 5.4	million	 cases	 of	 paratyphoid	 fever	 worldwide	 (Crump	 et	 al.,	 2004;	 Crump	 &	Mintz,	 2010).	 Non-typhoidal	 Salmonella	 (NTS)	 serovars,	 most	 commonly	 S.	Typhimurium	 and	 S.	 Enteritidis,	 cause	 gastroenteritis	 in	 healthy	 patients	 and	invasive	bacteraemia	in	the	immuno-compromised.	Gastroenteritis	is	generally	a	self-limiting	disease	with	non-treated	patients	clearing	 the	 infection	within	3-7	days.	However,	 the	global	 incidence	of	Salmonella-mediated	gastroenteritis	has	been	estimated	at	93	million	cases	per	annum,	resulting	in	155,000	deaths	and	so	is	still	a	major	health	concern	(Majowicz	et	al.,	2010).	There	are	an	estimated	3.4	million	cases	of	invasive	bacteraemia	a	year,	resulting	in	680,000	deaths.	It	is	most	prevalent	in	sub-Saharan	Africa,	where	confounding	factors	such	as	malaria	and	malnourishment	 in	 children	 and	HIV	 in	 adults	 increase	 the	 risk	 of	 enteric	NTS	infections	becoming	invasive	(Ao	et	al.,	2015).		
1.2.1	Gastroenteritis		 Gastroenteritis	 is	 most	 commonly	 acquired	 by	 faecal-oral	 transmission	through	 contaminated	 food	 or	water	 sources.	 It	 is	 characterised	 by	 symptoms	including	 abdominal	 pain,	 diarrhoea,	 fever	 and	 vomiting	 occurring	 8-72	 hours	post	 infection.	 Upon	 colonisation	 of	 the	 ileum,	 bacteria	 disseminate	 to	 the	Peyer’s	 patches	 and	 mesenteric	 lymph	 nodes	 (MLN).	 	 Here,	 the	 NTS	 cause	inflammation	 of	 the	 gut	 and	 the	 recruitment	 of	 large	 numbers	 of	polymorphonuclear	lymphocytes	(PMNs)	to	the	site	of	infection.	This	PMN	influx	results	 in	 a	 protein	 rich	 exudate	 and	 diarrhoea.	 Treatment	 normally	 includes	fluid	and	electrolyte	replacement,	though	is	not	necessary	in	most	cases	(Coburn	
et	al.,	2007).		
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1.2.2	Invasive	bacteraemia		 Invasive	 bacteraemia	 occurs	 when	 the	 bacteria	 cross	 the	 intestinal	epithelium	 and	 enter	 the	 blood.	 	 Symptoms	 vary	 depending	 on	 the	 secondary	site(s)	of	infection.	In	healthy	individuals	antibody-mediated	complement	killing	of	the	extra-intestinal	bacteria	is	sufficient	to	clear	the	infection.	Children	under	2	 years	 who	 have	 not	 yet	 acquired	 anti-Salmonella	 antibodies	 are	 at	 risk	 of	invasive	 infection	 (MacLennan	 et	 al.,	 2008).	 In	 sub-Saharan	 Africa,	 where	malarial	 infection	 is	 prevalent,	 this	 risk	 is	 increased	 as	 malarial	 infection	 has	been	 shown	 to	 reduce	 complement	 levels	 (Goh	 &	 MacLennan,	 2013).	 HIV	positive	 adults	 constitute	 another	 high-risk	 population.	 The	 aberrant	 humoral	immune	response	in	these	individuals	results	in	a	high	titre	of	antibodies	specific	to	 Salmonella	 LPS	 which	 leads	 to	 a	 loss	 of	 complement-mediated	 killing	 of	bacteria	(Maclennan	et	al.,	2010).		
1.2.3	Typhoid	fever		 Clinical	 manifestations	 of	 typhoid	 fever	 include	 incremental	 fever,	abdominal	 pain	 and	 transient	 diarrhoea.	 The	 pathological	 hallmark	 is	hypertrophy	 of	 the	 organs	 within	 the	 reticuloendothelial	 system	 (RES)	 and	invasion	of	monocytes	(Ohl	&	Miller,	2001).	In	typhoid	fever,	upon	colonisation	of	the	ileum,	bacteria	also	infect	the	Peyer’s	patches,	however,	in	contrast	to	NTS,	they	 only	 induce	 mild	 inflammation	 (Parry	 et	 al.,	 2002).	 From	 the	 Peyer’s	patches	 bacteria	 spread	 to	 the	 MLN	where	 they	 begin	 to	 replicate.	 They	 then	disseminate	 to	 the	 liver,	 spleen	 and	 bone	 marrow	 via	 the	 bloodstream	 and	invade	 various	 monocytes	 at	 these	 sites.	 Bile	 excretion	 from	 the	 liver	 carries	bacteria	 to	 the	 gall	 bladder	 (Watson	&	Holden,	 2010)	where	 they	 can	 re-enter	
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the	gut	and	re-infect	the	Peyer’s	patches	with	much	higher	titres	of	bacteria.	This	leads	 to	 considerable	 inflammation,	 necrosis	 and	 ulceration	 of	 the	 intestinal	mucosa.	 In	 approximately	 4%	 of	 cases	 bacteria	 can	 persist	 in	 the	 gall	 bladder	resulting	 in	 the	 patient	 becoming	 a	 chronic,	 asymptomatic	 carrier	 of	 infection.	These	 individuals	 continually	 shed	 bacteria	 in	 their	 urine	 and	 faeces	 and	 are	thought	to	be	an	important	reservoir	for	transmission	within	a	community	(Bhan	
et	al,	2010).		
1.3	Models	of	Salmonella	infections	Animal	 models	 have	 been	 widely	 used	 to	 investigate	 the	 complex	processes	 involved	 in	 Salmonella	 infections	 in	 humans.	 They	 have	 greatly	advanced	 our	 knowledge	 of	 the	 progression	 of	 diseases	 and	 the	 complex	interplay	between	host	and	pathogen	during	infection.	
1.3.1	Animal	models	of	gastroenteritis	 		 Mice	are	often	the	first	choice	for	animal	models	of	 infection	as	they	are	genetically	 malleable	 and	 have	 a	 comparable	 immune	 system	 to	 humans;	however,	they	are	intrinsically	resistant	to	S.	Typhimurium	intestinal	infections.	Nonetheless,	 one	 study	 has	 shown	 that	 treatment	 of	 mice	 with	 streptomycin	prior	 to	 infection	with	S.	Typhimurium	results	 in	successful	 colonisation	of	 the	gut.	 Once	 colonised,	 the	 mouse	 intestinal	 infection	 parallels	 that	 of	 human	gastroenteritis	 and	 results	 in	 colitis	 and	 a	 pronounced	 influx	 of	 PMN	 to	 the	intestinal	 lumen	 (Barthel	 et	 al.,	 2003).	 This	 demonstrates	 that	 under	 these	conditions	mice	can	be	used	as	an	effective	model	for	S.	Typhimurium	mediated	gastroenteritis.	 The	 caveat	 to	 this	 model	 is	 that	 the	 antibiotic	 pre-treatment	
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works	by	eradicating	the	mouse	gut	microbiota	and	so	cannot	reflect	the	natural	process	of	infection.			Cattle	 are	 a	 natural	 host	 for	 S.	 Typhimurium;	 indeed	 it	 is	 the	 most	commonly	isolated	serovar	from	ill	cattle	in	the	USA.	Moreover,	S.	Typhimurium	infection	in	cattle	results	in	an	intestinal	infection	with	strikingly	similar	clinical	and	pathological	features	to	that	of	the	human	disease.	In	both	cattle	and	humans	
S.	 Typhimurium	 causes	 infections	 localised	 to	 the	 intestinal	 mucosa	 and	 MLN	where	 it	 exhibits	 the	 typical	 influx	 of	 PMN	 and	 the	 accompanying	 exudate.	 As	such,	calf	and	ligated	bovine	ileal	loops	present	an	excellent	model	for	human	S.	Typhimurium-mediated	gastroenteritis	 (Zhang	et	al.,	2003).	However,	as	whole	animal	models	calves	are	expensive	and	because	they	are	outbred	there	is	large	genetic	variation	between	hosts.	
1.3.2	Animal	models	of	typhoid	fever		 The	 host	 specificity	 of	 S.	 Typhi	 to	 humans	 and	 higher	 primates	 makes	studying	the	pathology	of	the	disease	and	host-pathogen	interactions	in	vivo	very	difficult.	 	 To	 circumvent	 these	 limitations	 susceptible	mouse	 strains	have	been	generated	which	 allow	 researchers	 to	 recreate	 a	 systemic	Salmonella	 infection	(Zhang	 et	al.,	 2003).	 Susceptible	mice	 infected	with	S.	 Typhimurium	develop	 a	systemic	 infection	 that	 closely	 resembles	 typhoid	 fever	 in	 humans,	 displaying	many	of	the	characteristic	pathologies	including	replication	in	macrophages	and	dissemination	to	and	colonisation	of	the	MLN,	spleen	and	liver	(Carter	&	Collins,	1974).	 	 Though	 this	model	 has	 furthered	 our	 knowledge	 of	 systemic	 infection	caused	 by	 Salmonella	 greatly,	 there	 are	 some	 important	 differences	 in	 the	pathology	 of	 the	 two	 diseases.	 In	 the	 later	 stages	 of	 human	 infection	 bacteria	
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occupying	 the	 gall	 bladder	 can	 re-infect	 through	 the	 gut	 causing	 massive	inflammation	and	necrosis	of	the	gut	mucosa.	In	the	mouse	model,	bacteria	have	been	shown	to	reach	the	gall	bladder,	however,	there	is	little	evidence	to	suggest	that	they	can	re-infect	the	gut	from	here	(Menendez	et	al.,	2009).	There	are	also	differences	in	the	repertoire	of	virulence	factors	borne	by	S.	Typhimurium	and	S.	Typhi	that	may	affect	the	outcome	of	disease	and	interactions	between	bacteria	and	the	host.	One	particular	virulence	factor	is	the	Vi	capsular	antigen	of	S.	Typhi,	which	 is	 involved	 in	 down-regulation	 of	 host	 inflammatory	 responses	 and	resistance	to	complement	(Raffatellu	et	al.,	2007).	The	Vi	capsular	antigen	is	not	found	in	S.	Typhimurium	and	its	anti-inflammatory	properties	are	thought	to	be	one	 of	 the	 main	 factors	 involved	 in	 the	 progression	 from	 localised	 enteric	 to	systemic	disease.		
1.3.3	In	vitro	models		 One	of	the	main	characteristics	of	S.	Typhi	infection,	which	is	mimicked	by	infection	of	S.	Typhimurium	in	 the	mouse	model,	 is	bacterial	replication	within	host	cells.	A	simplified	but	very	effective	model	for	the	study	of	bacterial	host	cell	interaction	is	the	use	of	in	vitro	cultured	cells.	In	vitro	cell	culture	has	been	used	extensively	 to	 elucidate	 various	 stages	 of	 Salmonella	 infection	 including	 the	invasion	of	non-phagocytic	 cells	 (Patel	&	Galán,	2006),	 intracellular	 replication	and	 survival	 (Helaine	 et	 al.,	 2010)	 and	 the	 formation	 and	 maturation	 of	 the	Salmonella	Containing	Vacuole	(SCV)	(Méresse	et	al.,	1999).	There	are	a	number	of	cell	 lines	available	for	use.	The	most	widely	used	are	 often	 immortalised	 cell	 lines,	 which	 are	 cells	 that	 have	mutations	 causing	aberrant	 uncontrolled	 proliferation.	 They	 are	 often	 the	 preferred	 cell	 lines	 as	
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they	can	be	cultured	and	stored	in	laboratories	for	long	periods	of	time.	They	are	either	harvested	from	naturally	occurring	cancerous	tumours,	such	as	HeLa	cells,	or	are	immortalized	via	introduction	of	a	viral	gene	that	partially	deregulates	the	cell	 cycle,	 such	 as	HEK	293	 cells.	 The	most	 commonly	 used	 immortalised	 cells	line	 for	 the	studies	of	Salmonella	 infection	are	HeLa	cells	and	RAW	264.7	cells,	which	are	human	epithelial-like	and	murine	macrophage-like	cells	respectively.	The	cell	lines	can	only	be	cultured	for	a	minimum	number	of	cellular	replication	cycles	and	so	fresh	cells	are	constantly	required.	However,	removal	of	a	cell	from	its	 natural	 host	 environment	 inevitably	 results	 in	 changes	 in	 essential	 cellular	process	 and	 so	 is	 not	 always	 considered	 physiologically	 relevant.	 One	 way	 to	ensure	the	model	is	as	physiological	as	possible	is	to	use	primary	cells.	These	are	cells	that	have	been	extracted	directly	from	the	host	organism	and	are	cultured	for	 short	 periods	 of	 time	 only.	 For	 example	 primary	 bone	 marrow	 derived	macrophages	(BMMø)	are	commonly	used.	These	are	more	expensive,	however,	as	 they	 need	 to	 be	 harvested	 quickly	 after	 the	 death	 of	 the	 host	 organism	 so	onsite	facilities	for	the	housing	of	the	animals	are	necessary.			
1.4	Bacterial	persistence	
1.4.1	A	brief	history	to	persistence		 Bacterial	persistence	was	first	described	by	Joseph	Bigger	In	1944	when	he	was	studying	the	killing	of	Staphylococcus	aureus	by	penicillin.	He	noticed	that	penicillin	treatment	failed	to	completely	sterilize	exponentially	growing	cultures	and	resulted	in	a	typical	biphasic	killing	pattern	(Figure	1).	This	pattern	resulted	from	 a	 rapid	 killing	 of	 the	 susceptible	 population	 after	 antibiotic	 addition	 (B)	
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followed	 by	 a	 phase	 of	 greatly	 reduced	 killing	 where	 just	 the	 slowly	 growing	antibiotic	 tolerant	 cells	 remain	 (C).	 When	 progeny	 of	 these	 tolerant	 bacteria	were	 re-treated	 with	 antibiotics	 they	 were	 found	 to	 be	 as	 susceptible	 as	 the	parental	culture	and	formed	a	new	tolerant	subpopulation	comparable	to	that	of	the	progenitor	 cells.	This	 indicated	 that	 the	 tolerance	was	a	 feature	of	a	minor	part	of	the	population	rather	than	resulting	from	selection	of	a	genetic	mutation	conferring	 antibiotic	 resistance.	 Bigger	 correctly	 assumed	 that	 these	 tolerant	cells	 were	 non-growing	 bacteria	 present	 within	 the	 culture	 and	 termed	 them	‘persisters’	 (Bigger,	 1944).	 This	 is	 an	 intriguing	 phenotype	 that	 suggests	heterogeneity	 within	 an	 apparent	 isogenic	 population.	 Persisters	 have	 since	been	 described	 in	 many	 other	 pathogenic	 species	 including	 Salmonella,	
Mycobacterium,	 Chlamydia,	 Pseudomonas,	 Streptococcus	 and	 pathogenic	
Escherichia	 coli	 (Helaine	 et	 al.,	 2014;	 Wayne	 &	 Sohaskey,	 2001;	 Dreses-Werringloer	et	al.,	2000;	Brooun	et	al.,	2000;	Leung	&	Lévesque,	2012;	Norton	&	Mulvey,	2012).	
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Figure	1:	Representative	antibiotic	killing	curve.	The	bacterial	culture	before	addition	of	the	antibiotic	(A)	is	a	mix	of	exponentially	growing	and	persister	cells.	Upon	addition	of	the	antibiotic	to	 the	 medium	 the	 susceptible,	 growing	 population	 is	 rapidly	 lysed	 (B).	 This	 results	 in	 the	isolation	of	the	antibiotic	tolerant	persister	cells	(C).	Adapted	from	Maisonneuve	&	Gerdes	2014.		 A	few	attempts	were	made	to	study	this	odd	phenomenon	though	the	low	frequency	 of	 natural	 occurrence	 undoubtedly	 hindered	 the	 investigations.	Shortly	after	the	discovery	of	penicillin,	resistant	strains	of	bacteria	had	begun	to	be	reported.		This	resulted	in	the	study	of	antibiotic	resistance	and	the	hunt	for	new	antimicrobials	 to	 become	of	 paramount	 importance	 and	 as	 such	persister	cells	 were	 all	 but	 forgotten.	 	 It	 was	 not	 until	 40	 years	 later,	 when	 Harris	 and	Moyed	 set	 out	 to	 isolate	 High	 Persister	 (Hip)	 mutants	 in	 E.	 coli	 that	 the	 field	really	took	off	(Moyed	&	Bertrand,	1983).		Persisters	 are	 often	 split	 into	 two	 categories;	 Type	 I	 and	 Type	 II	persisters.	 Type	 I	 persisters	 are	 formed	 stochastically	 via	 a	phenotypic	 switch,	where	 a	 cell	 can	 switch	 between	 a	 normally	 growing	 and	 persister	 state	 in	response	 to	 a	 change	 in	 the	 environment.	 Type	 II	 persisters	 are	 very	 slow	growing	cells	present	within	the	culture	that	are	constantly	being	produced	and	
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are	not	the	result	of	any	environmental	triggers	(Kussell	et	al.,	2005;	Balaban	et	
al.,	2004).	Here,	I	will	solely	discuss	Type	I	persisters.		
1.4.2	Stochasticity	and	single	cell	decision-making	 	Persisters	 are	 present	 in	 an	 in	vitro	 exponentially	 growing	 culture	 of	E.	
coli	 at	 rates	 of	 around	 10-5	 –	 10-6	 (Moyed	 &	 Bertrand,	 1983).	 They	 have	 also	been	shown	to	occur	as	a	result	of	a	change	in	the	environment,	such	as	nutrient	limitation	 (Nguyen	 et	 al.,	 2011),	 SOS	 response	 (Dörr	 et	 al.,	 2010),	 biofilm	formation	 (Wang	 &	 Wood,	 2011),	 quorum	 sensing	 (Kayama	 et	 al.,	 2009)	 and	intracellular	residence	(Helaine	et	al.,	2014).	However,	this	raises	the	question	as	to	why	all	the	cells	do	not	respond	in	the	same	manner	to	the	same	stress.		One	 hypothesis	 to	 explain	 this	 variation	 in	 response	 is	 that	 the	composition	 and	 distribution	 of	 diffusible	 chemical	 signals	 within	 the	extracellular	 medium	 may	 cause	 fluctuations	 in	 the	 microenvironments	 of	individual	 cells.	 For	 example,	 it	 has	 been	 reported	 that	 supplementing	 the	medium	with	 physiological	 levels	 of	 indole,	 a	 signal	 released	 by	E.	 coli	 during	stationary	phase,	 leads	 to	an	 increase	 in	E.	coli	persister	 formation	but	did	not	cause	all	bacteria	within	the	population	to	become	persisters	(Vega	et	al.,	2012).	The	 authors	 hypothesise	 that	 the	 signal	 is	 sensed	 in	 a	 heterogeneous	manner	and	 thus	 only	 those	 bacteria	 that	 encounter	 enough	 of	 the	 signal	 to	 activate	stress	 response	 pathways	 become	 persisters.	 Another,	 more	 fundamental,	hypothesis	 is	 that	 cell-to-cell	 individuality	 arises	 from	 stochasticity	 in	 gene	expression	 resulting	 from	 variations	 in	 transcription	 and	 translation.	 This	fluctuation	 in	 gene	 expression	 in	 individual	 cells	 in	 response	 to	 comparable	stimuli	 results	 from	 intrinsic	and	extrinsic	 ‘noise’.	Extrinsic	noise	 is	defined	by	
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the	 concentrations	 and	 locations	 of	molecules	 such	 as	 regulatory	 proteins	 and	transcription	 and	 translation	 machinery.	 Fluctuations	 in	 these	 molecular	components	 result	 in	 concomitant	 fluctuations	 in	 gene	 expression.	 Intrinsic	noise	 arises	 due	 to	 the	 random	 events	 that	 govern	 biochemical	 reactions	 and	how	 and	 when	 each	 reaction	 occurs	 (Elowitz	 et	 al.,	 2002).	 Together	 these	variations	in	noise	can	result	in	the	existence	of	distinct	states	through	positive	feedback	loops	(Eldar	&	Elowitz,	2010).		The	current	general	hypothesis	incorporates	both	of	the	aforementioned	theories.	Various	stresses,	including	entry	into	stationary	phase,	activation	of	the	SOS	response	and	amino	acid	starvation,	 lead	to	an	 increase	 in	transcription	of	genes	involved	in	persister	formation	(discussed	in	chapter	1.5)	on	a	population	level.	 The	 stochastic	 fluctuations	 of	 the	 transcription	 and	 translation	 of	 these	genes	 in	 individual	 cells,	 arising	 from	 intrinsic	 and	 extrinsic	 noise,	 results	 in	some	 cells	 having	 much	 more	 translated	 products.	 It	 is	 assumed	 that	 cells	 in	which	 the	 concentration	 of	 persister	 forming	 proteins	 reaches	 a	 certain	threshold	will	then	switch	into	the	persister	state	(Keren	et	al.,	2004b;	Rotem	et	
al.,	2010).	The	bacteria	can	use	this	stochasticity	in	response	to	various	stresses	as	 a	 bet–hedging	 strategy,	 giving	 the	 population	 the	 best	 possible	 chance	 for	survival	in	the	face	of	many	dangers	(Kussell	et	al.,	2005).	
1.4.3	Persisters	and	recurrent	infections		 This	 transient	 antibiotic	 tolerance	 of	 a	 small	 sub-population	 of	 bacteria	has	been	postulated	to	be	a	major	contributing	factor	in	recurrent	and	persistent	infections	 (Lewis,	 2010).	 It	 is	 widely	 considered	 to	 be	 a	 bet-hedging	 strategy	utilized	 by	 the	 bacteria	 to	 protect	 the	 population	 from	 both	 environmental	
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stresses	and	those	encountered	during	infection.	Bacterial	biofilms	are	found	in	65%	of	all	 infections	 in	developed	countries	and	are	well	known	 for	 their	high	recalcitrance	 to	 antibiotics.	 Biofilms	 can	 be	 caused	 by	 a	 variety	 of	 pathogenic	species	 including	 S.	 aureus,	 S.	 epidermidis	 and	 P.	 aeruginosa	 and,	 as	 discussed	later,	 their	 multidrug	 tolerance	 has	 been	 since	 attributed	 to	 persister	 cells	(Brooun	et	al.,	2000).	Moreover,	many	chronic	 infections	such	as	Lyme	disease	and	tuberculosis,	which	can	persist	for	many	years,	have	also	had	their	repetitive	recurrence	 attributed	 to	 persister	 cells	 in	 recent	 studies	 (Sharma	 et	 al.,	 2015;	Keren	et	al.,	2011).	Recurrent	infections	are	a	major	clinical	problem,	indeed,	of	the	21	million	reported	cases	of	typhoid	fever	each	year	15%	of	patients	suffer	a	relapse	(Bhan	et	al.,	2010;	Parry	et	al.,	2002).	A	study	of	invasive	NTS	infections	in	 Africa,	 seeking	 to	 determine	 the	 varying	 rates	 of	 relapse	 and	 reinfection	 in	recurrent	 infections,	 discovered	 that	 78%	 of	 the	 recurrences	 resulted	 from	phylogenetically	 identical	 strains	 (Okoro	 et	 al.,	 2012).	 Furthermore,	 persisters	have	been	implicated	in	incurable	P.	aeruginosa	infections	in	cystic	fibrosis	(CF)	patients	 (Mulcahy	et	al.,	 2010).	The	 ramifications	of	persistent	 infections	 in	CF	and	 other	 immuno-compromised	 patients	 are	 often	 fatal,	 not	 to	 mention	 the	financial	 consequences	 of	 re-treatment,	 the	 associated	 risks	 of	 development	 of	resistance	mechanisms	and	the	ubiquity	of	the	phenomenon	makes	research	into	persisters	imperative.		
1.4.4	Triggers	of	Persistence	 		 Of	 the	many	stresses	 that	persister	cells	are	protected	 from,	 there	are	a	few	that	have	been	reasonably	well	characterised	which	will	be	discussed	here.	However,	 there	may	well	 be	many	more	 as	 yet	 undiscovered,	 this	 is	 a	 current	and	very	active	field	of	research.		
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1.4.4.1	Quorum	sensing	One	study,	previously	mentioned,	linked	the	release	of	indole	by	bacteria	entering	 stationary	 phase	 as	 a	 ‘trigger’	 of	 persister	 cell	 formation	 (Vega	 et	al.,	2012).	The	increase	in	persister	cells	in	a	stationary	phase	population	compared	to	an	exponentially	growing	one	has	been	well	documented	(Keren	et	al.,	2004a;	Luidalepp	 et	 al.,	 2011).	 Though	 this	 antibiotic	 indifference	 results	 from	exhaustion	of	the	nutrients	accompanied	by	concomitant	reduced	growth	and	so	is	 different	 to	 the	 antibiotic	 tolerance	 exhibited	 by	 persister	 cells,	 which	 have	arisen	within	 an	 exponentially	 growing	 culture.	 The	observations	made	 in	 this	study	 show	 that	 a	 bacterial	 culture	 can	 influence	 its	 own	 rate	 of	 persister	formation	 via	 the	 release	 of	 cell-cell	 signalling	 molecules.	 Another	 well	documented	cell-cell	signalling	pathway	is	quorum	sensing;	the	production	and	release	of	chemical	signalling	molecules	by	bacteria	 in	response	 to	 fluctuations	in	cell	density	(Miller	&	Bassler,	2001).	Quorum	sensing	has	also	been	linked	to	biofilm	formation,	which	has	itself	been	implicated	in	the	formation	of	persister	cells	(discussed	in	section	1.4.4.4).	 Indeed,	 it	has	been	shown	that	perturbation	of	the	Las	system,	one	of	the	main	regulators	of	quorum	sensing,	in	P.	aeruginosa	resulted	in	reduced	persister	formation	(Kayama	et	al.,	2009).	However,	this	was	shown	to	be	indirect	as	it	was	a	result	of	a	decrease	in	RpoS	activation,	which	is	known	 to	 activate	 a	 number	 of	 stress	 responses	 in	 bacteria	 (Hengge-Aronis,	2002).	 Another	 study	 showed	 that	 incubation	 of	 P.	 aeruginosa	 in	 media	containing	physiological	 levels	of	 the	quorum	sensing	molecules	PYO	and	acyl-HSL	 resulted	 in	 increased	 persister	 formation.	 Interestingly,	 this	 observation	was	specific	to	actively	growing	bacteria.	No	increase	in	persister	formation	was	
	 	 Chapter	one:	Introduction	
	 30	
seen	when	stationary	phase	P.	aeruginosa	were	 incubated	 in	 the	same	medium	(Möker	et	al,	2010).	
1.4.4.2	SOS	response	The	SOS	response	in	bacteria	is	a	complex	network	of	more	than	40	genes	involved	 in	the	response	to	and	repair	of	DNA	damage.	E.	coli	mutants	 that	are	deficient	 in	 induction	 of	 the	 SOS	 response	 produced	 less	 persisters	 than	 their	wild-type	 (WT)	 counterpart.	 Moreover,	 induction	 of	 the	 SOS	 regulon	 and	activation	 of	 the	 SOS	 response	 to	 mitomycin	 treatment	 increased	 persister	formation	(Debbia	et	al.,	2001;	Dörr	et	al,	2009).	This	phenotype	has	been	linked	specifically	 to	 the	 activation	 of	 the	 SOS	 response	 by	 ciprofloxacin	 treatment.	Ciprofloxacin	is	a	fluoroquinolone,	which	targets	DNA	gyrase	and	topoisomerase	IV,	inhibiting	their	ligation	reactions.	This	results	in	double	stranded	DNA	breaks	(Malik	 et	al.,	 2006)	 and	 as	 such	 has	 been	 shown	 to	 activate	 the	 SOS	 response.	These	 results	 suggested	 that	 DNA	 damage	 induced	 by	 the	 fluoroquinolones	actively	triggers	persister	formation	through	activation	of	the	SOS	response.	This	was	 the	 first	 observation	 of	 a	 deterministic	 component	 in	 the	 formation	 of	persister	bacteria.	
1.4.4.3	Stringent	response	Similar	to	the	SOS	response,	the	stringent	response	is	a	complex	network	encompassing	at	least	80	genes.	It	is	broadly	governed	by	intracellular	levels	of	the	global	transcriptional	regulator	(p)ppGpp,	which	in	turn	are	maintained,	in	E.	
coli	by	RelA,	a	synthase,	and	SpoT,	primarily	a	hydrolase	but	which	can	also	have	synthase	 activity	 under	 certain	 conditions.	 During	 nutritional	 stress,	 RelA	synthesises	ppGpp	in	response	to	the	presence	of	uncharged	tRNA	bound	to	the	
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ribosomal	 A	 site	 (Potrykus	 &	 Cashel,	 2008).	 Accumulation	 of	 ppGpp	 leads	 to	dramatic	transcriptional	changes,	activation	of	the	cellular	protease	Lon	and	cell	cycle	arrest	(Ferullo	&	Lovett,	2008).	However,	due	to	stochastic	fluctuations	in	gene	 expression,	 bacteria	 exhibit	 heterogeneous	 levels	 of	 activation	 of	 the	stringent	 response	 when	 faced	 with	 nutrient	 limitation	 (Ghosh	 et	 al.,	 2011).	ppGpp	accumulation	and	activation	of	the	stringent	response	has	been	linked	to	formation	of	persisters	in	many	bacteria	(Hansen	et	al.,	2008;	Primm	et	al.,	2000;	Nguyen	et	al.,	2011;	Amato	et	al.,	2013;	Germain	et	al.,	2013,	2015).		
1.4.4.4	Biofilm	formation	Biofilms	occur	when	a	number	of	bacteria	group	together	and	produce	a	matrix	of	an	exopolysaccharide	substance.	They	often	adhere	to	surfaces	and,	as	previously	 mentioned,	 are	 well	 known	 for	 their	 antibiotic	 recalcitrance.	 The	formation	 of	 bacterial	 biofilms	 has	 been	 linked	 to	 many	 recurrent	 infections	(Chen	&	Wen,	2011).	Bacteria	engaged	in	a	biofilm	enter	a	slowly	growing	state.	Initially,	 their	 antibiotic	 tolerance	 was	 attributed	 to	 this	 slow	 growth	 and	 an	inability	 for	 the	antibiotics	 to	penetrate	 the	biofilm	effectively.	However,	 it	has	been	 shown	 that	 both	 ciprofloxacin	 and	 tobramycin	 effectively	 penetrated	 P.	
aeruginosa	 biofilms	 (Walters	 III	et	al.,	 2003).	 In	 the	 case	of	 antimicrobials	 that	require	 cell	 growth	 for	 efficacy	 the	 initial	 hypothesis	 stands	 true.	 However,	P.	
aeruginosa	 biofilms	 show	 a	 typical	 biphasic	 killing	 pattern	 in	 response	 to	ofloxacin	 treatment,	 which	 is	 known	 to	 effectively	 kill	 non-growing	 bacteria	(Spoering	&	Lewis,	2001).	This	 suggests	 that	when	 treated	with	antimicrobials	whose	 efficacy	 does	 not	 rely	 on	 the	 bacteria	 actively	 replicating,	 it	 is	 the	presence	of	persister	cells	that	account	for	the	biofilms	tolerance.	Furthermore,	
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it	was	noticed	that	the	tolerance	of	biofilms	to	fluoroquinolones	was	the	result	of	a	small	number	of	 	 ‘super-persistent’	bacteria,	which	went	on	to	repopulate	the	biofilm	 upon	 removal	 of	 the	 antibiotic	 (Brooun	 et	 al.,	 2000).	 These	 have	 since	been	 identified	 as	 comparable	 to	 planktonic	 persister	 cells	 (Spoering	&	 Lewis,	2001).	Moyed	 and	 Bertrand	 utilised	 chemical	 mutagenesis	 to	 screen	 for	 hip	mutants,	 an	 approach	 that	 has	 been	 successfully	 replicated	 since	 (Moyed	 &	Broderick,	 1986;	 Wolfson	 et	 al.,	 1990).	 However,	 hip	 strains	 have	 also	 been	isolated	 without	 conducting	 any	 mutagenesis,	 suggesting	 that	 stressful	conditions	encountered	in	the	environment	may	also	lead	to	the	formation	of	hip	mutants.	Quorum	sensing	molecules	isolated	from	the	lungs	of	CF	patients	show	that	 biofilms	 occur	 with	 the	 lungs	 of	 these	 individuals	 (Singh	 et	 al.,	 2000).	Furthermore,	high	persister	forming	mutant	strains	have	been	isolated	from	the	lungs	 of	 CF	 patients	 who	 have	 undergone	 repeated	 antibiotic	 treatments	(Mulcahy	 et	al.,	 2010).	 Isolation	 of	 hip	mutants	 from	 these	 individuals	 is	most	likely	due	to	the	biofilms	formed	within	their	lungs	withstanding	multiple	bouts	of	antibiotic	treatment.		
1.4.4.5	Interaction	with	host	Bacteria	 can	 encounter	many,	 if	 not	 all,	 of	 the	 triggers	 described	 above	during	a	normal	infection	process,	suggesting	that	more	in	vivo	investigations	are	required	 to	 fully	 determine	 the	 role	 of	 persister	 cells	 during	 infection.	 Indeed,	many	more	and	variable	factors	have	been	linked	to	persister	formation	in	vivo.	
S.	aureus	has	been	shown	to	down-regulate	virulence	factors	and	auxotrophism	whilst	in	their	small	colony	variant	state,	a	phenotype	that	has	been	proposed	to	
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be	 essential	 for	 intracellular	 persistence	 (Tuchscherr	 et	 al.,	 2011;	 Kahl	 et	 al.,	1998).	 Moreover,	 during	 Salmonella	 infection,	 persister	 formation	 has	 been	shown	to	increase	100-1,000	fold	in	response	to	internalisation	by	primary	bone	marrow	macrophages	(Helaine	et	al.,	2014).	This	is	due	to	the	hostile	conditions	encountered	 by	 the	 bacteria	when	 they	 enter	 the	 SCV.	 Together	 these	 studies	highlight	the	importance	of	interactions	between	pathogen	and	host	in	formation	of	persisters.		
1.4.5	Persistence	and	antibiotic	tolerance	Most	 stresses	 encountered	 by	 bacteria	 result	 in	 an	 alteration	 in	 the	regulation	of	essential	cellular	processes	such	as	transcription,	translation	or	cell	wall	 synthesis,	 through	 the	 activation	 of	 stress	 responses.	 Moreover,	 most	antibiotics	are	effective	as	a	result	of	targeting	active	cellular	machinery.	Indeed,	it	has	been	well	documented	that	antibiotic	efficacy	correlates	with	the	growth	rate	of	bacteria	(Tuomanen	et	al.,	1986;	Eng	et	al.,	1991).	 It	 is	 foreseeable	then	that	 the	 non-growth	 state	 of	 persister	 cells	 could	 confer	 tolerance	 to	antimicrobials	 and	 would	 explain	 the	 transient,	 non-genetic	 nature	 of	 their	multidrug	 tolerance	 (Keren	 et	 al.,	 2004a;	 Lewis,	 2010;	 Bigger,	 1944).	Notwithstanding	that	persister	cells	display	a	slowly	growing	physiological	state,	it	 is	 becoming	 apparent	 that	 dormancy,	 as	 characterised	 as	 a	 complete	 yet	temporary	 cessation	 of	 cellular	 functions,	 is	 not	 the	 best	 description	 of	 the	persister	 phenotype.	 Indeed,	 there	 may	 be	 considerable	 variation	 within	persister	populations	(Orman	&	Brynildsen,	2013a;	Roostalu	et	al.,	2008;	Nguyen	
et	al.,	2011).		
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The	first	inclination	to	this	effect	was	observed	in	2006.	At	the	time	it	was	hypothesised	 that	 dormant	 cells	 would	 have	 decreased	 protein	 synthesis.	 As	such,	the	authors	used	a	swiftly	degradable	Gfp	reporter	to	distinguish	between	bacteria	 that	were	 growing	 and	 those	 that	had	arrested	growth.	However,	 this	population	 of	 dim	 cells	was	 only	moderately	 enriched	 for	 persisters	 and	 there	were	 persister	 cells	 still	 being	 isolated	 from	 the	 bright	 population.	 This	suggested	that	not	all	dormant	cells	are	persisters	and	that	not	all	persisters	are	metabolically	 dormant	 (Shah	 et	 al.,	 2006;	 Gefen	 et	 al.,	 2008).	 This	 work	 was	corroborated	by	studies	showing	that	addition	of	certain	metabolites	alongside	aminoglycoside	 treatment	 lead	to	 the	eradication	of	persister	cells.	Here	 it	was	shown	 that	 the	 metabolites	 activated	 proton	 motive	 forces	 in	 the	 bacteria,	facilitating	 the	 uptake	 of	 the	 aminoglycosides.	 Once	 inside	 the	 cell	 the	aminoglycosides	were	then	able	to	kill	the	apparently	dormant	cells,	suggesting	that	 they	 were	 still	 metabolically	 active	 (Allison	 et	 al.,	 2011b;	 Orman	 &	Brynildsen,	 2013b).	 More	 recently	 in	 my	 lab,	 when	 studying	 the	 increase	 in	persister	formation	upon	macrophage	internalisation,	reported	that	a	proportion	of	 the	 dormant	 cells	 are	 responsive	 when	 induced	 to	 produce	 a	 fluorescent	protein	(Helaine	et	al.,	2014).	It	has	also	been	observed	that	different	antibiotics	isolate	 different	 proportions	 of	 persisters	 suggesting	 that	 factions	 of	 the	persister	 population	 have	 varying	 activity	 levels	 of	 different	 cellular	 processes	and	so	are	more	or	less	susceptible	to	different	classes	of	antibiotics	(Helaine	et	
al.,	2014;	Luidalepp	et	al.,	2011).	This	observation	could	be	linked	to	the	growing	evidence	 implicating	 different	 stress	 responses	 in	 the	 formation	 of	 persisters	(Dörr	et	al.,	2009;	Dörr	et	al.,	2010;	Helaine	et	al.,	2014;	Nguyen	et	al.,	2011).	It	is	
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reasonable	 to	 hypothesise	 that	 persisters	 formed	 in	 response	 to	 different	stresses	have	different	tolerances	(Allison	et	al.,	2011a).		
	
1.5	Toxin-Antitoxin	(TA)	modules		
1.5.1	The	hunt	for	persistence	genes		 Various	 genetic	 screens	 have	 been	 carried	 out	 in	 the	 hunt	 for	 persistence	genes.	 However,	 all	 failed	 to	 find	 genes	 that,	 when	 deleted,	 completely	 abolished	persister	 formation	(De	Groote	et	al.,	2009;	Hu	&	Coates,	2005;	Hansen	et	al.,	2008;	Spoering	et	al.,	2006).	This	suggests	that	there	may	be	more	than	one	gene	involved	in	persister	formation	and	that	there	may	be	a	high	level	of	redundancy	between	them.	The	first	genes	associated	with	the	persister	phenotype	were	on	the	locus	containing	the	hipA7	mutation	(Moyed	&	Bertrand,	1983),	termed	the	hip	 locus,	which	encodes	the	 Toxin-Antitoxin	 (TA)	 module	 HipBA	 (Moyed	 &	 Broderick,	 1986).	 TA	 modules	have	 been	 found	 in	 almost	 all	 free	 living	 bacteria,	 many	 archaea	 and	 even	 fungi	(Lewis,	2010;	Yamaguchi	et	al.,	2011).		They	are	encoded	on	bicistronic	operons	and	consist	of	 a	 stable	 toxin	protein,	which	 subverts	an	essential	 cellular	 target	 causing	growth	arrest	or	cell	death,	and	an	RNA	or	proteinaceous	antitoxin,	which	precludes	toxin	 activity.	 It	 is	 this	 capacity	 for	 transient	 toxin	 activity	 that	 makes	 them	interesting	suspects	as	they	could	cause	the	tell-tale	transient	growth	arrest	seen	in	persister	cells.		The	 first	 TA	 module	 was	 discovered	 on	 the	 E.	 coli	 F	 plasmid	 when	 the	bicistronic	ccdAB	locus	was	shown	to	be	essential	for	plasmid	stability.	In	this	system,	plasmid-free	daughter	cells	are	swiftly	eradicated	by	the	stable	CcdB	toxin	when	the	protection	 of	 the	 labile	 CcdA	 antitoxin	 diminishes	 (Ogura	 &	 Hiraga,	 1983).	
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Consequently	 TA	 modules	 were	 initially	 only	 thought	 of	 as	 plasmid	 addiction	modules.	However,	it	is	now	known	that	most	TA	modules	are	chromosomal	(Sberro	
et	 al.,	 2013)	 further	 suggesting	 a	 function	 beyond	 simple	 maintenance	 of	 mobile	genetic	 elements.	 Moreover,	 the	 evidence	 linking	 TA	 modules	 to	 the	 persister	phenotype	suggests	 that	most	TA	modules	do	not	kill	 the	bacteria	but	 render	 them	dormant	(Pedersen	et	al.,	2002).		Since	the	initial	discovery	linking	HipBA	to	persisters	many	more	TA	modules	have	been	 identified	as	being	 involved	 in	 this	phenomenon.	Methods	such	as	 single	cell	 sorting,	 using	 fluorescent	 reporter	 plasmids	 to	 distinguish	 between	 active	 and	inactive	cells,	or	antibiotic	 lysis	of	 the	growing	population	can	be	used	to	enrich	for	the	 persistent	 bacteria.	 Using	 these	 methods	 two	 studies	 have	 examined	 the	transcriptome	of	persisters	and	showed	that	the	mRNA	levels	of	a	number	of	Type	II	TA	modules	were	increased	in	these	cells	compared	to	both	growing	and	stationary	cells	(Keren	et	al.,	2004b;	Shah	et	al.,	2006).	In	recent	years	there	has	been	a	surge	in	the	identification	of	novel	TA	modules	and	with	it	an	increase	in	the	evidence	linking	them	 to	persister	 formation.	Many	groups	have	 shown	direct	 association,	 reporting	that	over-expression	of	the	toxin	component	of	a	predicted	TA	module	results	 in	an	increase	 in	persister	 formation	and	 that	 subsequent	over-expression	of	 the	 cognate	antitoxin	 counteracts	 this	 persister	 formation	 increase	 (Keren	 et	 al.,	 2004b;	Maisonneuve	et	al.,	2011;	Vazques-Laslop	et	al.,	2006).	Intriguingly,	there	have	been	a	few	studies	that	suggest	that	deletion	of	a	single	 TA	module	 can	 result	 in	 a	 noticeable	 decrease	 in	 persister	 formation	 in	response	to	a	specific	stress.	This	poses	the	possibility	that	there	is	not	complete	redundancy	 between	 genes	 associated	 with	 persistence	 and	 there	 may	 be	individual	TA	modules	principally	involved	in	persister	formation	in	reaction	to	
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specific	stresses.	For	example,	 it	has	been	shown	that	deletion	of	the	Type	I	TA	module	 tisBA	 resulted	 in	 a	 reduction	 in	 persister	 formation	 in	 reaction	 to	activation	 of	 the	 SOS	 response	 by	 ciprofloxacin	 treatment	 (Dörr	 et	 al.,	 2010).	Similarly,	 the	 Type	 II	 TA	 module	 DinJ-YafQ	 has	 been	 identified	 as	 being	necessary	 for	E.	 coli	 persister	 formation	 in	 biofilms.	Here	 it	was	 reported	 that	deletion	of	E.	coli	yafQ	resulted	in	reduced	persister	formation	in	cells	engaged	in	biofilms,	however,	they	saw	no	discernable	decrease	in	the	number	of	persisters	formed	 in	 planktonic	 or	 stationary	 phase	 cells	 (Harrison	 et	 al.,	 2009).	Furthermore,	my	lab	has	shown	that	single	deletions	of	14	Type	II	TA	modules	in	
Salmonella	 resulted	 in	 varying	 though	 significant	 decreases	 in	 persister	formation	in	response	to	internalisation	by	macrophages	(Helaine	et	al.,	2014).		
1.5.2	Types	of	TA	modules	 		 	There	are	currently	five	classes	of	TA	module	(Figure	2).	These	are	based	on	the	structure	of	the	antitoxin	and	its	mode	of	toxin	neutralisation.	In	all	cases	the	antitoxins	are	co-transcribed	with	their	toxin	counterpart	and	the	TA	module	is	 ‘activated’	 upon	 degradation	 of	 the	 cognate	 antitoxin,	 either	 at	 the	 RNA	 or	protein	level.	
1.5.2.1	Type	I	TA	modules	The	antitoxins	encoded	 for	by	 type	 I	TA	 loci	 are	 small	 regulatory	RNAs,	which	are	antisense	 to	 the	 toxin	mRNA.	Upon	 transcription,	 the	antisense	RNA	antitoxin	 binds	 to	 the	 toxin	mRNA	 thereby	 inhibiting	 ribosome	binding	 and	 in	some	 occurrence	 leading	 to	 RNase	 III	 dependent	 degradation	 of	 the	 toxin-antitoxin	RNA	duplex	(Figure	2A)	(Gerdes	et	al.,	1986;	Thisted	et	al.,	1994;	Van	Melderen	&	Saavedra	De	Bast,	2009;	Fozo	et	al.,	2008;	Kawano,	2012;	Dörr	et	al.,	
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2010).	 Type	 I	 TA	 toxins	 that	 have	 been	 linked	 to	 persister	 formation,	 such	 as	HokB	 and	TisB,	 are	 typically	 small	 hydrophobic	 proteins	 that,	 upon	 activation,	form	membrane	pores	 (Gurnev	et	al.,	 2012;	Dörr	et	al.,	 2010).	There	are	other	well	 described	 examples,	 such	 as	 SymER	 which	 is	 a	 ribonuclease	 involved	 in	recycling	of	damaged	RNAs	in	response	to	SOS	activation	(Kawano	et	al.,	2007).	
1.5.2.2	Type	II	TA	modules	The	 antitoxin	 genes	 of	 type	 II	 TA	 modules	 encode	 a	 protein.	 During	exponential	 growth,	 the	 antitoxin	 binds	 to	 and	 neutralizes	 its	 cognate	 toxin.	Another	 highly	 conserved	 method	 of	 toxin	 regulation	 by	 type	 II	 antitoxins	 is	auto-regulation	 of	 their	 expression.	Here,	 the	 antitoxins	 have	 one	 of	 four	DNA	binding	 domains	 at	 the	 N-terminal	 region,	 HTH,	 RHH,	 AbrB	 or	 Phd/YefM,	through	 which	 they	 bind	 their	 own	 promoter	 region,	 repressing	 the	transcription	of	the	operon	(Gerdes	et	al.,	2005).	Often	the	tightly	formed	toxin-antitoxin	 complex	 binds	 the	 promoter	 more	 avidly	 than	 the	 antitoxin	 alone	(Figure	2B)	(Yamaguchi	&	Inouye,	2011).	Upon	activation	type	II	toxins	act	on	a	variety	of	targets.	The	toxins	can	be	grouped	into	sub-families	based	on	the	process	they	target.	Group	I	toxins	inhibit	DNA	replication	(Loris	et	al.,	1999;	Dao-Thi	et	al.,	2005;	Jiang	et	al.,	2002;	Harms	
et	al.,	2015).	Group	II	 includes	toxins	that	inhibit	protein	translation	by	various	modes,	 including	 ribosome-dependent	 and	 independent	 mRNA	 degradation	(Galvani	et	al.,	 2001;	Christensen	et	al.,	 2001;	Christensen-Dalsgaard	&	Gerdes,	2008),	degradation	of	 tRNA	(Winther	&	Gerdes,	2011),	 inhibition	of	elongation	(Castro-Roa	 et	 al.,	 2013)	 and	 inhibition	 of	 tRNA	 synthetases	 (Germain	 et	 al.,	2013).	Group	III	toxins	inhibit	cell	wall	synthesis	(Mutschler	et	al.,	2011).	
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1.5.2.3	Type	III	TA	modules		 The	antitoxins	of	type	III	TA	modules	are	small	RNAs,	which	contain	short	tandem	repeats	of	the	toxin	sequence.	Three	antitoxin	RNAs	form	a	pseudoknot	which	 then	 bind	 three	 toxin	 proteins	 forming	 trimeric	 RNA-protein	 complex	(Figure	2C)(Blower	et	al.,	 2011).	 In	 this	group	 the	 toxin	encodes	a	highly	 toxic	ribonuclease,	which	upon	activation	reportedly	 leads	 to	cell	death	or	cell	 statis	(Fineran	et	al.,	2009;	Samson	et	al.,	2013).	There	are	three	families	of	type	III	TA	module	based	of	 structural	 homology;	 these	 are	ToxIN,	TempIN	and	CptIN.	All	three	have	 tertiary	 folds	 related	 to	 that	 of	 the	MazF	 family	 and	 are	 thought	 to	play	a	role	in	phage	protection	(Blower	et	al.,	2012).	
1.5.2.4	Type	IV	TA	modules	There	 is	 one	 described	 type	 IV	 TA	module,	 CbeA-CbtA.	 In	 this	 instance,	the	 antitoxin,	 CbeA,	 neutralises	 CbtA	 by	 interacting	 directly	 with	 its	 cellular	targets	rather	than	forming	a	complex	with	the	toxin	itself	(Figure	2D)	(Masuda	
et	al.,	2012).	When	released	CbtA	inhibits	growth	by	interfering	with	cell	division	(Tan	et	al.,	2011).		
1.5.2.5	Type	V	TA	modules	The	 type	 V	 TA	 module	 group	 also	 contains	 only	 one	 characterised	member.		In	this	class	of	TA	module	the	antitoxin,	GhoS,	is	an	endoribonuclease	that	cleaves	specifically	the	mRNA	of	its	cognate	toxin	ghoT	(Figure	2E)	(Wang	et	
al.,	2012).		With	 the	 increasing	 number	 of	 sequenced	 bacterial	 genomes	 and	 ever	improving	analysis	tools	it	is	expected	that	more	TA	modules	will	be	discovered	and	 there	 may	 have	 to	 be	 revisions	 to	 the	 current	 classification	 system.	 For	
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example,	 Aakre	 et	 al	 described	 a	 novel	 TA	 module	 in	 Caulobacter	 cresentus,	SocAB.	In	this	example	the	antitoxin	SocA	neutralises	SocB	toxicity	by	acting	as	a	proteolytic	adapter	for	the	cellular	protease	ClpXP	facilitating	SocB	degradation	(Aakre	 et	 al.,	 2013).	 This	 mode	 of	 neutralisation	 does	 not	 fit	 into	 any	 of	 the	current	classifications	and	so	could	constitute	a	novel	class	of	TA	module.																					
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Figure	2:	TA	module	modes	of	action.	Adapted	from	Wen	et	al.,	2014.	
1.5.3	Conditional	cooperativity	Notwithstanding	 the	 differences	 between	 the	 families	 of	 type	 II	 TA	modules	and	their	independent	evolutionary	origins,	their	regulation	and	genetic	organization	 are	 remarkably	 similar.	 As	 previously	 stated,	 they	 invariably	
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consist	 of	 two	 closely	 linked	 genes,	 usually	 encoded	 antitoxin	 –	 toxin,	 and	 the	constitutive	expression	of	the	TA	operon	is	repressed	by	its	cognate	TA	complex.	Another	seemingly	conserved	trait	of	type	II	TA	modules	is	the	phenomenon	of	conditional	 cooperativity.	 This	 is	 a	 form	 of	 transcriptional	 regulation	 that	 has	been	 described	 only	 in	 these	TA	modules.	 In	 this	mechanism	 the	 toxin	 acts	 as	both	 a	 co-	 and	 de-repressor	 of	 transcription	 depending	 on	 the	 ratio	 of	 T:A	(Overgaard	et	al.,	2009).	For	example	when	 the	 intracellular	 ratio	of	 the	RelBE	TA	module	 is	2:1	 (antitoxin	 to	 toxin),	 they	 form	a	stable	heteromeric	structure	that	 binds	 the	 RelO	 operator	 avidly.	 When	 RelE	 is	 in	 excess	 of	 RelB,	 due	 to	degradation	of	the	antitoxin,	it	causes	a	partial	de-repression	of	RelO	leading	to	increased	transcription	of	the	loci	(Figure	3)(Overgaard	et	al.,	2008).		Conditional	 cooperativity	 permits	 the	 TA	 modules	 to	 control	 the	bistability	exhibited	in	the	persister	phenotype,	where	the	cell	can	readily	switch	between	the	antitoxin-dominated	state,	allowing	growth,	or	the	toxin-dominated	state	of	growth	inhibition	(Cataudella	et	al.,	2013).	It	has	been	described	in	many	TA	loci	including	relBE,	ccdAB,	vapBC,	phd-doc	and	kid-kis	(Overgaard	et	al.,	2008;	Afif	et	al.,	2001;	Winther	&	Gerdes,	2012;	Magnuson	&	Yarmolinsky,	1998;	Monti	
et	 al.,	 2007).	 This	 stoichiometric	 auto-regulation	 is	 proposed	 to	 enable	 swift	entry	 into	 and	 exit	 from	 the	 persister	 state.	 This	mechanism	 also	 protects	 the	cells	 from	 accidental	 ‘activation’	 of	 the	 TA	 module	 in	 non-starved	 conditions.	Here	 the	 increase	 in	 transcription	 caused	by	destabilisation	of	 the	TA	complex	will	 result	primarily	 in	 the	production	of	 the	antitoxin,	 re-equilibrating	 the	T:A	ratio	(Cataudella	et	al.,	2012).			
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Figure	 3:	 Conditional	 cooperativity.	 When	 the	 ratio	 of	 toxin	 to	 antitoxin	 is	 stable	 the	 two	proteins	form	a	complex,	which	tightly	binds	the	TA	promoter	repressing	transcription.	Here	the	toxin	is	acting	a	co-repressor	of	transcription	and	the	bacteria	grow	(A).		Should	the	antitoxin	be	degraded,	this	will	lead	to	an	excess	of	the	toxin.	Here	the	toxin	then	destabilises	the	TA	complex	acting	as	a	de-repressor	of	transcription.	Any	antitoxin	produced	will	be	swiftly	degraded	leading	to	a	rapid	production	of	toxin	proteins	and	growth	inhibition	(B).		
1.5.4	Toxin	functions		 As	mentioned,	many	 of	 the	 TA	modules	 have	 independent	 evolutionary	origins,	for	this	reason	it	is	not	surprising	that	the	toxins	inhibit	growth	by	many	different	functions.	Indeed	the	myriad	of	approaches	that	have	evolved	to	inhibit	a	number	of	cellular	processes	is	quite	astounding.		
1.5.4.1	Disruption	of	membrane	potential		 Two	 well-characterised	 toxins	 that	 disrupt	 membrane	 potential	 are	components	of	type	I	TA	modules,	Hok	and	TisB	(Gerdes	&	Bech,	1986;	Unoson	&	Wagner,	 2008;	 Dörr	 et	 al.,	 2010).	 Both	 encode	 small,	 hydrophobic,	 positively	charged,	membrane	associating	peptides.	Upon	activation,	 they	are	reported	 to	form	 membrane	 pores,	 which	 disrupt	 the	 proton	 motive	 force	 reducing	
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membrane	 potential	 (Gerdes	 &	 Bech,	 1986;	 Unoson	 &	Wagner,	 2008).	 This	 in	turn	 leads	 to	 a	 decrease	 in	ATP	 synthesis	 (Maloney	et	al.,	 1974)	 resulting	 in	 a	global	reduction	of	cellular	processes	and	an	increase	in	persistence	(Unoson	&	Wagner,	2008;	Dörr	et	al.,	2010;	Verstraeten	et	al.,	2015).	The	toxin	component	of	 the	 one	 type	 V	 TA	 module	 group	 has	 also	 been	 shown	 to	 interfere	 with	membrane	 potential.	 GhoT,	 encodes	 a	 membrane	 lytic	 protein	 which,	 when	released,	leads	to	an	increase	in	persister	formation	with	cells	exhibiting	a	‘ghost’	like	cell	phenotype	 (Wang	et	al.,	2012).	 	The	exact	mode	of	action	 is	unknown,	however,	it	is	thought	that	GhoT	functions	in	a	similar	manner	to	Hok	and	TisB.		
1.5.4.2	Inhibition	of	cell	wall	synthesis	and	cell	division		 ξ-ζ	 TA	modules	 are	 members	 of	 the	 group	 III	 type	 II	 TA	modules.	 The	archetype	of	this	group	of	TA	module	is	PezAT,	which	has	been	shown	to	inhibit	growth	by	phosphorylation	of	uridine	diphosphate-N-acetylglucosamine	(UNAG)	(Seok	et	al.,	2007;	Mutschler	et	al.,	2011).	This	leads	to	inhibition	of	the	enzyme	MurA,	which	catalyses	the	first	step	of	peptidoglycan	synthesis	(Barreteau	et	al.,	2008;	Mutschler	et	al.,	2011).	Activation	of	CbtA,	the	toxin	component	of	the	sole	member	of	type	IV	TA	module	group,	has	also	been	reported	to	result	in	aberrant	cell	 morphology.	 It	 directly	 interacts	 with	 both	 MreB	 and	 FtsZ,	 which	 are	essential	 for	 cell	 division.	 By	 directly	 interfering	with	 its	 targets,	 CbtA	 inhibits	the	polymerisation	of	both	MreB	and	FtsZ	(Tan	et	al.,	2011).		
1.5.4.3	Inhibition	of	DNA	replication		 There	 are	 a	number	of	TA	modules	 that	 target	DNA	 replication	 thereby	inhibiting	cell	growth,	all	of	which	have	evolved	individual	methods	of	doing	so.	The	toxin	CcdB,	has	been	shown	to	inhibit	DNA	synthesis	by	interaction	with	the	
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GyrA	 subunit	 of	 DNA	 gyrase	 (Bernard	 &	 Couturier,	 1992).	 The	 GyrA	 subunit	contains	the	catalytic	domain	and	requires	dimerization	to	function.	CcdB	binds	directly	 the	GyrA	dimerization	domain,	 leading	 to	 inhibition	of	 typical	 function	and	 results	 in	 CcdB	 mediated	 double	 stranded	 DNA	 breaks	 and	 subsequent	activation	of	the	SOS	response	(Bernard	&	Couturier,	1992;	Dao-Thi	et	al.,	2005;	Bahassi	et	al.,	1999).	Similarly	to	CcdD,	ParE	also	 interacts	with	GyrA	to	 inhibit	DNA	 replication	 (Jiang	 et	 al.,	 2002).	 Furthermore,	 ParE	mediated	 inhibition	 of	GyrA	results	in	activation	of	the	SOS	response	(Yuan	et	al.,	2011).	However,	ParE	homologues	of	Vibrio	cholera	are	reported	to	require	ATP	to	inhibit	GyrA	activity	and	inhibit	DNA	supercoiling.	Moreover,	ParE	binds	residues	distinct	to	those	of	CcdB	suggesting	that	ParE	 inhibits	DNA	replication	 in	a	novel	manner	(Yuan	et	
al.,	2010).	A	recent	study,	which	described	the	TA	module	FicTA,	reported	that	FicT	inhibited	both	DNA	gyrase	and	Topoisomerase	IV	activity.	This	inhibition	of	DNA	 gyrase	 is	 reported	 to	 be	 the	 primary	 mode	 of	 growth	 arrest	 and	 was	separate	 again	 to	CcdB	 and	ParE	 as	 it	 is	 affected	 through	 adenylation	 of	 the	B	subunit,	 GyrB	 (Harms	 et	 al.,	 2015).	 SocB,	 of	 the	 recently	 described	 SocAB	 TA	module	in	Caulobacter	crecentus,	inhibits	DNA	replication	through	binding	of	the	β-sliding	 clamp,	 DnaN.	 Here	 it	 competes	 with	 DNA	 Polymerase	 III	 to	 interact	with	 DnaN	 resulting	 in	 a	 block	 in	 both	 leading	 and	 lagging	 strand	 synthesis	(Aakre	et	al.,	2013).	
1.5.4.4	Inhibition	of	protein	translation			 There	are	many	steps	 in	 the	 translation	process	 that	can	be	 interrupted	resulting	in	inhibition	of	protein	synthesis.	TA	modules	have	evolved	numerous	functions	and	modes	of	action	to	 interfere	with	almost	every	stage.	 Indeed,	 the	
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increasing	wealth	of	 information	regarding	different	homologues	of	TA	module	families,	 discussed	 bellow,	 is	 beginning	 to	 highlight	 the	 variation	within	 them,	further	emphasising	the	need	to	functionally	characterise	individual	modules.		
1.5.4.4.1	Endoribonucleases	Degradation	of	mRNA	can	lead	to	both	global	inhibition	of	translation	and	inhibition	of	translation	of	specific	mRNA	transcripts.	This	degradation	can	occur	in	either	a	ribosome-dependent	or	independent	manner.	
1.5.4.4.1.1	Ribosome	independent		 MazF	 is	 a	well-characterized	 toxin	 of	E.	coli.	 Canonically	MazF	 acts	 as	 a	ribosome-independent	mRNase,	cleaving	mRNA	substrates	at	ACA	(Christensen-Dalsgaard	 &	 Gerdes,	 2008)	 or	 UACAU	 sites	 (Zhu	 et	 al.,	 2009;	 Schuster	 et	 al.,	2013).	However,	 recent	 studies	 show	 that	 this	 strict	 specificity	 and	 function	 is	not	 true	 of	 all	 MazF	 homologues.	Mycobacterium	 tuberculosis	 has	 three	 MazF	homologues	with	unique	functions.	MazF-mt6	has	been	shown	to	digest	mRNA	at	UUCCU	sequences,	more	specifically	cleaving	M.	tuberculosis	23s	rRNA	at	a	single	UUCCU	site	 in	 the	ribosome	active	centre	(Schifano	et	al.,	2013),	MazF-mt7	has	been	shown	to	interact	with	the	M.	tuberculosis	DNA	Topoisomerase	I	(Huang	&	He,	 2010)	 and	 MazF-mt9,	 which	 has	 been	 shown	 to	 hydrolyse	 tRNA	 modules	(Schifano	 et	 al.,	 2016).	 Notably,	M.	 tuberculosis	 also	 harbours	 five	 other	 MazF	proteins,	 four	 of	 which	 target	 the	 more	 canonical	 three	 –	 five	 base	 pair	sequences	 (Zhu	 et	 al.,	 2006,	 2008).	 Another	 ribosome-independent	 RNase	 is	HicA.	 HicA	 degrades	 tmRNA	 at	 two	 AAAC	 sites,	 inhibiting	 ribosome	 rescue,	 as	well	as	 inhibiting	global	 transcription	by	 free	mRNA	degradation	 (Jørgensen	et	
al.,	2009).	Interestingly,	E.	coli	toxin	YoeB	has	been	shown	to	cleave	free	mRNA,	
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specifically	 lpp	 transcripts,	 in	vitro	 as	well	 as	having	 the	 capacity	 for	 ribosome	associated	 A	 site	 cleavage	 of	mRNA	 in	 vivo	 (Christensen	 et	 al.,	 2004;	 Zhang	 &	Inouye,	2009)	.		
1.5.4.4.1.2	Ribosome	dependent	RelBE	 is	 one	 of	 the	 most	 extensively	 studied	 type	 II	 TA	 modules.	 Like	YoeB	 it	 is	 a	 ribosome-dependent	mRNase.	Upon	 release	 from	RelB,	RelE	 binds	tightly	 to	 the	 16S	 rRNA,	 at	 the	 ribosome	 A	 site	 (Pedersen	 et	 al.,	 2003).	 Here	residue	Y87	of	RelE	and	16S	 rRNA	of	 the	 ribosome	work	 together	 to	orientate	the	substrate	mRNA	correctly	to	cleave	after	the	second	nucleotide	in	the	A-site	(Neubauer	et	al.,	2009),	efficiently	blocking	translation.	Though	this	is	the	most	commonly	reported	mode	of	RelE	action,	RelE	toxins	have	also	been	reported	to	cleave	tmRNA	(Christensen	&	Gerdes,	2003).	Other	TA	module	toxins	have	been	described	as	structurally	and	functionally	similar	to	RelE	and	so	are	deemed	to	be	members	of	the	RelE-like	family.	These	include,	YafQ	toxins;	which	bind	to	the	50S	 ribosomal	 subunit	 and	 cleave	 specific	mRNA	 transcripts	 such	 as	 lpp,	acpP	and	hns	(Armalyte	et	al.,	2012)	and	HigB	toxins,	which	are	also	known	to	cleave	RNA	in	association	with	the	ribosome	(Christensen-Dalsgaard	et	al.,	2010).	
1.5.4.4.2	PIN	domain	nucleases		 VapBC	TA	modules	are	highly	abundant	and	there	are	frequently	multiple	paralogs	found	in	bacterial	genomes,	such	as	M.	tuberculosis,	which	harbours	40	(Pandey	&	Gerdes,	2005;	 Jørgensen	et	al.,	2009).	The	toxic	protein	VapC	shares	sequence	identity	with	the	eukaryotic	PIN	domain,	which	is	normally	associated	with	ribonuclease	activity.	Again,	various	modes	of	activity	have	been	described	for	 different	 homologues	 of	 VapC.	 VapC-mt4	 of	 M.	 tuberculosis	 inhibits	
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translation	 by	 binding	 ssRNA	 as	 opposed	 to	 cleaving	 it	 (Sharp	 et	 al.,	 2012).	VapC20	 of	M.	tuberculosis	was	 shown	 to	 cleave	 23S	 rRNA	 in	 a	 prominent	 loop	region	 (Winther	 et	 al.,	 2013)	 and	 the	 single	 VapC	 homologue	 in	M.	 smegmatis	exhibits	 RNase	 activity,	 cleaving	AUAU	 and	AUAA	 sites.	 Overexpression	 of	 this	toxin	 results	 in	 differential	 expression	 of	 almost	 3%	 of	 the	 genome,	 with	 the	most	 striking	 differences	 being	 the	 down-regulation	 in	 genes	 related	 to	carbohydrate	metabolism	(McKenzie	et	al.,	 2012).	 In	S.	Typhimurium	 the	VapC	toxin	 specifically	 targets	 initiator	 tRNA,	 cleaving	 it	 at	 the	 anticodon	 stem	 loop	(Winther	&	Gerdes,	2011;	Miallau	et	al.,	2009).	
1.5.4.4.3	Kinases	 	The	 Doc	 toxin	 of	 the	 TA	 module	 Phd-Doc	 was	 discovered	 on	 the	bacteriophage	 P1.	 Early	 research	 suggested	 that	 Doc	 worked	 to	 inhibit	translation	 by	 associating	 directly	 with	 the	 30S	 subunit	 of	 the	 ribosome	 thus	mimicking	the	effects	of	hygromycin	B	(Liu	et	al.,	2008).	However,	more	recent	evidence	 suggests	 a	 different	 mechanism	 of	 action	 for	 Doc.	 The	 Doc	 toxin	harbours	 a	 non-canonical	 Fic	 domain,	 which	 instead	 of	 conferring	 ampylation	activity,	begets	Doc	kinase	activity.	Doc	has	been	shown	to	inhibit	translation	by	phosphorylating	the	elongation	 factor	EF-Tu	on	residue	T382,	 inhibiting	binding	and	thus	transfer	of	aatRNA	to	the	ribosomal	A	site.	Interestingly,	it	was	initially	hypothesised	 that	 HipA	 phosphorylated	 EF-Tu	 (Schumacher	 et	 al.,	 2009).		However,	 recent	studies	have	refuted	 this	evidence	showing	 that	HipA	actually	phosphorylates	Glutamyl	tRNA	synthetase	(GltX)	at	residue	S239	inhibiting	tRNA	amino	 acylation,	which	 leads	 to	 a	 build	 up	 of	 uncharged	 tRNA	 (Germain	 et	al.,	2013;	Kaspy	et	al.,	2013).	
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Figure	 4:	 TA	 modules	 and	 translation.	 TA	 modules	 can	 interfere	 with	 translation	 in	 many	ways,	 including	 1.	 Cleavage	 of	 free	mRNA	 transcripts	 (MazF,	 HicA,	 VapC,	 YoeB)	 2.	 Cleavage	 of	ribosomal	rRNA	(MazF-mt6,	VapC20)	3.	Cleavage	of	ribosome-associated	mRNA	(RelE,	YoeB)	4.	Cleavage	 of	 tRNA	 (MazF-mt9,	 VapC)	 5.	 Cleavage	 of	 tmRNA	 (RelE,	 HicA)	 6.	 Inhibition	 of	 tRNA	aminoacylation	(HipA)	7.	Inhibition	of	elongation	(Doc).	Adapted	from	Bertram	&	Schuster	2014.		
1.5.5	TA	modules	and	molecular	mechanisms	of	persister	formation		 TA	 modules	 have	 been	 reported	 to	 respond	 to	 various	 environmental	stresses,	 including	 starvation	 (Maisonneuve	 et	 al.,	 2011;	 Christensen	 et	 al.,	2003),	low	pH	(Heaton	et	al.,	2012),	SOS	response	(Dörr	et	al.,	2010)	and	quorum	sensing	(Leung	&	Lévesque,	2012).	It	is	well	established	that	activation	of	type	II	TA	 modules	 occurs	 via	 Lon-	 or	 Clp-dependent	 degradation	 of	 the	 antitoxin	proteins	in	vitro	(Christensen	et	al.,	2001,	2003;	Melderen	et	al.,	1996;	Aizenman	
et	al.,	1996;	Cherny	&	Gazit,	2004;	Lehnherr	&	Yarmolinsky,	1995).	Furthermore,	deletion	of	 lon	 resulted	 in	an	almost	complete	abolishment	of	 intramacrophage	persister	formation	in	Salmonella	(Helaine	et	al.,	2014).		As	previously	described,	
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during	 nutritional	 stress,	 stringent	 response	 is	 activated	 resulting	 in	 RelA	 or	SpoT-mediated	accumulation	of	the	alarmone	ppGpp.	This	leads	to	an	increase	in	the	inorganic	phosphate	PolyP,	which	in	turn	activates	Lon	(Kuroda	et	al.,	1997,	2001)	leading	to	degradation	of	the	type	II	TA	module	antitoxins	(Christensen	et	
al.,	2001,	2003;	Melderen	et	al.,	1996).	Until	recently,	however,	little	was	known	on	how	the	remaining	classes	were	activated.	A	recent	study	has	implicated	the	ubiquitous	and	multi-functional	cellular	GTPase,	Obg,	 in	the	activation	of	 type	I	TA	modules	(Verstraeten	et	al.,	2015).	 	Obg	has	been	shown	to	couple	DNA	and	protein	 synthesis	 (Berthon	 et	 al.,	 2009)	 in	 reaction	 to	 stringent	 response	activation,	by	regulating	ppGpp	levels	by	promoting	hydrolysis	by	SpoT	(Buglino	
et	al.,	2002;	 Jiang	et	al.,	2007).	 In	 this	study,	Obg	mediates	persistence	 through	activation	of	HokB	(Verstraeten	et	al.,	2015).		Interestingly,	with	the	discovery	of	the	true	mode	of	HipA	toxicity,	it	was	identified	that	HipA	acted	as	a	global	activator	of	TA	modules	in	E.	coli	(Germain	
et	 al.,	 2013;	 Kaspy	 et	 al.,	 2013;	 Germain	 et	 al.,	 2015).	 As	 mentioned,	 HipA-mediated	inhibition	of	GltX	leads	to	a	build	up	of	uncharged	tRNA,	which,	when	bound	 to	 the	ribosome,	 trigger	stringent	 response	via	RelA-mediated	synthesis	of	ppGpp	(Potrykus	&	Cashel,	2008).	 It	was	reported	that	ectopic	expression	of	HipA	resulted	in	a	concomitant	increase	in	ppGpp	levels,	which	in	turn	leads	to	the	activation	of	the	remaining	TA	modules	(Germain	et	al.,	2013).	Indeed,	it	was	observed	 that	 the	 additional	 TA	 modules	 within	 E.	 coli	 are	 critical	 for	 HipA	induced	persistence	(Germain	et	al.,	2015).	
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1.5.6	TA	modules	as	multi-level	interaction	system	The	work	with	HipA	highlights	the	interactions	between	the	different	TA	modules	within	a	bacterium,	suggesting	they	may	act	together	to	form	persisters.	Indeed,	this	phenomenon	of	inter-activation	of	TA	modules	has	been	reported	in	other	studies.	MqsR,	the	toxin	component	of	type	II	TA	module	MqsR/MqsA,	is	an	mRNase	 that	 cleaves	 GCU	 sites	 (Yamaguchi,Park	 &	 Inouye,	 2009).	 It	 has	 been	shown	to	lead	to	the	activation	of	type	V	TA	module	GhoST	by	enriching	for	ghoT	mRNA,	which	does	not	contain	the	MqsR	digestion	site	(Wang	et	al.,	2012,	2013).	Furthermore,	similar	abilities	have	been	attributed	to	many	mRNases,	which	can	activate	other	TA	modules	via	degradation	of	 the	 cognate	antitoxin	mRNA.	For	example,	many	MazF	cleavage	 sites	are	 found	 in	 the	antitoxin-coding	 region	of	the	 mRNA	 for	 relBE.	 The	 resulting	 cleavage	 products	 remain	 translationally	functional,	 leading	 to	an	 increase	 in	production	of	 the	 toxin	 that	 in	 turn	would	cause	a	tipping	in	the	balance	of	the	T:A	ratio	(Kasari	et	al.,	2013).	In	this	same	study	it	was	reported	that	the	RelBE	operon	was	critical	for	MazF	activation.		There	 is	 also	 evidence	 to	 suggest	 that	 TA	 modules	 are	 involved	 in	 the	regulation	 of	 other	 global	 cellular	 processes.	 Interestingly,	 MqsR	 stands	 for	motility	quorum-sensing	regulator	and	was	first	discovered	as	a	global	mediator	of	biofilm	formation	through	Autoinducer	2	(Gonzalez	Barrios	et	al.,	2006).	MqsR	has	 also	 been	 shown	 to	 regulate	 RelBE	 and	 Hok-Sok,	 which	 are	 reportedly	necessary	for	its	toxicity.	Likewise,	it	has	been	linked	to	regulation	of	the	cellular	proteases	Lon	and	Clp	and	other	stress	related	toxins	such	as	CspD	(Kim	et	al.,	2010;	Kim	&	Wood,	2010).	 Furthermore,	 in	S.	aureus	MazF	has	been	 shown	 to	regulate	virulence	factors	such	as	the	pathogenic	adhesive	factor	SraP,	which	is	unusually	 laden	with	 specific	MazF	 cut	 sites	 (Zhu	 et	al.,	 2009).	 Together	 these	
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studies	 demonstrate	 that	 TA	 modules	 may	 operate	 in	 complex	 regulatory	pathways	to	mediate	cell	responses	to	stress.	
1.5.7	TA	modules	of	Salmonella	 		 Previous	work	in	my	lab	has	focused	on	14	chromosomally	encoded,	type	II	TA	modules	in	S.	Typhimurium.	These	TA	modules	were	taken	from	the	TADB	website	 (http://202.120.12.135/TADB2/index.php),	which	 is	 a	 comprehensive,	integrated	 database	 of	 type	 II	 TA	 modules	 compiling	 BLASTP-predicted	 TA	modules,	 RASTA-Bacteria	 predicted	 TA	 modules	 and	 finally	 experimentally	validated	TA	modules	(Shao	et	al.,	2011).	Only	one,	VapBC,	has	been	functionally	characterised	(Winther	&	Gerdes,	2009,	2011).	Ten	of	the	remaining	TA	modules	can	 be	 grouped	 into	 known	 families	 based	 on	 sequence	 homology	 with	previously	characterised	E.	coli	TA	modules	(Yamaguchi	&	Inouye,	2011).	There	are	 six	 TA	modules	with	 homology	 to	 the	 relBE	 family;	 including	 one	 that	 has	been	partially	characterised	and	denoted	shpAB	(Slattery	et	al.,	2012),	one	parDE	homologue,	two	higBA	homologues	and	one	phd-doc	homologue.	The	remaining	three	 constitute	 a	 putative	 novel	 family	 of	 TA	 modules,	 where	 the	 toxin	component	 contains	 a	 predicted	 Gcn5	N-acetyltransferase	 (GNAT)	 domain.	 	 A	study	 that	 focused	 on	 identifying	 all	 type	 I	 and	 type	 II	 TA	 modules	 in	 S.	Typhimurium	strain	SL1344	later	reported	there	to	be	at	least	27	TA	modules	in	this	strain.	This	 included	20	 type	 II	TA	modules,	17	of	which	were	 found	to	be	chromosomal	(Lobato-Márquez	et	al.,	2015).		
1.5.8	TA	modules,	persistence	and	infection		 Evidence	 linking	 TA	 modules	 to	 intracellular	 survival	 is	 beginning	 to	amass.	 The	 first	 indication	 of	 the	 role	 of	 TA	 modules	 during	 infection	 was	
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reported	in	2009,	with	two	studies	showing	the	upregulation	of	genes	encoding	TA	 modules	 during	 macrophage	 infection	 (Korch	 et	 al.,	 2009;	 Ramage	 et	 al.,	2009).		Since	then	it	has	been	shown	that	some	TA	modules	are	required	for	the	colonisation	and	survival	of	uropathogenic	E.	coli	 and	Haemophilus	influenza	 in	animal	 infection	models	 (Norton	 &	Mulvey,	 2012;	 Ren	 et	 al.,	 2012;	 Ren	 et	 al.,	2014).	 Furthermore,	 work	 carried	 out	 previously	 in	 my	 lab	 reported	 that,	 in	
Salmonella,	 genes	 encoding	 14	 TA	 modules	 were	 upregulated	 upon	internalisation	 by	macrophages	 in	 a	 RelA-SpoT	 dependent	manner	 (Helaine	 et	
al.,	 2014).	 This	 was	 confirmed	 by	 a	 subsequent	 study	 that	 used	 mass	spectrometry	 to	 identify	 TA	 module	 proteins	 from	 Salmonella	 isolated	 from	fibroblasts	(Lobato-Márquez	et	al.,	2015).	More	directly,	we	showed	using	a	dual	fluorescence-reporter	 plasmid	 (Helaine	 et	 al.,	 2010),	 that	 over	 half	 of	 the	
Salmonella	 that	 are	 internalised	by	macrophages	enter	a	non-growing	 state.	Of	these	non-growing	bacteria	a	 large	proportion	remain	metabolically	active	and	some	 are	 capable	 of	 regrowth	 and	 reinfection.	 Moreover,	 in	 these	 infection	conditions,	 formation	 of	 persisters	 is	 increased	 100-1,000	 fold	 compared	 to	bacteria	grown	in	rich	medium	and	single	deletion	of	each	of	the	14	TA	modules	resulted	in	a	decrease	in	macrophage-induced	persister	formation	compared	to	a	wild-type	strain	(Helaine	et	al.,	2014).	Together	these	studies	strongly	implicate	TA	modules	as	key	regulators	of	persistence	during	infection	and	further	support	the	 notion	 that	 they	 are	 involved	 in	 persister	 cell-mediated	 recurrent	 and	chronic	infections.			 	
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1.6	GNATs	and	lysine	acetylation	in	prokaryotes		 GNATs	 are	 an	 important	 enzyme	 superfamily.	 Numerous	 genome-sequencing	 projects	 over	 the	 last	 decade	 have	 revealed	 upwards	 of	 10,000	members	 [http://supfam.mrc-lmb.cam.ac.uk/SUPERFAMILY].	 They	 are	universally	 distributed	 with	 diverse	 functions.	 Structural	 characterization	 of	several	members	 of	 the	 family	 has	 revealed	 a	 conserved	 fold	 at	 the	 active	 site	(Vetting	et	al.,	2005)	though	generally	they	share	little	sequence	homology.	GNAT	enzymes	catalyse	 the	acetylation	of	 target	proteins.	Acetylation	 is	characterised	 as	 the	 transfer	 of	 an	 acetyl	 group,	 usually	 from	 a	 donor	 carrier	such	as	Acetyl	Coenzyme	A	(Ac-CoA),	to	the	primary	amine	of	an	acceptor	amino	acid	 (Dyda	 et	 al.,	 2000).	 It	 can	 either	 occur	 co-	 or	 post-translationally.	 Co-translational	 acetylation	 occurs	 on	 the	 alpha	 amine	 group	 of	 the	 N-terminal	residue.	 It	 is	 an	 irreversible	 modification	 and	 is	 commonly	 referred	 to	 as	 N-terminal	acetylation.	N-terminal	acetylation	is	a	common	protein	modification	in	eukaryotic	 cells	 and	 is	 crucial	 for	 the	 regulation	 and	 function	 of	 different	proteins	 (Polevoda	 &	 Sherman,	 2000)	 but	 is	 rare	 in	 bacteria	 (Hentchel	 &	Escalante-Semerena,	 2015).	 Posttranslational	 acetylation	 occurs	 on	 the	 epsilon	amine	 group	 of	 lysine	 residues	 exposed	 on	 the	 proteins	 surface.	 This	posttranslational	 modification	 (PTM)	 is	 reversible	 through	 the	 action	 of	deacetylase	enzymes.	Until	recently,	acetylation	in	bacteria	was	thought	to	be	a	sparsely	utilised	modification	with	only	a	few	characterised	instances.	However,	it	is	now	known	to	be	ubiquitous,	with	85	lysine-acetylated	proteins	in	E.	coli	and	91	 in	 Salmonella.	 Approximately	 half	 of	 all	 of	 these	 proteins	were	 involved	 in	metabolism	(Yu	et	al.,	2008;	Zhang	et	al.,	2009)	and	the	remaining	were	involved	in	 diverse	 array	 of	 cellular	 functions,	 including	 transcription,	 translation	 and	
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regulating	growth	rate	(Yu	et	al.,	2008;	Lima	et	al.,	2011,	2012;	Wang	et	al.,	2010;	Weinert	et	al.,	2013).	However,	as	measures	were	taken	to	enrich	for	acetylated	peptides	 in	 these	experiments	 it	 is	unknown	whether	 the	ratio	of	acetylated	 to	unacetylated	 variants	 of	 each	 peptide	 is	 biologically	 significant	 or	 merely	 an	artefact	of	the	enrichment	selecting	for	randomly	acetylated	peptides.	The	 paradigm	 of	 reversible	 lysine	 acetylation	 in	 prokaryotic	 cells	 is	Pat/CobB-dependent	 modulation	 of	 Acetyl	 CoA	 synthetase	 (Acs),	 the	 enzyme	responsible	 for	 synthesis	 of	 Ac-CoA,	 in	 Salmonella	 (Starai,	 2002;	 Starai	 &	Escalante-Semerena,	2004).	Protein	acetyltransferase	Enzyme	(Pat)	is	a	member	of	the	GNAT	superfamily.	Pat	acetylates	Acs	on	Lys609	resulting	in	its	inactivation	(Starai	&	Escalante-Semerena,	2004).	CobB	is	described	as	a	homologue	of	a	Sir2	family	 of	 proteins	 (Tsang,	 1998).	 These	 are	 NAD+	 dependent	 protein	deacetylases	involved	in	chromosome	stability	and	gene	silencing	in	eukaryotes	and	archaea	(Bell,	2002).	CobB	deacetylates	AcsAc,	resulting	in	its	activation	and	a	 concomitant	 increase	 in	 Ac-CoA	 production	 (Starai,	 2002).	 In	 concert	 to	regulating	 Acs	 activity,	 Pat	 and	 CobB	 have	 recently	 been	 shown	 to	 regulate	global	levels	of	acetylation	and	in	doing	so	these	two	proteins	regulate	the	ability	of	the	bacteria	to	grow	on	a	variety	of	carbon	sources	(Wang	et	al.,	2010).		GNAT	 proteins,	 as	 part	 of	 a	 TA	module,	 have	 been	 identified	 in	 several	pathogenic	 bacterial	 species	 including	 Salmonella,	 Shigella,	 Pseudomonas,	
Mycobacterium	 and	 pathogenic	 E.	 coli	(http://202.120.12.135/TADB2/index.php).	This	link	to	pathogenic	bacteria	and	the	 abundance	 of	 evidence	 linking	 acetylation	 to	 growth	 state	 highlights	 the	compelling	nature	of	 this	novel	putative	TA	module	 family	and	emphasizes	 the	need	for	a	full	functional	characterization	of	the	them.		
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1.7	Aims	and	Objectives	The	 wealth	 of	 research	 implicating	 TA	 modules	 in	 the	 formation	 of	persisters	 and	 the	 work	 replicating	 this	 link	 in	 an	 infection	 setting	 further	emphasise	 the	 necessity	 to	 fully	 understand	 the	 molecular	 mechanisms	underlying	the	actions	of	TA	modules.		The	putative	novel	family	of	TA	modules	in	Salmonella,	as	previously	mentioned,	are	predicted	to	contain	a	GNAT	domain.	A	 previous	 study	 has	 reported	 that	 homologues	 of	 the	 GNAT	 TA	modules	 are	
bona	 fide	 TA	 modules	 (Lobato-Márquez	 et	 al.,	 2015),	 however,	 a	 complete	characterisation	has	yet	 to	be	carried	out.	 In	 this	PhD	I	aimed	to	 fully	describe	this	novel	family	of	TA	module.	This	was	achieved	by:			
• Confirming	they	were	bona	fide	TA	modules	by	determining	whether	they	were	 encoded	 for	 on	 bicistronic	 operons	 and	 showing	 transient	 growth	arrest	induced	by	toxicity	and	neutralisation	upon	over-expression	of	the	toxin	and	antitoxin.		
• Examination	 of	 the	 predicted	 acetyltransferase	 domain	 of	 the	 toxin	proteins	to	determine	whether	their	enzymatic	 function	was	 involved	 in	toxicity.	
• Investigation	 of	 the	 effects	 of	 over-expression	 of	 the	 toxin	 on	 cellular	processes	to	elucidate	a	possible	mode	of	action.	
• Determination	of	the	exact	target	and	mechanism	of	growth	arrest	by	this	novel	family.			
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Chapter	Two	
Materials	and	Methods	
2.1	Bacterial	strains,	plasmids	and	primers	Name	 Description	 Source	Wild-type	 12023	S.	Typhimurium	wild-type	 NTCC	
∆ta6	 12023	S.	Typhimurium	∆ta6::kan	 Helaine,	2014	
∆ta8	 12023	S.	Typhimurium	∆ta8::kan	 Helaine,	2014	
∆ta9	 12023	S.	Typhimurium	∆ta9::kan	 Helaine,	2014	
∆ta6∆ta8	 12023	S.	Typhimurium	∆ta6::cat∆ta8::kan	 This	study	
∆ta6∆ta9	 12023	S.	Typhimurium	∆ta6::cat∆ta9::kan	 This	study	
∆ta8∆ta9	 12023	S.	Typhimurium	∆ta8::kan∆ta9::cat	 This	study	
∆ta6∆ta8∆ta9	 12023	S.	Typhimurium	∆ta6::cat∆ta8::kan∆ta9	 This	study	
∆ta6∆cobB	 12023	S.	Typhimurium	∆ta6::kan∆cobB::cat	 This	study	
∆ta8∆cobB	 12023	S.	Typhimurium	∆ta8::kan∆cobB::cat	 This	study	
∆parDE	 12023	S.	Typhimurium	∆parDE::kan	 Helaine,	2014	TS-Pth	 12023	S.	Typhimurium	pthG101D::kan	 B.	Gollan	
Table	2.1:	S.	Typhimurium	12023	strains	
	 Name	 Description	 Source	DH5α	 E.	coli	DH5	α	 Invitrogen	PC2	 BL21(DE3)endA::TetR	T1R	pLysS	 Cherepanov,	2007	BL21-AI	 F-ompTgal	dcm	araB::T7RNAP-tetA	 Invitrogen	
Table	2.2:	E.	coli	strains	
	 Name	 Description	 Source	pNDM220	 R1	bla	lacIq	pA1/04/03	 Gotfredsen	&	Gerdes,	1998	pBAD33	 p15	cat	araC	PBAD	 Guzman,	1995	pBAD18	 pMB1	bla	araC	PBAD	 Guzman,	1995	pBR322	 pMB1	bla	 Bolivar,	1977	pKD46	 Plasmid	encoding	arabinose-inducible	λ	red	recombinase.	Temperature	sensitive;	retained	at	30	˚,	cured	at	≥37	˚C.	(bla)	 Datsenko	&	Wanner,	2000	pKD3	 Chloramphenicol	cassette	flanked	by	FLP	sites.	(cat)	 Datsenko	&	Wanner,	2000	pKD4	 Kanamycin	cassette	flanked	by	FLP	sites	(kan)	 Datsenko	&	Wanner,	2000	pCP20	 Plasmid	encoding	arabinose-inducible	FLP		recombinase.	Temperature	sensitive;	retained	at	30	˚,	cured	at	≥37	˚C.	(Amp)	 Datsenko	&	Wanner,	2000	pNT6	 pNDM220	Plac	::t6	 Mei	Leu	pNT8	 pNDM220	Plac	::t8	 This	work	pNT9	 pNDM220	Plac	::t9	 This	work	
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pNParE	 pNDM220	Plac	::parE	 Mei	Leu	pBA6	 pBAD33	PBAD::a6	 This	work	pBA8	 pBAD33	PBAD::a8	 This	work	pBA9	 pBAD33	PBAD::a9	 This	work	pBPthhis	 pBAD33	PBAD::pth::6His	 This	work	pBArgDhis	 pBAD33	PBAD::argD::6His	 This	work	pBArtJhis	 pBAD33	PBAD::artJ::6His	 This	work	pBT6	 pBAD33	PBAD::t6	 This	work	pBT8	 pBAD33	PBAD::t8	 This	work	pB18T8	 pBAD18	PBAD::t8	 This	work	pNT6A90P	 pNDM220	Plac	::t6A96P	 This	work	pNT6Y140F	 pNDM220	Plac	::t6Y141F	 This	work	pNT8A93P	 pNDM220	Plac	::t8A93P	 This	work	pNT8Y140F	 pNDM220	Plac	::t8Y140F	 This	work	pHISH::t8Y140F	 pET15b,	bla,	lacIQ,	T7::6His-T8Y140F	 M.	Pryzdacz	pRSFduet::ta8	 pRSFduet-1,	kan,	lacIQ,	T7::6His-T8,	T7::A8	 Novagen,	M.	Pryzdacz	pNT8K33E	 pNDM220	Plac	::t8K33E	 This	work	pNT8K36E	 pNDM220	Plac	::t8K36E	 This	work	pNT8R77E	 pNDM220	Plac	::t8R77E	 This	work	pNT8R78E	 pNDM220	Plac	::t8R78E	 This	work	pNT8R91E	 pNDM220	Plac	::t8R91E	 This	work	pNT8K146E	 pNDM220	Plac	::t8K146E	 This	work	pNT8R158E	 pNDM220	Plac	::t8R158E	 This	work	pNT8K33E/R91E	 pNDM220	Plac	::t8K33E//r91E	 This	work	
Table	2.3:	Plasmids	
	 Name	 5’	to	3’	nucleotide	sequence	 Description	TA6	KO	F	 AAGCGTACAGATATGTATTATAATTGT
ACATATTGTTCATAAACAGGAGGGTGTAGGCTGGAGCTGCTTC	 Deletion	of	ta6;	homology	to	gene	target	in	bold	TA6	KO	R	 GTATCCTTATCGTTGGCCGATTCTGAA
TTATTCAACAAAGCCTCATGTTGCATATGAATATCCTCCTTAGT	 Deletion	of	ta6;	homology	to	gene	target	in	bold	TA8	KO	F	 GATGTATACCGTTTGCTATACATGGTG
GTTGTGCTATTCTTGTAAAGCAAGTGTAGGCTGGAGCTGCTTC	 Deletion	of	ta8;	homology	to	gene	target	in	bold	TA8	KO	R	 TTCTATCAAATTATCGCTTATAGCGAT
TTGAACATAACAGTCTTTGCATTCATATGAATATCCTCCTTAGT	 Deletion	of	ta8;	homology	to	gene	target	in	bold	TA9	KO	F	 TTACGCGTGTTGTATGCTTAATATCCA
CAGAAGTACAAGAGGACAACACTGTGTAGGCTGGAGCTGCTTC	 Deletion	of	ta9;	homology	to	gene	target	in	bold	TA9	KO	R	 TATCCACAGCGAATTCCGGCCATCAGA
AGCTAAGGGATGCGTTCTGGAGCATATGAATATCCTCCTTAGT	 Deletion	of	ta9;	homology	to	gene	target	in	bold	TA6	upstream	 GCCTCATATGTACGCCTTGAAAGCG	 Homologous	to	upstream	of	ta6:	mutant	genotyping	TA6	downstream	 GGCCGATTCTGAATTATTCAACAAAGCC	 Homologous	to	downstream	of	ta6:	mutant	genotyping	TA8	upstream	 GGTGGTTGTGCTATTGTTGTAAAGC	 Homologous	to	upstream	of	ta8:	mutant	genotyping	TA8	downstream	 CGTATTCTTCCTGAATTTAACCTTAGAC	 Homologous	to	downstream	of	ta8:	mutant	genotyping	TA9	upstream	 TTGTATGCTTAATATCCACAGAAGT	 Homologous	to	upstream	of	ta9:	mutant	genotyping	TA9	downstream	 CAGAAGCTAAGGGATGCGTTCTGGAG	 Homologous	to	downstream	of	ta9:	
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mutant	genotyping	CobB	KO	F	 CGATGCGTCCGGCGTAGAGGATCTTTT
TCAGAGACAGAGTGGTGCCGCATGTGTAGGCTGGAGCTGCTTC	 Deletion	of	cobB;	homology	to	gene	target	in	bold	CobB	KO	R	 GAACGTAACGTGAAATGTAGGCCGGAT
AAGGCGTTACCGGGCAAACAGCAATGGGAATTAGCCATGGTCC	 Deletion	of	cobB;	homology	to	gene	target	in	bold	CobB	upstream	 ACTAATCAAAAAAAGAGGTT	 Homologous	to	upstream	of	cobB:	mutant	genotyping	CobB	downstream	 TGAACGTAACGTGAAATGTA	 Homologous	to	downstream	of	cobB:	mutant	genotyping	T6	pNDM220	F	 TTGGTACCTTGCCCTGCCGGACATGAAGAA	 Amplification	of	t6	for	cloning	into	pNDM220,	KpnI	site	underlined	T6	pNDM220	R	 ACTCGAGTCATAACCTACCAGATGCAGATAAA	 Amplification	of	t6	for	cloning	into	pNDM220,	XhoI	site	underlined	T8	pNDM220	F	 TTGGTACCTTGGTCGCAGATGATCCCGTTATC	 Amplification	of	t8	for	cloning	into	pNDM220,	KpnI	site	underlined	T8	pNDM220	R	 ACTCGAGAACAGTCTTTGCATTCTATTGAGGG	 Amplification	of	t8	for	cloning	into	pNDM220,	XhoI	site	underlined	T9	pNDM220	F	 AAGGTACCAAGGGAGCAGGAAAAATGATCTCC	 Amplification	of	t9	for	cloning	into	pNDM220,	KpnI	site	underlined	T9	pNDM220	R	 ACTCGAGATGCGTTCTGGAGTTTAAACACTCT	 Amplification	of	t9	for	cloning	into	pNDM220,	XhoI	site	underlined	ParE	pNDM220	F	 TTGGTACCTTACAGGGATGATCAAACCCGATG	 Amplification	of	parE	for	cloning	into	pNDM220,	KpnI	site	underlined	ParE	pNDM220	R	 ACTCGAGAGGCTATAACCAATTTACATGCTTAC	 Amplification	of	parE	for	cloning	into	pNDM220,	XhoI	site	underlined	A6	pBAD33	F	 GGGGTCGACGGGGTTCATAAACAGGAGGATGA	 Amplification	of	a6	for	cloning	into	pNDM220,	SalI	site	underlined	A6	pBAD33	R	 GGGCTGCAGCTGTAAACATCATTTCTTCA	 Amplification	of	a6	for	cloning	into	pNDM220,	PstI	site	underlined	A8	pBAD33	F	 GGGGTCGACGGGGTGCTATTCTTGTAAAGCAA	 Amplification	of	a8	for	cloning	into	pNDM220,	SalI	site	underlined	A8	pBAD33	R	 GGGAAGCTTGGGTTCTGGTGCTGTTACACGTC	 Amplification	of	a8	for	cloning	into	pNDM220,	HindIII	site	underlined	A9	pBAD33	F	 GGGGTCGACGGGAAGAGGACAACACTATGCCA	 Amplification	of	a8	for	cloning	into	pNDM220,	SalI	site	underlined	A9	pBAD33	R	 GGGAAGCTTGGGGGTGGAGATCATTTTTCCTG	 Amplification	of	a9	for	cloning	into	pNDM220,	HindIII	site	underlined	T6	A96P	F	 CGTCTGGGTCGTTTACCCGTAGACAAATCTA	 Substitution	of	an	alanine	to	proline	at	ala96,	mutation	underlined	T6	A96P	R	 TAGATTTGTCTACGGGTAAACGACCCAGACG	 Substitution	of	an	alanine	to	proline	at	ala96,	mutation	underlined	T6	Y141F	F	 ACAGGTCTGCGACTGGTTCAAAGGA	 Substitution	of	a	tyrosine	to	a	phenylalanine	at	tyr141,	mutation	underlined	T6	Y141F	R	 TCCTTTGAACCAGTCGCAGACCTGT	 Substitution	of	a	tyrosine	to	a	phenylalanine	at	tyr141,	mutation	underlined	T8	A93P	F	 ATACTTGCCCGTCTTCCTGTCGATCTCTCAT	 Substitution	of	an	alanine	to	proline	at	ala93,	mutation	underlined	T8	A93P	R	 ATGAGAGATCGACAGGAAGACGGGCAAGTAT	 Substitution	of	an	alanine	to	proline	at	ala93,	mutation	underlined	T8	Y140F	F	 AAGAAGCCAAAAATTTCTTCATTCA	 Substitution	of	a	tyrosine	to	a	phenylalanine	at	tyr140,	mutation	underlined	T8	Y140F	R	 TGAATGAAGAAATTTTTGGCTTCTT	 Substitution	of	a	tyrosine	to	a	phenylalanine	at	tyr140,	mutation	underlined	
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T6	pBAD	R	 GGGAAGCTTGGGAAGCCTCATGTTGTCATAACCT	 Amplification	of	t6	for	cloning	into	pNDM220,	HindIII	site	underlined	T8	pBAD	R	 GGGAAGCTTGGGAGTCTTTGCATTCTATTGAGGG	 Amplification	of	t8	for	cloning	into	pNDM220,	HindIII	site	underlined	ArgD	pBAD	F	 NNNNGTCGACATTTCTACTTAACCGGGTGG	 Amplification	of	argD	for	cloning	into	pNDM220,	SalI	site	underlined	ArgD	pBADhis	R	 NNNNAAGCTTTCAGTGATGGTGATGGT
GATGGGCCACCACCTTCCCTA	 Amplification	of	argD	for	cloning	into	pNDM220,	HindIII	site	underlined.	6His	in	bold,	stop	codon	in	red	ArtJ	pBAD	F	 NNNNGTCGACTGCCGCAGACACGGCGCATA	 Amplification	of	artJ	for	cloning	into	pNDM220,	SalI	site	underlined	ArtJ	pBADhis	R	 NNNNAAGCTTTTAATGGTGATGGTGAT
GGTGATGCTGCGGGAACCACTGAT		 Amplification	of	pth	for	cloning	into	pNDM220,	HindIII	site	underlined.	6His	in	bold,	stop	codon	in	red	Pth	pBAD	F	 NNNNGTCGACAGACAGTAAACTACGCGCCAGTTATG	 Amplification	of	pth	for	cloning	into	pNDM220,	SalI	site	underlined	Pth	pBADhis	R	 NNNNAAGCTTCACTGGTTAATGGTGAT
GGTGATGGTGATGTTGCGCCTTAAAGGTATGC	 Amplification	of	pth	for	cloning	into	pNDM220,	HindIII	site	underlined.	6His	in	bold,	stop	codon	in	red	Pth-ts	F	 GTGGCAATTAAATTGATTG	 Homologous	to	N-terminal	region	of	Pth		Pth-ts	R	 GAAGCAGCTCCAGCCTACACTTATTGCG
CCTTAAAGGTATGC	 Homologous	to	C-terminal	region	of	Pth,	in	bold,	and	Kan	cassette	Pth-ts	G-	F	 TCTCCCTCCGGACGTCGCGAAAT	 Substitution	of	glycine	to	aspartic	acid	at	residue	Gly101,	mutation	underlined	Pth-ts	G-A	R	 ATTTCGCGACGTCCGGAGGGAGA	 Substitution	of	glycine	to	aspartic	acid	at	residue	Gly101,	mutation	underlined	Pth-ts	Kan	F	 GCATACCTTTAAGGCGCAATAAGTGTAGGCTGGAGCTGCTTC	 Homologous	to	C-terminal	region	of	Pth,	in	bold,	and	Kan	cassette	Pth-ts	Kan	R	 AACTTCGCCTATTATACACGGCGTGCG
GCAAAAATGCCGCACATCACTGGATGGGAATTAGCCATGGTCC	 Homologous	to	downstream	region	of	Pth,	in	bold,	and	Kan	cassette	Pth-ts	Seq	F	 CGGAACTTTTGGGTTGTTTTTAG	 Sequence	verification	Pth-ts	Seq	R	 GCGGTTTAACAATCTCAGC	 Sequence	verification	T8	K33E	F	 GTTGAAGCAAGAGGGCCT	 Substitution	of	a	lysine	to	a	glutamic	acid	at	lys33,	mutation	underlined	T8	K33E	R	 AGGCCCTCTTGCTTCAAC	 Substitution	of	a	lysine	to	a	glutamic	acid	at	lys33,	mutation	underlined	T8	K36E	F	 GTTGAAGCAAAAGGGCCTCGAAAACC	 Substitution	of	a	lysine	to	a	glutamic	acid	at	lys36,	mutation	underlined	T8	K36E	R	 GCCTGGTTTTCGAGGCCC	 Substitution	of	a	lysine	to	a	glutamic	acid	at	lys36,	mutation	underlined	T8	R77E	F	 CAACCTTGAACGTAACAT	 Substitution	of	an	arginine	to	a	glutamic	acid	at	arg77,	mutation	underlined	T8	R77E	R	 ATGTTACGTTCAAGGTTG	 Substitution	of	an	arginine	to	a	glutamic	acid	at	arg77,	mutation	underlined	T8	R78E	F	 AACCTTCGGGAAAACATG	 Substitution	of	an	arginine	to	a	glutamic	acid	at	arg78,	mutation	underlined	T8	R78E	R	 CATGTTTTCCCGAAGGTT	 Substitution	of	an	arginine	to	a	glutamic	acid	at	arg78,	mutation	underlined	T8	R91E	F	 ACTTGCCGAACTTGCTGT	 Substitution	of	an	arginine	to	a	glutamic	acid	at	arg91,	mutation	underlined	T8	R91E	R	 ACAGCAAGTTCGGCAAGT	 Substitution	of	an	arginine	to	a	glutamic	acid	at	arg91,	mutation	
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underlined	T8	K146E	F	 TGGTTTCGAATCATCACA	 Substitution	of	a	lysine	to	a	glutamic	acid	at	lys146,	mutation	underlined	T8	K146E	R	 TGTGATGATTCGAAACCA	 Substitution	of	a	lysine	to	a	glutamic	acid	at	lys146,	mutation	underlined	T8	R158	R	 AAACTCGAGTTGCATTCTATTGAGGGAGTTCAAGGA	 Substitution	of	an	arginine	to	a	glutamic	acid	at	arg158,	mutation	underlined	pNDM220	Seq	F	 AGCAATTTCCGTTGCACCAG	 Upstream	of	pNDM220	MCS	pNDM220	Seq	R	 GCGGGCCTCTTCGCTATTAC	 Downstream	of	pNDM220	MCS	pBAD	Seq	F	 AACTCTCTACTGTTTCTCCA	 Upstream	of	pBAD	MCS	pBAD	Seq	R	 TGATTTAATCTGTATCAGGC	 Downstream	of	pBAD	MCS	pBR322	Seq	F	 GATGCAATTTCTATGCGCACCC	 Upstream	of	pBR322	MCS	pBR322	Seq	R	 CCGAAACAAGCGCTCATGAG	 Downstream	of	pBR322	MCS	ASKA	Seq	F	 GGCGTATCACGAGGCCCTTTCGTCTTCACC	 Upstream	of	MCS	ASKA	Seq	R	 TTGCATCACCTTCACCCTCTCCACTGACAG	 Downstream	of	MCS	relB1RT-F	 CAGAACTGAAACGTGATCCA	 relB1-RT	PCR	relB1RT-R	 ATGTTGACCTCAATGACGCG	 relB1-RT	PCR	relE1RT-F	 GCTGGCATTTAACGAATCAG	 relE1-RT	PCR	relE1RT-R	 TTCATCTTCGACGCTGTACA	 relE1-RT	PCR	relB2RT-F	 GCTGAAATGGGGTTAACCAT	 relB2-RT	PCR	relB2RT-R	 TCAGATCCCTAACTGGTCAA	 relB2-RT	PCR	relE2RT-F	 TGAATATTCGGGACAGTTCC	 relE2-RT	PCR	relE2RT-R	 AAGAATCCAGTCAGGCTCAA	 relE2-RT	PCR	relB3RT-F	 CGTCTGGATGACAAACTCAA	 relB3-RT	PCR	relB3RT-R	 ATTCCCTTTTGCGGACTAGA	 relB3-RT	PCR	relE3RT-F	 TATGAACTGGAATTCGACCC	 relE3-RT	PCR	relE3RT-r	 AACCTGGTACACCAGACGAT	 relE3-RT	PCR	parDRT-F	 ATGAACTGCGCGAGTTTATT	 parD-RT	PCR	parDRT-R	 ACCTTCCGTAAAAAGGCATC	 parD-RT	PCR	parERT-F	 AATTAACGCCAAAGGCCAGT	 parE-RT	PCR	parERT-R	 GCCTTTTAAACGGTAAGGCA	 parE-RT	PCR	higB1RT-F	 AAATTGGGGCTGGGGTAAAT	 higB1-RT	PCR	higB1RT-R	 AAGCTGTTTCTCCGTTGTTG	 higB1-RT	PCR	higA1RT-F	 AGTGATATTCGCCATGTGAC	 higA1-RT	PCR	higA1RT-R	 AACTGTAGCAACCTCGGCTT	 higA1-RT	PCR	higB2RT-F	 GTGGTGATGTCATTCAGGAA	 higB2-RT	PCR	higB2RT-R	 TCATTCAGCATACGAAGCAC	 higB2-RT	PCR	higA2RT-F	 AAATCATTGAAGGGACCCGT	 higA2-RT	PCR	higA2RT-R	 AATGGCGCGAAGTAACGCTT	 higA2-RT	PCR	vapB1RT-F	 TTTTTAGTAACCGGACCCAG	 vapB1-RT	PCR	vapB1RT-R	 AAATCCTTCCCGTTCCTGTA	 vapB1-RT	PCR	vapC1RT-F	 ATAAGCCCGAACACATCAGA	 vapC1-RT	PCR	vapC1RT-R	 ATTTGACCGGTATGTATCGC	 vapC1-RT	PCR	phdRT-F	 AAAATCTGGCCGAAGTCCTG	 phd-RT	PCR	phdRT-R	 CCTGAGCTCATTGCCATGAA	 phd-RT	PCR	docRT-F	 CTACAACTTATCTCAGCGGA	 doc-RT	PCR	docRT-R	 TCATTGAAGATATGCCCACG	 doc-RT	PCR	relB4RT-F	 CAAAATCGCGATCGCGCAAT	 relB4-RT	PCR	relB4RT-R	 CGCACCTCTACCAGTTCTTT	 relB4-RT	PCR	relE4RT-F	 AAAAGCCCTGCCTTTGAACC	 relE4-RT	PCR	relE4RT-R	 TACGCTGGTATTCAGGTACC	 relE4-RT	PCR	relB5RT-F	 CATTCACTCAGCCTGAAGAG	 relB5-RT	PCR	relB5RT-R	 ATTACCCCGATAGTATGCGG	 relB5-RT	PCR	relE5RT-F	 GGATGCAACCAGCGCAAAAA	 relE5-RT	PCR	relE5RT-R	 CCGGCGCATGTTTTTCGTAT	 reE51-RT	PCR	A6RT-F	 AGGCTGTCGTTACGTGTATC	 a6-RT	PCR	
	 	 Chapter	two:	Materials	and	Methods	
	 62	
A6RT-R	 CGCTGGCGGGTTATCTAAAA	 a6-RT	PCR	T6RT-F	 TTTACAGACTGGCATGAGGC	 t6-RT	PCR	T6RT-R	 TGATGCAGGACTGACTGAGT	 t6-RT	PCR	A8RT-F	 GGGGTGTCTCATGAAATCAG	 a8-RT	PCR	A8RT-R	 GCAGATTGATGAACTCCTCA	 a8-RT	PCR	T8RT-F	 GACGTGTAACAGCACCAGAA	 t8-RT	PCR	T8RT-R	 TCTGTATGGTTGACGCTACC	 t8-RT	PCR	A9RT-F	 AACCGCACAGACTTTGTGCT	 a9-RT	PCR	A9RT-R	 TCATTTTTCCTGCTCCCACG	 a9-RT	PCR	T9RT-F	 CTGCGGTGTGGATTCTATAG	 t9-RT	PCR	T9RT-R	 GAATCGGGTCAGGCATATTG	 t9-RT	PCR	shpART-F	 GATGCGGTACTGGTGTTTGA	 shpA-RT	PCR	shpART-R	 ACCATGCTCATAACGATTCC	 shpA-RT	PCR	shpBRT-F	 TGAGTGCTCAGCATGAGGCT	 shpB-RT	PCR	shpBRT-R	 TTCAGCCACTCCATCACATC	 shpB-RT	PCR	16sRT-F	 AAGGCCTTCGGGTTGTAAAG	 16s-RT	PCR	16sRT-R	 GGGATTTCACATCCGACTTG	 16s-RT	PCR	
Table	2.4:	Primers	
2.2	Bacterial	growth	conditions		 S.	 Typhimurium	and	E.	coli	 cultures	were	 typically	 grown	 in	Lennox	 (L)	Broth	 (LB)	 (10	 g/L	 Bacto-tryptone,	 5	 g/L	 yeast	 extract,	 5	 g/L	 NaCl,	 pH	 7.5),	autoclaved	 to	 sterilize.	 For	 LB	 agar	 plates	 15	 g/L	 of	 bacteriological	 agar	No.	 1	(Oxoid,	 Basingstoke,	 GBR)	was	 added	 to	 the	 LB	 broth	mix	 before	 sterilization.	Where	stated,	bacteria	were	grown	in	M9	minimal	medium	(12.8	g/L	Na2HPO4-7H20,	3	g/L	KH2PO4,	0.5	g/L	NaCl,	1	g/L	NH4Cl,	2	mM	MgSO4,	100	µM	CaCl2,	0.2%	(w/v)	 glucose),	 filter	 sterilized.	 	 Chemically	 competent	 and	 electroporated	bacteria	 were	 recovered	 in	 SOC	 medium	 (20	 g/L	 bacto-tryptone,	 5	 g/L	 yeast	extract,	0.5	g/L	NaCl,	2.5	mM	KCl,	10	mM	glucose).	Where	appropriate,	growth	medium	 was	 supplemented	 with	 antibiotics	 at	 the	 following	 concentrations:	carbenicillin;	 50	 µg/ml,	 kanamycin;	 50	 µg/ml,	 chloramphenicol;	 30	 µg/ml.	Unless	otherwise	stated	10	mM	IPTG	was	added	 to	 induce	expression	of	genes	under	 the	 control	 of	 the	 Plac	 promoter	 and	 0.2%	 L-arabinose	 was	 added	 to	induce	expression	of	genes	under	the	control	of	the	Para	promoter.	
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2.3	Eukaryotic	cell	culture	conditions		 RAW	 264.7	 murine	 macrophage-like	 cells	 were	 obtained	 from	 the	European	 Collection	 of	 Cell	 Cultures	 (ECACC;	 catalogue	 No.	 91062702).	 Cells	were	cultured	 in	Dulbecco’s	modified	Eagle	medium	(DMEM;	PAA	 laboratories,	Pasching,	 AUT)	 supplemented	with	 10%	 (final	 concentration)	 heat-inactivated	foetal	calf	serum	(FCS;	PAA	laboratories)	at	37	°C,	5%	CO2.		 Bone	marrow	derived	macrophages	were	extracted	 from	C57BL/6	mice.	Mice	were	sacrificed	and	bone	marrow	cells	were	harvested	from	the	tibia	and	femurs	 (Racoosin	 &	 Swanson,	 1989).	 Red	 blood	 cells	 were	 lysed	 with	 0.83%	NH4Cl,	 the	 remaining	 undifferentiated	 cells	 were	 then	 cultured	 in	 complete	medium	 (RPMI-1640	 supplemented	 with	 10%	 FCS	 (PAA	 laboratories),	 1	 mM	sodium	 pyruvate,	 2	mM	 glutamine,	 10	mM	HEPES,	 0.05	M	 β-Mercaptoethanol,	20%	 L929-cell	 conditioned	 medium	 (LCM;	 National	 Institute	 of	 Medical	Research)	 and	 100	 U/ml	 penicillin/streptomycin.	 	 Cells	 were	 grown	 in	 10	 cm	petri	dishes	 (Sterilin,	Caerphilly,	GBR)	at	 a	density	of	3	x	106,	 at	37	 ˚C	and	5%	CO2,	for	6	days.	Differentiated	macrophages	were	seeded	for	infection	on	day	6.	Cells	were	detached	by	incubation	in	ice-cold	1	x	PBS	for	10	min.	Cells	were	then	centrifuged	 at	 300	 x	g	 for	 5	min	 before	 seeding	 in	 6	well	 plates	 (Sterilin)	 at	 a	density	 of	 1	 x	 106	 per	 well,	 in	 complete	 medium	 without	 LCM	 or	penicillin/streptomycin	(infection	medium).		
2.4	Extraction	of	plasmid	DNA		 Plasmid	 DNA	 was	 extracted	 from	 5	 ml	 bacterial	 cultures,	 grown	 to	stationary	phase	in	LB,	using	the	GenElute	Plasmid	Miniprep	Kits	(Sigma-Aldrich,	
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Missouri,	USA),	according	to	the	manufacturers	specifications,	and	eluted	in	50	µl	sterile	water.	
2.5	Polymerase	Chain	Reaction	(PCR)		 Amplification	of	DNA,	 for	 cloning	or	mutagenesis,	was	 carried	out	using	the	 Expand	 High-Fidelity	 PCR	 system	 (Roche,	 Basel,	 CHE),	 according	 to	 the	manufacturers	 specifications.	 Typical	 reactions	 contained	 1	 x	 Expand	 High	Fidelity	buffer	 (to	give	a	 final	Mg2+	concentration	of	1.5	mM),	0.1	µM	 forward	primer	and	0.1	µM	reverse	primer,	0.2	µM	each	of	dATP,	dTTP,	dCTP	and	dGTP	(Sigma-Aldrich)	2.5	U	of	Expand	High	Fidelity	enzyme	mix	and	template	DNA	in	a	reaction	 mix	 of	 50	 µl.	 Thermocycler	 parameters	 varied	 depending	 on	 the	amplicon	size	and	GC	content.	A	typical	PCR	cycle	was;	denaturation	at	95	˚C	for	5	min	and	then	30	cycles	of	denaturation	at	95	°C	for	30	sec,	annealing	at	50	˚C	for	30	sec,	extension	at	68	˚C	for	1	min	per	kb	of	amplicon,	final	extension	at	68	˚C	for	10	min.	For	colony	and	all	other,	PCR	Taq	DNA	polymerase	(Sigma-Aldrich)	was	used	with	its	corresponding	buffer	and	an	extension	temperature	of	72	˚C,	as	per	the	manufacturers	instructions.		
2.6	DNA	gel	electrophoresis		 DNA	was	separated	via	electrophoresis	through	1%	agarose	Tris-acetate	EDTA	 buffer	 (TAE)	 gels	 and	 visualised	 with	 SYBR	 Safe	 Stain	 (Invitrogen,	California,	USA)	at	a	dilution	of	1:10	000,	using	a	Geneflash	UV	transilluminator	(Syngene,	Bangalore,	 IND).	 	 Fragment	 size	was	determined	using	HyperLadder	(Bioline,	London,	GBR)	as	a	marker.	
	 	 Chapter	two:	Materials	and	Methods	
	 65	
2.7	Preparation	and	transformation	of	electro-competent	
bacterial	cells	
	 Bacterial	strains	were	grown	to	stationary	phase	overnight	in	LB	medium.	Subsequently,	 cultures	 were	 diluted	 1:50	 in	 5	 ml	 of	 fresh	 LB	 medium	 and	incubated	at	37	˚C,	200	rpm	until	an	OD600	of	0.4-0.6	was	reached.		Bacteria	were	then	incubated	on	ice	for	15	min,	centrifuged	at	5	000	x	g,	4	˚C	for	5	min	and	the	supernatant	 discarded.	 The	 pellet	was	 resuspended	 in	 1	ml	 of	 ice-cold,	 sterile	MilliQ	water	followed	by	centrifugation	as	before.	This	step	was	repeated	three	times,	first	washing	in	1	ml,	then	in	500	µl	of	ice-cold	MilliQ	water	and	finally	in	500	µl	of	ice-cold,	sterile	10%	glycerol.	Cells	were	then	resuspended	in	100	µl	of	ice-cold,	 sterile	 10%	 glycerol	 and	 50	 µl	 aliquots	were	 prepared	 for	 immediate	use.	 For	 the	 preparation	 of	 electro-competent	 bacteria	 harbouring	 either	 the	pKD46	 or	 pCP20	 plasmids,	 bacteria	 were	 grown	 at	 30	 ˚C	 in	 LB	 medium	supplemented	 with	 0.2%	 L-arabinose	 to	 induce	 expression	 of	 the	 lambda	 red	and	FLP	recombinase	respectively.			 50	 µl	 aliquots	 of	 electro-competent	 cells	 were	 incubated	 with	transformation	 DNA	 (PCR	 products	 or	 plasmids)	 on	 ice	 for	 5	 min	 and	subsequently	 transferred	 to	 a	 2	 mm	 electroporation	 cuvette	 (Molecular	BioProducts,	San	Diego,	USA).	Samples	were	electroporated	at	2.5	kV,	200	Ω,	25	µF,	 for	 approximately	 5	 msec	 using	 a	 GenePulser	 (BioRad,	 California,	 USA).	Bacteria	were	recovered	in	1	ml	SOC	medium,	at	37	˚C,	200	rpm	for	1	h.	Selection	of	 transformants	 was	 achieved	 by	 plating	 on	 LB	 agar	 supplemented	 with	 the	appropriate	 antibiotic	 and	 incubated	 overnight	 at	 37	 °C.	 Again,	 bacterial	
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transformants	 harbouring	 either	 the	 pKD46	 or	 the	 pCP20	 plasmids	 were	recovered	and	incubated	at	30	˚C.		
2.8	Deletion	of	S.	Typhimurium	genes	and	construction	of	S.	
Typhimurium	Pth-ts	mutant		 S.	 Typhimurium	 deletion	mutant	 strains	were	 generated	 using	 the	 one-step	 lambda	 red	 recombinase	 method	 described	 by	 Datsenko	 and	 Wanner	(Datsenko	 &	Wanner,	 2000).	 	 Primers	 were	 designed	 to	 amplify	 an	 antibiotic	resistance	 cassette	 from	 the	 template	 plasmids	 pKD3	 and	 pKD4	 (to	 create	 a	chloramphenicol	 (catr)	 or	 kanamycin	 (kanr)	 resistance	 cassette,	 respectively).		These	 primers	 also	 contained	 a	 50	 nucleotide	 sequence	 homologous	 to	 the	immediate	 flanking	 regions	 of	 the	 gene	 to	 be	 deleted.	 	 Amplification	 of	 the	relevant	antibiotic	resistance	cassette	was	carried	out	as	described	in	section	2.5.	The	 desired	S.	 Typhimurium	 strain	was	 first	 transformed	with	 the	 pKD46,	 the	arabinose	inducible	plasmid	containing	the	lambda	red	recombinase	enzyme,	by	electroporation	 as	 described	 in	 section	 2.7.	 This	 strain	was	 then	 grown	 under	inducing	 conditions	 and	 transformed	 with	 the	 relevant	 antibiotic	 resistance	cassette	amplicon.	Positively	transformed	colonies	were	selected	for	on	the	basis	of	 their	 antibiotic	 resistance.	 Confirmation	 of	 the	 deletion	 was	 performed	 by	colony	PCR,	using	primers	homologous	to	the	areas	upstream	or	downstream	of	the	 deleted	 gene	 and	 those	 used	 to	 amplify	 the	 antibiotic	 resistance	 cassette	(Table	2.4),	with	subsequent	measurement	of	amplicon	size	by	electrophoresis.	The	antibiotic	resistance	cassette	was	removed	by	transformation	of	the	deletion	strain	with	 the	pCP20	plasmid	 expressing	 the	 FLP	 recombinase	 enzyme	 in	 the	presence	 of	 0.2%	 L-arabinose.	 Loss	 of	 antibiotic	 resistance	 was	 confirmed	 by	
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patching	on	selective	media	and	colony	PCR.	Plasmids	pCP20	and	pKD46	were	cured	by	growth	overnight	at	42	˚C.		 The	Pth	 temperature	 sensitive	mutant	was	 generated	by	 substitution	of	glycine101	to	an	aspartic	acid	residue	(Cruz-vera	et	al.,	2000).		In	order	to	do	this	a	 three	 step	 over-lapping	 PCR	method	was	 used.	 The	 first	 round	 of	 PCR	 used	primer	 pairs	 homologous	 to	 the	N-terminal	 region	 of	 pth	 (Pth	 TS	 F)	 and	 the	region	 surrounding	Gly101,	with	 the	 nucleotide	 switch	 resulting	 in	 the	G101D	substitution	 embedded	 within	 (Pth	 TS	 G-A	 R),	 and	 the	 complimentary	 primer	harbouring	 the	 G101D	 substitution	 (Pth	 TS	 G-A	 F)	 and	 a	 primer	 containing	homology	 to	 the	C-terminal	 region	of	pth	 at	 the	3’	end	and	homology	 to	 the	N-terminal	of	the	kanr	cassette	at	the	5’	end		(Pth	TS	R).	The	second	round	of	PCR	used	primers;	Pth	TS	F	and	Pth	TS	R,	to	fuse	the	two	fragments	obtained	in	the	first	round	together,	resulting	in	the	full-length	pth	gene	harbouring	the	G101D	substitution,	 with	 20	 bp	 homology	 to	 the	 kanr	 cassette	 at	 the	 C-terminal.	 In	parallel,	 the	kanr	 cassette	was	 amplified	 from	pKD4	with	primer	Pth	TS	Kan	F	and	 Pth	 Kan	 R,	 resulting	 in	 the	 full-length	 kanr	 cassette	 with	 a	 22	 bp	 region	homologous	 the	 C-terminal	 of	 pth	 at	 the	 N-terminal	 and	 50	 bp	 region	homologous	the	immediately	downstream	of	the	pth	gene	at	the	C-terminal.	The	full-length	pthG101D	gene	and	the	kanr	cassette	were	fused	by	a	third	over-lapping	PCR,	 using	 primers	 Pth	 TS	 F	 and	 Pth	 kan	 R	 to	 generate	 a	 PCR	 amplicon	containing	 the	 full	 length	 pthG101D	 immediately	 upstream	 of	 the	 kanr	 cassette.	This	 PCR	 product	 was	 then	 transformed	 into	 electro-competent	 WT	 S.	Typhimurium	and	successful	transformants	were	sequence	verified.		
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2.9	Sodium	dodecyl	sulphate	polyacrylamide	gel	electrophoresis	
(SDS-PAGE)			 Protein	 samples	 were	 harvested	 from	 bacterial	 cultures.	 To	 ensure	protein	 comparison	 was	 from	 comparable	 bacterial	 numbers,	 samples	 were	adjusted	to	OD600	values	such	that	1	ml	of	culture	of	OD600	0.1	was	lysed	in	10	µl	of	laemmli	buffer	(0.25	mM	Tris-HCl	pH	6.8,	10%	sodium	dodecyl	sulphate	[SDS],	50%	glycerol,	5%	β-mercaptoethanol).	1	ml	of	culture	was	centrifuged	at	21	000	x	g	 for	1	min,	 resuspended	 in	 the	 calculated	volume	of	buffer	 and	boiled	 for	5	min	at	95	 ˚C,	samples	were	used	 immediately	or	stored	at	 -20	 ˚C	until	analysis.	Proteins	were	separated	by	12%	SDS-PAGE	in	running	buffer	(25	mM	Tris-HCl,	250	mM	glycine,	2	%	SDS).		Gels	were	visualised	by	Coomassie	staining,	western	blot,	northern	blot	or	autoradiography.	
2.10	Western	blot	SDS-PAGE	gels	were	washed	 in	 transfer	buffer	(44	mM	Tris-HCl,	29	mM	glycine,	 20%	 methanol)	 for	 5	 min.	 In	 parallel,	 Immunobilon-P	 polyvinyldene	fluoride	 (PVDF)	 membranes	 (Millipore,	 Massachusetts	 USA)	 were	 activated	 in	ethanol	 for	 10	 seconds	 and	 washed	 in	 milliQ	 water	 for	 2	 min.	 Proteins	 were	transferred	to	 the	membrane	using	a	semi-dry	transfer	cell	 (BioRad,	California,	USA),	to	the	manufacturers	instructions,	at	0.5	mA/cm2,	24V	for	1	h.	Membranes	were	subsequently	incubated	in	blocking	buffer	(PBS	0.01%	Tween-20,	5%	milk)	for	1	h	at	room	temperature	to	block	non-specific	 labelling.	Primary	antibodies	were	 diluted	 to	 the	 manufacturers	 specifications	 in	 blocking	 buffer	 and	incubated	 with	 the	 membrane	 for	 1	 h	 at	 room	 temperature.	 Subsequently	membranes	 were	 washed	 three	 times	 in	 PBS	 0.01%	 Tween-20	 for	 10	 min	 to	
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remove	excess	primary	antibody	and	ready	the	membrane	for	binding	with	the	secondary	 antibody.	 The	 horseradish	 peroxidase	 (HRP)-conjugated	 secondary	antibody	was	diluted	in	blocking	buffer	and	incubated	with	the	membrane	for	30	min	 at	 room	 temperature,	 followed	 by	 5	 washes	 in	 PBS	 0.01%	 Tween-20.	Proteins	were	detected	with	 the	 enhanced	 chemiluminescence	 (ECL)	detection	system	(GE	Healthcare,	Little	Chalfont,	GBR)	as	directed	by	the	manufacturer.		
2.11	Analysis	of	mRNA	levels	by	Reverse-Transcription	
quantitative	PCR	(RT	qPCR)		 Bacterial	 samples	 for	 RNA	 extraction	 were	 prepared	 as	 stated.	Intracellular	 RNA	 was	 stabilized	 using	 RNA	 protect	 Bacteria	 Reagent	 (Qiagen,	Hilden,	DEU),	according	to	the	manufacturers	specifications.	Purification	of	total	RNA	 was	 performed	 using	 RNAeasy	 Miniprep	 Kit	 (Qiagen),	 as	 per	 the	manufacturers	 protocol	 and	 eluted	 in	 50	 µl	 RNase	 free	 water	 (Ambion,	Massachusetts,	 USA).	 Genomic	 DNA	 (gDNA)	 was	 digested	 by	 incubation	 with	DNase	 I	 (Qiagen)	 for	10	min	at	 room	 temperature.	RNA	was	 then	purified	and	concentrated	 using	 MinElute	 Cleanup	 kit	 (Qiagen),	 to	 the	 manufacturers	specifications.	 RNA	was	 quantified	 by	measurement	 at	 OD260	using	 a	 NanoVue	Plus	spectrophotometer	(GE	Healthcare).		Complimentary	 DNA	 (cDNA)	 synthesis	 was	 performed	 using	 the	QuantiTect	 Reverse	 Transcription	 Kit	 (Qiagen),	 400	 ng	 of	 RNA	 was	 reverse	transcribed	 to	 the	 manufacturers	 specifications.	 cDNA	 was	 quantified	 by	measurement	at	OD260	and	samples	were	stored	at	-20	°C.	Quantitative	PCR	amplification	was	performed	on	 the	 cDNA	using	 SYBR	green	 real	 time	 PCR	 master	 mix	 (Thermofisher,	 Massachusetts,	 USA)	 on	 the	
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Rotor-Gene	 3000	 (Corbett	 Research,	 Sydney,	 AUS)	 with	 the	 necessary	 primer	pairs	and	the	control	primers	specific	to	the	16s	rRNA	housekeeping	gene	(Table	2.4).	A	typical	reaction	mix	contained	13.5	µl	of	SYBR	green	master	mix,	2	mM	of	each	primer	and	500	ng	of	cDNA	in	a	total	volume	of	25	µl	in	duplicate	and	with	a	negative	 control	 in	 the	 absence	 of	 cDNA.	 Typical	 parameters	 for	 the	 PCR	amplification	were	 as	 follows:	 10	min	denaturing	 at	 95	 ˚C;	 45	 cycles	 of	 10	 sec	denaturing	at	95	˚C,	30	sec	annealing	at	50	˚C,	15	sec	extension	at	68	˚C	and	45	sec	 at	 95	 ˚C,	 followed	 by	 a	 gradual	 decrease	 of	 temperature	 every	 5	 sec	 to	determine	the	melting	curve.	Analysis	was	based	on	comparative	quantitation	of	a	 treated	 sample	 (pH	 shock,	 SHX	 treatment,	 macrophage	 internalization,	induction	of	the	target	gene	etc.)	and	the	LB	broth	grown	only	control	and	mRNA	levels	were	normalized	to	the	control	gene,	16s	rRNA.	
2.12	Construction	of	bacterial	over-expression	vectors		 Restriction	 enzymes	 were	 obtained	 from	 New	 England	 Biolabs	 (New	England	Biolabs	[NEB],	Massachusetts,	USA)	and	used	with	the	correct	buffers	as	recommended	by	the	manufacturers.	Where	necessary	restriction	products	were	purified	 by	 DNA	 gel	 electrophoresis	 and	 gel	 excision	 using	 QIAquick	 Gel	Extraction	Kit	(Qiagen),	to	the	manufacturers	specifications.	Ligation	of	digested	DNA	 products	 and	 linearized	 vectors	 was	 performed	 using	 T4	 DNA	 ligase	(Invitrogen)	 as	 per	 the	 manufacturers	 instructions.	 Unless	 otherwise	 stated	ligation	reactions	were	carried	out	at	16	˚C	overnight	and	the	ligase	reaction	was	subsequently	 heat	 inactivated	 by	 incubation	 at	 65	 ˚C	 for	 20	min.	 A	 full	 list	 of	primers	used	in	the	construction	of	all	over-expression	vectors	can	be	found	in	table	2.4		
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For	insertion	of	genes	into	the	pNDM220	plasmid,	primers	were	designed	to	amplify	the	required	gene,	including	ribosome-binding	site.	Unless	otherwise	stated	the	forward	primer	also	contained	the	KpnI	digestion	sequence	at	 the	5’	end	of	the	primer	and	the	reverse	primer	contained	the	XhoI	digestion	sequence	at	the	5’	end,	in	order	to	introduce	restriction	sites	for	KpnI	and	XhoI	upstream	and	 downstream,	 respectively,	 of	 the	 PCR	 fragment.	 The	 PCR	 fragments	 were	introduced	 into	 the	multiple	cloning	site	of	pNDM220,	placing	 their	expression	under	 the	 control	 of	 the	 LacZ	 promoter.	 Vector	 and	 insert	 digestion	 reactions	were	carried	out	 for	1	h	at	37	 °C.	Thereafter	digested	 fragments	were	purified	and	 ligated	 as	 previously	 described.	 The	 ligated	product	was	 transformed	 into	chemically	competent	E.	coli	DH5α.	Colonies	were	selected	for	on	LB	agar	plates	supplemented	with	50	µg/ml	carbenicillin.	Colonies	were	screened	for	successful	ligations	by	colony	PCR	and	sequencing.	For	 insertion	of	genes	 into	 the	pBAD33	plasmid,	primers	were	designed	to	amplify	the	required	gene,	including	ribosome-binding	site.	Unless	otherwise	stated	the	forward	primer	also	contained	the	HindIII	digestion	sequence	at	the	5’	end	of	the	primer	and	the	reverse	primer	contained	the	SalI	digestion	sequence	at	the	5’	end,	in	order	to	introduce	restriction	sites	for	HindIII	and	SalI	upstream	and	 downstream,	 respectively,	 of	 the	 PCR	 fragment.	 The	 PCR	 fragments	 were	then	 introduced	 into	 the	 multiple	 cloning	 site	 of	 pBAD33,	 placing	 their	expression	under	the	control	of	 the	Para	promoter.	Vector	and	 insert	digestion	reactions	were	carried	out	for	1	h	at	37	˚C.	Thereafter	digested	fragments	were	purified	 and	 ligated	 as	 previously	 described.	 The	 ligated	 product	 was	 then	transformed	into	chemically	competent	E.	coli	DH5α	and	colonies	selected	for	on	LB	 agar	 plates	 supplemented	 with	 30	 µg/ml	 chloramphenicol.	 Colonies	 were	
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screened	for	successful	ligations	by	colony	PCR	and	sequencing.	For	insertion	of	T6	and	T8	 into	the	pBAD33	and	pBAD18	plasmids,	genes	were	amplified	using	T6	pNDM220	F	and	T6	pBAD	R	and	T8	pNDM220	F	and	T8	pBAD	R,	respectively.	PCR	 products	 and	 the	 relevant	 pBAD	 vector	were	 digested	with	KpnI	 and	 SalI	restriction	enzymes	and	ligated	as	previously	described.		For	insertion	of	a	6His	tag	at	the	C-terminal	of	a	desired	protein,	reverse	(C-terminal)	 primers	 were	 designed	 as	 before	 to	 amplify	 the	 desired	 protein,	however,	 in	 this	 instance	 primers	 contained	 the	 sequence	 for	 6	 histidine	residues	immediately	before	the	stop	codon.		For	 the	generation	of	point-mutated	 toxins,	 an	overlapping	PCR	method	was	used.	As	an	example,	T8Y140F	was	generated	using	primers	T8	Y140F	F	and	T8	Y140F	R;	which	are	homologous	to	the	20	nucleotide	sequence	surrounding	residue	 Tyr140	 and	 containing	 the	 necessary	 nucleotide	 switch	 to	 mutant	Tyr140	 to	 a	 phenylalanine	 residue,	 and	 primers	 T8	 pNDM220	 F	 and	 T8	pNDM220	 R;	 which	 are	 designed	 to	 amplify	 the	 whole	 T8	 gene	 whilst	introducing	the	KpnI	and	XhoI	digestion	sequences	upstream	and	downstream	of	the	gene,	respectively.	First,	PCR	reactions	using	primer	pairs	T8	Y140F	F	and	T8	pNDM220	R	(reaction	1)	and	T8	pNDM220	F	and	T8	Y140F	R	(reaction	2)	were	performed	 with	 S.	 Typhimurium	 WT	 gDNA	 as	 the	 template.	 The	 resultant	amplicons	were	T8	gene	fragments	harbouring	the	T140F	mutation	at	the	3’	end	of	the	amplicon	in	reaction	1	and	the	5’	end	of	the	amplicon	in	reaction	2.	Gene	fragments	 from	 these	 two	 reactions	 were	 purified	 and	 then	 used,	 in	 equal	concentrations,	 as	 a	 template	 for	 the	 final	 PCR	 reaction	 using	 primer	 pairs	 T8	pNDM220	 F	 and	 T8	 pNDM220	 R	 to	 generate	 a	 full-length	 t8Y140F.	 These	 DNA	fragments	were	 then	digested,	 recovered	 and	 ligated	 into	 vector	 pNDM220,	 as	
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previously	described.	 Successful	 ligations	were	 sequenced	 to	 confirm	mutation	of	the	t8	gene.	
2.12	Mid	exponential	phase	over-expression	assay		 The	relevant	bacterial	strains	were	grown	to	stationary	phase	overnight	in	 LB	medium.	 Subsequently	 they	were	diluted	1:100	 in	 fresh	LB	medium	and	grown	to	an	OD600	of	0.4	–	0.6.	Cultures	were	then	diluted,	to	an	OD600	of	0.2,	in	fresh	LB	medium	supplemented	with	10	mM	 IPTG.	 	Growth	was	monitored	by	measuring	at	OD600	at	hourly	intervals.		
2.13	Lag	phase	over-expression	assay		 The	relevant	bacterial	strains	were	grown	to	stationary	phase	overnight	in	LB	medium.	Subsequently	 they	were	diluted	 to	 an	OD600	of	0.01	 in	 fresh	LB	medium	 supplemented	 with	 10	 mM	 IPTG	 and	 0.2%	 L-arabinose,	 where	necessary.	Growth	was	monitored	by	measuring	OD600	at	half	hourly	intervals.	
2.14	In	vivo	persister	assay		 Murine	 derived	 bone	 marrow	 derived	 macrophages	 were	 seeded	 24	 h	prior	to	infection	at	a	density	of	1	x	106	cells	per	well	 in	6	well	plates.	Bacteria	were	grown	to	stationary	phase	overnight	in	LB.	Bacteria	were	the	opsonized	for	20	min	at	room	temperature.	Opsonisation	mixes	were	as	follows:	20	µl	mouse	serum	 (Sigma-Aldrich),	 40	 µl	 overnight	 bacterial	 culture	 and	 170	 µl	 infection	medium.	600	µl	of	infection	medium	was	added	after	20	min	of	opsonisation	and	30	 µl	 of	 final	 opsonisation	mix	was	 added	 to	 the	 cell	monolayers,	 6	wells	 per	bacterial	 strain,	 to	 give	 an	 MOI	 of	 approximately	 10.	 The	 plates	 were	 then	centrifuged	at	110	x	g	for	5	min	and	 incubated	at	37	 ˚C	 in	5%	CO2	 for	25	min.	
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After	30	min	cells	were	washed	3	times	with	2	ml	per	well	of	sterile	PBS	and	0.2	ml	0.1	%	triton-PBS	added	to	each	well.	The	bacterial-triton	mix	from	each	plate	was	 collected	 and	 pooled,	 centrifuged	 at	 full	 speed	 for	 4	 min	 to	 pellet	 the	bacteria.	The	supernatant	was	aspirated	and	the	cells	resuspended	in	1	ml	fresh	LB.	 The	 macrophage-extracted	 bacteria	 were	 then	 added	 to	 3	 ml	 of	 fresh	 LB.	Serial	 dilutions	 were	 plated	 onto	 LB	 agar	 plates	 to	 enumerate	 CFU	 (T=0).	Gentamycin	was	added	to	the	cultures	at	a	final	concentration	of	100	µg/ml,	the	samples	were	divided	into	two	universal	tubes	and	incubated	for	24	h	at	37	˚C,	200	rpm.	After	24	h	1	ml	was	harvested,	cells	were	washed	once	with	sterile	PBS,	resuspended	 in	 1	 ml	 sterile	 PBS	 and	 100	 µl	 plated	 onto	 LB	 agar	 plated	 to	enumerate	CFU	(T=24).	For	the	comparable	LB-grown	only	samples,	80	µl	of	the	same	 bacterial	 cultures	 was	 inoculated	 into	 8	 ml	 of	 fresh	 LB.	 serial	 dilutions	were	 plated	 onto	 LB	 agar	 to	 enumerate	 CFU	 (T=0).	 Gentamycin	was	 added	 as	before,	the	samples	divided	into	two	universal	tubes	and	incubated	for	24	h	at	37	˚C,	200	rpm.	After	24	h	each	4	ml	sample	was	harvested,	cells	were	washed	once	with	 sterile	 PBS,	 resuspended	 in	 800	µl	 sterile	 PBS	 and	200	µl	 plated	 onto	 LB	agar	plates	to	enumerate	CFU	(T=24).	Percentage	survival	was	calculated	as	the	proportion	of	CFU	at	T=24	relevant	to	T=0	and	the	fold	change	calculated	as	the	difference	 between	 percentage	 survival	 of	 macrophage	 internalised	 bacteria	compared	to	LB-grown	only	bacteria.	
2.15	In	vitro	persister	assay		 The	 relevant	 bacterial	 strains	 were	 grown	 to	 stationary	 phase	 in	 M9	minimal	medium	overnight.	Subsequently	they	were	diluted	1:20	into	fresh	M9	minimal	medium,	supplemented	with	the	relevant	antibiotics,	10	mM	IPTG	and	0.2%	 L-arabinose	 to	 induce	 expression	 of	 genes	 on	 pNDM220	 and	 pBAD33	
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vectors	 respectively,	 and	 incubated	 at	 37	 ˚C,	 200	 rpm.	 After	 1	 h	 of	 induction	samples	were	taken	and	serial	diluted	to	determine	the	CFU	(T=0).	 	Gentamicin	was	added	to	a	final	concentration	of	100	µg/ml	and	the	culture	incubated	for	a	further	4	h	at	37	˚C,	200	rpm.	After	the	gentamicin	treatment,	1	ml	samples	were	taken	 and	 the	 bacteria	 pelleted	 by	 centrifugation,	 at	 full	 speed	 for	 5	min.	 The	supernatant	was	carefully	aspirated,	 the	cells	washed	once	with	1	ml	of	 sterile	PBS,	 resuspended	 in	 100	 µl	 sterile	 PBS	 and	 plated	 onto	 LB	 agar	 plates	 to	determine	 CFU	 (T=4).	 Percentage	 survival	was	 calculated	 as	 the	 proportion	 of	CFU	at	T=4	relevant	to	T=0.		
2.16	Rates	of	protein,	DNA	and	RNA	synthesis		 	The	 relevant	 bacterial	 strains	 were	 grown	 to	 stationary	 phase	 in	 LB	medium	overnight.	Subsequently	they	were	diluted	to	an	OD600	of	0.1	in	fresh	LB	medium	 supplemented	 with	 10	 mM	 IPTG	 or	 the	 relevant	 antibiotic	 control,	chloramphenicol	 (30	µg/ml),	 ciprofloxacin	 (1µg/ml)	or	 rifampicin	 (100	µg/ml)	to	 inhibit	 protein	 synthesis,	 DNA	 synthesis	 and	 RNA	 synthesis	 respectively.	Cultures	were	incubated	at	37	˚C,	200	rpm.	At	stated	time	points	500	µl	samples	were	harvested	and	normalized	to	an	OD600	of	0.1.	Subsequently,	samples	were	incubated	at	room	temperature	with	1	µCi	of	Methionine-35S	(10	mCi/ml)	2.5	of	µCi	 Thymidine-2-14C	 (10	 µCi/ml)	 or	 of	 2.5	 µCi	 Uracil-2-14C	 (10	 µCi/ml)	 (all	purchased	 from	 Biotrend,	 Florida,	 USA)	 to	 monitor	 rates	 of	 protein,	 DNA	 and	RNA	 synthesis	 respectively.	 After	 5	 min	 of	 incorporation	 of	 radiolabelled	isotopes,	0.5	mg	of	the	respective	cold	isotope	(excess	of	at	least	10	times	that	of	the	radiolabelled	isotope)	was	added	to	the	bacterial	cultures	and	incubated	for	a	further	10	min.	Cells	were	then	centrifuged	at	full	speed	for	5	min	to	pellet	and	
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then	washed	with	500	µl	70%	ethanol	3	times.	Pellets	were	then	resuspended	in	10	 µl	 70%	 ethanol	 and	 dotted	 onto	 Whatman	 gel	 blotting	 paper	 (GB003).	Exposed	 to	 a	 photostimulable	 phosphor	 (PSP)	 plate	 overnight.	 Levels	 of	incorporation	of	the	radiolabelled	isotopes	were	then	visualised	using	a	Typhoon	FLA	 7000	 phosphorimager	 (GE	 Healthcare).	 Images	 were	 then	 analysed	 using	Image	J	to	quantify	the	intensity	of	the	radiation	signal.	
2.17	gDNA	plasmid	library	preparation		 WT	 S.	 Typhimurium	 was	 grown	 overnight	 in	 LB	 medium.	 gDNA	 was	harvested	 using	 Wizard	 Genomic	 DNA	 Purification	 Kit	 (Promega)	 to	 the	manufacturers	specifications.	The	gDNA	was	 then	partially	digested	with	serial	three-fold	dilutions	of	Sau3AI	(NEB),	ranging	from	1	U/µg	of	DNA	to	0.04	U/µg	of	DNA,	 for	 30	 min	 at	 37	 ˚C.	 Individual	 digestion	 reactions	 were	 separated	 and	visualised	 via	 electrophoresis,	 as	 previously	 described.	 Fragments	 of	 digested	DNA	ranging	 from	1	kb	 to	5	kb	were	excised	and	extracted	 from	 the	gel	using	QIAquick	 Gel	 Extraction	 kit	 (Qiagen)	 to	 the	 manufacturers	 specifications.	Extracted	samples	were	pooled	and	purified	using	QIAquick	PCR	purification	kit	(Qiagen)	 as	 directed.	 pBR322	 plasmid	 was	 digested	 with	 BamHI	 and	dephosphorylated	 using	 calf	 intestinal	 alkaline	 phosphatase	 (NEB),	 both	 as	directed	 by	 the	 manufacturer.	 Sau3AI-digested	 DNA	 and	 BamHI-digested	pBR322	 vector	 were	 ligated	 using	 T4	 DNA	 ligase,	 as	 previously	 described.	Ligation	 reactions	were	 pooled	 and	 transformed	 into	 chemically	 competent	E.	
coli	DH5α.	Colonies	were	selected	 for	on	LB	agar	plates	 supplemented	with	50	µg/ml	carb.	The	following	day	CFU	was	determined,	the	colonies	pooled	into	1.5	ml	 LB	 and	 plasmids	 extracted	 as	 previously	 described.	 Using	 the	 carbon	 and	
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Clarke	 formula,	 it	was	determined	 that	over	24	000	colonies	would	need	 to	be	pooled	in	order	to	ensure	complete	coverage	of	the	genome.	
2.18	Identification	of	T8	titrating	proteins	using	the	gDNA	
library		 E.	coli	 DH5α	harbouring	 the	pBT6	or	 pBT8	plasmid	were	made	 electro-competent	and	transformed	with	the	pooled	gDNA	plasmid	library,	as	previously	described.	After	1	h	recovery,	the	cells	were	centrifuged	at	full	speed	for	1	min,	washed	 once	 in	 sterile	 PBS	 and	 resuspend	 in	 1	 ml	 sterile	 PBS.	 10%	 of	 the	bacterial	 solution	 was	 then	 plated	 on	 LB	 agar	 plates	 supplemented	 with	 the	relevant	 antibiotics	 to	 select	 for	 positive	 transformants	 (non-inducing	conditions).	 The	 remaining	 90%	 was	 plated	 on	 LB	 agar	 plates	 supplemented	with	the	selective	antibiotics	and	50	mM	L-arabinose	to	induce	expression	of	the	toxins.	CFU	of	the	non-induced	transformants	was	used	to	determine	the	overall	number	of	colonies	screened.	Colonies	from	the	inducing	plates	were	sequenced	to	determine	the	contents	of	the	gDNA	library	plasmid.		
2.19	 Identification	 of	 T8	 titrating	 proteins	 using	 the	 ASKA	
library		 E.	 coli	 DH5α	 harbouring	 the	 pB18T8	 plasmid	 were	 made	 electro-competent	and	transformed	with	the	pooled	ASKA	plasmid	library	(Kitagawa	et	
al.,	2005),	as	previously	described.	After	1	h	recovery,	the	cells	were	centrifuged	at	full	speed	for	1	min,	washed	once	in	sterile	PBS	and	resuspend	in	1	ml	sterile	PBS.	 10%	 of	 the	 bacterial	 solution	 was	 then	 plated	 on	 LB	 agar	 plates	supplemented	with	 the	relevant	antibiotics	 to	 select	 for	positive	 transformants	
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(non-inducing	 conditions).	 The	 remaining	 90%	 was	 plated	 on	 LB	 agar	 plates	supplemented	 with	 the	 selective	 antibiotics,	 50	 mM	 L-arabinose	 and	 250	 µM	IPTG	 to	 induce	 gene	 expression	 from	 both	 plasmids.	 CFU	 of	 the	 non-induced	transformants	was	used	 to	determine	 the	overall	number	of	colonies	screened.	Colonies	from	the	inducing	plates	were	sequenced	to	determine	the	contents	of	the	ASKA	library	plasmid.		
2.20	Cell	free	in	vitro	expression	assay		 Cell	 free	 in	vitro	expression	assays	were	carried	out	using	PurExpress	 in	
vitro	 protein	 synthesis	 kits	 (NEB),	 a	 cell-free	 transcription/translation	 system	reconstituted	 from	the	purified	components	necessary	 for	E.	coli	translation,	 to	the	 manufacturers	 specifications.	 Murine	 RNAse	 (NEB)	 was	 always	 added	 as	advised.	 10	 mM	 Ac-CoA	 (Sigma-Aldrich)	 and	 2	 ng	 of	 purified	 T8	 were	 added	where	 stated.	 For	 radioactive	 experiments,	 reactions	were	 supplemented	with	0.2	mM	[14C]Ac-CoA		(Perkin	Elmer,	Massachusetts,	USA).	Samples	were	analysed	by	12%	SDS-PAGE	or	10%	acid-urea	PAGE	and	stained	by	Coomassie,	methylene	blue	staining,	autoradiography	or	Northern	blot.	
2.21	Expression	and	purification	of	recombinant	T8	
	 The	E.	 coli	 expression	 strain	 PC2,	 BL21(DE3)pLysS	 (Cherepanov,	 2007)	harbouring	 pRSFduet	 expression	 plasmid,	 that	 contained	 the	 t8	 gene	 in	 one	multiple	cloning	site	and	the	a8	gene	in	the	second	multiple	cloning	site	(strain	generated	by	M.	Pryzydacz,	Hare	Lab,	Imperial	College	London),	were	grown	to	stationary	phase	overnight.	Subsequently,	cultures	were	diluted	1/100	into	1	L	of	LB	broth	and	grown	to	an	OD600	of	0.6-0.8	at	37	˚C,	200	rpm.	Gene	expression	was	induced	by	the	addition	of	0.5	mM	IPTG	and	cultures	were	then	incubated	at	
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18	˚C,	200	rpm	overnight.	Bacteria	were	harvested	by	centrifugation	at	10	000	x	
g	for	10	min	at	4	°C.	Pellets	were	frozen	at	-20	°C	overnight.	Upon	thawing	pellets	were	resuspended	in	50	ml	of	lysis	buffer	(50	mM	Tris	pH	7.5,	500	mM	NaCl,	1	mg/ml	Lysozyme,	0.5	mM	phenylmethanesulfonyl	fluoride	(PMSF))	and	lysed	by	sonication,	1	min	cycles	at	50%	power.	Lysate	was	then	cleared	by	centrifugation	at	16	000	x	g	for	30	min.	The	cleared	lysate	was	then	incubated	with	2	ml	of	Ni-NTA	resin	(Qiagen)	for	1	h	at	4	 ˚C	with	agitation.	The	lysate/resin	mixture	was	applied	to	a	column	and	the	resin	washed	with	50	ml	wash	buffer	(50	mM	Tris	pH7.5,	 500	 mM	 NaCl,	 40	 mM	 Imidazole).	 To	 denature	 the	 TA	 complex,	 the	protein	bound	resin	was	washed	with	50	ml	denaturation	buffer	(50	mM	Tris	pH	7.5,	500	mM	NaCl,	5	M	GnHCl)	and	then	50	ml	of	denaturation	wash	buffer	(50	mM	 Tris	 pH	 7.5,	 500	 mM	 NaCl,	 5	 M	 GnHCl,	 40	 mM	 Imidazole).	 Finally,	 the	denatured	toxin	was	eluted	in	10	ml	denaturation	elution	buffer	(50	mM	Tris	pH	7.5,	500	mM	NaCl,	5	M	GnHCl,	500	mM	Imidazole).	The	denatured	protein	was	refolded	via	overnight	dialysis	at	4	˚C,	against	2	L	dialysis	buffer	(25	mM	Tris	pH	7.5,	25	mM	NaCl,	5%	glycerol)	using	3500	MWCO	dialysis	tubing	(Spectrum	labs,	California,	USA).	Refolded	T8	was	concentrated	via	centrifugation	using	Amicon	Ultra-4	 10K	 filter	 columns	 (Millipore,	 Massachusetts,	 USA)	 as	 per	 the	manufacturers	specifications	and	stored	at	-80	°C.		
2.22	 Expression	 and	 purification	 of	 recombinant	 T8Y140F	 (Hare	
Lab,	Imperial	College	London)	The	E.	 coli	 expression	 strain	 PC2,	 BL21(DE3)pLysS	 (Cherepanov,	 2007)	harbouring	 the	 pHISH::t8Y140F	 vector,	 encoding	 a	 C-terminal,	 cleavable	 6His	tagged	 T8Y140F	 gene	 (strain	 generated	 by	 M.	 Pryzydacz,	 Hare	 Lab,	 Imperial	
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College	 London),	 was	 grown	 to	 stationary	 phase	 overnight.	 Subsequently,	cultures	were	diluted	1/100	into	1	L	of	LB	broth	and	grown	to	an	OD600	of	0.6-0.8	at	37	˚C,	200	rpm.	Gene	expression	was	induced	by	the	addition	of	0.5	mM	IPTG	and	 cultures	 were	 then	 incubated	 at	 18	 ˚C,	 200	 rpm	 overnight.	 Bacteria	 were	harvested	by	centrifugation	at	10	000	x	g	for	10	min	at	4	°C.	Pellets	were	frozen	at	 -20	 °C	 overnight.	 Upon	 thawing	 pellets	were	 resuspended	 in	 50	ml	 of	 lysis	buffer	(50	mM	Tris	pH	7.5,	500	mM	NaCl,	1	mg/ml	Lysozyme,	0.5	mM	PMSF)	and	lysed	 by	 sonication,	 1	 min	 cycles	 at	 50%	 power.	 Lysate	 was	 then	 cleared	 by	centrifugation	at	16	000	x	g	 for	30	min.	The	cleared	 lysate	was	then	 incubated	with	2	ml	of	Ni-NTA	resin	(Qiagen)	for	1	h	at	4	˚C	with	agitation.	The	lysate/resin	mixture	was	applied	to	a	column	and	the	resin	washed	with	50	ml	wash	buffer	(50	 mM	 Tris	 pH7.5,	 500	 mM	 NaCl,	 20	 mM	 Imidazole).	 The	 protein	 was	 then	eluted	 in	 10	 ml	 elution	 buffer	 (50	 mM	 Tris	 pH7.5,	 500	 mM	 NaCl,	 500	 mM	imidazole)	 and	 the	6His	 tag	was	 cleaved	 from	 the	 toxin	with	3C	protease.	 The	protein	was	diluted	to	decrease	the	NaCl	concentration	to	100	mM	and	further	purified	 by	 ion	 exchange	 column	 chromatography	 using	 a	 1	ml	 HiTrap	 SP	 HP	column	(GE	Healthcare)	equilibrated	with	(50	mM	Tris	pH7.5,	100	mM	NaCl,	10	mM	β-mercaptoethanol).	Elution	was	 carried	out	using	 the	Akta	Prime	protein	purification	system	(GE	Healthcare)	with	a	salt	gradient	ranging	from	0.1	M	to	1	M	 NaCl.	 Fractions	 containing	 the	 protein	 were	 pooled	 and	 subjected	 to	 size	exclusion	 column	 chromatography	 using	 HiLoad	 Superdex-75	 16/600	 column	(GE	Healthcare)	equilibrated	with	(50	mM	Tris	pH7.5,	150	mM	NaCl,	10	mM	β-mercaptoethanol).	 
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2.23	Crystallization	and	structure	determination	of	recombinant	
T8Y140F	(Hare	Lab,	Imperial	College	London)	Purified	 T8Y140F	 protein	 (10	 mg/ml)	 was	 crystallized	 by	 hanging	 drop	vapour	 diffusion	 against	 a	 reservoir	 of	 22	%	 (w/v)	 Pentaerythritol	 ethoxylate	(15/4	 EO/OH),	 100	 mM	 Bis-tris	 pH6.5,	 50	 mM	 Ammonium	 sulphate.	Crystallization	 was	 enhanced	 by	 streak	 seeding.	 Crystals	 were	 harvested	 and	frozen	directly	by	immersion	in	liquid	nitrogen.	Diffraction	data	were	acquired	at	Diamond	 light	 source	 (Oxfordshire,	 UK)	 on	 beamline	 I04-1.	 A	 high-resolution	native	 dataset	was	 integrated	with	mosflm	 (Leslie	&	 Powell,	 2007)	 and	 scaled	using	scala	(Evans,	2006)	of	the	ccp4i	suite	(Winn	et	al.,	2011).	For	experimental	phasing,	 crystals	were	 soaked	 in	 reservoir	 solution	 supplemented	with	 0.5	 -	 1	mM	NaBr	for	up	to	60	seconds	before	freezing.	Highly	redundant	datasets	were	collected	 at	 the	bromide	 edge	 from	 five	NaBr-soaked	 crystals,	 processed	using	the	 XDS	 and	 XSCALE	 via	 the	 xia2	 pipeline	 (Kabsch,	 2010;	 Sauter	 et	 al.,	 2004;	Winter	et	al.,	2013;	Zhang	et	al.,	2006)	and	merged	together	using	blend	(Foadi	
et	al.,	2013)	to	give	a	final	dataset	with	>50	fold	anomalous	redundancy.	Phases	were	 obtained	 from	 single	 wavelength	 anomalous	 dispersion	 using	 PHENIX	AutoSol,	 which	 also	 performed	 density	 modification	 and	 automated	 model	building	(Adams	et	al.,	2010).	The	AutoSol	output	model	was	manually	improved	using	coot	(Emsley	et	al.,	2010)		and	refined	using	phenix	and	refmac	(Adams	et	
al.,	2010;	Murshudov	et	al.,	1997)	against	the	high-resolution	native	data	to	give	a	final	structure	with	an	Rfree	of	22.5	%	and	good	geometry.	
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2.24	Expression	and	purification	of	recombinant	Pth	(Protein	
Purification	and	Analysis	Facility,	Imperial	College	London)	
E.	coli	BL21-AI	(Invitrogen)	harbouring	pBPth,	encoding	a	C-terminal	his	tag	pth	gene,	were	grown	to	stationary	phase	overnight.	Subsequently,	cultures	were	diluted	1/100	into	1	L	of	LB	broth	and	grown	to	an	OD600	of	0.6-0.8	at	37	˚C,	200	rpm.	Gene	expression	was	induced	by	the	addition	of	0.2	%	L-arabinose	and	incubated	for	3	h	at	37	˚C.	Cells	were	harvested	by	centrifugation,	as	previously	described,	and	resuspended	in	50	ml	lysis	buffer	(300	mM	NaCl,	50	mM	Tris	pH	7.5,	 15	 mM	 imidazole,	 2	 mM	 β-mercaptoethanol,	 with	 EDTA-free	 protease	inhibitor	cocktail	(Roche)).	Lysate	was	then	cleared	by	centrifugation	as	before,	the	cleared	lysate	was	applied	to	TALON	Cobalt	resin	(Clontech,	California,	USA)	and	washed	extensively	firstly	with	lysis	buffer	and	then	with	wash	buffer	(150	mM	NaCl,	50	mM	Tris	pH	7.5,	15	mM	imidazole,	2	mM	β-mercaptoethanol).	The	protein	was	eluted	with	10	ml	elution	buffer	(250	mM	imidazole	in	25	mM	Tris	pH	7.5,	150	mM	NaCl,	2	mM	β-mercaptoethanol),	and	dialysed	overnight	against	2	L	dialysis	 buffer	 (25	mM	Tris	pH	7.5,	 150	mM	NaCl,	 5	mM	DTT)	using	3500	MWCO	 dialysis	 tubing	 (Spectrum	 labs).	 Purified	 Pth	 was	 concentrated	 via	centrifugation	 Amicon	 Ultra-4	 10K	 filter	 columns	 (Millipore)	 as	 per	 the	manufacturers	specifications	and	stored	at	-80	°C.	
2.25	Analysis	of	tRNA	and	peptidyl-tRNAs	(ptRNA)	by	gel	
electrophoresis	Total	 RNA	was	 extracted	 from	 Salmonella	by	 acid-phenol	 extraction,	 to	maintain	 the	 ester	 link	 between	 tRNA	 and	 amino	 acid/peptide	 (Kohrer	 &	RajBhandary,	 2008).	 Briefly,	 bacteria	 were	 harvested	 by	 centrifugation	 and	
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resuspended	in	300	µl	10	mM	sodium	acetate	pH	4.5.	One	volume	of	acid-phenol	was	 added	 and	 incubated	 for	 on	 ice	 for	 15	min,	 with	 vortexing.	 The	 aqueous	phase	 was	 separated	 by	 centrifugation,	 at	 4	 ˚C,	 and	 collected	 on	 ice.	 This	extraction	was	repeated	and	the	aqueous	phases	pooled	and	ethanol	precipitated	by	 incubation	 in	 absolute	 ethanol	 at	 -80	 ˚C	 overnight.	 Subsequently,	 samples	were	centrifuged	at	21	000	x	g	for	30	min,	4	˚C	and	washed	twice	with	ice-cold	70%	 ethanol.	 Pellets	 were	 air	 dried	 for	 10	 min	 and	 resuspended	 in	 10	 mM	sodium	acetate	pH	4.5	This	allows	isolation	of	ptRNA	molecules	carrying	nascent	chains	 of	 up	 to	 80	 residues	 (Janssen	 et	 al.,	 2012).	 Deacylated,	 aminoacyl-	 and	ptRNAs	were	separated	by	acid-urea	PAGE.	tRNA	samples	were	resuspended	in	tRNA	loading	buffer	(8M	Urea,	10	mM	NaOAc,	1	mM	EDTA,	0.01%	xylene	cyanol,	0.01%	bromophenol	blue,	50%	glycerol,	50%	dH20)	and	separated	over	a	10%	acid	urea	gel	(10%	v/v	30%	acrylamide/bis-acylamide	solution,	8	M	Urea,	0.1	M	NaOAc	pH	4.5,	1	mM	EDTA,	.15%	v/v	TEMED,	0.7%	w/v	Ammonium	persulfate)	in	running	buffer	(100	mM	NaOAc,	1	mM	EDTA)	and	stained	by	methylene	blue	(500	mM	sodium	acetate,	0.06	%	methylene	blue)	(Janssen	et	al.,	2012).	
2.26	T8	in	vitro	functional	assay		 Purified	 ptRNA	 was	 incubated	 with	 purified	 T8	 (2	 µg/ml)	 in	 enzyme	activity	 buffer	 (10	 mM	 Tris	 acetate,	 10	 mM	 magnesium	 acetate,	 20	 mM	ammonium	 acetate	 pH	 8.0)	 1	 h	 at	 37	 ˚C.	 Subsequently,	 samples	 were	 ethanol	precipitated	 as	 previously	 described,	 separated	 by	 acid-urea	 PAGE	 and	visualised	 by	methylene	 blue	 staining,	 as	 previously	 reported	 in	 (Vandavasi	 et	
al.,	2014)	or	by	autoradiography.	
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2.27	Pth	in	vitro	functional	assay	Purified	peptidyl-	or	modified	tRNAs	were	incubated	with	purified	Pth	(4	ug/ml)	 in	 enzyme	 activity	 buffer	 (10	 mM	 Tris	 acetate,	 10	 mM	 magnesium	acetate,	 20	 mM	 ammonium	 acetate	 pH	 8.0)	 1	 h	 at	 37	 ˚C.	 The	 samples	 were	ethanol	 precipitated,	 as	 previously	 described,	 and	 were	 run	 side-by-side	 with	uncleaved	 ptRNA	 on	 acid-urea	 PAGE	 and	 stained	 with	 methylene	 blue	 or	visualised	by	autoradiography.		
2.28	Northern-blot	(Bridget	Golan)	Northern	analysis	was	used	 for	detection	of	 tRNA	molecules.	Total	RNA	was	fractionated	by	acid	urea-PAGE,	as	previously	described.	tRNA	was	blotted	onto	 a	 Nytran	 membrane	 (Whatman	 0.45uM	 pore	 Nytran	 supercharge	membrane).	Briefly,	both	the	gel	and	membrane	were	washed	in	0.5	x	TBE	for	1	minutes	and	RNA	transferred	using	a	semi	dry	transfer	cell	at	650	mA	for	30	min.	Membranes	were	then	equilibriated	in	5x	saline-sodium	citrate	buffer	(SSC)	(750	mM	NaCl,	75	mM	Sodium	citrate,	pH	7)	for	2	min	and	then	subsequently	washed	in	 0.1	 x	 SSC,	 0.1%	 SDS	 at	 65˚C	 for	 30	 min.	 Membranes	 were	 blocked	 in	 pre-hybridisation	buffer	(10%	Denhardts	solution,	0.1%	SDS,	6	x	SSC)	for	1	hour	at	45˚C	 and	 hybridized	 with	 a	 single-stranded	 32P-labelled	 riboprobe	 primer	complementary	to	tRNAala	overnight.	The	membrane	was	then	washed	3	times	in	6	x	SSC,	0.1%	SDS	at	room	temperature	and	once	at	50˚C	to	remove	excess	probe.	Finally	membranes	were	exposed	to	a	PSP	plate	and	the	radiolabelling	visualised	using	a	Typhoon	FLA	7000	phosphorimager	(Janssen	et	al.,	2012).	
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2.29	Sample	preparation	for	mass	spectrometry	analysis		 The	 putative	 targets	were	 purified	 from	 Salmonella,	 with	 or	without	 t8	over-expression.	 Bacteria	 were	 grown	 to	 stationary	 phase	 overnight.	Subsequently,	cultures	were	diluted	1/100	into	250	ml	of	LB	broth	and	grown	to	an	 OD600	 of	 0.6-0.8	 at	 37	 ˚C,	 200	 rpm.	 Gene	 expression	 was	 induced	 by	 the	addition	of	10	mM	IPTG	and	0.2%	L-arabinose	and	incubated	at	37	˚C,	200	rpm	for	3	h.	Cells	were	harvested	by	centrifugation	at	8	000	x	g	for	10	min	at	4	 °C,	resuspended	in	10	ml	of	lysis	buffer	(50	mM	Tris	pH	7.5,	500	mM	NaCl,	1	mg/ml	Lysozyme,	0.5	mM	PMSF)	and	 lysed	by	sonication,	1	min	cycles	at	50%	power.	Lysate	was	then	cleared	by	centrifugation	at	16	000	x	g	for	30	min.	The	cleared	lysate	was	 then	 incubated	with	500	µl	of	Ni-NTA	resin	 (Qiagen)	 for	1	h	at	4	 ˚C	with	agitation.	The	 lysate/resin	mixture	was	 then	applied	 to	a	 column	and	 the	resin	washed	with	10	ml	wash	buffer	(50	mM	Tris	pH7.5,	500	mM	NaCl,	40	mM	Imidazole).	 Finally,	 the	 putative	 target	 proteins	were	 eluted	 in	 4	ml	 of	 elution	buffer	 (50	 mM	 Tris	 pH	 7.5,	 500	 mM	 NaCl,	 500	 mM	 Imidazole).	 The	 purified	protein	was	concentrated	via	 centrifugation	Amicon	Ultra-4	10K	 filter	 columns	(Millipore)	as	per	the	manufacturers	specifications,	separated	by	SDS-PAGE	and	visualised	by	Coomassie	 staining,	as	previously	described.	Gel	areas	containing	the	purified	protein	were	excised	and	sent	for	analysis	by	nLC-ESI-MS/MS	at	the	BRSC	 Mass	 Spectrometry	 and	 Proteomics	 facility,	 University	 of	 St.	 Andrews.	Peptides	of	the	putative	target	proteins	were	identified	using	the	Mascot	search	engine	and	potential	acetylation	events	were	predicted	based	on	the	appearance	of	 a	 42	 Da	 shift	 in	 the	 peptide	 mass.	 Confirmation	 of	 any	 predicted	 lysine-acetylation	events	were	determined	by	the	identification	of	126	m/z	peak	in	the	raw	data	(Couttas	et	al.,	2008).	
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Chapter	three	
Functionality	and	regulation	of	the	GNAT	TA	
modules	
3.1	Introduction		 As	previously	mentioned,	my	lab	has	shown	that	there	 is	a	repertoire	of	14	chromosomally	encoded	type	II	TA	modules	that	are	involved	in	macrophage-induced	persister	formation	(Helaine	et	al.,	2014).	Eleven	share	significant	amino	acid	 sequence	 similarity	 with	 previously	 characterised	 TA	 modules	 (RelBE	 -	Gotfredsen	 &	 Gerdes	 1998,	 HigBA	 -	 Tian	 et	 al.,	 1996,	 Phd-Doc	 -	 Lehnherr	 &	Yarmolinsky,	 1995,	 ParDE	 –	 Roberts	 et	 al.,	 1994),	 one	 has	 been	 functionally	characterised	 in	E.	coli	(VapC	–	Winther	&	Gerdes,	2011).	The	 remaining	 three	constitute	 a	 poorly	 characterised	 new	 family	 of	 TA	 modules	 where	 the	 toxin	component	of	the	operon	is	predicted	to	be	a	GCN5	N-acetyltransferase.	During	the	course	of	my	PhD,	homologues	of	this	family	have	been	shown	to	be	bone	fide	TA	 modules	 in	 Salmonella	 (Lobato-Márquez	 et	 al.,	 2015),	 however,	 a	 detailed	structural	 and	 functional	 characterisation	 had	 yet	 to	 be	 carried	 out.	 In	 this	chapter,	I	report	the	work	I	undertook	to	further	examine	the	activation	of	all	14	TA	modules	in	response	to	macrophage	internalisation;	to	confirm	that	all	three	elements	 of	 the	 novel	 GNAT	 TA	 family,	 TA6,	 TA8	 and	 TA9	 in	 S.	Typhimurium	strain	 12023,	 were	 bona	 fide	 TA	modules;	 and	 to	 investigate	 any	 interactions	between	them	in	in	vitro	and	in	vivo	culture	conditions.		
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3.2	Results		
3.2.1	Activation	of	type	II	TA	modules	upon	S.	Typhimurium	internalisation	
by	macrophages		 My	lab	has	shown	that	internalisation	of	S.	Typhimurium	by	BMMø	led	to	a	100-1000	fold	increase	in	the	number	of	persisters.	Single	deletion	mutants	of	each	 of	 the	 14	 type	 II	 TA	 module,	 depicted	 on	 the	 S.	 Typhimurium	 12023	chromosome	(Figure	3.1.1),	resulted	in	a	decrease	in	these	macrophage	induced	persisters	 compared	 to	 WT	 (Helaine	 et	 al.,	 2014).	 According	 to	 the	 accepted	model	of	TA	activation,	degradation	of	the	antitoxin	leads	to	an	alteration	in	the	ratio	 of	 antitoxin	 to	 toxin	 proteins	 resulting	 in	 derepression	 of	 the	 TA	 operon	promoter.	As	such,	an	increase	in	mRNA	levels	of	the	TA	modules	can	be	used	as	an	indicator	of	their	activation.	I	monitored	the	fold	changes	in	the	mRNA	levels	of	 14	TA	modules	 upon	macrophage	 internalisation	 to	 test	whether	 they	were	indeed	activated.	Here,	WT	bacteria	were	isolated	30	min	after	internalisation	by	BMMø.	Total	 bacterial	RNA	was	 then	 extracted	 from	 the	 released	bacteria	 and	the	 corresponding	 inoculum	culture.	A	DNase	 treatment	was	used	 to	eliminate	gDNA	 and	 cDNA	 was	 synthesised	 from	 the	 mRNA	 via	 one-step	 reverse	transcription.	Quantitative	PCR	(qPCR)	was	then	used	to	amplify	the	cDNA	with	28	primer	pairs	specific	to	the	toxin	and	antitoxin	of	each	of	the	14	TA	modules.	Levels	of	mRNA	of	each	TA	module	 from	the	macrophage-internalised	bacteria	were	 normalised	 to	 those	 of	 the	 inoculum	 culture,	 and	 the	 fold	 increase	 was	calculated	(Figure	3.1.2A).	Although	the	extent	of	the	increase	varied	among	the	TA	module	 genes,	 ranging	 from	 a	 4-	 (relB2)	 to	 a	 35-fold	 increase	 (higB1),	 the	mRNA	levels	of	all	the	toxin-antitoxin	pairs	increased,	suggesting	that	all	14	are	
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activated	 in	 response	 to	 internalisation	 by	 BMMø.	 As	 these	 experiments	 were	carried	 out	 in	 primary	BMMø,	 it	was	 necessary	 to	 use	macrophages	 harvested	from	 a	 different	 mouse	 for	 each	 biological	 replicate.	 There	 are	 inevitable	variations	between	the	macrophage	batches,	such	as	bacterial	uptake	and	intra-SCV	 conditions,	which	would	 lead	 to	 variation	 in	 activation	of	 the	TA	modules	and	may	account	for	the	large	error	bars.		Upon	 internalisation	 by	 macrophages	 S.	 Typhimurium	 enters	 the	 SCV,	within	 which	 they	 encounter	 a	 number	 of	 hostile	 conditions	 such	 as	 low	 pH,	nutrient	 limitation	 and	 ROS.	 It	 was	 shown	 that	 among	 these	 stresses,	 the	combination	of	low	pH	and	nutrient	limitation	is	responsible	for	the	induction	of	persister	formation	(Helaine	et	al.,	2014).	As	I	have	shown	that	TA	modules	are	activated	 upon	 internalisation,	 I	 tested	 whether	 I	 could	 recapitulate	 this	activation	 in	vitro.	To	 test	 this,	 total	RNA	was	extracted	 from	bacteria	 that	had	been	subjected	to	exposure	to	Serine	Hydroxymate	(SHX),	to	induce	amino-acid	starvation,	or	pH	shock,	 from	pH	7.5	 to	pH	4.5,	 for	30	min.	Extracted	RNA	was	treated	 with	 DNase,	 cDNA	 synthesised	 and	 qPCR	 with	 the	 14	 primer	 pairs	specific	to	each	toxin	gene	was	used	to	amplify	the	cDNA	as	previously	described.	Levels	 of	mRNA	 corresponding	 to	 each	 toxin	 gene	 from	 treated	 bacteria	were	normalised	 to	 those	of	untreated	bacteria	and	 the	 fold	 increase	was	 calculated	(Figure	 3.1.2B).	 pH	 shock	 induced	 moderate	 increases	 in	 toxin	 mRNA	 levels,	whereas	SHX	treatment	led	to	a	2-	7-	fold	increase	in	mRNA	levels	for	all	toxins.	Thus,	mimicking	conditions	encountered	within	 the	SCV	 that	are	 important	 for	persister	formation	lead	to	an	increase	in	mRNA	levels	for	each	toxin	gene.	These	results	correlate	with	the	previous	reports	showing	that	all	of	the	14	 TA	 modules	 are	 involved	 in	 macrophage	 induced	 persister	 formation,	
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strongly	 suggesting	 that	 they	 are	 activated	 upon	 macrophage	 internalisation.	Furthermore,	they	confirm	that	 it	 is	the	conditions	encountered	within	the	SCV	that	lead	to	activation	of	the	TA	modules.			
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Figure 3.1.1: TA modules on S. Typhimurium 12023 Chromosome. S. Typhimurium harbours at least 14 chro-
mosomally encoded putative TA modules.  
 
Figure 3.1.2: Increase in mRNA levels of each TA module in response to transient exposure to various stress-
es. A) Fold increase in mRNA levels for each putative TA gene pair in WT Salmonella after 30 min internalization by 
primary murine BMMĭ relative to levels in LB medium-grown bacteria. B) Fold increase in mRNA levels of each puta-
tive toxin gene in WT Salmonella following 30 min exposure to SHX (blue bars) or pH shift (green bars) from 7.0 to 
4.5, relative to levels in LB medium-grown bacteria. Data represent the mean ± SEM (n=3).  
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3.2.2	GNAT-RHH	toxin-antitoxin	family		 Out	 of	 the	 14	 TA	 modules	 that	 are	 involved	 in	 Salmonella	 persister	formation,	we	 decided	 to	 focus	my	 efforts	 on	 the	 characterisation	 of	 the	 three	modules	containing	a	predicted	GNAT	toxin	component.		We	have	shown	previously	that	all	three	GNAT	TA	modules	are	important	for	persister	formation	in	response	to	macrophage	internalisation	(Helaine	et	al.,	2014).	 During	 the	 course	 of	 my	 PhD,	 two	 studies	 have	 shown	 that	 GNAT	 TA	modules	 are	 bona	 fide	 TA	 modules.	 In	 Salmonella,	 GNAT	 TA	 modules	 are	predicted	to	be	composed	of	a	toxin	protein	belonging	to	the	GNAT	superfamily	and	an	antitoxin	protein.	The	first	attempt	at	characterising	such	a	module	was	published	 in	2013,	 in	a	 study	of	 the	 repertoire	of	TA	modules	of	Acinetobacter	
baumannii.	 However,	 in	 this	 study	 the	 authors	 described	 the	 predicted	 HTH	antitoxin	to	be	toxic	when	over-produced.	This	toxicity	was	rescued	by	parallel	over-production	 of	 the	 predicted	 GNAT	 toxin.	 As	 such	 the	module	was	 named	CheTA	for	switched-element	toxin-antitoxin	system	(Jurenaite	et	al.,	2013).	The	 second	 characterisation	 of	 a	 GNAT	 TA	 module	 was	 as	 part	 of	 the	analysis	 of	 the	 role	 of	 27	 chromosomal	 and	 plasmidic	 type	 I	 and	 type	 II	 TA	modules	in	S.	Typhimurium	strain	SL1344	during	infection	published	during	the	third	 year	 of	 my	 project	 (Lobato-Márquez	 et	 al.,	 2015).	 In	 this	 study	 it	 was	determined	 that	 the	 predicted	 GNAT	 toxins	 encoded	 by	 SL13144_2885	 (t6	homologue),	 SL1344_3617	 (t8	 homologue)	 and	 SL1344_4254	 (t9	 homologue)	were	toxic	when	over-produced.	This	toxicity	was	counteracted	by	parallel	over-expression	 of	 the	 cognate	 antitoxin.	Moreover,	 the	 authors	 identified	 all	 three	
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toxins	 by	 mass	 spectrometry	 analysis	 in	 bacteria	 isolated	 from	 human	fibroblasts	 (Lobato-Márquez	 et	al.,	 2015).	 This	 study,	 in	 concert	with	 the	 data	previously	reported	by	my	lab	show	the	importance	of	GNAT	TA	modules.	First	 of	 all,	 as	 type	 II	 TA	 modules	 are	 generally	 bicistronic	 operons,	 I	tested	whether	this	was	the	case	for	the	three	GNAT	TA	modules.	Total	RNA	was	extracted	from	a	stationary	phase	culture	of	WT	S.	Typhimurium,	and	following	reverse	 transcription,	 I	 used	 primer	 pairs	 specific	 to	 each	 antitoxin	 and	 toxin	gene	 to	 amplify	 by	 PCR	 the	 individual	 genes	 or	 the	 whole	 operons	 (Figure	3.2.1A).	Amplicons	were	separated	by	DNA	gel	electrophoresis.	When	using	the	combination	of	 the	antitoxin	 forward	and	 the	 toxin	reverse	primers,	 I	detected	an	amplification	product	corresponding	to	the	antitoxin	and	the	toxin	genes	of	all	three	TA	modules,	suggesting	that	all	three	form	operons	(Figure	3.2.1B).	Examination	 of	 the	 amino	 acid	 sequence	 of	 each	 of	 the	 antitoxin	components	of	the	three	GNAT	TA	modules	suggested	that	they	all	contain	an	N-terminal	 ribbon-helix-helix	 (RHH)	 domain.	 Based	 on	 the	 knowledge	 obtained	from	 previously	 characterised	 TA	 modules,	 it	 could	 be	 predicted	 that	 these	antitoxins	 bind	 their	 own	 promoter	 through	 this	 RHH	domain	 (Figure	 3.2.2A).	The	C-terminal	region	of	antitoxins	that	constitutes	the	toxin-binding	domain	is	generally	largely	unstructured	in	its	free	form	as	revealed	in	a	model	of	A6	using	the	Phyre	protein	prediction	software	(Figure	3.2.2B).	Although	the	three	toxins	share	 little	 amino	 acid	 identity,	 a	 simple	 NCBI	 protein	 BLAST	 alignment	(http://blast.ncbi.nlm.nih.gov/Blast.cgi)	 revealed	 the	 presence	 of	 a	 conserved	domain	 specific	 to	 the	 GCN5	N-acetyltransferase	 superfamily	 and	 showed	 that	they	contain	the	predicted	Ac-CoA	binding	residues	(Figure	3.2.2C).	A	predicted	structure	 of	 each	 toxin	 protein	 could	 be	 modelled	 using	 the	 Phyre	 protein	
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prediction	 software.	 The	 Salmonella	 N-acetyltransferase	 RimI	 was	 used	 as	 a	template	for	structure	prediction	(Figure3.2.2D).	Based	on	these	predictions	the	three	 toxins	 have	 a	 dissimilar	 tertiary	 structure,	 however	 all	 three	 fold	 to	identify	the	canonical	Ac-CoA	binding	pocket.	
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3.2.3	Construction	and	validation	of	the	TA	module	expression	plasmids		 To	 test	 the	 functionality	 of	 the	 components	 of	 the	 three	 GNAT	 TA	modules,	I	first	cloned	the	TA	module	components	into	over-expression	vectors.	Full-length	 toxin	 genes	 were	 cloned	 individually	 into	 the	 pNDM220	 over-expression	 vector,	 placing	 them	 under	 the	 control	 of	 the	 Plac	 IPTG	 inducible	promoter.	 The	 full-length	 antitoxin	 genes	 were	 cloned	 individually	 into	 the	pBAD33	over-expression	 vector	 and	placed	under	 the	 control	 of	 the	 arabinose	inducible	 Para	 promoter	 (Figure	 3.3.1).	 These	 compatible	 vectors	 were	 co-transformed	into	the	relevant	single	TA	deletion	mutant	in	order	to	remove	any	effect	of	the	endogenous	toxin	and	antitoxin	proteins.	To	confirm	the	expression	of	genes	from	each	of	the	constructs	(Table	3.1),	these	strains	were	incubated	in	LB	medium	 supplemented	 with	 the	 relevant	 sugar	 to	 induce	 gene	 expression.		Total	 RNA	was	 extracted	 from	bacteria	 pre-	 and	 post	 induction,	 and	 following	reverse	 transcription,	 qPCR	was	 used	 to	 amplify	 the	 cDNA	 using	 primer	 pairs	specific	 to	 the	 each	 of	 the	 toxin	 genes	 (Figure	 3.3.2A)	 and	 the	 antitoxin	 genes	(Figure	3.3.2B).		The	inducible	promoters	allowed	leaky	expression	of	the	cloned	genes,	 so	 the	mRNA	 levels	 for	 each	 gene	 from	 post-induction	 conditions	were	normalised	 to	 those	 quantified	 in	 the	 respective	 pre-induction	 conditions	 to	measure	the	increase	in	expression	resulting	solely	from	induction.	Figure	3.3.2	shows	that	 induction	of	expression	from	all	plasmids	resulted	 in	an	 increase	 in	the	 mRNA	 levels	 of	 the	 toxins	 and	 antitoxins.	 The	 large	 discrepancies	 in	 the	increase	in	mRNA	levels	could	be	due	to	variation	in	induction	and	plasmid	copy	number.	 As	 these	 results	 represent	 only	 one	 experiment,	 repeating	 to	 confirm	them	and	to	determine	statistical	significance	would	be	necessary.	To	determine	whether	 this	expression	of	 the	 toxin	genes	enabled	 the	production	of	 the	 toxin	
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proteins,	 stationary	phase,	 single	TA	deletion	mutants	 harbouring	 the	 relevant	toxin	 over-expression	 plasmid	 were	 subcultured	 in	 fresh	 LB	medium,	 with	 or	without	IPTG	supplementation,	and	incubated	for	1	hour	at	37	˚C.	Total	proteins	were	 extracted,	 separated	 by	 SDS-PAGE	 and	 visualised	 by	 Coomassie	 staining.	Figure	3.3.3	shows	that	induction	of	gene	expression	did	not	allow	detection	of	a	band	at	the	expected	size	for	the	toxin	proteins	(approximately	17	kDa).		
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Figure 3.3.2 Increase in mRNA levels of TA genes upon induction.  A) Fold increase in mRNA levels of 
each toxin gene in the respective 6DOPRQHOOD¨WD + pNT strain after 1 hour incubation in LB supplemented with 
IPTG relative to levels in LB medium-grown bacteria. B) Fold increase in mRNA levels of each  antitoxin gene 
in the respective 6DOPRQHOOD¨WD + pBA strain after 1 h incubation in LB supplemented with arabinose relative 
to levels in LB medium-grown bacteria (n=1). 
Figure 3.3.3 Production of toxin proteins.  6DOPRQHOOD¨WD strains harbouring the respective toxin containing 
pNT plasmid were grown to OD600 of 0.4 and subsequently incubated with or without IPTG supplementation 
for 1 h. Samples were harvested and total proteins isolated before subjecting to SDS-PAGE and Coomassie 
staining.
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Figure 3.3.1: Maps of toxin and antitoxin over-expression plasmids. Representative plasmid maps of 
pNDM220 harbouring the toxin coding sequence and pBAD33 harbouring the antitoxin coding sequence.
Table 3.1: TA module over-expression plasmids. Toxin containing plasmids using the pNDM220 vector are 
selectable by ampicillin resistance and are under the control of the lacIQ operon. Antitoxin containing plasmids 
using the pBAD33 vector are selectable by chloramphenicol resistance and are under the control of the ara 
operon.
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3.2.4	Effects	of	expression	of	ta6	and	ta8	on	bacterial	growth		 To	 determine	 whether	 a	 putative	 TA	 module	 is	 functional,	 bacterial	growth	is	monitored	upon	over-expression	of	the	TA	module	genes.	The	effect	of	toxin	 protein	 over-production	 on	 growth	 is	 tested	 first.	 Then,	 we	 test	 if	subsequent	or	parallel	over-production	of	the	antitoxin	neutralises	the	toxicity	of	its	 partner.	 Initially,	 I	 replicated	 experiments	 that	have	been	used	 to	 show	 the	functionality	 of	 well-characterised	 TA	modules	 such	 as	 HipBA	 (Germain	 et	 al.,	2013).	Briefly,	stationary	phase	single	TA	deletion	mutants	harbouring	the	toxin	containing	vector	or	 the	empty	pNDM220	vector	(control)	were	subcultured	 in	fresh	 LB	medium	 and	 grown	 to	 an	OD600	 of	 0.6.	 They	were	 then	 diluted	 to	 an	OD600	 of	 0.2	 in	 fresh	 LB	 medium	 supplemented	 with	 IPTG,	 and	 growth	 upon	over-expression	of	the	toxin	gene	was	monitored	by	measuring	OD600	at	hourly	intervals.	 The	 growth	 kinetics	 of	 bacteria	 over-expressing	 t6	 were	indistinguishable	 from	 those	 of	 their	 respective	 control	 strain	 (Figure	 3.4.1A).	The	 growth	 kinetics	 showed	 that	 bacteria	 over-expressing	 t8	 had	 an	 apparent	reduced	growth	rate,	however,	it	was	not	significantly	different	from	that	of	the	control	strain	at	any	time	point	(Figure	3.4.1B).	These	observations	suggest	that	the	GNAT	toxins	do	not	arrest	growth	upon	over-expression	in	these	conditions.	It	 had	 been	 shown	 that	 these	 TA	 modules	 were	 involved	 in	 persister	formation	 upon	 internalisation	 by	 macrophages	 (Helaine	 et	 al.,	 2014),	 which	suggested	that	 they	were	 functional	TA	modules	 in	 the	 infection	conditions.	To	infect	 macrophages,	 stationary	 phase	 Salmonella	 are	 used	 as	 exponentially	growing	bacteria	express	genes	whose	products	are	highly	cytotoxic	to	this	cell	type.	Hence,	the	toxin	functional	assays	were	repeated,	monitoring	the	effects	of	
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over-expression	of	 the	 toxin	 and	antitoxin	 genes	 in	bacteria	 immediately	upon	subculture	of	an	overnight	culture	 into	 fresh	medium	supplemented	with	 IPTG	and	arabinose.	In	these	conditions	bacteria	over-expressing	t6	and	t8	displayed	an	 extended	 lag	 phase	 (Figure	 3.4.2A-B).	 The	 growth	 delay	 induced	 by	 over-expression	 of	 t6	 or	 t8	 was	 counteracted	 by	 parallel	 over-expression	 of	 their	cognate	 antitoxin	 gene	 (Figure	 3.4.2A-B).	 Although	 the	 counteraction	 of	 T6	toxicity	 by	 A6	 was	 partial,	 it	 was	 highly	 statistically	 significant	 as	 shown	 in	Figure	3.4.2A.	These	results	corroborate	the	data	reported	by	Lobato-Marques	et	
al	and	confirm	that	the	TA6	and	TA8	homologues	of	the	S.	Typhimurium	12023	strain	are	bona	fide	TA	modules.	I	was	unable	to	test	the	functionality	of	TA9	due	to	repeated	point	mutations	occurring	during	cloning.			
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Figure 3.4.1: T6 and T8 lack of toxicity in mid exponential phase bacteria. S. Typhimurium ¨WD(A) and 
¨WD (B) strains harbouring either the pNDM220 empty vector  (     ) or the respective pNT  plasmid  (     ), were 
grown to mid exponential phase and then subcultured to an OD600 of 0.2 in fresh LB medium supplemented 
with IPTG to induce gene expression. Induction began at time point 0 and OD600 measured at hourly intervals. 
Data represent mean ± SEM (n=3).
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Figure 3.4.2: T6 and T8 toxicity revealed in lag phase. Stationary phase S. Typhimurium ¨WD(A) and ¨WD
(B) strains harbouring either the pNDM220 empty vector  (     ), the respective toxin containing plasmid  (     ) 
or the toxin and antitoxin plasmids  (     ), were incubated in LB medium supplemented with IPTG and arabinose 
to induce gene expression. Induction began at time point 0 and OD600 measured at 30 min intervals. Data 
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3.2.5	Toxicity	of	T6	and	T8	is	transient	 	
	 After	2	hours	of	 over-expression	of	 t6,	 inhibitory	 effects	 of	 the	 toxin	on	bacterial	 growth	 seemed	 to	 subside	 (Figure	 3.4.2A).	 We	 carried	 out	 extended	functional	assays,	monitoring	the	effects	of	both	T6	and	T8	over-production	for	a	further	2	hours,	to	determine	whether	a	similar	subsidence	occurred	for	bacteria	over	 expressing	 t8.	 These	 extended	 functional	 assays	 revealed	 as	 well	 that,	although	parallel	over-expression	of	a6	seemed	to	initially	counteract	the	growth	inhibitory	 effects	 of	 T6	 (Figure	 3.5.1A),	 after	 3	 hours	 the	 bacteria	 had	 halted	growth	completely.	Even	after	5	hours	of	over-expression	of	both	genes	no	 re-growth	 occurred	 (Figure	 3.5.1A).	 	We	 cannot	 rule	 out	 that	 the	 extremely	 high	levels	of	expression	of	both	a6	and	t6	in	parallel	could	lead	to	protein	aggregates	forming,	causing	non-specific	effects	on	growth.		The	extended	functional	assays	also	revealed	that	toxicity	of	T8	was	transient	(Figure	3.5.1B).	Interestingly,	the	effects	of	over-expression	of	t8	took	longer	for	the	bacteria	to	overcome.	After	4	h,	the	bacteria	began	to	regrow	(Figure	3.5.1B).	This	over-powering	of	the	toxic	effect	of	T6	and	T8	could	be	due	 to	a	number	of	events,	 such	as	availability	or	essentiality	 of	 the	 toxins	 targets	 or	 the	 increasing	 activity	 of	 third-party	detoxifying	elements.		
3.2.6	Effects	of	expression	of	ta6	and	ta8	on	persister	formation		 Deletion	of	ta6	or	ta8	had	been	shown	to	lead	to	a	decrease	in	the	fraction	of	persisters	being	formed	in	response	to	macrophage	internalisation	(Helaine	et	
al.,	 2014).	 I	 investigated	 whether	 t6	 and	 t8	 expression	 led	 to	 an	 increase	 in	persister	 formation	 by	 testing	 the	 ability	 of	 Salmonella	 to	 survive	 antibiotic	treatment	 after	 induction	 of	 toxin	 genes	 (Figure	 3.5.2A-B).	 Briefly,	 single	 TA	
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deletion	 strains	harbouring	 either	 the	 control	 plasmid	 (orange	bars),	 the	 toxin	gene	 containing	 plasmid	 (red	 bars)	 or	 both	 the	 toxin	 and	 the	 antitoxin	 gene	containing	plasmids	(green	bars)	were	grown	to	stationary	phase	in	M9	minimal	medium.	 They	 were	 subsequently	 subcultured	 in	 fresh	 M9	 minimal	 medium	supplemented	with	IPTG	and	arabinose	to	induce	production	of	the	proteins	and	incubated	at	37	 ˚C.	After	1	hour	of	 induction,	 the	cultures	were	enumerated	by	CFU	 counts,	 then	 gentamicin	 was	 added	 at	 bactericidal	 concentrations.	 The	percentage	 of	 survival	 was	 calculated	 after	 4	 hours	 of	 treatment.	 Here,	 over-expression	of	 t8	 lead	 to	a	15	 fold	 increase	 in	 the	number	of	 antibiotic	 tolerant	cells	 compared	 to	 the	 S.	 Typhimurium	 ∆ta8	 strain	 alone	 (Figure	 3.5.2B	 and	Supplementary	 figure	 4).	 This	 increase	 in	 persisters	 was	 completely	counteracted	by	parallel	over-expression	of	a8.	However,	 there	was	 little	 to	no	increase	in	the	proportion	of	persisters	in	cultures	of	bacteria	after	induction	of	
t6	over-expression	(Figure	3.5.2A).	This	could	be	due	to	the	shorter	length	of	T6	toxicity,	 as	 after	 4	 hours	 of	 over-expression,	 bacteria	 producing	 T6	 have	overcome	 T6	 toxicity	 and	 reached	 exponential	 growth.	 Interestingly,	 parallel	over-expression	of	both	t6	and	a6	lead	to	a	near	10-fold	increase	in	the	number	of	antibiotic	tolerant	bacteria	compared	to	S.	Typhimurium	∆ta6	bacteria	alone.	This	increase	correlated	with	the	inhibitory	effects	seen	in	the	growth	kinetics	of	the	 same	 strain	 (Figure	 3.5.1A)	 and	 is	 most	 likely	 an	 artefact	 of	 this	 growth	inhibition.	It	is	important	to	note	that	when	these	experiments	were	carried	out	growing	 the	 bacteria	 in	 rich	 medium,	 to	 parallel	 the	 over-expression	 growth	assays,	 such	 small	 numbers	 of	 bacteria	 were	 recovered	 after	 gentamicin	treatment	 that	 an	accurate	quantification	was	 impossible.	Results	only	became	robust	and	reproducible	after	growing	the	bacteria	in	MM.		
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Figure 3.5.2: Effects of T6 and T8 on persister formation. S. Typhimurium ¨WD (A) and¨WD (B) strains 
harbouring either the pNDM220 empty vector, the respective toxin containing plasmid or the toxin and cognate 
antitoxin containing plasmids were grown overnight in M9MM. Subsequently, cultures were diluted 1:20 into 
fresh M9MM supplemented with IPTG and arabinose to induce gene expression. After 1 h of induction bacteria 
were exposed to 100 µg/ml gentamycin for 4 h and bacterial survival calculated as a percentage of 
pre-antibiotic treatment. Data represent mean ± SEM. Statistical significance was determined using Student 
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Figure 3.5.1:Transience of T6 and T8 toxicity. S. Typhimurium ¨WD (A) and¨WD (B) strains harbouring 
either the pNDM220 empty vector  (     ), the respective toxin containing plasmid  (     ) or the toxin and cognate 
antitoxin containing plasmids  (      ), were incubated in LB medium supplemented with IPTG and arabinose to 
induce gene expression. Inducing sugars were added at time point 0 and OD600 measured at hourly intervals. 
Data represent mean ± SEM.  (n=2).
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3.2.7	Cross-activation	of	GNAT	TA	modules	in	vivo		 Since	 there	 have	 been	 studies	 reporting	 cross-activation	 of	 TA	modules	(Kasari	et	al.,	2013;	Yang	et	al.,	2010)	 I	questioned	whether	 this	was	occurring	within	the	GNAT	TA	module	family.	Though	there	have	been	no	reported	cases	of	direct	interaction	between	non-cognate	toxin-antitoxin	pairs	(Fiebig	et	al.,	2010;	Ahidjo	 et	 al.,	 2011;	 Goeders	 &	 Van	 Melderen,	 2014),	 structural	 similarities	 of	related	 toxin-antitoxin	 pairs	 raise	 the	 possibility	 that	 some	 antitoxins	 may	 be	interchangeable	and	cause	destabilisation	of	a	cognate	TA	complex.		Figure	3.6.1	depicts	the	various	models	through	which	this	could	occur.	Figure	3.6.1A	shows	the	 regulation	 of	 the	 TA	 operon	 under	 normal	 growth	 conditions.	 Here,	 the	antitoxin	 and	 toxin	 proteins	 bind	 to	 form	 a	 complex,	 which,	 through	 the	 DNA	binding	 domains	 of	 the	 antitoxin,	 binds	 to	 and	 represses	 the	 TA	 operon	promoter.	 Excess	 antitoxin	 proteins,	 if	 similar	 enough	 in	 structure,	 could	destabilise	 this	complex,	releasing	the	 toxin	and	derepressing	the	TA	promoter	leading	to	activation	(Figure	3.6.1B).	Similarly,	excess	toxin	proteins	could	have	the	same	effect	(Figure	3.6.1C).			To	 investigate	 whether	 any	 cross-regulation	 is	 necessary	 for	 the	activation	of	the	GNAT	TA	modules,	I	monitored	the	mRNA	levels	of	the	toxins	in	single	 (Figure	3.6.2A)	and	double	TA	deletion	 (Figure	3.6.2B)	mutants	after	30	minutes	 of	macrophage	 internalisation	 in	RAW	264.7	macrophages.	 Total	RNA	was	extracted	and	following	reverse	transcription,	qPCR	was	used	to	amplify	the	cDNA	pertaining	to	the	GNAT	toxins.	Levels	of	 toxin	mRNA	were	normalised	to	those	 quantified	 in	 the	 respective	 inoculum	 cultures	 and	 WT	 Salmonella	extracted	 from	 macrophages	 (Figure	 3.6.2	 A-B).	 Double	 TA	 module	 deletions	were	generated	using	the	one-step	 lambda	red	recombinase	method	developed	
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by	 Datsenko	 and	 Warner	 (Datsenko	 &	 Wanner,	 2000).	 Confirmation	 of	 the	deletions	 was	 carried	 out	 using	 PCR	 with	 primer	 pairs	 designed	 to	 amplify	specifically	the	antibiotic	resistance	cassette	inserted	into	the	correct	position	on	the	 chromosome	 (Table	 3.2	 and	 Figure	 3.7.1).	 The	 mRNA	 levels	 of	 t6	 were	increased	upon	deletion	of	 ta8	 and	decreased	 in	 the	∆ta9	mutant	 compared	 to	the	WT.	The	levels	of	t8	mRNA	were	significantly	decreased	in	both	the	ta6	and	
ta9	deletion	 mutants,	 compared	 to	 the	WT.	 The	 mRNA	 levels	 of	 t9	were	 also	decreased	 in	 both	 the	 ta6	 and	 ta8	 deletion	 mutants	 (Figure	 3.6.2A).	 Similar	results	were	observed	in	the	double	deletion	mutants	(Figure	3.6.2B).	t6	mRNA	was	 increased	upon	deletion	 of	 both	 ta8	 and	 ta9,	whereas	 the	mRNA	 levels	 of	both	t8	 and	 t9	were	significantly	decreased	 in	both	 the	 ta6ta9	deletion	mutant	and	the	ta6ta8	deletion	mutant,	respectively.	Together	 these	 results	 suggest	 that	 there	 is	 interplay	 and	 potentially	cross-regulation	 between	 this	 family	 of	 TA	 module.	 However,	 the	 biological	implications	 of	 these	 results	 is	 unaddressed	 here.	 More	 work	 is	 necessary	 to	determine	 the	 specific	 interactions	 and	 their	 roles	 during	 activation	 and	persistence.	 Given	 the	 weak	 reproducibility	 of	 qPCR,	 Northern	 blot	 analysis	could	be	utilised	to	confirm.	
	 Chapter	three:	Results		
	 106	
Promoter Antitoxin Toxin
0 1 2 3 
t6 WT
t8 WT
t9 WT
t6 ¨WD
t6 ¨WD
W¨WD
W¨WD
W¨WD
W¨WD
**
*
*
0 2 4 6 8 
t6 WT
t8 WT
t9 WT
W¨WD¨WD
t8 ¨WD¨WD
t9 ¨WD¨WD
*
*
Promoter Antitoxin Toxin
Promoter Antitoxin Toxin
Figure 3.6.1
Figure 3.6.2
A
B
A
C
B
Figure 3.6.1: Possible modes of TA cross regulation. A) Cognate toxin and antitoxin proteins bind to form a 
complex which represses their promoter. B) An abundance of non-cognate but structurally similar antitoxin proteins 
may destabilise this complex leading to de-repression of the TA promter and TA activation. C) An abundance of non 
cognate but structurally similar toxin proteins may destabilise the TA complex leading to de-repression of the 
promoter and TA activation. 
Figure 3.6.2: Toxin mRNA levels in single and double TA deletion mutants. Fold change in mRNA levels of toxin 
genes in all (A) single and (B) double TA deletion mutants after 30 min internalization in RAW 264.7 macrophages 
normalised to those of LB treated only bacteria, relative to levels in WT 6DOPRQHOOD. Data represent the mean ± SEM. 
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3.2.8	Effects	of	deletion	of	multiple	TA	modules	on	macrophage	induced	
persister	formation		 Our	 group	 showed	 that	 single	 TA	 deletion	 mutants	 displayed	 a	 stark	decrease	 in	 persister	 formation	 in	 response	 to	 macrophage	 internalisation	(Helaine	et	al.,	2014).	Since	Salmonella	internalisation	by	macrophages	amplifies	the	number	of	persisters,	differences	in	the	effects	of	individual	TA	modules	can	be	 more	 easily	 studied.	 I	 took	 advantage	 of	 this	 robust	 assay	 to	 determine	whether	the	changes	in	mRNA	levels	of	the	GNAT	TA	modules	observed	lead	to	an	 alteration	 in	 persister	 formation.	 Stationary	 phase	 bacteria	 were	 used	 to	infect	 macrophages	 to	 avoid	 the	 high	 cytotoxicity	 exerted	 by	 exponentially	growing	 Salmonella.	 Bacteria	 were	 opsonised	 using	 mouse	 serum	 to	 facilitate	phagocytosis,	and	 then	added	 to	macrophages	at	an	MOI	of	5-10.	Macrophages	were	allowed	to	 internalise	bacteria	 for	30	minutes.	 Internalised	bacteria	were	then	isolated	and	transferred	to	fresh	LB	medium	(Mø).	Here,	bacteria	from	the	corresponding	inoculum	culture	were	also	subcultured	into	fresh	medium,	as	an	
in	vitro	counterpart	(In	vitro).	Both	cultures	were	enumerated	by	CFU	counts	and	then	 gentamicin	 was	 added	 to	 bactericidal	 concentrations.	 The	 percentage	 of	survival	 was	 calculated	 after	 24	 hours	 of	 treatment	 and	 the	 fold	 increase	 in	persister	 formation	 determined	 (Figure	 3.7.2).	 	 Data	 is	 shown	 as	 the	 fold	increase	in	persister	formation	normalised	to	WT	(Figure	3.7.3).	 	As	previously	published	by	my	 lab	 (Helaine	et	al.,	 2014),	∆ta6,	∆ta8	 and	∆ta9	 single	deletion	mutants	 of	 S.	 Typhimurium	 formed	 fewer	 persisters	 than	 WT	 strain	 when	internalised	by	macrophages	(Figure	3.7.3).	Here,	S.	Typhimurium	∆ta6	showed	a	 reduction	 in	 persister	 formation	 that	 did	 not	 reach	 statistical	 significance.	However,	 the	∆ta8	 and	∆ta9	mutants	had	a	 strong	and	 significant	 reduction	 in	
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the	 number	 of	 persisters	 being	 formed.	 Interestingly,	 deletion	 of	 both	 ta6	 and	
ta8	 resulted	 in	 drop	 in	 persister	 formation	 similar	 to	 that	 observed	 following	single	ta9	deletion,	forming	significantly	less	persisters	than	WT	Salmonella	and	both	 single	 ta6	 and	 ta8	 deletions.	 For	 both	 the	∆ta6∆ta9	 and	∆ta8∆ta9	 double	deletion	 mutants	 there	 was	 a	 small	 but	 not	 significant	 reduction	 in	 persister	formation,	which	 is	paradoxical	when	 considering	 that	deletion	of	 ta9	 by	 itself	resulted	 in	 such	 a	 significant	 decrease	 in	 persister	 formation.	 However,	 as	previously	discussed	in	section	1.5.6,	there	are	levels	of	interaction	between	the	various	 TA	 module	 families	 that	 are	 not	 fully	 understood	 yet.	 These	 results	corroborate	the	data	presented	in	the	 last	section,	 that	there	may	be	 inter-play	between	the	GNAT	TA	modules	during	infection.		
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Figure 3.7.1: Generation of double GNAT TA deletion mutants. Genes encoding full length GNAT 
toxin-antitoxin operons were replaced with kanamycin and chloramphenicol resistance cassettes using the 
lambda red recombinase method resulting in S. Typhimurium ¨WDFDW¨WDNDQ¨WDNDQ¨WDFDWand ¨
WDNDQ¨WDFDt. Mutant genotypes were confirmed using colony PCR and separated by DNA gel 
electrophoresis. for a detailed protocol please refer to section 2.8.
Table 3.2: Primers pairs used for genotyping of double deletion mutants.
Figure 3.7.2: In vivo persister assay. Stationary phase bacteria were incubated with macrophages for 30 
min. Macrophages were lysed and internalised bacteria collected (Mø). CFU was calculated for the Mø 
bacteria and corresponding inoculum (in vitro) before incubation with bactericidal concentrations of gentamicin 
for 24 h (T0). CFU of the surviving bacteria was calculated (T24), the percentage survival calculated for Mø 
and in vitro samples and the fold change calculated for each deletion mutant. 
Figure 3.7.3: Formation of macrophage induced persisters in single and double TA deletion mutants. 
S. Typhimurium single and double TA deletion mutants were internalised by macrophages as described and 
fold increase in persister formation calculated. Results are shown normalised to those of WT S. Typhimurium. 
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3.2.9	Functional	analysis	of	T6	and	T8	in	S.	Typhimurium	∆ta689	
	 As	the	GNAT	toxins	have	predicted	acetyltransferase	enzymatic	activity,	I	considered	whether	the	3	different	modules	could	regulate	one	another	through	posttranslational	 modifications	 of	 the	 TA	 module	 proteins.	 	 To	 examine	 this	possibility	I	wanted	to	determine	whether	T6	and	T8	retained	their	toxic	effect	when	over-expressed	in	S.	Typhimurium	∆ta689	(Figure	3.8.1A-B).	First,	a	triple	TA	deletion	mutant	was	generated	using	the	one-step	 lambda	red	recombinase	method	 (Datsenko	 &	 Wanner,	 2000)	 and	 confirmed	 via	 PCR	 as	 previously	described	 (Supplementary	 figure	 3).	 Stationary	 phase	 S.	 Typhimurium	 ∆ta689	bacteria	 harbouring	 the	 empty	 pNDM220	 plasmid,	 the	 pNT6	 plasmid	 (Figure	3.8.1A)	 or	 the	 pNT8	 (Figure	 3.8.1B),	 were	 subcultured	 into	 fresh	 LB	 medium	supplemented	with	 IPTG	 to	 induce	 expression	 of	 the	 toxin	 genes.	 Growth	was	monitored	 upon	 over-production	 of	 the	 toxins	 by	 measuring	 OD600	 at	 hourly	intervals.	The	growth	of	the	respective	toxin	over-expressing	single	TA	deletion	strain	was	monitored	in	parallel	as	a	comparison.		Interestingly,	over-expression	of	both	t6	and	t8	in	the	triple	mutant	background	resulted	in	an	extended	toxicity	phenotype.	The	 lag	phase	of	 triple	deletion	mutant	bacteria	over-expressing	 t6	was	 2	 hours	 longer	 than	 their	 single	 deletion	 counterparts,	 increasing	 from	 2	hours	 to	 4	 hours	 (Figure	 3.8.1A).	 Similarly,	 the	 lag	 phase	 of	 triple	 deletion	mutant	bacteria	over-expressing	t8	was	3	hours	longer	than	that	of	their	single	deletion	counterpart,	increasing	from	3	hours	to	6	hours		(Figure	3.8.1B).		These	results	 suggest	 that	 the	 GNAT	 toxins	 may	 be	 able	 to	 negatively	 regulate	 the	activity	of	other	members	of	the	family,	however,	more	research	will	be	needed	to	confirm	these	findings.		
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To	determine	whether	this	increase	in	toxicity	resulted	in	a	concomitant	increase	 in	 persister	 formation,	 I	 wanted	 to	 investigate	 the	 ability	 of	 these	bacteria	 to	withstand	 antibiotic	 treatment	 upon	 expression	 of	 the	 toxin	 genes.	Single	TA	deletion	strains	harbouring	either	 the	control	plasmid	(orange	bars),	the	 toxin	 gene	 containing	 plasmid	 (red	 bars)	 or	 the	 triple	 deletion	 mutant	harbouring	 the	 same	plasmids	 (control	 -	 orange	patterned,	 pNT6	–	white	with	red	dots	or	pNT8	–	red	with	white	dots)	were	grown	to	stationary	phase	in	M9	minimal	 medium.	 They	 were	 subsequently	 subcultured	 in	 fresh	 M9	 minimal	medium	 supplemented	 with	 IPTG	 to	 induce	 expression	 of	 the	 genes	 and	incubated	at	37	 ˚C.	After	1	hour	of	 induction,	 the	cultures	were	enumerated	by	CFU	 counts,	 gentamicin	 was	 added	 at	 bactericidal	 concentrations	 and	 the	percentage	 survival	 was	 calculated	 after	 4	 hours	 of	 treatment	 (Figure	 3.8.2).		Here,	again	no	increase	in	persister	formation	could	be	seen	for	S.	Typhimurium	
∆ta6	 over-expressing	 t6	 compared	 to	 ∆ta6	 bacteria	 harbouring	 the	 control	plasmid	 and	 a	 10	 fold	 increase	 in	 persister	 formation	 could	 be	 seen	 for	 S.	Typhimurium	∆ta8	over-expressing	t8	compared	to	∆ta8	bacteria	harbouring	the	control	 plasmid.	 The	 triple	 GNAT	mutant	 had	 a	 higher	 basal	 level	 of	 persister	formation	 when	 compared	 to	 either	 single	 deletion	 mutant.	 Again,	 t6	 over-expression	 did	 not	 lead	 to	 an	 increase	 in	 persister	 formation	 and	 t8	 over-expression	 lead	 to	 a	 10	 fold	 increase	 in	 persister	 formation	 compared	 to	 the	
∆ta689	 mutant.	 These	 results	 indicate	 that	 even	 though	 over-expression	 of	 t6	and	 t8	 in	 the	 triple	mutant	 background	 resulted	 in	 a	 two-fold	 extension	 in	 lag	phase	compared	to	single	deletion	mutants	over-expressing	the	same	toxins,	this	did	 not	 correspond	 to	 an	 increase	 in	 the	 ability	 of	 these	 bacteria	 to	withstand	antibiotic	treatment.		
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Figure 3.8.2: Effects of  T6 and T8 proteins on persister formation in S. Typhimurium ¨WD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strains harbouring either the pNDM220 empty vector or the respective 
toxin containing plasmid were grown overnight in M9MM. Subsequently, cultures were diluted 1:20 into fresh 
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3.2.10	Interactions	between	non-cognate	toxins	and	antitoxins		 Notwithstanding	 the	 frequency	 of	 occurrence	 of	 multiple	 paralogues	 of	TA	 modules	 found	 on	 bacterial	 chromosomes,	 there	 has	 been	 no	 reported	incidence	of	direct	interaction	between	non-cognate	toxin	and	antitoxin	proteins.	To	determine	whether	this	was	the	case	for	the	GNAT	TA	modules,	I	investigated	whether	 parallel	 over-expression	 of	 non-cognate	 antitoxin	 genes	 would	neutralise	 the	 toxic	 effect	 of	 T6	 and	 T8	 (Figure	 3.9A-D).	 Stationary	 phase	 S.	Typhimurium	 single	 TA	 deletion	mutants	 harbouring	 the	 control	 plasmid,	 the	respective	 toxin	gene	containing	plasmid,	or	 the	 toxin	gene	containing	plasmid	and	 either	 pBA6,	 pBA8	 or	 pBA9,	 were	 subcultured	 in	 fresh	 LB	 medium	supplemented	with	IPTG	and	arabinose	to	induce	gene	expression.	Growth	was	monitored	upon	over-expression	of	 the	proteins	by	measuring	OD600	 at	 hourly	intervals.	Here,	over-expression	of	a8	or	a9	in	conjunction	with	t6	had	no	effect	on	 the	 growth	 kinetics	 of	 the	 bacteria	 compared	 to	 those	 over-expressing	 t6	alone	(Figure	3.9A-B).	A	similar	result	was	observed	when	monitoring	the	effects	of	 the	 non-cognate	 antitoxins	 on	 T8	 toxicity:	 over-expression	 of	 a6	 or	 a9	 in	conjunction	 with	 T8	 had	 no	 effect	 on	 the	 growth	 kinetics	 of	 the	 bacteria	compared	 to	 those	 over-expressing	 t8	 alone	 (Figure	 3.9C-D).	 These	 results	indicate	 that	 there	 is	 no	 cross	 neutralisation	 between	 toxin	 and	 non-cognate	antitoxin	proteins.		
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3.3	Summary		 	The	work	presented	here	has	focused	on	the	characterisation	of	the	novel	GNAT	 TA	 module	 family,	 specifically	 TA6	 and	 TA8,	 further	 investigating	interactions	 between	 the	 three	 modules.	 All	 are	 activated	 in	 response	 to	macrophage	 internalisation	 and	 contain	 a	 predicted	 GCN5	N-acetyltransferase	domain	within	 the	 toxin	 component.	 Despite	 repeated	 efforts,	 I	was	 unable	 to	clone	 t9	 and	 so	 continued	with	 TA6	 and	 TA8.	 Both	modules	 are	 bona	 fide	 TA	modules.	Over-expression	of	the	toxin	gene	leads	to	an	extension	in	the	lag	phase	of	 the	 bacteria	 and	 not,	 as	 other	 characterised	 TA	 modules,	 an	 arrest	 of	exponential	growth.	t8	over-expression	leads	to	a	direct	increase	in	the	number	of	 persister	 cells,	 counteracted	 fully	 by	 over-expression	 of	 a8,	 suggesting	 TA8	plays	a	role	 in	persister	formation.	No	such	increase	was	seen	in	bacteria	upon	over-expression	of	t6,	however,	 the	effect	of	t6	over-expression	on	 lag	phase	 is	more	transient	than	that	of	t8.	The	results	presented	here	suggest	 that	there	 is	interaction	 between	 the	GNAT	TA	modules	 but	 the	 direct	 interactions	 and	 the	effects	 of	 these	were	 not	 investigated.	 Overall,	 this	 novel	 TA	module	 family	 is	involved	in	the	formation	of	Salmonella	persisters.					
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Chapter	four	
Characterisation	of	the	toxicity	of	T6	and	T8	
4.1	Introduction		 To	 date	 no	 characterisation	 of	N-acetyltransferases,	 as	 part	 of	 a	 toxin-antitoxin	module,	has	been	carried	out.	Until	recently	acetylation	in	bacteria	was	considered	 to	be	a	sparsely	utilised	PTM.	However,	as	discussed	 in	section	1.6,	many	 recent	 reports	 have	 shown	 that	 acetylated	 proteins	 in	 bacteria	 are	ubiquitous	and	involved	in	a	number	of	cellular	pathways.	 	As	mentioned,	over	half	 of	 all	 the	 acetylated	 proteins	 in	 Salmonella	 and	 E.	 coli	 are	 linked	 to	metabolism	(Wang	et	al.,	2010;	Zhang	et	al.,	2009),	those	remaining	are	generally	involved	in	protein	synthesis,	stress	response	and	transcription	(Yu	et	al.,	2008;	Zhang	 et	 al.,	 2009).	 Many	 ribosomal	 proteins	 were	 shown	 to	 be	 acetylated,	including	the	well-characterised	L7/L12	(Yu	et	al.,	2008).	L7	and	L12	are	two	forms	of	the	same	ribosomal	protein	and	the	ratio	of	the	 two	proteins	varies	with	growth	phase	(Ramagopal	&	Subramanian,	1974).	L12	 is	 the	 unacetylated	 version	 and	 is	 the	 most	 abundant	 variant	 in	 early	exponential	 phase,	 reaching	 about	 85%	 of	 the	 total.	 The	 ratio	 switches	 in	stationary	 phase,	 with	 the	 acetylated	 version,	 L7,	 reaching	 about	 70-80%	(Ramagopal	&	Subramanian,	1974).	This	 ribosomal	protein	has	been	 shown	 to	be	 required	 for	 regulating	 rates	 of	 translation	 (Pettersson	 &	 Kurland,	 1980).	Rnase	R,	an	exoribonuclease	that	is	an	important	stress	response	regulator,	has	
	 	 Chapter	four:	Results	
	 117	
also	 been	 shown	 to	 be	 regulated	 by	 acetylation	 (Liang	 et	 al.,	 2011).	 In	exponential	 phase,	 the	 instability	 of	 Rnase	 R	 is	 due	 to	 acetylation	 of	 its	 C-terminal	 region.	 This	 results	 in	 increased	 binding	 by	 tmRNA,	 which	 facilitates	degradation	 by	 Lon	 protease	 (Liang	 et	al.,	 2011).	 This	 Rnase	R	modification	 is	not	only	growth	phase	dependent	but	has	also	been	linked	to	stress	responses,	such	 as	 cold	 shock	 (Liang	 &	 Deutscher,	 2012).	 Given	 the	 cellular	 processes	already	reported	to	be	regulated	by	acetylation	and	the	reversible	nature	of	the	modification,	 it	 is	not	unreasonable	to	consider	that	this	PTM	could	be	used	by	bacteria	to	transiently	arrest	growth	as	observed	in	persister	cells.		In	this	chapter	I	report	the	investigation	of	the	toxicity	of	T6	and	T8,	the	role	of	 their	predicted	acetyltransferase	 activity.	 I	 then	decided	 to	 focus	on	T8	and	elucidated	its	crystal	structure	in	collaboration	with	Dr	Stephen	Hare.		
4.2	Results	
4.2.1	T8	and	T6	inhibit	protein	synthesis			 Toxins	 of	 TA	 modules	 have	 been	 reported	 to	 interfere	 with	 DNA	replication,	 including	 ParE	 and	 Fic	 (Jiang	 et	 al.,	 2002;	 Harms	 et	 al.,	 2015)	 cell	permeability,	 such	 as	 TisB	 and	 hok	 (Unoson	&	Wagner,	 2008;	 Gerdes	 &	 Bech,	1986)	 and	 translation,	 including	 MazF	 and	 HipA	 (Christensen-Dalsgaard	 &	Gerdes,	 2008;	 Germain	 et	al.,	 2013).	 To	 determine	which	 cellular	 process	was	being	interrupted	upon	over-expression	of	t6	and	t8,	 I	monitored	rates	of	DNA,	RNA	and	protein	synthesis	using	radiolabelled	isotopes	of	14-C	thymidine,	14-C	uracil	 and	 35-S	 methionine	 respectively,	 in	 a	 pulse-chase	 assay	 (Winther	 &	Gerdes,	2009).	Here,	stationary	phase	S.	Typhimurium	∆ta6	or	∆ta8	harbouring	
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either	 the	 empty	 pNDM220	 plasmid	 or	 the	 pNT6/pNT8	 plasmid	 were	subcultured	 into	 fresh	 LB	 medium	 supplemented	 with	 IPTG.	 As	 a	 control	 S.	Typhimurium	 ∆ta6	 or	 ∆ta8	 was	 incubated	 with	 bacteriostatic	 levels	 of	ciprofloxacin,	 rifampicin	 or	 chloramphenicol	 to	 block	 DNA	 replication,	transcription	or	translation	respectively.	All	cultures	were	then	incubated	at	37	˚C.	 Samples	were	 taken	 at	 different	 time-points,	 bacterial	 load	was	normalised	based	 on	 OD600	 and	 samples	were	 incubated	with	 the	 necessary	 radiolabelled	isotope.	After	5	minutes	of	incubation,	the	radiolabelled	isotope	was	chased	with	excess	 cold	 isotope.	 Samples	 were	 then	 washed	 and	 spotted	 onto	 Whatman	paper,	which	was	 subsequently	 exposed	 to	 a	 Phosphostimulated	 luminescence	plate	 and	 the	 intensity	 of	 the	 radiation	 signal	 visualised	 using	 a	 phosphor-imager.	The	levels	of	incorporation	for	each	sample	at	the	first	time-point	were	set	at	100	and	all	subsequent	readings	were	normalised	to	this	point.		
4.2.1.1	T8	pulse-chase	results		The	 incorporation	 of	 radiolabelled	 methionine,	 for	 bacteria	 over-expressing	 t8,	 was	 swiftly	 inhibited	 by	 induction	 of	 gene	 expression	 (Figure	4.1.1A).	The	rate	of	 incorporation	of	 radiolabelled	 thymidine	 in	 turn	decreased	30	minutes	after	induction	of	t8	expression	(Figure	4.1.1B).	There	was	no	effect	on	 the	 rate	 of	 incorporation	 of	 radiolabelled	 uracil,	 upon	 induction	 of	 t8	expression,	 compared	 to	 the	 control	 strain	 (Figure	 4.1.1C).	 These	 results	accurately	represent	the	radiation	signals	observed	for	each	experiment	on	the	phosphoimager	 (Figure	 4.1.2A-C).	 Because	 the	 effect	 of	 induction	 of	 the	 toxin	gene	expression	can	be	very	rapid,	I	also	determined	whether	the	initial	signals	were	 comparable	 (Figure	 4.1.3).	Here,	 I	 normalised	 the	 values	 observed	 for	 t8	
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over-expressing	 bacteria	 at	 5	 minutes	 post-induction	 to	 those	 of	 the	 control	sample.	 There	 was	 no	 significant	 difference	 between	 the	 initial	 levels	 of	incorporation	for	methionine	(Figure	4.1.3A),	thymidine	(Figure	4.1.3B)	or	uracil	(Figure	 4.1.3C).	 Together	 these	 results	 show	 that,	 upon	 over-expression,	 t8	specifically	 interferes	 with	 methionine	 incorporation,	 strongly	 suggesting	 that	T8	inhibits	protein	synthesis.		
4.2.1.2	T6	pulse	chase	results		 Upon	t6	over-expression,	the	rates	of	incorporation	of	methionine	seemed	to	be	unaffected	(Figure	4.2.1A),	whereas	 thymidine	 incorporation	appeared	to	be	 increased	 (Figure	4.2.1B)	and	uracil	 incorporation	 inhibited	 (Figure	4.2.1C).	However,	 these	 results	 do	 not	 accurately	 portray	 the	 autoradiograph	 images	(Figure	 4.2.2A-C).	 As	 early	 as	 5	 minutes	 post-induction,	 there	 was	 a	 stark	difference	 in	 the	 incorporation	 of	 methionine	 (Figure	 4.2.2A)	 and	 thymidine	(Figure	 4.2.2B)	 between	 bacteria	 over-expressing	 t6	 and	 the	 control	 strain.	Indeed,	 when	 comparing	 the	 initial	 levels	 of	 incorporation	 for	 all	 three	radiolabelled	 isotopes	 it	 became	 apparent	 that	 there	was	 already	 significantly	less	incorporation	of	methionine	(Figure	4.2.3A)	and	thymidine	(Figure	4.2.3B),	in	 bacteria	 over-expressing	 t6.	 Moreover,	 there	 was	 a	 slight	 but	 significant	increase	 in	 the	 levels	 of	 uracil	 incorporation	 (Figure	 4.2.3C).	 	 These	 results	suggest	 that	 the	effects	of	T6	are	occurring	 in	 less	 than	5	minutes.	At	 this	 time	point	both	thymidine	and	methionine	incorporation	had	already	been	affected	by	
t6	expression.	Together,	 these	results	suggest	 that	T6	has	a	swift	and	transient	effect	 on	 both	 protein	 and	 DNA	 synthesis,	 More	work	 is	 needed	 to	 determine	which	process	is	primarily	affected.	
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Figure 4.1.1: Inhibition of protein synthesis by T8. Levels of incorporation of radiolabelled methionine (A), 
thymidine (B) or uracil (C) were monitored in S. Typhimurium ¨WD harbouring pNDM220 (    ), TpNT8 (     ) or 
treated with bacteriostatic concentrations of chloramphenicol (A), ciprofloxacin (B) or rifampicin (C) (     ). All 
cultures were supplemented with IPTG at T=0 and all measures were normalised to those at T=5. Data repre-
sent the mean ± SEM (n=3). For a detailed protocol please refer to section 2.16.
Figure 4.1.2: Representative autoradiograph images. Levels of incorporation of radiolabelled methionine 
(A), thymidine (B) or uracil (C) in S. Typhimurium ¨WDharbouring pNDM220 (-T8), pNT8 (+T8) or incubated in 
bacteriostatic concentrations of chloramphenicol (+Cm), ciprofloxacin (+Cip) or rifampicin (+Rif). Repesented 
as autoradiograph images. 
Figure 4.1.3: Incorporation of radiolabelled isotopes after 5 minutes of induction. Levels of incorporation 
of radiolabelled methionine (A), thymidine (B) or uracil (C) in S. Typhimurium ¨WD harbouring pNDM220 (-T8) 
or pNT8 (+T8) at T=5. All cultures were supplemented with  IPTG a T=0 and normalised to -T8 T=5. Data repre-
sent the mean ± SEM (n=3). 6WDWLVWLFDOVLJQLILFDQFHZDVGHWHUPLQHGXVLQJ6WXGHQWWWHVW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Figure 4.2.1: Inhibition of protein and DNA synthesis by T6. Levels of incorporation of radiolabelled methio-
nine (A), thymidine (B) or uracil (C) were monitored in S. Typhimurium ¨WD harbouring pNDM220 (    ), TpNT6 
(     ) or treated with bacteriostatic concentrations of chloramphenicol (A), ciprofloxacin (B) or rifampicin (C)          
(     ). All cultures were supplemented with IPTG at T=0 and all measures were normalised to those at T=5. Data 
represent the mean ± SEM (n=3 for A and C, n=2 for B). For a detailed protocol please refer to section 2.16.
Figure 4.2.2: Representative autoradiograph images. Levels of incorporation of radiolabelled methionine 
(A), thymidine (B) or uracil (C) in S. Typhimurium ¨WDharbouring pNDM220 (-T6), pNT6 (+T6) or incubated in 
bacteriostatic concentrations of chloramphenicol (+Cm), ciprofloxacin (+Cip) or rifampicin (+Rif). Repesented 
as autoradiograph images. 
Figure 4.2.3: Incorporation of radiolabelled isotopes after 5 minutes of induction. Levels of incorporation 
of radiolabelled methionine (A), thymidine (B) or uracil (C) in S. Typhimurium ¨WD harbouring pNDM220 (-T6) 
or pNT6 (+T6) at T=5. All cultures were supplemented with IPTG at T=0 and normalised to -T6 T=5. Data repre-
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4.2.2	Comparison	of	GNAT	toxin	sequences				 GNAT	toxins	are	found	in	two	types	of	TA	modules:	GNAT-RHH,	where	the	toxin	is	associated	with	an	antitoxin	containing	a	ribbon-helix-helix	domain,	as	is	the	case	of	T6,	T8	and	T9,	and	GNAT-XRE,	with	the	antitoxin	containing	an	XRE-like	helix-turn-helix	domain.	GNAT-XRE	associated	toxins	show	no	similarity	to	the	GNAT-RHH	associated	toxins,	suggesting	they	may	be	a	separate	family.		RHH-associated	 GNAT	 toxins	 are	 found	 in	 a	 number	 of	 pathogenic	bacteria,	 including	Mycobacterium	tuberculosis,	Vibrio	sp.	and	Shigella	sp.	When	comparing	 the	 sequence	 identity	 of	 the	 three	 Salmonella	 GNAT	 toxins,	 it	 is	apparent	 that	 there	 is	 very	 little	 identity	between	 them.	The	predicted	Ac-CoA	binding	residues,	among	others,	are	conserved	throughout	all	 three.	T8	and	T9	share	more	identity	than	T6	raising	the	possibility	that	T6	may	have	a	separate	target	 and	 increasing	 the	 likelihood	 that	T8	 and	T9	 target	 the	 same	protein[s]	(Figure	4.3.1).	In	general,	there	is	little	amino	acid	sequence	identity	between	the	different	 GNAT	 toxins.	However,	 nearly	 identical	 homologues	 of	 TA6,	 TA8	 and	TA9	are	found	in	S.	Paratyphi	and	S.	Typhi	(Figure	4.3.2A-C).		The	GNAT-XRE	modules	are	also	found	in	a	variety	of	bacteria,	including	
Pseudomonas	 sp.,	 Burkholderia	 sp.	 and	 Acinetobacter	 sp.	 Most	 have	 been	identified	 by	 in	 silico	 sequence	 analysis	 but	 have	 not	 been	 experimentally	analysed	yet	(Makarova	et	al.,	2009;	Sberro	et	al.,	2013).			 Multiple	 alignments	 of	 the	 amino	 acid	 sequences	 of	 a	 number	 of	 GNAT	toxins	with	at	least	60%	identity	to	that	of	T6	reveal	relative	disparity	between	homologues	(Figure	4.3.2A).	GNAT	toxins	with	sequence	identity	to	T8	of	at	least	60%,	exist	 in	Mycobacterium	 sp.	The	activity	of	 these	 toxins	 in	Mycobacteria	 is	unknown	 (Figure	 4.3.1B).	 Contrary	 to	 T9	 homologues,	 which	 show	 a	 much	
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higher	degree	of	similarity.	Interestingly,	S.	Typhi	strains	Ty2	and	CT18	harbour	two	T9	paralogues	that	contain	a	number	of	 identical	amino	acid	substitutions,	however,	the	significance	of	these	mutations,	if	any,	is	unknown	(Figure	4.3.2C).																			
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T6
T9
T8
T6
T9
T8
Figure 4.3.1
4.3.1: Disparity between amino acid sequences of T6, T8 and T9 . Amino acid sequences of S. Typhimuirum 12023 T6, T8 and T9 were aligned using JalView 
multiple sequence alignment tool. Colours represent percentage identity.
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S. Dublin
S. Agona
R. palustris
P. luminescens
P. propionicus
P. phaeoclathratiforme
C. phaeobacteroides
S. melitoli
V. cholerae
T6
S. Typhi str. CT18
S. Typhi str. Ty2
S. Paratyphi AKU
S. Paratyphi ATCC
S. Dublin
S. Agona
R. palustris
P. luminescens
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V. cholerae
T8
S. Typhi str. CT18
S. Typhi str. Ty2
S. Paratyphi AKU
S. Paratyphi ATCC
S. Arizonae
M. tuberculosis F11
M. tuberculosis H37Ra
M. tuberculosis H37Rv
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S. boydii
Enterbacter sp. 638
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M. tuberculosis F11
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E. coli
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X. campestris str.ATCC
P. naphthalenivorans
T9
S. Typhi str. CT18
S. Typhi str. Ty2
S. Paratyphi AKU
S. Paratyphi ATCC
S. Dublin
E. coli
X. campestris str.B100
S. Typhi str. CT18 - 2
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X. campestris str.8004
X. campestris str.ATCC
P. naphthalenivorans
Figure 4.3.2
A
B
C
4.3.2: Multiple alignments of GNAT toxin amino acid sequences from various bacterial species. Amino acid sequences of predecited GNAT toxins with at least 
60% identity to T6 (A), T8 (B) and T9 (C) (TADB website - http://202.120.12.135/TADB2/index.php) were aligned using JalView multiple sequence alignment tool. 
Colours represent percentage identity.
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4.2.3	Point	mutations	in	the	putative	Ac-CoA	binding	domain	abolish	T6	
and	T8	toxicity		 As	 both	 T6	 and	 T8	 sequences	 contain	 a	 predicted	 N-acetyltransferase	domain	 (Figure	 3.2.2C)	 and	 structural	 predictions	 reveal	 an	 Ac-CoA	 binding	domain	 (Figure	 4.4.1),	 we	 hypothesised	 that	 both	 T6	 and	 T8	 inhibit	 bacterial	growth	 via	 transfer	 of	 an	 acetyl	 moiety	 from	 Ac-CoA	 to	 a	 target	 protein[s].	 I	carried	 out	 site	 directed	 mutagenesis	 of	 these	 domains	 in	 order	 to	 test	 their	importance	 during	 toxicity.	 Two	 point	 mutant	 variations	 of	 T6	 and	 T8	 were	generated	 using	 overlapping	 PCR	 (described	 in	 full	 in	 section	 2.12).	 The	 first	point	mutation	resulted	in	the	substitution	of	a	highly	conserved	alanine,	located	within	the	Ac-CoA	binding	domain,	to	a	proline.	This	substitution	is	predicted	to	disrupt	the	ability	of	the	toxin	to	bind	Ac-CoA	(Abo-Dalo	et	al.,	2004).	The	second	point	 mutation	 resulted	 in	 the	 substitution	 of	 a	 highly	 conserved	 tyrosine	(Figure	 4.4.2),	 located	 in	 a	 side	 chain	 of	 Ac-CoA	 binding	 pocket,	 to	 a	phenylalanine.	 This	 substitution	 is	 predicted	 to	 block	 transfer	 of	 the	 acetyl	moiety	 resulting	 in	 a	 catalytically	 inactive	 mutant.	 Full-length	 toxin	 genes,	harbouring	 the	 point	 mutations,	 were	 then	 cloned	 in	 the	 pNDM220	 plasmid	placing	 them	 under	 the	 control	 of	 the	 Plac	 IPTG	 inducible	 promoter,	 listed	 in	table	 4.1.	 Each	 plasmid	 was	 then	 transformed	 into	 the	 respective	 single	 TA	deletion	mutant.	 	 Stationary	phase	S.	Typhimurium	single	TA	deletion	mutants	harbouring,	the	empty	pNDM220	plasmid	or	the	plasmid	encoding	the	WT	toxin	or	 the	 point	 mutants,	 were	 subcultured	 into	 fresh	 LB	 medium	 supplemented	with	 IPTG	 to	 induce	 gene	 expression.	 Growth	 was	 monitored	 upon	 over-expression	of	the	toxin	variant	genes	by	measuring	OD600	at	30-minute	intervals	
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(Figure	4.4.3A-B).	The	growth	kinetics	for	all	bacteria	producing	a	point-mutated	toxin	variant	showed	no	inhibition	in	growth	compared	to	the	respective	control	strains.	 These	 results	 indicate	 that	 site-directed	 mutagenesis	 of	 the	 Ac-CoA	binding	domain	abolishes	the	toxicity	of	T6	and	T8,	highlighting	the	importance	of	this	predicted	enzymatic	activity	for	the	functions	of	the	toxins.	
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Figure 4.4.1: Predicted secondary structure of T6 bound to Ac-CoA. Structural prediction of T6 bound to its 
putative ligand, Ac-CoA. Structural prediction carried out using Robetta online prediction software - 
Figure 4.4.2: Structural alignment of predicted Ac-CoA binding domain side chain. Structural alignment of T6 
(    ), T8 (    ) and T9 (    ) to RimI (    ) showing a conserved tyrosine in the predicted Ac-CoA binding pocket. Alignment 
carried out by Dr Stephen Hare.
Table 4.1
Figure 4.4.2Figure 4.4.1
Time (h) Time (h)
Table 4.1: W and W Ac-CoA binding mutant over-expression plasmids. Plasmids harbouring respective toxin 
coding sequences containing point mutations at the stated position. 
Plasmid name Plasmid properties
pNT6AP pNkatT6 A93P substitution
pNT8AP pNkatT8 A96P substitution
pNT6YF pNkatT6 Y140F substitution
pNT8YF pNkatT8 Y141F substitution
Figure 4.4.3: Abolition of T6 and T8 toxicity by point mutations in the predicted Ac-CoA binding site. 
Stationary phase S. Typhimurium ¨WD(A) and ¨WD(B) strains harbouring either the pNDM220 empty vector (      ), 
the respective WT toxin containing plasmid (     ), the respective toxin plasmid harbouring an alanine to proline point 
mutation (     ) or a tyrosine to phenalalanine point mutation (    ) were incubated in LB medium supplemented with 
IPTG to induce gene expression. Inducing sugars were added at time point 0 and OD600 measured at 30-minute 
intervals. Data represent mean ± SEM (n=3). 
A B
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4.2.4	Deletion	of	the	endogenous	deacetylase	cobB	eliminates	the	growth	
phase	dependency	of	T6	and	T8	toxicity		 The	 transience	 of	 T6	 and	 T8	 toxicity	 that	 was	 observed	 in	 the	 over-expression	 assays	 (Figure	 3.4.2A-B)	 and	 the	 inability	 of	 T6	 and	 T8	 to	 arrest	growth	 in	mid	 exponential	 phase	 bacteria	 (Figure	 3.4.1A-B)	 could	 be	 due	 to	 a	number	of	reasons;	the	essentiality	of	the	target,	the	abundance	of	the	target	or	the	 presence	 of	 a	 third-party	 detoxifying	 element.	 As	 we	 have	 shown	 the	acetyltransferase	 activity	 to	 be	 important	 in	 toxicity,	 an	 interesting	 hypothesis	was	that	the	activity	of	a	deacetylase	protein	could	be	counteracting	T6	and	T8	toxicity.	 	 Currently,	 there	 is	 only	 one	 known	 global	 deacetylase	 in	 Salmonella,	CobB	(Tsang,	1998;	Tucker	&	Escalante-Semerena,	2010).	To	determine	whether	the	activity	of	CobB	lead	to	the	resumption	of	growth	observed	in	Figures	3.4.2	A	and	B,	I	deleted	cobB	from	each	of	the	single	TA	deletion	mutants	using	the	one-step	lambda	red	recombinase	method	(Datsenko	&	Wanner,	2000)	(Figure	4.5.1).		These	S.	Typhimurium	∆ta∆cobB	strains	were	then	transformed	with	either	the	empty	pNDM220	plasmid	or	the	respective	toxin	containing	plasmid.	Stationary	phase	bacteria	were	subcultured	into	fresh	LB	medium	supplemented	with	IPTG	to	 induce	 expression	 of	 the	 toxin	 genes.	 Growth	 was	 monitored	 upon	 over-expression	of	the	toxin	by	measuring	OD600	at	hourly	intervals.	Growth	kinetics	of	 the	 respective	 single	 TA	 deletion	 mutants	 over-expressing	 toxins	 were	monitored	 in	 parallel	 (Figure	 4.5.2A-B).	 S.	 Typhimurium	 ∆ta6∆cobB	 over-expressing	 t6	 had	 a	 lag	 phase	 twice	 as	 long	 as	 that	 of	 the	 ∆ta6	 counterpart	(Figure	 4.5.2A).	 The	 extension	 in	 lag	 phase	 for	 S.	 Typhimurium	 ∆ta8∆cobB	compared	to	∆ta8	was	not	as	pronounced	but	T8	production	still	resulted	in	an	hour	 increase	 in	 lag	phase	 	 (Figure	4.5.2B).	 These	 results	 suggest	 that	CobB	 is	
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involved	in	over-coming	T6	and	T8	toxicity,	allowing	for	the	bacteria	to	resume	growth	 and	 suggests	 that	 the	 GNAT	 toxins	 inhibit	 growth	 via	 reversible	acetylation	of	their	target[s].	Interestingly,	 cobB	 has	 been	 shown	 to	 be	 down-regulated	 in	 stationary	phase	 and	 up-regulated	 in	 mid	 exponential	 phase	 (Kroger	 et	 al.,	 2013).	 This	increase	 in	 cobB	mRNA	 levels	 in	mid	 exponential	 phase	 could	 account	 for	 the	perceived	lack	of	toxicity	of	T6	and	T8	when	their	production	was	induced	in	this	phase	 of	 growth.	 I	 monitored	 the	 effects	 of	 over-expression	 of	 t6	 and	 t8	 in	 S.	Typhimurium	∆ta∆cobB	 in	exponentially	growing	bacteria	to	elucidate	whether	the	presence	of	cobB	was	 counteracting	 toxicity	 in	 these	 cells.	Here,	 stationary	phase	 S.	 Typhimurium	∆ta∆cobB,	 harbouring	 the	 empty	 pNDM220	 plasmid	 or	the	 respective	 WT	 toxin	 containing	 plasmid,	 were	 subcultured	 into	 fresh	 LB	medium	and	grown	to	an	OD600	of	0.6.	They	were	then	diluted	to	an	OD600	of	0.2	in	 fresh	LB	medium	supplemented	with	 IPTG	and	 their	growth	was	monitored	upon	over-expression	of	the	toxin	genes	by	measuring	OD600	at	hourly	intervals.	Figure	4.5.3	A	and	B	show	that	over-expression	of	t6	and	t8	in	Salmonella	deleted	of	cobB	led	to	growth	arrest.	This	raises	the	possibility	that	increased	CobB	levels	in	mid	exponential	phase	bacteria	counteract	the	toxicity	of	the	GNAT	toxins.	Taken	 together	 these	 results	 suggest	 that	 the	 well-characterised	 lysine	deacetylase	 CobB	 is	 involved	 in	 detoxification	 of	 T6	 and	 T8	 in	 Salmonella,	thereby	 indirectly	 supporting	 the	 hypothesis	 that	 both	 toxins	 are	 indeed	acetyltransferases	and	that	acetylation	of	their	target	protein[s]	is	reversible.	
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Figure 4.5.2: Extended toxicity of T6 and T8 in S. Typhimurium ¨WD¨FRE%. Stationary phase S. 
Typhimurium¨WD¨FRE%(A)  and ¨WD¨FRE% (B) harbouring either the pNDM220 empty vector (     ) or the 
respective toxin containing plasmid  (     ) and the respective single deletion mutant strains harbouring the toxin 
containing plasmid (     ), were incubated in LB medium supplemented with IPTG to induce gene expression. 
Induction began at time point 0 and OD600 measured at hourly intervals. Data represent mean ± SEM (n=3).
Figure 4.5.3: Abolition of growth phase dependency of T6 and T8 toxicity by deletion of FRE%. S. 
Typhimurium¨WD¨FRE% (A) and ¨WD¨FRE% (B) harbouring either the pNDM220 empty vector  (     ) or the 
respective toxin containing plasmid  (     ) were grown to mid exponential phase and then subcultured to an 
OD600 of 0.2 in fresh LB medium supplemented with IPTG to induce gene expression. Induction began at time 
point 0 and OD600 measured at 30-minute intervals. Data represent mean ± SEM (n=3).
Figure 4.5.1: Generation of S. Typhimurium ¨WD¨FRE%mutants. Full length FRE% was replaced by the 
chloramphenicol resistance cassette in single TA deletion mutants resulting in S. Typhimurium ¨WDNDQ¨
FRE%FDWand ¨WDNDQ¨FRE%FDW. Mutant genotypes were confirmed using colony PCR and separated by 
DNA gel electrophoresis. For a detailed protocol please refer to section 2.28.
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4.2.5	Crystal	structure	of	T8Y140F	variant			 After	 accumulating	 indirect	 evidence	 that	 T6	 and	 T8	 were	acetyltransferases,	I	undertook	to	purify	T8	to	try	and	solve	its	crystal	structure	in	 collaboration	 with	 the	 Hare	 lab.	 We	 took	 advantage	 of	 the	 t8Y140F	 point	mutation	to	purify	easily	large	amounts	of	the	non-toxic	T8.	I	cloned	t8Y140F	in	the	pHiSH	vector,	allowing	for	a	cleavable	N-terminal	6His-tag	to	be	attached	to	the	toxin	variant,	and	expressed	it	in	E.	coli	PC2.	After	harvesting	the	cells	and	lysis	by	 sonication,	 the	 protein	was	 bound	 to	 Ni-NTA	 resin	 and	 purified	 by	 affinity	column	chromatography.	Subsequently,	the	N-terminal	6His-tag	was	cleaved	by	digestion	 with	 3C	 protease.	 The	 purified	 T8Y140F	 variant	 was	 subjected	 to	 ion	exchange	chromatography	followed	by	size	exclusion	chromatography	to	obtain	a	pure	protein	sample.	The	crystal	structure	was	then	solved	to	a	resolution	of	1.7Å	by	Dr	Stephen	Hare.		The	asymmetric	unit	of	the	crystals	contained	a	T8	dimer	engaging	4739	Å2	 of	 surface	 area	 in	 the	 dimeric	 interface	 (Figure	 4.6.1A).	 The	 T8	 monomer	clearly	showed	an	acetyltransferase	domain,	complete	with	an	Ac-CoA	molecule	bound	in	place	in	the	active	site	(Figure	4.6.1A).	The	sequence	of	T8	is	shown	in	Figure	 4.6.1B,	 with	 the	 secondary	 structure	 shown	 underneath.	 Here,	 grey	diamonds	 highlight	 the	 residues	 that	 are	 involved	 in	 dimerization	 and	 those	involved	 in	 Ac-CoA	 binding	 are	 highlighted	 by	 black	 dots.	 Comparing	 the	structure	 of	 T8Y140F	and	 that	 of	 other	 known	 acetyltransferases	 revealed	 novel	features	 in	 the	 tertiary	 structure	of	T8	 (Figure	4.6.2).	The	α3	helix	 is	extended	and	 the	β2	 and	β3	 strands	 are	 curved	with	 the	 insertion	of	 the	η1	 and	 the	α2	helix	between	them	(Figure	4.6.2).	Together	these	results	show	that	T8	folds	as	
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an	acetyltransferase	and	suggest	that	it	constitutes	a	novel	class	with	the	unique	α3,	β2	and	β3	features.		
	
	
	
	
					
Figure 4.6.2: T8, a novel acetyltransferase. Superimposition of T8Y140F with three other GNATs that have 
been identified as close structural homologues by the DALI server (PMID:20457744). T8Y140F (grey), pbd ID 
5+ \HOORZ&10 RUDQJHDQG39 SXUSOH7KH IHDWXUHVXQLTXH WR7ĮĮȕȕDQGȘDUH
labelled and highlighted in black circles. 
Figure 4.6.2
Figure 4.6.1: T8 forms a dimer. (A) Cartoon depiction of the dimeric structure of T8Y140F. Chain A is coloured 
from blue to red, N-terminus to C-terminus, and chain B is light grey. Ac-CoA molecules are depicted as stick 
representations and highlight the Ac-CoA binding domains. (B) Sequence of T8 with secondary structual 
elements illustrated underneath and coloured as in chain A. Black dots indicate residues involved in Ac-CoA 
binding and grey diamonds indicate residues involved in dimerisation. pdb ID 5FVJ. 
Figure 4.6.1
A B
	 	 Chapter	four:	Results	
	 134	
4.2.6	Effects	of	over-expression	of	t6	and	t8	on	the	lysine-acetylome	of	
Salmonella		 Building	 upon	 the	 structure	 of	 T8	 indicating	 it	 folds	 as	 an	acetyltransferase	 and	 in	 the	 aim	 of	 identifying	 T6	 and	 T8	 target[s],	 I	 analysed	changes	 in	 the	 lysine-acetylome	 of	Salmonella	 upon	 induction	 of	 expression	 of	the	 toxin	 genes.	 Stationary	 phase	 single	 TA	 deletion	 mutants,	 harbouring	 the	empty	 pNDM220	 vector	 (lanes	 1	 and	 4),	 the	 respective	 toxin	 gene	 containing	vector	 (lanes	2	 and	5)	or	 the	 toxin	 and	 the	 cognate	 antitoxin	 genes	 containing	vectors	(lanes	3	and	6),	were	subcultured	into	fresh	LB	medium	and	grown	at	37	°C.	 After	 2	 hours	 of	 growth,	 cultures	 were	 supplemented	 with	 IPTG	 and	arabinose	to	induce	gene	expression.	Samples	were	taken	before	the	addition	of	the	inducers	and	at	hourly	intervals	post-induction.	Bacterial	load	in	the	samples	was	normalised	based	on	OD600	and	total	proteins	were	 isolated	and	separated	via	 SDS-PAGE.	 The	 lysine-acetylome	 was	 visualised	 via	 western	 blot,	 probing	with	 an	 anti-lysine	 acetylated	 protein	 antibody	 (ab21623,	 Abcam	 Cambridge,	GBR).		 I	 observed	 an	 increase	 in	 the	 number	 of	 lysine-acetylated	 proteins	between	 0	 and	 1	 hour	 post	 induction.	 This	 could	 be	 due	 to	 the	 increased	production	 of	 proteins	 involved	 in	 metabolism	 of	 growing	 bacteria,	 many	 of	which	 have	 been	 shown	 to	 be	 acetylated	 (Wang	 et	 al.,	 2010)	 (Figure	 4.7.1).	Specifically,	 at	 1	 hour	 post-induction,	 a	 band	 correlating	 to	 a	 protein	 with	 an	apparent	molecular	weight	 of	 approximately	 25	 kDa,	was	 detected	 in	 samples	corresponding	 to	 bacteria	 harbouring	 either	 the	 empty	plasmid	 or	 those	 over-expressing	 both	 the	 toxin	 and	 the	 antitoxin	 genes.	 No	 equivalent	 band	 was	observed	in	samples	corresponding	to	bacteria	over-expressing	the	toxin	genes	
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alone.	 At	 2	 hours	 post	 induction,	 however,	 the	 band	 could	 be	 observed	 in	 the	sample	corresponding	to	bacteria	over-expressing	t6.	The	25	kDa	band	was	still	missing	 in	 the	 lane	 corresponding	 to	 bacteria	 over-expressing	 t8.	 The	 lysine-acetylome	 profiles	 were	 the	 same	 at	 3	 hours	 as	 2	 hours	 post-induction.	Monitoring	 the	 growth	 of	 the	 bacteria	 (Figure	 4.7.2A-B)	 revealed	 that	 the	appearance	of	the	25	kDa	band	correlated	with	the	bacteria	reaching	an	OD600	of	approximately	0.7.	These	results	suggest	that	the	delay	in	the	appearance	of	the	band	at	25	kDa	was	most	likely	due	to	the	inhibition	of	growth	caused	by	over-expression	of	the	toxin	and	that	the	differences	in	the	lysine-acetylome	observed	between	 the	various	strains	were	dependent	on	 the	growth	phase.	There	 is	no	obvious	 alteration	 in	 the	 lysine-acetylome	 upon	 over-expression	 of	 the	 toxin	genes	and	as	such	no	inference	can	be	made	as	to	the	target[s]	of	the	toxins.		
4.2.7	Effects	of	over-expression	of	t6	and	t8	on	the	lysine-acetylome	of	a	
Salmonella	strain	deleted	of	cobB		 In	 order	 to	 obtain	 sufficient	 proteins	 to	 assess	 the	 lysine-acetylome	 of	
Salmonella	 over-expressing	 the	TA	module	 genes,	 it	was	 required	 to	 allow	 the	bacteria	to	grow	to	mid	exponential	phase.	However,	as	we	had	shown	that	the	toxic	effect	of	T6	and	T8	was	masked	in	mid	exponential	phase,	possibly	due	to	the	increased	levels	of	the	deacetylase	CobB,	I	hypothesised	that	the	endogenous	CobB	could	be	deacetylating	the	target	protein[s]	and	then	aimed	to	investigate	the	 lysine-acetylome	 of	 a	 cobB	 deletion	 mutant	 strain	 of	 Salmonella	 over-expressing	t6	or	t8.	Here,	stationary	phase	S.	Typhimurium	∆ta∆cobB	harbouring	either	 the	 empty	 pNDM220	 vector	 (lanes	 1	 and	 3)	 or	 the	 respective	 toxin	containing	vector	(lanes	2	and	4),	were	subcultured	into	fresh	LB	and	grown	at	
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37	˚C.	After	2	hours	of	growth,	cultures	were	supplemented	with	IPTG	to	induce	expression	 of	 the	 toxin	 genes.	 Samples	 were	 taken	 before	 induction	 and	 at	hourly	intervals	after	induction.	Bacterial	loads	in	the	samples	were	normalised	by	 OD600,	 total	 proteins	 extracted	 and	 separated	 via	 SDS-PAGE.	 The	 lysine-acetylome	was	visualised	by	western	blot,	probing	with	an	anti-lysine	acetylated	antibody	(ab21623,	Abcam).		Consistently	with	the	previous	results,	a	 lysine-acetylated	protein	with	a	predicted	 molecular	 weight	 of	 approximately	 25	 kDa	 appeared	 in	 samples	corresponding	 to	 the	 control	 strains	 at	 1	 hour	 post	 induction	 (Figure	 4.8.1).	There	was	 no	 equivalent	 band	 in	 samples	 corresponding	 to	 the	 bacteria	 over-expressing	t6	or	t8,	respectively.	Interestingly,	unlike	in	the	previous	experiment,	even	at	3	hours	post	induction	there	was	no	appearance	of	a	band	corresponding	to	a	 lysine-acetylated	protein	of	approximately	25	kDa	 in	either	of	 the	samples	corresponding	 to	 the	 bacteria	 over-expressing	 the	 toxin	 genes.	 Again,	 when	taking	into	account	the	growth	kinetics	of	the	bacterial	strains	(Figure	4.8.2A-B),	it	 was	 apparent	 that	 neither	 of	 the	 bacterial	 strains	 over-expressing	 the	 toxin	genes	exceeded	an	OD600	of	0.7.	These	results	suggest	that	the	differences	in	the	acetylome	observed	between	 the	 bacteria	 over-expressing	 the	 toxin	 genes	 and	the	respective	control	strains	were	dependent	on	the	growth	phase.		Together	with	 the	 results	 reported	 in	 section	4.2.4,	 those	 reported	here	show	 that	 no	 effect	 of	 the	 GNAT	 toxins	was	 visualised	 by	western	 blot.	 I	 then	considered	 that	 the	 target	 protein[s]	 might	 be	 transiently	 expressed	 or	 that	acetylation	of	the	target	could	lead	to	its	degradation.	
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Figure 4.7.1: N-acetylome of S. Typhimuirum over-expressing W and W. S. Typhimurium strains ¨WD and 
¨WD harbouring either the pNDM220 plasmid (lanes 1 and 4 respectively), the respective toxin containing 
plasmid (lanes 2 and 5) or both the toxin and the antitoxin containing plasmids (lanes 3 and 6), were incubated  
at 37°C with shaking. After 2 h IPTG and arabinose were added to the medium to induce gene expression. At 
hourly time points 1 ml of bacterial culture was harvested and the total proteins separated via SDS-PAGE and 
probed with an anti-lysine acetylated protein antibody. Red arrows highlight inconsistencies betweem strains. 
Representative images, experiment was replicated three times.
Figure 4.7.2: Growth kinetics of respective bacterial strains. S. Typhimurium strains ¨WD (A) and ¨WD (B) 
harbouring either the pNDM220 plasmid (     ), the respective toxin containing plasmid (     ) or both the toxin 
and the antitoxin containing plasmids (     ), were incubated at 37°C with shaking. After 2 h IPTG and arabinose 
were added to the medium to induce gene expression. Growth was monitored by measuring the OD600 at hourly 
time points.
A B
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Figure 4.8.1: N-acetylome of S. Typhimuirum ¨WD¨FRE% over-expressing W and W. S. Typhimurium 
strains ¨WDFRE% and ¨WD¨FRE% harbouring either the pNDM220 plasmid (lanes 1 and 3 respectively) or the 
respective toxin containing plasmid (lanes 2 and 4), were incubated at 37°C with shaking. After 2 h IPTG was 
added to the medium to induce gene expression. At hourly time points 1 ml of bacterial culture was harvested 
and the total proteins separated via SDS-PAGE and probed with an anti-lysine acetylated protein antibody. Red 
arrows highlight inconsistencies betweem strains. Representative images, experiment was replicated three 
times.
Figure 4.8.2: Growth kinetics of respective bacterial strains. S. Typhimurium strains ¨WD¨FRE% (A) and ¨
WD¨FRE% (B) harbouring either the pNDM220 plasmid (     ), the respective toxin containing plasmid (     ), were 
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4.2.8	Purification	of	T8		 In	 face	 of	 a	 lack	 of	 informative	 observations	 studying	 the	 overall	acetylome	 of	 Salmonella	 upon	 toxins	 production,	 I	 decided	 to	 use	 another	approach	and	to	test	directly	T8	enzymatic	activity	in	in	vitro	biochemical	assays.	However,	purification	of	a	protein	that	is	toxic	to	the	bacteria	that	produce	it	has	obvious	 drawbacks.	 We	 set	 up	 an	 approach	 in	 collaboration	 with	 Michal	Pryzdacz	 and	 Dr	 Stephen	 Hare.	 As	 the	 toxicity	 of	 T8	 was	 overcome	 by	 co-expressing	t8	alongside	a8,	the	antitoxin	and	toxin	component	of	the	TA8	module	were	cloned	successively	 into	pRSFduet	plasmid	(Novagen,	Madison,	USA).	The	Antitoxin	was	cloned	 first	 in	 the	MCS2	site	and	 then,	 in	a	 subsequent	 round	of	cloning,	the	toxin	was	cloned	into	the	MCS1	site,	so	that	an	N-terminal	6His-tag	was	added.	pRSFduetTA8	was	 then	 transformed	 into	E.	coli	PC2	 for	expression	and	 purification.	 Cultures	 of	 E.	 coli	 over-expressing	 the	 ta8	 module	 were	harvested	by	 centrifugation	and	 lysed	by	 sonication.	The	whole	 cell	 lysate	was	incubated	 with	 Ni-NTA	 resin	 to	 allow	 binding	 of	 the	 6His-tagged	 toxin	 and	affinity	 chromatography	 was	 used	 to	 crudely	 purify	 the	 TA8	 complex.	Throughout	 the	 purification	 process	 samples	 were	 analysed	 via	 SDS-PAGE	(Figure	 4.9.1A).	 To	 acquire	 clean	 TA8	 complex,	 size	 exclusion	 column	chromatography	was	used.	However,	the	elution	did	not	result	 in	a	satisfactory	resolution	of	peaks	(Figure	4.9.1B).	Size	exclusion	column	chromatography	was	not	sufficient	to	obtain	pure	TA8	complex,	however,	these	results	show	that	the	TA8	complex	binds	avidly.		In	order	to	liberate	T8	from	the	neutralising	effects	of	the	A8	protein,	we	undertook	to	denaturate	the	TA8	complex	on	the	column.	Here,	the	TA8	complex	was	expressed	in	E.	coli	PC2	as	previously	described,	cells	were	harvested,	lysed	
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by	 sonication	and	 the	6His-tagged	TA	complex	bound	 to	 the	Ni-NTA	as	before.	The	TA8	complex	bound	to	the	resin	was	then	washed	with	denaturation	buffer,	in	 order	 to	 break	 the	 interactions	 between	 the	 toxin	 and	 the	 antitoxin,	 and	eluted,	 maintaining	 the	 denaturing	 conditions.	 Refolding	 of	 the	 toxin	 was	achieved	 via	 overnight	 dialysis.	 Samples	 were	 taken	 at	 every	 step	 of	 the	purification	 process	 and	 analysed	 via	 SDS-PAGE	 (Figure	 4.9.2A).	 Though	 there	are	 still	 impurities	 in	 the	 final	 solution	 of	 T8,	 the	 process	 has	 cleared	 the	antitoxin.	 I	 repeated	 this	 process	 with	 purification	 of	 the	 T8Y140F	 variant	alongside	WT	T8	(Figure	4.9.2B).	
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Figure 4.9.1: TA8 purifies as a complex. TA8-pRSFduet was expressed in E. coli 3&DWÛ&RYHUQLJKW
&HOOVZHUH KDUYHVWHG O\VHGDQGSXULILHG E\1L17$DIILQLW\ FKURPDWRJUDSK\6XEVHTXHQWO\ WKH HOXDWHZDV
VXEMHFWHGWRVL]HH[FOXVLRQFKURPDWRJUDSK\WRUHPRYHLPSXULWLHV$OOVWDJHVRIWKHSXULILFDWLRQZHUHVHSDUDWHG
E\6'63$*(DQGYLVXDOLVHGE\&RRPDVVLHVWDLQLQJ$'/GHSOHWHGO\VDWH:ZDVK(HOXDWHIUDFWLRQV
IURPVL]HH[FOXVLRQFKURPDWRJUDSK\FRQWDLQLQJ7$FRPSOH[7KHEODFNDUURZVLQGLFDWH7DQG$7KH
UHGYHUWLFDOOLQHVLQGLFDWHIUDFWLRQFROOHFWLRQ%
Figure 4.9.2: Purification of T8 from TA complex. 7$S56)GXHWZDVH[SUHVVHGDQGO\VHGDVSUHYLRXVO\
GHVFULEHG3URWHLQZDVDSSOLHGWR1L17$UHVLQDQGZDVKHGZLWKP0,PLGD]ROHDVDPSOHRIWKHUHVLQZDV
WDNHQIRUDQDO\VLV7KHUHVLQZDVWKHQZDVKHGZLWKGHQDWXUDWLRQZDVKEXIIHUWZLFHZLWKUHVLQVDPSOHVWDNHQ
DIWHUHDFKZDVK)LQDOO\SURWHLQVZHUHHOXWHGLQGHQDWXUDWLRQHOXWLRQEXIIHU7ZDVUHIROGHGYLDGLDO\VLVDWÛ&
RYHUQLJKW5HIROGHGSURWHLQVZHUHFHQWULIXJHG WR UHPRYHSUHFLSLWDWHGPDWHULDODQGVDPSOHV IURPDOO VWDJHV
ZHUHDQDO\VHGE\6'63$*(:&/ZKROHFHOOO\VDWH'/GHSOHWHGO\VDWH:ZDVK:RZDVKUHVLQ*Q
GHQDWXULQJZDVK*QRZDVKUHVLQ*QGHQWDXULQJZDVK*QRZDVKUHVLQ(HOXDWH3SUHFLSLWDWH6XS
VXSHUQDWDQW$6HFRQGURXQGRISXULILFDWLRQDQGRQFROXPQGHQDWXUDWLRQWRSXULI\7DQG7<):&/
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4.3	Summary		 In	this	chapter	I	have	sought	to	investigate	the	toxicity	of	T6	and	T8.	Over-expression	 of	 t8	 results	 in	 a	 rapid	 and	 specific	 inhibition	 in	 protein	 synthesis.	The	results	 for	T6	were	 less	conclusive,	however,	 they	suggest	 that	T6	 inhibits	protein	 and	 DNA	 synthesis	 rapidly	 and	 transiently.	 GNAT	 toxins	 are	 found	 in	many	 bacterial	 species,	 however,	 there	 is	 often	 little	 amino	 acid	 sequence	similarity	between	them.	Comparison	of	the	amino	acid	sequences	of	T6,	T8	and	T9	 revealed	 that	 T6	 and	 T8	 share	 little	 sequence	 identity,	 suggesting	 the	 two	toxins	 may	 have	 different	 targets.	 Using	 a	 simple	 protein	 sequence	 BLAST	alignment	 the	 predicted	 conserved	 Ac-CoA	 binding	 residues	 could	 be	ascertained,	 and	 a	 predicted	 tertiary	 structure	 alignment	 highlighted	 further	important	 residues.	 Site	 directed	 mutagenesis	 resulting	 in	 amino-acid	substitutions	of	critical	residues	resulted	 in	 the	abolition	of	T6	and	T8	toxicity,	demonstrating	the	importance	of	this	region	for	their	function.	The	transience	of	the	 toxicity	of	T6	and	T8	was	 found	 to	be	due	 to	 the	detoxifying	 effects	of	 the	
Salmonella	 global	 deacetylase	 CobB,	 which	 further	 suggest	 that	 the	acetyltransferase	 activity	 of	 both	 T6	 and	 T8	 is	 crucial	 for	 their	 function.	 In	collaboration	 with	 members	 of	 the	 Hare	 group,	 T8Y140F	 was	 purified	 and	 its	crystal	 structure	 was	 solved.	 These	 results	 showed	 that	 T8	 is	 a	 novel	acetyltransferase	 that	dimerizes	 through	unique	 features.	Overall,	 these	results	strongly	 suggest	 that	 T6	 and	 T8	 are	 acetyltransferases	 reversibly	 corrupting	their	target.	However,	there	was	no	obvious	change	in	the	acetylome	of	bacteria	over-expressing	 either	 t6	 or	 t8	 compared	 to	 their	 respective	 control	 strains,	when	probing	the	proteome	with	an	anti-lysine	acetylated	protein	antibody.	This	may	 be	 due	 to	 the	 specificity	 of	 this	 particular	 antibody.	 As	 more	 work	 was	
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necessary	to	identify	the	target(s)	and	mode	of	action	of	the	toxins,	I	purified	the	WT	T8	and	T8Y140F	variants	to	use	it	in	in	vitro	assay.	
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Chapter	five	
T8	 induces	 persister	 formation	 by	
acetylation	of	tRNA		
5.1	Introduction	As	 discussed	 in	 section	 1.5.4,	 toxin	 components	 of	 TA	 modules	 have	evolved	to	target	an	array	of	cellular	processes	through	interfering	with	a	variety	of	 targets.	 With	 the	 increasing	 wealth	 of	 information	 on	 the	 molecular	mechanisms	 of	 individual	 toxin	 homologues,	 it	 is	 becoming	 apparent	 that	homologous	 toxins	can	 function	 in	different	ways.	 	The	 results	observed	so	 far	suggested	 that	 T8	 inhibits	 protein	 synthesis	 through	 an	 acetyltransferase	activity.	 Translation	 is	 targeted	 by	 a	 number	 of	 TA	modules	 (Section	 1.5.4.4),	highlighting	the	complexity	of	this	process.	In	brief,	mRNase	toxins	can	degrade	mRNA,	 globally	 or	 specifically,	 in	 a	 ribosome	 dependent	 and	 independent	manner	 (Pedersen	 et	 al.,	 2003;	 Christensen-Dalsgaard	 &	 Gerdes,	 2008).	Furthermore,	 both	 endoribonuclease	 toxins	 and	 those	 containing	 PIN	 domains	can	target	other	forms	of	RNA	including	ribosomal	and	tRNA	(Winther	&	Gerdes,	2011;	 Winther	 et	 al.,	 2013).	 Finally,	 the	 two	 known	 kinase	 toxins	 inhibit	elongation	 and	 tRNA	 aminoacylation	 (Castro-Roa	 et	 al.,	 2013;	 Germain	 et	 al.,	2013;	Kaspy	et	al.,	2013).			
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In	this	chapter,	I	report	the	elucidation	of	molecular	mechanism	of	action	of	 T8	 through	 identification	 of	 its	 specific	 target.	 Further,	my	work	 revealed	 a	detoxifying	mechanism	allowing	bacteria	to	resume	growth	after	corruption	by	T8.	Finally,	 I	propose	a	model	 through	which	T8	 inhibits	growth	and	promotes	persister	 formation	 in	Salmonella.	Radiation	work	 throughout	 this	 chapter	was	completed	with	the	help	of	Dr.	Bridget	Gollan.		
5.2	Results	
5.2.1	Titration	screen	using	a	Salmonella	gDNA	library		 In	most	cases,	activation	of	a	TA	module	results	in	cell	stasis,	rather	than	cell	death.	As	such,	over-expression	of	the	target	gene	can	result	in	counteraction	of	the	toxic	effect	by	titration	of	the	toxin	proteins.	This	can	be	exploited	by	way	of	 a	 genetic	 screen	 to	 search	 for	 possible	 targets,	 as	 was	 the	 case	 for	 the	discovery	of	the	true	target	of	HipA	(Germain	et	al.,	2013).	In	my	first	attempt	I	generated	 an	S.	 Typhimurium	gDNA	 library.	Genomic	DNA	was	 extracted	 from	stationary	 phase	 S.	 Typhimurium	 and	 partially	 digested	 with	 the	 Sau3AI	restriction	enzyme.	Purified	digestion	products	of	1	 to	5	kbp,	were	 ligated	 into	the	 high	 copy	 number	 plasmid,	 pBR322.	 To	 ensure	 good	 coverage	 of	 the	 S.	Typhimurium	genome	 in	 the	 library,	 I	pooled	at	 least	24,000	clones.	The	 toxin	genes	 were	 cloned	 into	 the	 pBAD33	 over-expression	 vector	 placing	 toxin	production	 under	 the	 control	 of	 the	 arabinose	 inducible	 Para	 promoter.	 The	pooled	 gDNA	 library	 was	 co-transformed	 with	 the	 toxin	 over-expression	plasmids	into	E.	coli	DH5α.	The	transformation	mix	was	plated	onto	two	LB	agar	plates	 both	 supplemented	 with	 selective	 antibiotics,	 while	 only	 one	 was	
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supplemented	with	arabinose	to	induce	expression	of	the	toxin	(Figure	5.1.1).	I	used	the	toxin	non-inducing	plate	to	determine	the	transformation	efficiency	and	calculate	 the	 total	number	of	colonies	screened	(Table	5.1).	Plasmids	extracted	from	colonies	obtained	on	 the	 toxin	 inducing	plate	were	 sequenced	 to	 identify	genes	whose	expression	suppressed	T6	or	T8	toxicity	(Table	5.2	and	5.3).		In	 the	 T6	 screen	 355,000	 colonies	were	 evaluated,	 covering	 the	 library	over	 14	 times	 and	 17	 colonies	were	 analysed.	 In	 the	 T8	 screen	 approximately	206,000	 colonies	 were	 evaluated,	 covering	 the	 library	 over	 8	 times	 and	 13	colonies	 were	 analysed	 (Table	 5.1).	 Of	 the	 17	 plasmids	 sequenced	 in	 the	 T6	screen,	 only	 3	 genes	were	 identified	 twice.	 These	were,	 fragments	 of	artJ,	mfd	and	a	gene	encoding	a	hypothetical	protein	containing	a	tpr	repeat	sequence.	The	plasmid	 containing	 the	 artJ	 gene	 fragment	 also	 encoded	 two	 other	 gene	fragments	 of	 a	 much	 smaller	 size	 (Table	 5.2).	 The	 results	 for	 the	 T8	 screen	seemed	much	more	specific	(Table	5.3).	Of	the	13	plasmids	that	were	sequenced,	9	contained	a	fragment	of	the	a8	antitoxin	gene.	Of	the	remaining	4,	2	contained	fragment	of	the	argD	gene.	Of	note,	these	two	plasmids	came	up	in	both	screens.	The	 sequencing	 results	 showed	 that	 only	 short	 fragments	 of	 each	 gene	were	 contained	 within	 the	 plasmids	 and	 that	 many	 of	 the	 plasmids	 that	counteracted	T6	 toxicity	contained	multiple	gene	 fragments.	This	revealed	 that	during	 construction	 of	 the	 gDNA	 library	 random	 re-ligation	 events	 occurred	resulting	 in	 multiple	 gene	 fragments	 from	 various	 loci	 cloned	 in	 the	 same	plasmid.	 However,	 I	 determined	 that	 the	 pBAD33	 over-expression	 vector	 still	contained	WT	toxins	and	had	not	accumulated	toxicity	abolishing	mutations.	As	such,	I	continued	to	investigate	how	counteraction	could	occur.	
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5.2.2	Validation	of	the	gDNA	titration	screen	results	by	over-expression	
assays	and	mass	spectrometry		 I	 chose	 to	 investigate	 if	 ArgD	was	 a	 target	 for	 T8,	 and	ArtJ,	 one	 for	 T6.	Interestingly	 both	 ArgD	 and	 ArtJ	 are	 enzymes	 involved	 in	 the	 arginine	biosynthesis	 and	 uptake	 pathways	 respectively.	 Hypothetically,	 interference	with	 both	 proteins	 could	 result	 in	 arginine	 starvation	 and	 a	 halt	 in	 protein	synthesis.	First,	I	re-cloned	the	full-length	argD	and	artJ	genes	into	the	pBAD33	over-expression	 vector,	 placing	 their	 expression	 under	 the	 control	 of	 the	arabinose	 inducible	 Para	 promoter	 and	 co-transformed	 them	 alongside	 the	pNDM220	toxin	containing	plasmids.	This	was	 to	 test	whether	over-expression	of	 the	 full-length	 gene	 resulted	 in	 a	 titration	 of	 the	 toxicity	 of	 T6	 and	 T8.	 I	included	a	C-terminal	6His-tag	to	aid	purification	of	the	putative	target	proteins	(Figure	5.2.1	and	Table	5.4).	Stationary	phase	single	TA	deletion	mutants	harbouring	either	the	empty	pNDM220	plasmid,	the	respective	toxin	containing	plasmid	or	the	toxin	and	the	
argD	 or	 artJ	 containing	 plasmids,	 were	 subcultured	 into	 fresh	 LB	 medium	supplemented	with	IPTG	and	arabinose	to	induce	gene	expression.	Growth	was	monitored	upon	over-expression	of	 the	 toxin	 genes	by	measuring	OD600	 at	30-minute	intervals.	Parallel	over-expression	of	argD	had	no	effect	on	either	T6	or	T8	 toxicity	 (Figure	 5.2.2A-B)	 compared	 to	 over-expression	 of	 the	 toxin	 alone,	whereas,	parallel	over-expression	of	artJ	appeared	to	have	a	small	titrating	effect	of	T6	but	not	T8	toxicity.		In	parallel	to	this,	I	also	aimed	to	determine	whether	T6	and	T8	acetylated	ArtJ	 or	 ArgD	 in	 vivo.	 To	 investigate	 this,	 I	 purified	 6His-tagged	 ArtJ	 and	 ArgD	from	 S.	 Typhimurium	 producing	 the	 potential	 target	 with	 or	 without	 parallel	
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over-expression	 of	 the	 toxin	 gene.	 Here,	 stationary	 phase	 single	 TA	 deletion	mutants	harbouring	either	 the	potential	 target	 containing	plasmid	or	 the	 toxin	and	 potential	 target	 containing	 plasmids,	 were	 subcultured	 into	 fresh	 LB	supplemented	with	the	relevant	antibiotics.	Cultures	were	grown	to	an	OD600	of	0.4	at	37	˚C	and	ITPG	and	arabinose	were	added	to	the	cultures	to	 induce	gene	expression.	After	2	hours	of	induction	cells	were	harvested	by	centrifugation	and	lysed	 by	 sonication.	 The	whole	 cell	 lysate	was	 incubated	with	Ni-NTA	 resin	 to	allow	binding	of	the	6His-tagged	targets	and	affinity	chromatography	was	used	to	 purify	 the	 potential	 targets.	 Purified	 proteins	 were	 then	 separated	 by	 SDS-PAGE	 and	 visualised	 by	 Coomassie	 staining	 (Figure	 5.2.3	 upper	 panels).	 A	western	blot,	probing	with	an	anti-6His	tag	antibody	(ab1187,	Abcam)	was	used	to	confirm	the	identity	of	the	purified	proteins	(Figure	5.2.3	lower	panels).	Areas	of	the	stained	SDS-PAGE	gel	containing	the	putative	target	proteins	were	excised	and	analysed	by	nLC-ESI-MS/MS	at	the	BRSC	Mass	Spectrometry	and	Proteomics	facility,	University	of	St.	Andrews.	Peptides	of	the	putative	target	proteins	were	identified	using	the	Mascot	search	engine	and	potential	acetylation	events	were	predicted	 based	 on	 the	 appearance	 of	 a	 42	 Da	 shift	 in	 the	 peptide	 mass.	Confirmation	of	any	predicted	acetylation	events	was	obtained	by	identification	of	 a	 126	 m/z	 peak	 in	 the	 raw	 data	 (Couttas	 et	 al.,	 2008).	 No	 differential	acetylation	 was	 seen	 in	 two	 individual	 repeats	 (an	 example	 of	 the	 mass	spectrometry	results	obtained	can	be	found	in	Appendix	1).		
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T6 T8
Total Colonies 355 000 205 992
Times library screened 14.79 8.5
Sequenced colonies 17 13
Clone Name Encodes
1 argD bifunctional N-succinyldiaminopimelate-aminotransferase
2 pcnB Poly A Polymerase
3 dnaE DNA Polymerase III subunit alpha
amiA N-acetylmuramoyl-l-alanine amidase I 
4 mfd transcrition repair coupling factor
5 hypothetical protein
6 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (Upstream)
7 mfd transcrition repair coupling factor
8 putative diaminopimelate decarboxylase
yhjC putative transcriptional regulator
9 hypothetical protein
10 artJ arginine transport system component
putative phosphoribulokinase/uridine kinase family
putative intergrase protein
11 hypothetical protein -  tpr repeat containing protein
beaR DNA binding transcriptional regulator
12 hypothetical protein -  tpr repeat containing protein
13 Putative glycosyl hydrolase
14 artJ arginine transport system component
putative phosphoribulokinase/uridine kinase family
putative intergrase protein
15 asrC anaerobic sulfide reductase
Putative outer membrane lipoprotein
16 putative mandelate racemase
17 gdhA glutamate dehydrogenase
Clone Name Encodes
1 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (upstream)
2 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (upstream)
3 argD bifunctional N-succinyldiaminopimelate-aminotransferase
4 argD bifunctional N-succinyldiaminopimelate-aminotransferase
5 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (upstream)
6 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (upstream)
7 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (upstream)
8 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (upstream)
9 yliC putative ABC transporter periplasmic binding protein
10 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (upstream)
11 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (upstream)
12 a8 putative cytoplasmic protein (Antitoxin)
putative acetyl transferase (upstream)
13 ydiK putative inner membrane protein
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Figure 5.1.1
Figure 5.1.1: Genetic screen for identification of T6 and T8 titrating proteins using a Salmonella gDNA 
library. WT Salmonella gDNA was digested with Sau3AI and ligated in the high-copy number plasmid, pBR322. 
Pooled library plasmids were co-transformed with pBT6 and pBT8 and transformants selected for on LB agar 
plates, both supplemented with the appropriate antibiotics (non-inducing) and one with arabinose (inducing). 
gDNA library plasmids from colonies obtained under toxin inducing conditions were sequenced to determine the 
genetic contents.
Table 5.1
Table 5.3Table 5.2
Table 5.1: Total colonies screened in gDNA assay.
Table 5.2: Sequencing results for T6 gDNA library screen. Sequencing results for pBR322 plasmids of 
colonies obtained upon induction of t6 expression.
Table 5.3: Sequencing results for T8 gDNA library sceen. Sequencing results for pBR322 plasmids of 
colonies obtained upon induction of t8 expression.
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pNT6 pNDM220::T6 This study
pNT8 pNDM220::T8 This study
pBArtJ pBAD33::artJhis This study
pBArgD pBAD33::argDhis This study
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Figure 5.2.1: Putative target over-expression plasmids. Representative plasmid maps of pBAD33 
harbouring the putative toarget coding sequences.
Table 5.4: Plasmids used to validate gDNA library screen results. Putative target containing plasmids using 
the pBAD33 vector are selectable by chloramphenicol resistance and are under the control of the ara operon.
Figure 5.2.2: Lack of titration of T6 and T8 toxicity by ArtJ and ArgD. Stationary phase 6Typhimurium ¨
WDDQG¨WDstrains harbouring either the pNDM220 empty vector  (     ), the respective toxin containing 
SODVPLGRUWKHWR[LQDQGSXWDWLYHWDUJHWSODVPLGV$UW-$UJ'ZHUHLQFXEDWHGLQ/%PHGLXP
supplemented with IPTG and arabinose to induce gene expression. Induction began at time point 0 and OD600 
PHDVXUHGDWPLQXWHLQWHUYDOV.  (n=1).
A B
Figure 5.2.3: Purification of ArgD and ArtJ for analysis by mass spectrometry. 6Typhimurium ¨WDDQG
¨WDstrains harbouring either the putative target plasmids or the toxin and putative target plasmids, were 
LQFXEDWHG LQ/%PHGLXPVXSSOHPHQWHGZLWK ,37*DQGDUDELQRVH WR LQGXFHJHQHH[SUHVVLRQ$UJ'KLVDQG
$UW-KLVZHUHSXULILHGRYHU1L17$FRORXPQDQGVHSDUDWHGE\6'63$*(DQGYLVXDOLVHGE\&RRPDVVLHVWDLQ
Bands correspponding to the molecular weight of putative targets were excised and analysed by 
Q/&(6,0606DWWKH%56&0DVV6SHFWURPHWU\DQG3URWHRPLFVIDFLOLW\8QLYHUVLW\RI6W$QGUHZV)RUD
detailed protocol please refer to section 2.29.
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5.2.3	Titration	screen	using	the	ASKA	library	
	 	As	our	Salmonella	gDNA	library	led	to	unsuccessful	results,	I	repeated	the	screen	 with	 the	 AKSA	 collection	 (Kitagawa	 et	 al.,	 2005)	 of	 high-copy	 number	plasmids	 containing	 most	 E.	 coli	 open	 reading	 frames	 (ORFs).	 In	 these	experiments	 I	 decided	 to	 focus	my	efforts	 solely	on	T8.	 In	order	 to	 repeat	 this	assay	 with	 the	 ASKA	 library	 it	 was	 necessary	 to	 clone	 the	 t8	 gene	 into	 the	pBAD18	vector	(pB18T8),	to	allow	for	compatible	co-transformation	of	the	toxin	containing	plasmid	and	the	ASKA	 library	plasmids.	Here,	E.	coli	DH5α	were	co-transformed	with	pB18T8	and	the	pooled	ASKA	library.	The	transformation	mix	was	 plated	 onto	 two	 LB	 agar	 plates,	 both	 supplemented	 with	 the	 selective	antibiotics	and	one	containing	arabinose	and	IPTG	to	induce	expression	of	t8	and	the	 gene	 in	 the	 ASKA	 library	 plasmid	 (Figure	 5.3.1).	 Colonies	 obtained	 on	 the	toxin	non-inducing	plate	were	used	 to	determine	 the	 transformation	efficiency	and	 calculate	 the	 total	 number	 of	 colonies	 screened	 (Table	 5.5).	 Plasmids	 of	colonies	obtained	on	the	toxin	inducing	plates	were	sequenced	(Table	5.6).		During	 this	 screen	 over	 2	million	 colonies	were	 evaluated,	 covering	 the	library	nearly	500	times,	and	43	plasmids	were	sequenced	(Table	5.6).	Of	the	43	plasmids	that	were	sequenced,	19	harboured	the	ORF	containing	Peptidyl	tRNA	hydrolase	 (Pth).	These	results	suggested	 that	Pth	was	capable	of	counteracting	the	toxicity	of	T8	and	so	warranted	further	validation	as	a	possible	target.		
5.2.4	Pth	counteracts	T8	toxicity	Pth	 is	 an	 essential	 enzyme,	with	 an	 important	 role	 in	 protein	 synthesis	(Menninger,	1975;	Das	&	Varshney,	2006).	During	translation	ribosome	stalling	occurs	 frequently.	 Stalled	 ribosomes	 are	 rescued	 by	 ribosome	 rescue	 factors	
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such	as	tmRNA,	which	functions	through	trans-translation	(Withey	&	Friedman,	2002).	However,	occasionally	after	stalling	the	ribosome	‘drops	off’,	dissociating	from	the	mRNA	and	resulting	in	the	release	of	peptidyl	tRNA	(ptRNA)	molecules.	Pth	hydrolyses	the	ester	bond	between	the	nascent	peptide	chain	and	the	tRNA	allowing	both	to	be	recycled	(Cuzin	et	al.,	1967).	This	is	an	essential	function	as	build	up	of	ptRNA	is	highly	toxic	to	the	bacteria	and	leads	to	a	rapid	inhibition	in	growth	(Figure	5.4.1)	(Menninger,	1979).	I	first	tested	if	parallel	over-expression	of	the	Salmonella	pth	titrated	out	T8	 toxicity.	 The	 full-length	Salmonella	pth	 gene	was	 cloned	 into	pBAD33	over-expression	 vector,	 placing	 its	 expression	 under	 the	 control	 of	 the	 arabinose	inducible	Para	promoter	and	allowing	co-transformation	with	the	pNT8	plasmid.	I	included	a	C-terminal	6His-tag	to	aid	purification	of	Pth	(Figure	5.4.2	and	Table	5.7).	 Stationary	 phase	 S.	 Typhimurium	 ∆ta8	 harbouring	 the	 empty	 pNDM220	plasmid,	the	pNT8	plasmid,	the	pBPth	plasmid	or	both	the	pNT8	and	the	pBPth	plasmids,	were	subcultured	into	fresh	LB	medium	supplemented	with	IPTG	and	arabinose	to	induce	gene	expression.	Growth	was	monitored	by	measuring	OD600	at	 30-minute	 intervals	 (Figure	 5.4.3A).	 Over-expression	 of	 pth	 had	 a	 slight	deleterious	effect	on	bacterial	growth,	however,	parallel	over-expression	of	pth	and	t8	counteracted	T8	toxicity.	To	test	if	this	counteraction	was	specific	to	T8,	I	induced	over-expression	of	pth	and	monitored	the	effects	it	had	on	the	toxicity	of	an	 unrelated	 toxin,	 ParE	 (Figure	 5.4.3B).	 Here,	 full	 length	 parE	 was	 over-expressed	 from	 the	 pNDM220	 plasmid.	 There	 was	 no	 counteraction	 of	 ParE	toxicity	 by	 parallel	 over-expression	 of	 pth.	 These	 results	 confirm	 that	 over-expression	of	pth	counteracts	specifically	T8	toxicity	and	suggests	that	Pth	could	be	the	target	of	T8.	
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Pooled ASKA 
library
Co-transform 
with toxin in 
E. coli
Sequence 
colonies
No toxin
induction
Toxin
induction
T8
Total colonies 20 155 91
Times library screened 491
Sequenced colonies 43
Clone Gene Encodes
1 pth Peptidyl-tRNA Hydrolase
2 hsp31 Partial chaperone protein HchA
3 pth Peptidyl-tRNA Hydrolase
4 pth Peptidyl-tRNA Hydrolase
5 mog Molybdochelatase incorporating molybdenum into molybdopterin
6 pyrL PyrBI operon leader peptide
7 pth Peptidyl-tRNA Hydrolase
8 rplR 50S ribosomal subunit L18
9 ygiW Hydrogen peroxide and cadmium resistance periplasmic protein, stress-induced OB-fold protein
10 ydeA L-arabinose/isopropyl-beta-D-thiogalactopyranoside export protein (MFS family)
11 pth Peptidyl-tRNA Hydrolase
12 fnr Oxygen-sensing anaerobic growth regulon transcriptional regulator FNR, autorepressor
13 pth Peptidyl-tRNA Hydrolase
14 pth Peptidyl-tRNA Hydrolase
15 yeeT CP4-44 prophage, uncharacterized protein
16 pth Peptidyl-tRNA Hydrolase
17 pth Peptidyl-tRNA Hydrolase
18 ybeF LysR family putative transcriptional regulator
19 pth Peptidyl-tRNA Hydrolase
20 pth Peptidyl-tRNA Hydrolase
21 pth Peptidyl-tRNA Hydrolase
22 pth Peptidyl-tRNA Hydrolase
23 pth Peptidyl-tRNA Hydrolase
24 argC N-acetyl-gamma-glutamylphosphate reductase, NAD(P)-binding
25 ycfH Putative DNase
26 yhdZ Putative amino acid ABC transporter ATPase
27 rmpG 50S ribosomal protein L33
28 pth Peptidyl-tRNA Hydrolase
29 pth Peptidyl-tRNA Hydrolase
30 pth Peptidyl-tRNA Hydrolase
31 pth Peptidyl-tRNA Hydrolase
32 hslO Heat shock protein Hsp33
33 pth Peptidyl-tRNA Hydrolase
34 ycfH Putative DNase
pBAD18
Toxin
Amp
r
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C
PBAD (+ara)
Figure 5.3.1
Table 5.5
Table 5.6
Figure 5.3.1: Genetic screen for identification of T8 titrating proteins using the ASKA library. Pooled 
ASKA library plasmids were cotransformed with pBT818 and transformants selected for on LB agar plates, both 
supplemented with the appropriate antibiotics (non-inducing) and one with ITPG and  arabinose (inducing). 
ASKA library plasmids from colonies obtained under toxin inducing condition were sequenced to determine the 
genetic contents.
Table 5.5: Total colonies screened in ASKA libray assay.
Table 5.6: Sequencing results for T8 ASKA library screen. Sequencing results for ASKA library plasmids of 
colonies obtained upon induction of t8 expression.
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Plasmid name Plasmid properties Reference
pNParDE pNDM220::parDE This study
pNT8 pNDM220::t8 This study
pBPth pBAD33::Pthhis This study
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Figure 5.4.2: Pth over-expression plasmid map. Representative plasmid map of pBAD33 harbouring the 
pth coding sequence.
Table 5.7: Plasmids used to validate T8 ASKA library screen results. 
Figure 5.4.1: Recycling of ptRNA molecules by Pth after dissociation from the ribosome. During 
translation ribosome stalling occurs. Generally ribosome rescue factors recycle the ribosome and the various 
components. Occasionally ribosome ‘drop off’ occurs and the ribosome discociates from the mRNA and 
releases the ptRNA. Build up of ptRNA is highly toxic to bacteria. Pth hydrolyses the ester bond between the 
peptide and the tRNA molecule allowing recycling and reuse
Figure 5.4.3: Counteraction of T8 toxicity by Pth. Stationary phase S. Typhimurium ¨WDand ¨SDU'(
strains harbouring either the pNDM220 empty vector  (     ), the toxin containing plasmid  (     ), the toxin and 
the pBPth plasmids (     ) or just the pBPth plasmid (    ), were incubated in LB medium supplemented with IPTG 
and arabinose to induce gene expression. Induction began at time point 0 and OD600 measured at 30-minute 
intervals. Data represent mean ± SEM.  (n=3).
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5.2.5	T8	does	not	acetylate	Pth	in	vivo		 Since	 Pth	 is	 essential	 for	 protein	 synthesis	 and	 its	 over-production	counteracts	T8	toxicity,	it	seemed	plausible	that	it	could	be	a	direct	target	for	T8.	To	 further	 investigate	 the	 interactions	 between	 T8	 and	 Pth,	 I	 determined	whether	 T8	 acetylated	 Pth.	 To	 do	 this,	 I	 purified	 C-terminally	 6His-tagged	 Pth	from	S.	Typhimurium	∆ta8,	with	or	without	parallel	over-expression	of	t8	(Figure	5.5.2).	Stationary	phase	S.	Typhimurium	∆ta8	harbouring	the	pBPth	plasmid	or	the	pNT8	and	pBPth	plasmids	(Figure	5.5.1	and	Table	5.8),	were	subcultured	in	fresh	LB	supplemented	with	the	relevant	antibiotics.	Cultures	were	grown	to	an	OD600	of	0.4	 at	37	 ˚C	before	 ITPG	and	arabinose	were	added	 to	 the	 cultures	 to	induce	expression	of	the	genes.	After	2	hours	of	 induction	cells	were	harvested	by	 centrifugation	and	 lysed	by	 sonication.	The	whole	 cell	 lysate	was	 incubated	with	 Ni-NTA	 resin	 to	 allow	 binding	 of	 6His-tagged	 Pth	 and	 affinity	chromatography	was	 used	 to	 purify.	 Purified	 proteins	were	 then	 separated	 by	SDS-PAGE	and	visualised	by	Coomassie	staining	(Figure	5.5.2	upper	panel)	and	by	western	blot,	probing	with	an	anti-his	tag	antibody	(Figure	5.5.2	lower	panel).	Areas	of	the	stained	SDS-PAGE	gel	containing	the	Pth	protein	were	excised	and	analysed	 by	 nLC-ESI-MS/MS	 as	 before.	 Pth	 peptides	 were	 identified	 using	 the	Mascot	search	engine	and	potential	acetylation	events	were	predicted	based	on	the	 appearance	 of	 a	 42	 Da	 shift	 in	 the	 peptide	 mass.	 Confirmation	 of	 any	predicted	 acetylation	 events	 was	 obtained	 by	 the	 identification	 of	 a	 126	 m/z	peak	 in	 the	 raw	 data	 as	 previously	 described.	 However,	 no	 differential	acetylation	was	seen	in	two	individual	repeats.		If	T8	were	to	acetylate	Pth	 in	vivo,	 leading	to	 its	 inactivation,	 it	could	be	expected	that	a	build	up	of	ptRNA	would	occur	in	bacteria	over-expressing	t8.	To	
Chapter	five:	Results		
	 156	
investigate	this	hypothesis	further,	I	observed	the	effects	of	over-expression	of	t8	on	the	tRNA	profile.	Stationary	phase	S.	Typhimurium	∆ta8∆cobB	harbouring	the	empty	pNDM220	plasmid	or	the	pNT8	plasmid	were	subcultured	and	grown	to	an	OD600	of	0.4-06	before	IPTG	was	added	to	the	cultures	to	induce	expression	of	
t8.	After	6	hours	of	induction	tRNA	was	extracted	using	acid-phenol	to	maintain	the	ester	bond	between	the	tRNA	and	the	amino	acid/nascent	peptide	(Kohrer	&	RajBhandary,	2008),	separated	by	acid-urea	PAGE	and	visualised	by	methylene	blue	 staining	 (Janssen	 et	 al.,	 2012).	 To	 provide	 a	 positive	 control	 of	 ptRNA	accumulation,	a	thermo-sensitive	Pth	(Pth-ts)	variant	was	generated	(Cruz-vera	
et	 al.,	 2000)	 and	 tRNA	 was	 extracted	 from	 this	 strain	 after	 shifting	 to	 a	 non-permissive	temperature	(Figure	5.5.3).	Lanes	1	and	2	show	the	tRNA	profiles	of	the	 control	 and	Pth-ts	 strains	 respectively.	 The	ptRNA	was	 evident	 as	 a	 smear	and	 highlighted	 by	 the	 black	 bracket.	 Lanes	 3	 to	 8	 contained	 increasing	quantities	 of	 tRNA	 extracted	 from	 t8	 expressing	 bacteria.	 Although,	 a	 clear	increase	 in	 the	 amount	 of	 tRNA	was	 visible	 there	 was	 no	 smear	 indicative	 of	ptRNA	 accumulation	 (Figure	 5.5.3).	 This	 shows	 that	 there	 was	 no	 ptRNA	accumulation	 following	 induction	 of	 t8	over-expression	 suggesting	 that	 Pth	 is	still	functional	in	these	bacteria.	
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Figure 5.5.1: Plasmids used to monitor interaction of Pth and T8 in vivo. 
Table 5.8: Plasmids used to monitor acetylation of Pth in vivo. 
Figure 5.5.2: Purification of Pth for analysis by mass spectrometry. S. Typhimurium ¨WDharbouring 
either the pBPth  of pBPth and pNT8, were incubated in LB medium supplemented with IPTG and arabinose 
to induce gene expression. Pthhis was purified over an Ni-NTA column, separated by SDS-PAGE and 
visualised by Coomassie stain. Bands corresponding to the molecular weight of Pth were excised and 
analysed by nLC-ESI-MS/MS at the BRSC Mass Spectrometry and Proteomics facility, University of St. 
Andrews. For a detailed protocol please refer section 2.29.
Figure 5.5.3: Lack of accumulation of ptRNA after over-expression of t8. Mid exponential phase S. 
Typhimurium ¨ WDwith (lane 3-8, increasing concentrations of tRNA) or without pNT8 (lane 1), were incubated 
in LB medium supplemented with IPTG to induce gene expression. In parallel mid exponential S. Typhimurium 
3WKWV ZDV VZLWFKHG WR JURZWK DW Û& ODQH  W51$ZDV H[WUDFWHG VHSDUDWHG E\ DFLGXUHD 3$*( DQG
visualised by methylene blue staining. For a detailed protocol please refer to section 2.25.
Coomassie stain
:HVWHUQEORWSUREELQJZLWKĮ+LVDQWLWERG\
1 8765432
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5.2.6.1	T8	does	not	acetylate	Pth	in	vitro		 There	 were	 caveats	 in	 our	 precedent	 approach	 to	 try	 and	 identify	acetylation	 of	 Pth	 purified	 from	bacteria	 over-expressing	 t8	(Figure	 5.5.2).	For	example,	achieving	the	coverage	necessary	to	accurately	determine	a	mass	shift	of	42	Da	to	any	degree	of	confidence	is	difficult.	This	was	only	exacerbated	by	the	conditions	in	which	it	was	necessary	to	prepare	the	Pth	protein	sample.	In	order	to	inhibit	the	toxic	effect	of	T8,	expression	of	pth	was	required	to	such	levels	as	to	titrate	out	the	T8	proteins.	This	would	have	resulted	in	an	excess	of	Pth	to	T8,	diluting	 the	 number	 of	 acetylated	 peptides	 (if	 any)	 and	 decreasing	 the	confidence	of	predicted	acetylation	events.	A	more	sensitive	and	direct	approach	to	detect	a	potential	acetylation	of	Pth	was	to	use	radiolabelled	[14C]Ac-CoA	and	incubate	 in	vitro	purified	 T8	 and	 Pth	 (received	with	 thanks	 from	Dr	Anastasia	Mylona	-	Imperial	College	PPA	facility).	After	1	at	37	˚C,	samples	were	separated	via	 SDS-PAGE,	 exposed	 to	 a	 phosphostimulated	 luminescence	 plate	 and	 the	intensity	 of	 the	 radiation	 signal	 visualised	 using	 a	 phosphor-imager	 (Figure	5.6.1).	No	radiolabelled	band	corresponding	to	acetylation	of	Pth	was	observed	on	the	autoradiograph	(lower	panel),	suggesting	that	in	these	conditions,	T8	did	not	transfer	any	acetyl	group	from	the	[14C]Ac-CoA	to	Pth.		Finally,	 I	 examined	 the	effects	of	T8	on	Pth	 function	 in	vitro.	To	do	 this,	
Salmonella	 ptRNA	 extracted	 from	 the	 thermo-sensitive	 Pth	 mutant	 was	incubated	with	purified	Pth,	with	or	without	T8	for	1	hour	at	37	˚C.	All	samples	were	supplemented	with	Ac-CoA.	 tRNA	was	ethanol	precipitated,	separated	via	acid-urea	PAGE	and	visualised	by	methylene	blue	staining	 (Figure	5.6.2).	Here,	ptRNA	 (lane	 1)	was	 efficiently	 hydrolysed	 by	 Pth	 (lane	 2).	 T8	 had	 no	 effect	 of	
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ptRNA	by	itself	(lane	4),	and	no	deleterious	effect	on	the	ability	of	Pth	to	cleave	ptRNA	(lane	3).		Together,	 these	 results	 strongly	 suggest	 that	 Pth	 is	 not	 acetylated	 or	inactivated	by	T8	and	therefore	is	unlikely	to	be	the	direct	target	of	T8.	However,	as	Pth	counteracts	T8	toxicity,	it	may	be	a	third-party	detoxifying	element.		
5.2.6.2	T8	inhibits	translation	in	an	in	vitro	translation	assay		 The	 results	 obtained	 in	 section	 4.8	 suggested	 that	 T8	 inhibits	 protein	synthesis	 in	vivo.	 I	 tested	the	effect	of	T8	 in	vitro	 in	a	cell	 free	expression	assay	(PURExpress,	NEB).	The	cell	fee	in	vitro	expression	assay	was	carried	out	to	the	manufacturers	 specifications.	 Reactions	 were	 supplemented	 with	 purified	 T8	and	 Ac-CoA,	 where	 specified,	 and	 incubated	 at	 37	 °C	 for	 2	 hours	 to	 allow	transcription	and	translation	to	occur.	Subsequently,	samples	were	separated	via	SDS-PAGE	 and	 visualised	 by	 Coomassie	 staining.	 The	 production	 of	 the	 DHFR	protein,	encoded	for	on	the	positive	control	plasmid	supplied,	was	used	as	a	read	out	of	successful	expression	and	is	highlighted	with	a	red	star	(Figure	5.6.3	left	panel).	Addition	of	T8	or	Ac-CoA	only	 to	 the	 reaction	mix	had	no	effect	on	 the	production	of	DHFR	(lanes	2	and	3).	It	was	only	when	T8	and	Ac-CoA	were	added	together	 that	 inhibition	of	expression	occurred	(lane	4).	This	result	shows	 that	T8	inhibits	translation	in	an	Ac-CoA	dependent	manner,	 in	a	reaction	devoid	of	Pth.	 To	identify	the	target(s)	of	T8,	I	repeated	the	assay	using	[14C]Ac-CoA	to	track	acetylation.	Reactions	were	 incubated	at	37	°C	 for	2	hours	and	separated	via	 SDS-PAGE,	 as	 previously	 described.	 Samples	were	 visualised	 by	 Coomassie	staining	 to	 confirm	 expression	 had	 been	 inhibited	 and	 then	 exposed	 to	 a	
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phosphostimulated	 luminescence	 plate.	 The	 intensity	 of	 the	 radiation	 signal	visualised	 using	 a	 phosphor-imager	 (Figure	 5.6.3	 right	 panel).	 In	 the	autoradiograph	 image	 a	 band	 can	 be	 seen	 corresponding	 to	 the	 lane	 in	which	addition	of	T8	and	Ac-CoA	had	 inhibited	the	reaction	(lane	4),	suggesting	T8	 is	acetylating	a	component	of	the	in	vitro	expression	assays	in	this	reaction	leading	to	inhibition	of	expression.	
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Figure 5.6.1: Lack of acetylation of Pth by T8 in vitro. Purified Pth (lane 1), was incubated with 
[14C]Ac-CoA (lane 2) or with T8, without or with [14C]Ac-CoA (lane 3 and 4, respectively) in enzyme activity 
DVVD\EXIIHUIRUKRXUDWÛ&7ZDVLQFXEDWHGZLWK>&@$F&R$DVDFRQWURO3URWHLQVZHUHVHSDUDWHG
E\6'63$*(DQGYLVXDOLVHGE\&RRPDVVLHXSSHUSDQHODQGDXWRUDGLRJUDSK\ORZHUSDQHO
Figure 5.6.2: Lack of effect of T8 on Pth in vitro. ptRNA extracted from the Pth-Ts mutant grown at a 
non-permissive temperature (lane 1) was incubated with purfied Pth (lane 2), purified T8 (lane 4) or a both 
3WKDQG7ODQHLQHQ]\PHDFWLYLW\DVVD\EXIIHUIRUKRXUDWÛ&$OOVDPSOHVZHUHVXSSOHPHQWHGZLWK
$F&R$6DPSHOVZHUHVHSDUDWHGE\DFLGXUHD3$*(DQGYLVXDOLVHGE\PHWK\OHQHEOXHVWDLQLQJ
Figure 5.6.3: Inhibition of cell free in vitro expression by T8 accompanied by acetylation of a low 
molecular weight component. Cell free in vitro expression assays were supplemented with T8 (lanes 2 
DQGRUZLWKRXWODQHDQGDQGLQFXEDWHGIRUKRXUVDWÛ&$OOVDPSOHVZHUHVXSSOHPHQWHGZLWK
>&@$F&R$3URGXFWLRQRIWKHFRQWUROSURWHLQ'+)5UHGDVWHUL[ZDVXVHGWRFRQILUPH[SUHVVLRQ6DP-
ples were separated by SDS-PAGE and visualised by Coomassie staining (left panel) and autoradiography 
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
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5.2.7	Purified	ribosomal	proteins	are	not	acetylated	by	T8	in	vitro	To	identify	which	component	of	the	in	vitro	expression	kit	was	acetylated,	reactions	 were	 carried	 out	 to	 the	 manufacturers	 specifications	 and	supplemented	with	 Ac-CoA	 and	 purified	 T8,	 where	 specified.	 After	 2	 hours	 of	incubation	at	37	˚C,	samples	were	separated	on	SDS-PAGE	gel	and	visualised	by	Coomassie	 staining	 (Figure	 5.7.1).	 Proteins	 migrating	 at	 a	 lower	 apparent	molecular	weight	than	10	kDa	were	excised	and	analysed	by	nLC-ESI-MS/MS	at	the	BRSC	Mass	Spectrometry	and	Proteomics	facility,	University	of	St.	Andrews.	All	 peptides	were	 identified	 as	 corresponding	 to	 ribosomal	 proteins	 using	 the	Mascot	 search	 engine.	 However,	 no	 differential	 acetylation	 could	 be	 seen	between	any	of	the	peptides	from	samples	isolated	with	and	without	T8,	out	of	three	biological	repeats.				To	 directly	 test	 if	 T8	 acetylated	 a	 ribosomal	 protein,	 I	 incubated	 pure	ribosomes	(NEB)	with	T8	and	[14C]Ac-CoA	(Figure	5.7.2).	An	in	vitro	expression	assay	 was	 carried	 out	 in	 parallel	 as	 a	 control	 for	 T8	 activity.	 Samples	 were	separated	 by	 SDS-PAGE	 and	 visualised	 by	 Coomassie	 staining	 to	 confirm	expression	had	been	inhibited	(Figure	5.7.2	upper	panel)	and	then	exposed	to	a	phosphostimulated	luminescence	plate.	The	intensity	of	the	radiation	signal	was	visualised	 using	 a	 phosphor-imager	 (Figure	 5.7.2	 lower	 panel).	 Expression	occurred	 in	 the	 control	 sample,	 evidenced	 by	 the	 appearance	 of	 a	 band	corresponding	 to	 the	 control	DHFR	protein	 (lane	 1),	 highlighted	 by	 a	 red	 star,	whereas	it	was	specifically	inhibited	by	T8	(lane	2).	This	inhibition	of	expression	was	 again	 accompanied	 by	 appearance	 of	 a	 radiolabelled	 band	 on	 the	autoradiograph,	highlighted	by	a	red	arrow.	However,	 there	was	no	correlative	band	appearing	for	the	sample	containing	pure	ribosomes	incubated	with	T8	and	
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Ac-CoA	 (lane	 6),	 showing	 that	 T8	 did	 not	 acetylate	 any	 ribosomal	 protein	 in	these	conditions.		I	 therefore	 considered	 that	 T8	 was	 targeting	 another	 molecule.	 We	realised	 that	 tRNA	 comprised	 in	 the	 in	 vitro	 expression	 assay	migrated	 on	 an	SDS-PAGE	 at	 a	 low	 apparent	molecular	 weight	 as	 revealed	 in	 Figure	 5.7.3,	 by	methylene	blue	staining	of	SDS-PAGE	gel	 (A),	or	by	northern	blot	probing	with	radiolabelled	primers	specific	to	tRNAala	(B).	These	results	confirm	that	in	the	in	
vitro	 expression	 assays,	 tRNA	 migrate	 at	 an	 apparent	 molecular	 weight	consistent	 with	 the	 size	 of	 the	 acetylated	 band	 detected	 by	 autoradiography,	raising	the	possibility	of	tRNA	being	a	target	for	T8.	
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Figure 5.7.1: Preparation of samples for analysis by mass spectrometry. Cell free in vitro expression 
DVVD\VZHUHVXSSOHPHQWHGZLWK7 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ing proteins of apparent molecular weight of less than 10 kDa (red boxes) were excised and analysed by 
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Figure 5.7.2: Lack of acetylation of ribosomal proteins by T8 in vitro. Cell free in vitro expression 
assays were supplemented with T8 (lanes 1) or without (lane 2) or purified E. coliULERVRPHV1(%ZHUH
LQFXEDWHGZLWKRXODQHDQGRUZLWK7ODQHDQGIRUKRXUVDWÛ&VDPSOHVZHUHVXSSOHPHQWHG
ZLWK>&@$F&R$ZKHUHVWDWHG3URGXFWLRQRIWKHFRQWUROSURWHLQ'+)5UHGDVWHUL[ZDVXVHGWRFRQILUP
H[SUHVVLRQDQGWKHDSSHDUDQFHRIDQDFHW\ODWHGSURWHLQZDVREVHUYHGUHGDUURZ6DPSOHVZHUHVHSDUDW-
HGE\6'63$*(DQGYLVXDOLVHGE\&RRPDVVLHVWDLQLQJXSSHUSDQHODQGDXWRUDGLRJUDSK\ORZHUSDQHO
Figure 5.7.3: Migration of tRNA via SDS-PAGE. W51$ZDVH[WUDFWHGIURPS. Typhimurium ¨WD, without 
(lane 1) or with (lane 2) expression of W6DPSOHVZHUHVHSDUDWHGE\6'63$*(DQGYLVXDOLVHGE\PHWK\O-
HQHEOXHVWDLQLQJ$Cell free in vitro expression assays were supplemented with T8 (lanes 2 and 4) or 
ZLWKRXWODQHDQGIRUKRXUVDWÛ&$OOVDPSOHVZHUHVXSSOHPHQWHGZLWK$F&R$3URGXFWLRQRIWKH
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VSHFLILFWRW51$alaDQGYLVXDOLVHGE\DXWRUDGLRJUDSD\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5.2.8	tRNA	extracted	from	in	vitro	expression	assays	are	acetylated	in	a	T8	
dependent	manner		 The	results	obtained	thus	far	indicated	that	tRNA	could	be	acetylated	by	T8,	 leading	 to	 inhibition	 of	 protein	 synthesis	 in	 the	 in	 vitro	 expression	 assay	reactions.	To	investigate	whether	this	was	the	case,	tRNA	was	extracted	from	in	
vitro	expression	assay	reactions	supplemented	with	[14C]Ac-CoA,	with	or	without	T8,	 by	 acid-phenol	 extraction.	 Samples	 were	 separated	 by	 acid-urea	 PAGE,	visualised	by	methylene	blue	staining	and	subsequently,	the	gel	was	exposed	to	a	phosphostimulated	luminescence	plate.	The	intensity	of	the	radiation	signal	was	visualised	 using	 a	 phosphor-imager	 (Figure	 5.8.1).	 Similar	 quantities	 of	 tRNA	were	 observed	 on	 the	 acid-urea	 gel	 (upper	 panel)	 and	 the	 corresponding	autoradiography	 shows	 that	 tRNA	 was	 labelled	 with	 [14C]Ac-CoA	 in	 a	 T8	dependent	manner	(lower	panel).		We	 then	 determined	 whether	 T8	 acetylated	 free	 tRNA	 molecules	 or	whether	activate	translation	was	necessary	for	tRNA	acetylation.	To	do	this,	we	monitored	 the	 acetylation	 of	 tRNA	 from	 in	vitro	 expression	 assay	mix	without	priming	 the	 expression	 with	 addition	 of	 template	 DNA	 (Figure	 5.8.2).	 In	 vitro	expression	reactions	were	supplemented	with	T8	and	[14C]Ac-CoA	where	stated.	At	different	times	samples	were	analysed	for	DHFR	production	by	SDS-PAGE	and	for	 tRNA	 acetylation	 by	 acid-urea	 PAGE.	 The	 first	 samples	 were	 analysed	immediately	 after	 addition	 of	 all	 components	 of	 the	 reaction	 mix,	 excepting	template	DNA	(lanes	1	and	2),	then	after	1	hour	of	incubation	(lanes	3	and	4)	and	after	 2	 hours	 of	 incubation	 with	 template	 DNA	 added	 (lanes	 5	 and	 6).	 As	expected,	 translation	 did	 not	 occur	 in	 samples	 where	 no	 template	 DNA	 was	added,	 (lanes	 3	 and	 4),	 contrary	 to	 the	 sample	 in	 lane	 5	 and	 T8	 efficiently	
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inhibited	 translation	 (lane	 6)	 (upper	 panel).	 tRNA	 subjected	 to	 acid-phenol	extraction	 from	 each	 of	 these	 samples	 was	 separated	 by	 acid-urea	 PAGE	 and	visualised	by	methylene	blue	staining	(middle	panel).	Subsequently,	the	gel	was	exposed	 to	 a	 phosphostimulated	 luminescence	 plate	 and	 the	 intensity	 of	 the	radiation	 signal	 visualised	 using	 a	 phosphor-imager	 (lower	 panel).	 The	autoradiography	 shows	 that	 acetylation	 of	 tRNA	 occurred	 in	 a	 T8	 dependent	manner	but	independently	of	active	translation.	This	suggests	that	T8	is	capable	of	acetylating	free	tRNA	molecules.		
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Figure 5.8.1: Acetylation of tRNA by T8 in a cell free in vitro expression assay. tRNA was extracted 
from cell free in vitro expression assay reactions, supplemented with [14c]Ac-CoA (lane 1 and 2) and T8 
(lane 2). tRNA was separated by acid-urea PAGE and visualised by methylene blue staining (upper panel) 
and the radiolabelled signal detected on the autoradiograph (lower panel).
Figure 5.8.2: Acetylation of free tRNA molecules by T8. Acetylation of tRNA was tracked in the cell free 
expression assay before and after translation. [14c]Ac-CoA was added to all samples. All samples 
contained all components of the transcription and translation machinery with T8 (lanes 1,3 and 5) or without 
T8 (lanes 2, 4 and 6). Template DNA was added after 60 min incubation (lanes 5 and 6) to start expression. 
After 0, 60 and 120 min samples were harvested, production of the DHFR protein (red asterix) was detected 
by SDS-PAGE followed by Coomassie staining (top panel), Concomitantly, extracted tRNA was separated 
by acid-urea PAGE and methylene blue staining (mid panel) and the radiolabelled intensity visualised by 
autoradiography (lower panel).
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5.2.9	Model	of	interaction	between	T8	and	tRNA	molecules		 Examination	 of	 the	 surface	 electrostatic	 potential	 of	 the	 T8	 dimer	highlighted	 a	 positively	 charged	 groove	 connecting	 the	 active	 site	 on	 one	monomer	and	another	positively	charged	patch	surrounding	the	novel	α2	region	of	 the	 second	monomer.	 The	 dimensions	 of	 these	 patches,	when	 engaged	 in	 a	dimer,	 are	 compatible	with	 the	binding	of	 a	negatively	 charged	 tRNA	molecule	(Figure	5.9.1A).	With	the	help	of	Dr	Stephen	Hare,	we	could	model	the	3’	stem	of	the	phosphodiester	backbone	of	the	tRNA	into	the	positively	charged	groove.	In	this	model,	the	phosphate	groups	interact	with	the	sidechains	of	residues	Arg-91,	Lys-33	and	Lys-36,	of	 the	 first	monomer	 (Figure	5.9.1B),	 and	 the	 remainder	of	the	tRNA	molecule	interacts	with	residues	Arg-77,	Arg-78,	Lys-146	and	Arg-158	of	the	second	monomer	(Figure	5.9.1A).	For	this	model	to	be	correct,	T8	would	be	required	to	dimerize	for	function.		To	 test	 this	 model,	 I	 used	 site	 directed	 mutagenesis	 to	 generate	 single	amino	 acid	 substitutions	 in	 the	 predicted	 tRNA	 binding	 groove	 and	 in	 the	positively	 charged	 patch	 around	 the	 novel	 α2	 region.	 Mutations	 resulting	 in	single	amino	acid	 substitutions	were	generated	using	overlapping	PCR	and	 the	resulting	 t8	 variants	 were	 cloned	 into	 pNDM220	 as	 previously	 described.	 All	substitutions	 were	 to	 negatively	 charged	 glutamic	 acid	 residues.	 Individual	 t8	variants	 containing	 plasmids	 were	 transformed	 into	 S.	 Typhimurium	 ∆ta8.	Growth	was	monitored	 upon	 over-expression	 of	 the	 toxin	 genes	 by	measuring	OD600	at	30-minute	intervals	(Figure	5.9.2A-B).	Growth	kinetics	of	bacteria	over-expressing	t8	variants	containing	substitutions	within	the	tRNA	binding	groove	are	 represented	 in	 Figure	 5.9.2A	 and	 those	 of	 bacteria	 over-expressing	 t8	variants	containing	substitutions	in	the	novel	α2	region	are	displayed	in	Figure	
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5.9.2B.	The	T8K33E	variant	showed	WT	toxicity	levels.	There	was	moderate	loss	 of	 toxicity	with	 T8R91E	 and	 nearly	 complete	 loss	 of	 toxicity	with	 T8K36E.	 A	double	substitution	of	R91	and	K33,	T8R91EK33E,	also	resulted	in	a	complete	loss	of	T8	 toxicity	 (Figure	5.9.2A).	These	results	support	our	predicted	model	of	 tRNA	binding.	 	All	of	 the	substitutions	 in	 the	novel	α2	region	diminished	T8	 toxicity,	though	in	the	case	of	the	T8R158E	variant	it	was	only	moderately	(Figure	5.9.2B),	suggesting	the	novel	α2	region	is	required	for	T8	toxicity.		These	results	support	our	predicted	model	of	T8	function,	suggesting	that	T8	 dimerization	 is	 required	 for	 toxicity	 and	 that	 the	 negatively	 charged	 tRNA	binds	 to	 the	 positively	 charged	 patches	 around	 the	 novel	 α2	 region	 and	 the	groove	leading	to	the	active	site.			
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Figure 5.9.1: Positive patches at the surface of T8 dimers. Electrostatic potential of the surface of a T8 dimer 
showing positively charged areas in blue and negatively charged areas in red. Residues predicted to be involved 
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Figure 5.9.2: Effects of point mutations within the predicted tRNA binding domains on T8 toxicity. Station
ary phase S. Typhimurium ¨WDstrains harbouring either the pNDM220 empty vector, the pNT8 plasmid or the 
YDULRXV7W51$ELQGLQJPXWDQWVZHUHLQFXEDWHGLQ/%PHGLXPVXSSOHPHQWHGZLWK,37*WRLQGXFHJHQHH[SUHV
sion. Induction began at time point 0 and OD600PHDVXUHGDWPLQXWHLQWHUYDOV. Mutations within the positive 
groove (K33E, K36E, R91E, K33E/R91E) are shown on the top panel, or within the positive patch of the second 
monomer (R77E, R78E, K146E, R158E) are shown in the lower panel. Data represent mean ± SEM. (n=3).  
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5.2.10	T8	acetylate	tRNA	on	the	primary	amine	of	the	charged	amino	acid	Thus	 far,	 all	 evidence	 suggesting	 that	 T8	 acetylated	 tRNA	was	 obtained	from	the	in	vitro	expression	assays	where	all	components	of	the	kit	are	purified	from	 E.	 coli.	 We	 examined	 whether	 T8	 was	 capable	 of	 acetylating	 Salmonella	tRNA.	 To	 this	 effect,	 tRNA	 was	 extracted	 from	 S.	 Typhimurium	 ∆ta8,	 with	 or	without	 t8	 over-expression,	 by	 acid-phenol	 extraction.	 Subsequently,	 tRNA	samples	were	incubated	with	[14C]Ac-CoA	and	T8,	where	stated,	for	1	hour	at	37	˚C.	 tRNA	 was	 then	 ethanol	 precipitated,	 separated	 by	 acid-urea	 PAGE	 and	visualised	 by	methylene	 blue	 staining	 (Figure	 5.10.1	 upper	 panel).	 Thereafter,	the	 gel	 was	 exposed	 to	 a	 phosphostimulated	 luminescence	 plate	 and	 the	intensity	 of	 the	 radiation	 signal	 visualised	 using	 a	 phosphor-imager	 (Figure	5.10.1	 lower	 panel).	 The	 autoradiography	 shows	 that	 T8	 acetylated	 free	
Salmonella	 tRNA	 molecules.	 The	 acid-urea	 PAGE	 image	 illustrates	 typical	accumulation	 of	 tRNA	 observed	 upon	 t8	 over-expression.	 Nevertheless,	 there	was	 a	 significant	 decrease	 in	 the	 acetylation	 of	 tRNA	 extracted	 from	 bacteria	over-expressing	t8	compared	to	those	that	were	not.	This	suggests	that	the	site	of	 acetylation	 of	 the	 tRNA	 extracted	 from	 t8	 expressing	 bacteria	 was	 already	unavailable.		Our	model	of	 interaction	of	T8	and	 tRNA	suggested	 that	 the	amino	acid	charged	 onto	 the	 tRNA	 would	 locate	 to	 the	 vicinity	 of	 the	 T8	 active	 site,	suggesting	T8	is	acetylating	the	tRNA	on	the	primary	amine	group	of	this	amino	acid.	To	determine	if	T8	acetylated	the	tRNA-bound	amino	acid,	tRNA	extracted	from	 S.	 Typhimurium	 ∆ta8	 bacteria	 was	 alkali	 treated	 to	 hydrolyse	 the	 bond	between	 the	 tRNA	 and	 the	 amino	 acid,	 resulting	 in	 uncharged	 tRNA.	Subsequently,	charged	and	uncharged	tRNA	was	incubated	with	T8	and	[14C]Ac-
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CoA,	 as	 previously	 described.	 In	 parallel	 to	 this	 experiment,	 tRNA	 was	 also	incubated	with	the	T8Y140F	variant	to	determine	whether	this	mutation	resulted	in	 abolition	 of	 the	 acetyltransferase	 function.	 After	 incubation	 with	 T8	 or	 the	T8Y140F	variant,	tRNA	was	ethanol	precipitated,	separated	by	acid-urea	PAGE	and	methylene	blue	stained.	Hereafter,	the	gel	was	exposed	to	a	phosphostimulated	luminescence	 plate	 and	 the	 intensity	 of	 the	 radiation	 signal	 visualised	 using	 a	phosphor-imager	 (Figure	 5.10.2).	 T8	 acetylated	 free	 tRNA	 charged	 with	 an	amino	 acid	 (lane	 1)	 but	 not	 the	 alkali	 treated,	 uncharged	 tRNA	 (lane	 3),	suggesting	 T8	 targets	 the	 amino	 acid	 bound	 the	 tRNA	 for	 acetylation.	Interestingly,	 the	 T8Y140F	 variant	 did	 not	 acetylate	 tRNA,	 confirming	 this	mutation	results	in	a	non-functional	toxin	(lane	2).	
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Figure 5.10.2: Acetylation of the amino acid bound to aatRNA by T8. aatRNA extracted from S. Typhi-
murium ¨ta8 (lane 1 and 2) or alkali treated (lane 3) before incubation with purified T8 (lanes 1 and 3) or 
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Figure 5.10.1: in vitro acetylation of purified Salmonella tRNA by T8. tRNA extracted from S. Typhimuri-
um ¨ WD (lane 1 and 2) or S. Typhimurium ¨ WD with over-expression of t8 (lanes 3 and 4) was incubated with  
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5.2.11	Model	of	molecular	mechanism	of	T8	toxicity				 The	results	presented	here	allow	us	 to	model	 the	molecular	mechanism	through	 which	 T8	 inhibits	 growth	 (Figure	 5.11).	 During	 normal	 translation	(Figure	5.11A)	charged	tRNA	(or	amino	acyl-tRNA)	is	bound	to	the	A	site	of	the	ribosome	 by	 EF-Tu.	 The	 nascent	 peptide	 chain	 bound	 to	 the	 tRNA	 in	 the	ribosomal	P	site	is	translocated	to	the	amino-acyl	tRNA	(aatRNA)	in	the	A	site.	In	our	 model	 (Figure	 5.11B),	 active	 T8	 dimerizes	 and	 acetylates	 free	 aatRNA	modules,	resulting	in	N-blocked	aatRNA.	Thereafter,	acetylated	aatRNA	bound	to	the	A	site	would	be	incapable	of	reacting	to	form	a	peptide	bond	with	the	nascent	peptide	 chain	 causing	 ribosome	 stalling.	 Interestingly,	 it	 has	 been	 reported	previously	 that,	 though	 Pth	 does	 not	 hydrolyse	 aatRNA,	 it	 can	 recognise	 and	hydrolyse	aatRNA	that	has	been	N-blocked	by	acetylation,	as	it	recognises	it	to	be	a	di-peptide	tRNA	(Cuzin	et	al.,	1967;	Ito	et	al.,	2012).	This	would	allow	for	Pth	to	counteract	T8	 toxicity	 (Figure	5.11C),	 leading	 to	detoxification	of	 the	T8	active	cell	and	normal	growth.		
5.2.12	Testing	the	model	of	the	molecular	mechanism	of	T8		 Results	observed	previously	showed	that	Pth	is	capable	of	counteracting	T8	 toxicity	 (Figure	 5.4)	 and	 that	 T8	 inhibits	 translation	 by	 acetylating	 aatRNA	resulting	 in	N-blocked,	 translationally	 incompetent	 tRNA	(Figure	5.10.2).	These	results	 led	 to	 our	 model	 of	 the	 molecular	 mechanism	 of	 T8.	 To	 validate	 our	model	I	wanted	to	test	if	Pth	counteraction	of	T8	toxicity	was	due	to	its	ability	to	hydrolyse	the	T8-acetylated	aatRNA.		tRNA	 extracted	 from	 in	 vitro	 expression	 assays,	 supplemented	 with	[14C]Ac-CoA	and	T8,	where	 stated,	was	 incubated	with	Pth	 for	1	hour	at	37	 ˚C.	
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Untreated	samples	were	subjected	to	mock	Pth	treatment	to	allow	for	accurate	comparison.	The	tRNA	was	subsequently	ethanol	precipitated,	separated	by	acid-urea	 PAGE	 and	 visualised	 by	methylene	 blue	 staining.	 Thereafter,	 the	 gel	 was	exposed	 to	 a	 phosphostimulated	 luminescence	 plate	 and	 the	 intensity	 of	 the	radiation	signal	visualised	using	a	phosphor-imager	(Figure	5.12.1A).	Upon	Pth	treatment,	a	significant	decrease	 in	the	radiolabelled	signal	was	observed	(lane	4)	 in	comparison	to	untreated	tRNA	(lane	3).	This	suggests	that	Pth	recognised	the	N-blocked	aatRNA	and	was	able	to	hydrolyse	the	acetylated	amino	acid.	We	then	established	whether	this	result	could	be	replicated	using	Salmonella	tRNA.	tRNA	extracted	from	S.	Typhimurium	∆ta8	was	incubated	with	[14C]Ac-CoA	with	or	without	 T8,	 as	 previously	 described.	 Subsequently,	 T8	 incubated	 tRNA	was	treated	with	Pth,	as	before	all	other	samples	were	mock	treated.	Samples	were	ethanol	precipitated,	separated	by	acid-urea	PAGE	and	visualised	by	methylene	blue	 staining.	 Thereafter,	 the	 gel	 was	 exposed	 to	 a	 phosphostimulated	luminescence	 plate.	 The	 intensity	 of	 the	 radiation	 signal	 visualised	 using	 a	phosphor-imager	 (Figure	 5.12.1B).	 Again,	 there	 is	 a	 significant	 decrease	 in	 the	intensity	 of	 the	 radiolabelled	 signal	 of	 Pth	 treated	 tRNA,	 compared	 to	 the	untreated.	 These	 results	 further	 substantiate	 the	 hypothesis	 that	 Pth	 is	hydrolysing	N-blocked	aatRNA	and	thus	counteracting	T8	toxicity.	These	 results	 are	 interesting	 and	 support	 the	 model	 being	 presented,	however,	 to	 demonstrate	 the	 significance	 of	 the	 observation	 in	 vivo	 I	 tested	 if	that	expression	of	pth	could	counteract	the	effect	of	T8	on	persister	formation.	I	tested	the	ability	of	Salmonella	to	survive	antibiotic	treatment	after	induction	of	
t8	or	t8	and	pth	expression	(Figure	5.12.2	and	Supplementary	figure	4).	Briefly,	S.	Typhimurium	 ∆ta8	 harbouring	 either	 the	 control	 plasmid	 (orange),	 the	 pNT8	
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plasmid	(red)	or	both	the	pNT8	and	the	pBPth	plasmids	(purple)	were	grown	to	stationary	phase	in	M9	minimal	medium.	They	were	subsequently	subcultured	in	fresh	 M9	 minimal	 medium	 supplemented	 with	 IPTG	 and	 arabinose	 to	 induce	expression	 of	 the	 genes	 of	 interest	 and	 incubated	 at	 37	 ˚C.	 After	 1	 hour	 of	induction,	the	cultures	were	enumerated	by	CFU	counts	before	gentamycin	was	added	at	bactericidal	concentrations.	The	percentage	of	survival	was	calculated	after	4	hours	of	treatment.	Over-expression	of	t8	led	to	a	15	fold	increase	in	the	number	of	antibiotic	tolerant	cells	compared	to	the	S.	Typhimurium	∆ta8	strain	alone,	as	previously	observed,	and	parallel	over-expression	of	pth	and	the	toxin	completely	 reduced	 this	 increase.	 These	 results	 confirm	 that	 Pth	 activity	neutralises	 the	 toxic	effect	of	T8,	 showing	 that	Pth	 is	capable	of	detoxifying	T8	active	 cells,	 thus	 restoring	 growth	 and	 removing	 the	 antibiotic	 protection	afforded	by	T8.	
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Figure 5.11: Proposed model of T8 mode of action. During normal translation, EF-Tu transfers the codon 
specifc aatRNA to the A site of ribosome, subsequently the carboxyl terminal of the nascent peptide chain 
bound to the tRNA in the P site reacts to form a peptide bond with the N-alpha amine group of the amino acid 
bound to the tRNA in A site (A). The negatively charged tRNA binds to the positive surface residues, such that 
the N-alpha amine group of the amino acid sits in the active site of T8. Acetylation results in the N-blocking of 
the alpha amine group, as such the amino acid cannot react to form a peptide bond with the carboxyl terminal 
of final amino acid the nascent peptide chain (B). Pth recognises N-blocked aatRNA as dipeptidyl-tRNA and 
hydrolyses the amino acid recycling the tRNA molecule and counteracting T8 activity (C).
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Figure 5.12.3: Counteraction of T8-mediated persister formation by Pth. Lag phase S. Typhimurium¨WD 
harbouring either the pNDM220 empty vector, the pNT8 plasmid or the pNT8 and pBPth plasmids, were grown 
overnight in M9MM. Subsequently, cultures were diluted 1:20 into fresh M9MM supplemented with IPTG and 
arabinose to induce gene expression. After 1 h of induction bacteria were exposed to 100 µg/ml gentamycin 
for 4 h and bacterial survival calculated as a percentage of pre-antibiotic treatment. Data represent mean ± 
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Figure 5.12.1A: Cleavage by Pth of T8 acetylated aatRNA extracted from LQYLWUR translation assay. tRNA 
was extracted from cell free expression assays, which had been supplemented with (lanes 3 and 4) or without 
(lanes 1 and 2) T8 [14C]Ac-CoA was added to all samples. tRNA was subsequently treated with Pth (lanes 2 
and 4) or mock treated (lanes 1 and 3). Samples were separated by acid-urea PAGE and visualised by 
methylene blue staining (upper panel) or autoradiography (lower panel). For a detailed protocol please refer to 
section2.27.
Figure 5.12.1B: Cleavage by Pth of T8 acetylated by 6DOPRQHOOD aaRNA. tRNA extracted S. Typhimurium 
¨WD (lane 1) was incubated with T8 (lanes 2 and 3) [14C]Ac-CoA was added to all samples. tRNA was 
subsequently  treated with Pth (lane 4) or mock treated (lanes 1 and 2). Samples were separated by acid-urea 
PAGE and visualised by methylene blue staining (upper panel) or autoradiography (lower panel). For a 
detailed protocol please refer to section 2.27.
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5.3	Summary			 The	work	presented	 in	 this	 final	 chapter	was	directed	at	 identifying	 the	target	 of	 T8	 and	 elucidating	 the	 molecular	 mechanisms	 through	 which	 T8	functions	to	inhibit	growth.	Using	a	screen	to	seek	out	proteins	able	to	titrate	out	T8	activity,	we	 identified	Pth	as	a	possible	 target.	Pth	 functions	as	a	hydrolase	enzyme	with	a	substrate	of	ptRNA	(Cuzin	et	al.,	1967;	Menninger,	1975).	Over-expression	of	pth	was	able	to	restore	the	growth	of	bacteria	over-expressing	t8,	however,	 no	 direct	 acetylation	 of	 Pth	 was	 observed.	 Furthermore,	 over-expression	of	t8	did	not	lead	to	an	accumulation	of	ptRNA,	as	would	be	expected	if	 Pth	 were	 inactivated	 by	 T8.	 We	 established	 that	 T8	 was	 able	 to	 inhibit	translation	 in	 an	Ac-CoA	dependent	manner,	when	added	 to	 a	 cell	 free	 in	vitro	expression	 reaction.	 Moreover,	 we	 observed	 the	 appearance	 of	 a	 band	corresponding	to	acetylation	of	a	 low	molecular	weight	molecule	when	T8	was	supplied	with	[14C]Ac-CoA	in	these	assays.	We	hypothesised,	due	to	the	apparent	low	molecular	weight,	that	this	was	acetylation	of	a	ribosomal	protein,	however,	further	 investigation	 invalidated	 this	 hypothesis.	 We	 then	 detected	 that	 tRNA	migrated	 at	 an	 apparent	 molecular	 weight	 corresponding	 to	 that	 of	 the	acetylated	band	observed	in	the	autoradiograph	images.	Therefore	we	extracted	tRNA	 from	 these	 reaction	mixes	 and	 observed	 acetylation	 of	 the	 tRNA	 in	 a	 T8	dependent	manner.	Upon	inspection	of	the	surface	electrostatic	potential	of	T8,	we	noticed	two	positively	charged	patches	that	could	facilitate	tRNA	binding.	Site	directed	 mutagenesis	 of	 these	 areas,	 resulting	 in	 a	 reversal	 of	 the	 charge,	abolished	 T8	 toxicity.	 These	 results	 suggest	 that	 T8	 requires	 dimerization	 to	
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function	and	further	substantiated	the	hypothesis	that	T8	dimers	bind	tRNA.	We	then	 confirmed	 that	T8	was	 capable	 of	 acetylating	 free	 aatRNA	extracted	 from	
Salmonella	and	that	the	acetylation	was	occurring	on	the	N-terminal	of	the	amino	acid	bound	to	the	tRNA	molecule.	Taken	together,	the	results	put	forward	in	this	chapter	allowed	for	a	prediction	of	the	molecular	mechanism	behind	T8	toxicity.	I	 propose	 that	 T8	 acetylates	 free	 aatRNA,	 resulting	 in	 N-blocked	 and	translationally	incompetent	tRNA	molecules.	This	acetylation	is	reversible	due	to	the	activity	of	Pth,	which	recognises	N-blocked	aatRNA	as	di-peptide	 tRNA	and	hydrolyses	 it	 as	 such	 (Cuzin	 et	 al.,	 1967).	 We	 corroborated	 this	 model	 by	showing	that	Pth	treatment	of	T8-acetylated	aatRNA	reduced	the	intensity	of	the	radiolabelled	signal	associated	with	acetylation	of	the	tRNA.	Finally,	we	showed	that	Pth	activity	was	capable	of	counteracting	the	increase	in	persister	formation	observed	upon	over-expression	of	t8.	Overall,	these	results	robustly	indicate	that	T8	inhibits	translation	by	acetylation	of	the	N-terminus	of	the	amino	acid	bound	to	 a	 tRNA	 molecule.	 Such	 an	 acetylation	 would	 result	 in	 the	 blocking	 of	 this	amino	 acid,	 making	 it	 unable	 to	 form	 a	 peptide	 bond	 with	 a	 nascent	 peptide	bound	 to	 the	 tRNA	 molecule	 in	 the	 P	 site,	 resulting	 in	 a	 block	 in	 translation.	Moreover,	we	show	that	this	acetylation	event	can	be	counteracted	by	Pth.	Pth	is	able	to	cleave	N-blocked	aatRNA,	recycling	it	and	allowing	translation	to	resume.						
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Chapter	six	
Discussion			
6.1	TA6	and	TA8	are	bona	fide	TA	modules	involved	in	persister	
formation		 All	 14	 of	 the	 chromosomally	 encoded	 type	 II	 TA	modules	 of	Salmonella	that	 were	 tested	 (Figure	 3.1.1)	 are	 important	 for	 the	 dramatic	 increase	 in	persister	 formation	seen	 in	response	to	macrophage	 internalisation	(Helaine	et	
al.,	2014).	My	contribution	to	further	this	work	showed	that	the	mRNA	levels	of	all	 14	 were	 increased	 after	 30	minutes	 of	 macrophage	 internalisation	 (Figure	3.1.2A),	 which	 suggests	 that	 all	 are	 activated	 in	 response	 to	 macrophage-engulfment.	 Upon	 internalisation,	 Salmonella	 enter	 the	 SCV,	 within	 which	 the	bacteria	 encounter	 stress	 conditions.	 We	 have	 shown	 previously	 that	 a	combination	of	 low	pH	and	nutrient	limitation,	experienced	within	the	SCV,	are	responsible	 for	 the	 increase	 in	 persister	 formation	 (Helaine	 et	 al.,	 2014).	 I	recapitulated	these	conditions	in	vitro	to	show	that	both	low	pH	and	amino-acid	starvation	 resulted	 in	an	 increase	 in	mRNA	 levels	of	 all	14	 toxin	genes	 (Figure	3.1.2B).	This	suggests	that	it	is	these	conditions	that	lead	to	the	activation	of	the	TA	modules	within	 the	SCV.	The	 increase	 in	 toxin	mRNA	was	more	substantial	for	 bacteria	 that	 had	 been	 subjected	 to	 SHX	 treatment	 to	 induce	 amino-acid	starvation.	 This	 correlated	 with	 the	 accepted	 model	 of	 type	 II	 TA	 module	activation,	whereby	antitoxins	are	degraded	by	the	stringent	response	activated	cellular	 protease	 Lon	 (Christensen	 et	 al.,	 2001,	 2003;	 Melderen	 et	 al.,	 1996;	
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Aizenman	et	al.,	1996).	Furthermore,	Lon	has	been	shown	to	be	critical	 for	 the	increase	in	persister	formation	seen	in	response	to	macrophage	internalisation.	Interestingly,	in	the	same	study,	we	showed	that	the	increase	in	mRNA	levels	of	the	14	TA	modules	was	RelA/SpoT	dependent	(Helaine	et	al.,	2014).	The	three,	previously	uncharacterised,	GNAT	TA	modules	responded	similarly	to	the	known	TA	modules	 in	 these	 experiments,	 corroborating	 the	 data	 reported	 by	 Lobato-Marquez	 and	 colleagues	 that	 all	 three	 are	 bona	 fide	 TA	 modules	 (Lobato-Márquez	et	al.,	2015).	Furthermore,	all	three	are	encoded	on	bicistronic	operons	and	so	uphold	the	canonical	genetic	conformation	of	known	TA	modules	(Figure	3.2.1B).				 The	report	showing	that	S.	Typhimurium	SL1344	homologues	of	ta6,	ta8	and	ta9,	were	bona	fide	TA	modules	was	not	published	until	the	third	year	of	my	PhD,	 by	when	 I	 had	 already	 completed	 this	 section	 of	my	work.	 To	 determine	whether	a	novel	TA	module	is	functional,	it	is	common	to	induce	over-production	of	 the	 TA	 proteins,	 in	 exponentially	 growing	 bacteria,	 to	 show	 growth	 arrest	upon	 expression	 of	 the	 toxin	 gene	 and	 counteraction	 of	 this	 by	 parallel	 or	subsequent	 expression	 of	 the	 antitoxin	 gene	 (Gotfredsen	 &	 Gerdes,	 1998;	Jørgensen	 et	 al.,	 2009;	 Harms	 et	 al.,	 2015).	 I	 used	 this	 method	 to	 test	 the	functionality	of	TA6	and	TA8.	However,	bacteria	over-producing	T6	or	T8	in	mid	exponential	phase	were	not	attenuated	for	growth	(Figure	3.4.1A-B).	As	we	had	already	 collected	 evidence	 that	 ta6,	 ta8	 and	 ta9	 are	 involved	 in	 persister	formation,	I	expected	these	TAs	to	be	functional.	At	the	time	these	experiments	were	undertaken,	the	most	compelling	evidence	to	suggest	TA6	and	TA8	should	be	 bona	 fide	 TA	 modules	 was	 the	 observation	 that	 deletion	 of	 the	 modules	resulted	 in	 a	 significant	 decrease	 in	 intra-macrophage	 persister	 formation	
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(Helaine	 et	al.,	 2014).	 As	mentioned,	 these	 experiments	 require	 infection	with	stationary	phase	bacteria.	Thus,	by	monitoring	the	effects	of	over-production	of	the	 toxins	 in	 lag	phase	bacteria	 the	growth	 inhibitory	effects	of	 the	 toxins	was	observed	(Figure	3.4.2A-B).	This	is	interesting	as	it	suggests	that	these	toxins	do	not	arrest	growth,	as	described	for	other	type	II	TA	modules	to	date.	Moreover,	these	results	raised	the	possibility	that	there	are	differences	in	the	proteome	of	exponentially	growing	bacteria	and	lag	phase	bacteria	that	could	counteract	the	GNAT	 toxicity,	 leading	 to	 this	 growth	 phase	 dependency.	 A	 previous	 study	described	third	party	protein	interaction	involved	in	type	II	toxin	neutralisation.	The	SocB	toxin	of	C.	cresentus	is	readily	degraded	by	the	cellular	protease	ClpXP,	thus	controlling	its	activity.	However,	this	degradation	is	facilitated	by	the	SocA	antitoxin	 and	 is	 the	 general	mode	of	 antitoxin-mediated	neutralisation	 for	 this	toxin	 (Aakre	 et	 al.,	 2013).	 The	 counteraction	 of	 the	 GNAT	 toxins	 in	 mid	exponential	 growth	 differs	 from	 this	 as	 it	 is	 independent	 of	 the	 antitoxins.	Furthermore,	 it	 is	restricted	to	exponentially	growing	cells	which	suggests	 that	the	bacteria	use	 this	 counteraction	 to	 inhibit	accidental	activation	of	 the	GNAT	TA	 modules	 by	 curbing	 the	 activity	 of	 unintentionally	 released	 toxins.	Additionally,	 in	 lag	 phase	 bacteria,	 we	 could	 observe	 that	 parallel	 over-production	 of	 the	 cognate	 antitoxins	 counteracted	 GNAT	 induced	 growth	inhibition,	 confirming	 that	 TA6	 and	 TA8	 are	 bona	 fide	 TA	 modules.	 Over-production	 of	 A6	 only	 counteracted	 T6	 toxicity	 moderately,	 however,	 the	counteraction	 seen	 was	 highly	 significant	 at	 the	 time	 points	 shown	 (Figure	3.4.2A).	 The	 inhibition	 of	 growth	observed	 in	 bacteria	 over-expressing	both	 t6	and	a6	beyond	3	hours	post-induction	could	be	due	to	the	formation	of	protein	aggregates.	As	it	is	well	documented	that	the	antitoxin	and	toxin	proteins	of	type	
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II	TA	modules	bind	 to	 form	complexes,	 it	 is	plausible	 to	 consider	 that	 the	high	levels	 of	 expression	 of	 these	 proteins	 and	 their	 tendency	 to	 form	 complexes	could	lead	to	aggregation.	Though	this	was	not	confirmed	to	be	the	cause	in	this	case.			 By	monitoring	the	antibiotic	susceptibility	of	bacteria	over-producing	the	TA	module	components,	I	was	able	to	show	directly	that	over-production	of	T8	increased	persister	formation	by	15	fold	and	that	parallel	over-production	of	A8	counteracted	completely	this	 increase	(Figure	3.5.2B	and	Supplementary	 figure	4).	This	is	consistent	with	the	results	previously	reported	showing	that	deletion	of	 ta8	 results	 in	a	decrease	 in	 intramacrophage	persister	 formation	(Helaine	et	
al.,	2014)	and	 further	 indicates	 that	TA8	 is	 involved	 in	regulating	 the	persister	phenotype.	Though	no	such	increase	in	persisters	is	observed	for	bacteria	over-expressing	t6,	this	is	most	likely	due	to	the	transience	of	T6	toxicity.	The	effect	of	T6	 over-production	 diminishes	 after	 2	 hours	 post	 induction	 in	 LB	 (Figure	3.4.2A).	The	effects	of	the	toxins	were	extended	when	the	bacteria	were	grown	in	minimal	 media	 (Supplementary	 figure	 2),	 however,	 at	 the	 time	 point	 that	corresponds	to	4	hours	of	incubation	with	gentamicin	(5	hours	post	induction	in	supplementary	 figure	 2),	 T6	 over-producing	 bacteria	 had	 entered	 early	exponential	phase.	However,	another	possibility	is	that	the	increase	in	lag	phase	seen	upon	over-expression	of	t6	(Figure	3.4.2A)	was	due	to	a	greater	number	of	unviable	bacteria	in	the	starter	culture.	A	way	to	determine	whether	this	was	the	case	would	be	to	monitor	the	growth	curves	by	CFU	count.	This	was	carried	out	for	bacteria	over-producing	TA8	proteins	(Supplementary	figure	1)	and	the	data	corroborated	the	observation	that	T8	over-producing	bacteria	had	an	extended	lag	phase	that	was	counteracted	by	parallel	over-production	of	A8.	However,	this	
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was	 not	 investigated	 for	 TA6	 over-producing	 bacteria.	 Furthermore,	 the	significant	 increase	 in	 persister	 formation	 observed	 in	 the	 bacteria	 over-producing	T6	 and	A6	was	most	 likely	 an	 artefact	 of	 the	 growth	 defect	 seen	 in	Figure	3.4.2A.	Interestingly,	a	study	has	shown	that	the	level	of	persisters	formed	in	 stationary	 phase	 bacteria	 directly	 correlated	 to	 protein	 aggregation	(Leszczynska	et	al.,	2013)	 further	suggesting	this	to	be	the	cause	of	 the	growth	defect	 and	 concomitant	 increase	 in	 persister	 formation	 seen	 in	 bacteria	 over-expressing	t6	and	a6	in	unison.	In	 Summary,	 my	 results	 suggest	 that	 there	 are	 specific	 environmental	factors	encountered	within	the	SCV	that	lead	to	activation	of	all	of	the	Salmonella	TA	modules	tested.	I	confirmed	that	TA6	and	TA8	are	bona	fide	TA	modules	and	showed	that	TA8	promotes	persister	formation	in	Salmonella.	Although	my	work	suggests	a	similar	role	for	TA6,	more	work	is	needed	to	confirm	this.	It	would	be	useful	 for	 example	 to	 monitor	 the	 antibiotic	 susceptibility	 of	 t6	 expressing	bacteria	 at	 earlier	 time	 points	 post	 induction	 to	 evaluate	 the	 rate	 of	 persister	formation	at	a	time	when	we	can	observe	the	effect	of	T6	toxicity	on	growth.			
6.2	 The	 transiency	 of	 T6	 and	 T8	 toxicity	 is	 due,	 in	 part,	 to	
activity	of	deacetylase	CobB	
	 Additionally	 to	 the	 growth	 phase	 dependency	 of	 the	 GNAT	 toxins	 the	effects	 of	 T6	 and	 T8	 over-production	 also	 subsided	 after	 2	 and	 3	 hours,	respectively	 (Figure	 3.5.1).	 At	 each	 measurement	 during	 these	 experiments,	there	was	a	slight	 increase	 in	 the	OD600	(raw	data	of	a	respective	growth	curve	can	 be	 found	 in	 supplementary	 table	 1),	 which	 shows	 that	 the	 bacteria	 over-
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expressing	t6	and	t8	are	growing,	albeit	very	slowly.	This	indicates	that	once	the	bacteria	 over-expressing	 these	 toxins	 reach	 a	 certain	 stage	 in	 growth	 they	 are	able	to	overcome	the	toxic	effects	of	T6	and	T8.	We	hypothesised	that	this	taming	of	the	toxins	might	be	the	effects	of	the	accumulation	of	a	third-party	detoxifying	protein.	As	the	toxins	were	predicted	acetyltransferases,	we	considered	that	the	detoxifying	 protein	 could	 be	 a	 deacetylase.	 There	 is	 one	 characterised	 global	deacetylase	 in	 Salmonella,	 CobB	 (Tsang,	 1998;	 Tucker	 &	 Escalante-Semerena,	2010).	 CobB,	 along	 with	 Pat,	 regulates	 Acs	 function	 (Starai,	 2002;	 Starai	 &	Escalante-Semerena,	2004)	as	well	 as	global	 levels	of	 acetylation	 in	Salmonella	(Wang	et	al.,	2010).	As	CobB	shows	relative	substrate	ambiguity	it	was	possible	that	one	of	its	targets	could	be	that	of	T6	or	T8.	Moreover,	it	has	been	reported	that	cobB	mRNA	levels	are	decreased	in	stationary	phase	bacteria	and	increased	in	mid	exponential	phase	bacteria	(Kroger	et	al.,	2013).	This	fluctuation	in	cobB	expression	is	consistent	with	reports	showing	an	increase	in	acetylated	proteins	in	stationary	phase	bacteria,	compared	to	mid	exponential	phase	bacteria	(Yu	et	
al.,	2008).	 To	 determine	whether	 increased	 levels	 of	 CobB	were	 leading	 to	 the	counteraction	of	T6	and	T8	activity,	resulting	in	the	transience	in	toxicity	and	the	growth	phase	dependency,	 I	 deleted	cobB	 from	 the	 single	TA	deletion	mutants	and	 monitored	 the	 effects	 of	 over-production	 of	 the	 toxins	 in	 these	 mutants	(Figure	4.5.3A-B).	 In	Salmonella	deleted	of	cobB,	 over-production	of	T6	and	T8	arrested	growth	in	mid	exponential	phase	bacteria,	suggesting	that	the	increased	levels	of	CobB	in	this	phase	of	growth	could	be	detoxifying	the	effects	of	T6	and	T8.	 Furthermore,	 over-production	 of	 T6	 and	 T8	 in	 these	mutants	 in	 lag	 phase	resulted	 in	 an	 extended	 toxic	 effect	 (Figure	 4.5.2A-B),	 suggesting	 that	 CobB	 is	required	for	counteracting	their	toxicity	in	this	phase	of	growth.		
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The	 results	 presented	 here	 strongly	 suggest	 that	 CobB	 is	 capable	 of	counteracting	 T6	 and	 T8	 toxicity,	 interestingly	 implying	 that	 Salmonella	counteract	 GNAT	 toxicity	 by	 multiple	 ways	 rather	 than	 just	 relying	 on	 the	cognate	antitoxin.	However,	 this	hypothesis	needs	 to	be	 investigated	 further.	 It	would	be	interesting	to	observe	the	effects	of	over-expression	of	cobB	in	parallel	to	the	toxins,	to	determine	if	there	is	counteraction	of	their	toxicity.	However,	as	CobB	 enzymatic	 activity	 is	 dependent	 of	 NAD+	 levels	 (Landry	 et	 al.,	 2000),	 it	might	 be	 necessary	 to	 ensure	 there	 are	 sufficient	 intracellular	 levels	 of	 this	coenzyme	 for	 CobB	 to	 function.	 Furthermore,	 it	 could	 be	 tested	 in	 vitro	 using	purified	 CobB	 to	 see	 if	 it	 can	 deacetylate	 the	 target	 tRNA	 of	 T8.	 	 Generally,	sirtuins	 are	 reported	 to	 hydrolyse	 Nε	 Lysine-acetylation	 of	 proteins,	 as	 such	whether	 CobB	 is	 capable	 of	 hydrolysing	 the	 Nα	 amine-acetylation	 of	 aatRNA	remains	to	be	determined.	Interestingly,	S.	Typhimurium	harbours	a	long	and	a	short	 isoform	 of	 CobB,	 termed	 CobBL	 and	 CobBS	 respectively	 (Tucker	 &	Escalante-Semerena,	 2010).	 Both	 are	 functional	 in	 that	 both	 deacetylate	 AcsAc,	however,	it	is	likely	that	Acs	is	not	their	only	physiologically	relevant	substrate.	Interestingly,	 the	 two	proteins	differ	by	 the	presence	of	an	N-terminal	arginine	rich	 extension	 of	 CobBL.	 This	 extension	 is	 similar	 to	 the	 arginine	 rich	 motifs	(ARMs)	common	to	many	viral	and	bacteriophage	RNA	binding	peptides	(Bayer	
et	 al.,	 2005;	 Lazinski	 et	 al.,	 1989)	 and	 so	 could	 facilitate	 binding	 of	 tRNA	molecules,	 further	 suggesting	 CobBL	 may	 be	 capable	 of	 deacetylating	 T8-acetylated	aatRNA.	By	generating	over-expression	plasmids	for	both	isoforms	of	CobB	 we	 could	 test	 the	 ability	 of	 each	 to	 counteract	 T6	 and	 T8	 toxicity.	Additionally,	purification	of	both	isoforms	would	allow	us	to	test	their	ability	to	deacetylate	 T8-acetylated	 aatRNA	 in	 in	 vitro	 deacetylation	 assays.	 Finally,	
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monitoring	 the	 effects	 of	 parallel	 over-production	 of	 the	 toxins	 and	 CobB	 on	antibiotic	 tolerance	 would	 determine	 whether	 this	 deacetylation	 of	 the	 target	resulted	in	a	counteraction	of	GNAT	induced	persister	formation.		
6.3	Cross-regulation	occurs	between	the	GNAT	TA	modules			 As	 discussed	 in	 chapter	 1.5.6,	 some	 TA	 modules	 have	 been	 shown	 to	regulate	 the	 activation	 of	 other	 modules	 resulting	 in	 multiple	 levels	 of	interaction.	 These	 reports	 indicate	 that	 specific	 TA	modules	 can	 be	 critical	 for	the	subsequent	activation	of	other	modules	 (Wang	et	al.,	2012,	2013;	Kasari	et	
al.,	2013;	Winther	&	Gerdes,	2009),	suggesting	that	TA	modules	may	activate	in	a	cascading	 fashion.	 One	 study,	 showing	 that	 activation	 of	 a	 MazF	 toxin,	 in	response	 to	 amino	 acid	 starvation,	 required	 the	 presence	 of	 a	 RelBE	 module	(Kasari	et	al.,	2013),	used	northern	blot	analysis	with	a	probe	specific	 to	mazF	mRNA	 to	monitor	mRNA	 levels	 as	 a	 readout	of	TA	module	 activity.	 I	 utilised	a	similar	 method,	 using	 RT-qPCR,	 to	 monitor	 mRNA	 levels	 of	 the	 GNAT	 toxins	during	macrophage	uptake	 in	 single	and	double	GNAT	TA	deletion	mutants,	 to	determine	whether	any	such	cross-activation	could	be	observed	(Figure	3.6).	As	I	had	 already	 determined	 that	 the	 mRNA	 levels	 of	 all	 GNAT	 TA	 modules	 are	increased	 in	response	 to	macrophage	engulfment	 (Figure	3.1.2	A),	 I	used	 these	conditions	to	monitor	the	effects	of	deletion	of	various	GNAT	TA	modules	on	the	activation	of	the	rest.	Activation	of	T8	appeared	to	be	partially	dependent	on	the	presence	of	both	ta6	and	ta9	as	there	was	a	decrease	in	t8	mRNA	levels	in	both	of	these	mutants	compared	to	WT	Salmonella.	Similarly,	T9	activation	appeared	to	be	partially	dependent	on	the	presence	of	both	ta6	and	ta8,	whereas	activation	of	
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T6	 appeared	 to	 be	 partially	 dependent	 on	 the	 presence	 of	 ta9	 and	 negatively	regulated	by	the	TA8	module	(Figure	3.6.2A).	The	mRNA	levels	of	both	t8	and	t9	were	 significantly	 decreased	 in	 the	 respective	 double	 deletion	 mutant	 when	compared	 to	 those	 quantified	 in	 WT	 Salmonella,	 which	 correlates	 with	 the	results	 observed	 in	 the	 single	 deletion	 mutants.	 Interestingly,	 in	 the	 double	
ta8/ta9	 deletion	 mutant	 t6	 mRNA	 remained	 increased	 compared	 to	 those	quantified	 in	 WT	 Salmonella,	 suggesting	 that	 the	 regulation	 by	 ta8	 is	 more	important	for	t6	activation	than	that	of	ta9	(Figure	3.6.2B).	These	results	suggest	that	 there	 is	 cross-interaction	between	 the	GNAT	TA	modules	during	 infection.	However,	 there	 does	 not	 seem	 to	 be	 any	 distinct	 hierarchy	 in	 the	 order	 of	activation.			As	 we	 know	 that	 the	 increase	 in	 mRNA	 levels	 seen	 in	 response	 to	macrophage	 internalisation	 correlates	 with	 a	 significant	 increase	 in	 persister	formation	(Helaine	et	al.,	2014),	I	wanted	to	determine	whether	these	changes	in	the	 mRNA	 levels	 of	 the	 GNAT	 toxin	 genes	 in	 the	 various	 deletion	 mutants	corresponded	to	variations	in	persister	formation.	As	mentioned,	we	can	exploit	the	 increase	 in	 Salmonella	 persisters	 upon	 internalisation	 by	 macrophages	 to	elucidate	more	 easily	 the	 significance	 of	 deletion	 of	 a	 TA	module	 on	 persister	formation.	 I	 observed	 that	 deleting	 different	 combinations	 of	 the	 GNAT	 TA	modules	 resulted	 in	 variation	 in	 the	 reductions	 of	 intra-macrophage	 persister	formation	 (Figure	 3.7.3).	 Deletion	 of	 both	 ta6	 and	 ta8	 resulted	 in	 a	 further	decrease	in	persister	formation	compared	to	either	single	deletion	mutant.	This	correlates	 with	 the	 results	 obtained	 showing	 that	 t9	 mRNA	 levels	 were	decreased	in	this	mutant	also	(Figure	3.6.2B).	Furthermore,	deletion	of	ta9	with	
ta8	 resulted	 in	 an	 increase	 in	 persister	 formation	 compared	 to	 the	 single	 ta9	
Chapter	six:	Discussion		
	 190	
deletion	mutant,	which	could	be	the	result	of	the	up-regulation	of	t6	in	this	strain	(Figure	3.6.2B).	There	was	also	a	larger	proportion	of	persisters	being	formed	in	the	∆ta6∆ta9	mutant	compared	to	the	single	ta9	deletion	mutant.	Unexpectedly	the	 mRNA	 levels	 of	 t8	 were	 also	 decreased	 in	 this	 mutant.	 However,	 it	 is	important	 to	 note	 that	 these	 experiments	 did	 not	 monitor	 the	 levels	 of	 the	remaining	 11	 TA	 modules	 in	 Salmonella,	 which	 could	 also	 be	 affected	 by	 the	activation	 or	 deletion	 of	 the	 GNAT	TA	modules.	 These	 results	 suggest	 that	 the	cross-interaction	 observed	 between	 the	 GNAT	 TA	 modules,	 during	 infection	affects	 the	 outcome	 of	 persister	 formation,	 though	 the	 exact	 interactions	 and	cross	 activation	 remain	 elusive.	 Such	 cross-activation	 between	 the	 GNAT	 TA	modules	could	occur	as	a	result	of	structural	similarities	between	the	proteins.	For	example,	excess	of	a	non-cognate	antitoxin	could	destabilise	the	TA	complex	resulting	 in	 derepression	 of	 the	 TA	 promoter	 and	 activation	 of	 the	 module.	Similarly,	excess	of	 toxin	proteins	could	have	the	same	effect	(Figure	3.6.1).	No	neutralisation	of	T6	and	T8	by	non-cognate	antitoxins	was	observed	(Figure	3.9),	which	correlates	with	all	previous	reports	that	suggest	there	is	strict	specificity	of	 the	 direct	 interactions	 between	 toxins	 and	 antitoxins	 (Fiebig	 et	 al.,	 2010;	Ahidjo	et	al.,	 2011;	Goeders	&	Van	Melderen,	2014).	 It	would	be	 interesting	 to	determine	whether	any	increase	in	GNAT	TA	module	mRNA	was	observed	upon	over-expression	 of	 the	 various	 GNAT	 toxin	 or	 antitoxin	 genes,	 in	 order	 to	elucidate	whether	any	such	destabilisation	was	occurring.			Another	 possibility	 is	 that	 the	 GNAT	 toxins	 are	 interacting	 via	 their	predicted	activity.	This	has	been	described	for	mRNAses	such	as	MazF	and	MqsR,	which	have	been	reported	to	cleave	specifically	antitoxin	mRNA	resulting	in	the	subsequent	 activation	 of	 other	 toxins	 (Wang	 et	 al.,	 2012,	 2013;	 Kasari	 et	 al.,	
Chapter	six:	Discussion		
	 191	
2013).	Acetylation	is	a	widely	used	PTM	in	bacteria,	involved	in	regulating	many	cellular	 processes	 (Wang	 et	 al.,	 2010;	 Yu	 et	 al.,	 2008;	 Zhang	 et	 al.,	 2009).	Furthermore,	in	Salmonella,	there	are	often	two	or	more	GNAT	modules	(Figure	4.3.2A-C),	as	such	it	would	be	interesting	to	investigate	whether	they	are	acting	on	 each	 other	 via	 acetylation.	 Such	 a	 PTM	 could	 result	 in	 activation	 or	deactivation	or	change	in	activity	of	the	toxins.	I	observed	prolonged	toxicity	of	T8	 and	 T6	 in	∆ta6∆ta8∆ta9	mutant	 strains.	 However,	 this	 did	 not	 result	 in	 an	increase	in	persister	formation	(Figure	3.8.1	and	3.8.2).	The	most	direct	way	to	monitor	interactions	would	be	to	purify	all	three	toxins	and	investigate	whether	there	was	any	acetylation	in	vitro	using	[14C]Ac-CoA	to	track	acetylation.			
6.4	T8	is	a	novel	acetyltransferase		 The	 GNAT	 superfamily	 contains	 upwards	 of	 10,000	 members	 that	 are	found	 in	 all	 domains	 of	 life	 [http://supfam.mrc-lmb.cam.ac.uk/SUPERFAMILY].	GNATs	 are	 known	 to	 acetylate	 a	 wide	 array	 of	 protein	 substrates	 and	 are	commonly	involved	in	reversible	lysine	acetylation	(Dyda	et	al.,	2000).	This	PTM	is	ubiquitous	in	eukaryotes	but	until	recently	was	considered	to	be	sparsely	used	in	 prokaryotes.	 Recent	 studies	 have	 now	 shown,	 by	 enriching	 for	 acetylated	proteins	 and	 analysis	 by	mass	 spectrometry,	 that	 lysine	 acetylation	 is	 a	 highly	abundant	modification	utilised	by	bacteria	such	as	S.	Typhimurium	(Wang	et	al.,	2010),	E.	coli	(Zhang	et	al.,	2009)	and	M.	tuberculosis	(Xie	et	al.,	2014),	involved	in	an	array	of	processes	ranging	from	metabolism,	(Zhang	et	al.,	2009;	Wang	et	
al.,	 2010;	 Xie	 et	 al.,	 2014),	 translation	 (Vetting	 et	 al.,	 2008;	 Ramagopal	 &	Subramanian,	 1974)	 and	 stress	 response	 (Ma	&	Wood,	 2011).	 Though	 there	 is	
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little	structural	similarity	between	GNATs,	all	contain	a	highly	conserved	fold	at	the	active	site	(Vetting	et	al.,	2005).	The	residues	responsible	for	this	domain	can	be	identified	by	a	simple	protein	sequence	BLAST	alignment	(Figure	3.2.2C).	By	substituting	 single	 amino	 acids	within	 the	predicted	Ac-CoA	domain	of	T6	 and	T8,	we	 confirmed	 the	necessity	of	 this	 region	 for	 each	 toxin	 function.	The	 first	mutation	 generated	 resulted	 in	 the	 substitution	 of	 a	 conserved	 alanine	 to	 a	proline	and	is	predicted	to	be	an	Ac-CoA	binding	mutant.	This	was	described	in	a	study	 investigating	 the	 acetyltransferase	 activity	 of	 a	 predicted	 GNAT	 in	
Caenorhabditis	 elegans,	 where	 this	 substitution	 resulted	 in	 a	 complete	 loss	 of	enzymatic	function	(Abo-Dalo	et	al.,	2004).	The	second	mutation	resulted	in	the	substitution	 of	 a	 conserved	 tyrosine	 to	 a	 phenylalanine.	 This	 substitution	was	selected	based	on	predicted	 structures	 for	T6	 and	T8	by	modelling	 them	 from	the	Salmonella	acetyltransferase	RimI.	This	tyrosine	was	predicted	to	reside	in	a	side	 pocket	 of	 the	 Ac-CoA	 binding	 domain	 and	 its	mutation	 should	 result	 in	 a	catalytic	mutant.	Both	mutations	resulted	in	complete	abolition	of	toxicity	of	T6	and	 T8	 (Figure	 4.4.3A-B).	 These	 results	 highlight	 the	 importance	 of	 this	predicted	Ac-CoA	binding	domain	for	toxin	function,	further	indicating	that	they	are	acetyltransferase	enzymes.				 In	 collaboration	 with	 the	 Hare	 group	 we	 purified	 WT	 T8	 for	 in	 vitro	biochemical	assays	and	the	T8Y140F	variant	to	solve	the	crystal	structure	(Figure	4.6).		There	are	obvious	problems	involved	in	purification	of	toxic	proteins.	One	method	 that	 has	 been	 described	 for	 purifying	 the	 toxin	 component	 of	 a	 TA	module	 is	 to	 co-express	 the	 toxin	 with	 its	 antitoxin	 counterpart	 to	 neutralise	toxicity	with	 subsequent	denaturation	of	 the	TA	complex	 (Galvani	et	al.,	 2001)	or,	 due	 to	 the	 instability	 of	 the	 antitoxin,	mild	 digestion	 of	 the	 TA	 complex	 to	
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leave	only	the	stable	toxin	protein	(McKenzie	et	al.,	2012).	After	testing	several	protocols	we	determined	 the	optimum	method	was	on-column	denaturation	of	the	TA	complex,	with	guanidine	hydrochloride,	followed	by	subsequent	refolding	of	T8.	 That	 such	 a	 harsh	 chemical	was	necessary	 for	 the	 removal	 of	A8	 shows	how	 avidly	 the	 TA	 complex	 interacts,	 indeed,	 even	 after	 denaturation	 and	separation	 of	 the	 complex,	 some	 A8	 protein	 remains	 in	 the	 sample	 (Figure	4.9.2A).	 Furthermore,	 during	 the	 refolding	 process,	 large	 amounts	 of	 the	 toxin	protein	precipitated	out	of	solution.	Various	methods	were	attempted	to	reduce	this	precipitation,	such	as	step-wise	dialysis	to	slow	down	the	refolding	process	and	 refolding	 in	 the	 presence	 of	 the	 coenzyme	 to	 stabilise,	 however,	 neither	approach	was	 very	 successful.	With	 the	 results	 obtained	 in	 this	 study,	 I	 could	now	suggest	that	parallel	over-expression	of	pth	with	T8	may	be	a	more	suitable	method	 for	purification	of	 the	WT	toxin	as	 it	would	counteract	 the	 toxic	effect,	allowing	 for	 high	 production	 of	 the	 toxin,	 but	 not	 interact,	 removing	 the	necessity	for	denaturation	and	refolding.		To	 purify	 proteins	 for	 crystallisation,	 large	 quantities	 of	 a	 highly	 pure	protein	are	required.	In	order	to	obtain	this,	we	took	advantage	of	the	non-toxic	T8Y140F	variant,	which	we	could	express	 in	high	quantities	without	the	need	for	co-expression	of	 the	antitoxin.	T8Y140F	 crystallised	as	a	dimer	and	 the	extent	of	the	dimeric	 interface	suggests	 that	 this	 is	a	physiologically	 relevant	 interaction	(Figure	 4.6.1A).	 Consistently,	 size	 exclusion	 chromatography	 with	 multi	 angle	laser	light	scattering	(SEC-MALLS)	analysis	carried	out	in	the	Hare	lab	confirmed	that	T8	was	dimeric	 in	 solution.	Furthermore,	overlaying,	 the	T8Y140F	 structure	with	other	known	GNAT	protein	(Figure	4.6.2)	showed	that	T8	has	two	unique	areas:	 an	 extension	 to	 the	 α3	 helix	 and	 longer,	 curved	 β2	 and	 β3	 strands.	
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Interestingly,	 many	 of	 the	 residues	 involved	 in	 dimerization	 are	 found	 within	this	 novel	 region	 (Figure	4.6.1B).	 The	 crystallised	T8	dimer	was	 bound	 to	 two	Ac-CoA	 molecules	 (Figure	 4.6.1A),	 allowing	 the	 precise	 determination	 of	 the	residues	 involved	 in	 Ac-CoA	 binding	 (Figure	 4.6.1B).	 The	 residues	 that	 are	involved	in	dimerization	are	conserved	in	the	Salmonella	GNAT	toxins	suggesting	that	T6	and	T9	may	also	form	dimers.	Dimerization	of	GNAT	enzymes	resulting	in	both	subunits	working	cooperatively	has	been	reported	previously	in	the	case	of	 the	 Enterococcus	 faecium	 AAC(6')-Ii,	 which	 acetylates	 aminoglycosides	(Draker	 et	 al.,	 2003).	 Together	 these	 results	 show	 that	 T8	 is	 a	 novel	acetyltransferase	and	suggest	that	it	may	dimerize	allowing	for	the	acetylation	of	two	substrate	molecules	at	a	time.			
6.5	T6	and	T8	inhibit	protein	synthesis			 As	 discussed	 in	 section	 1.5.4	 type	 II	 toxins	 inhibit	 a	 variety	 of	 cellular	processes,	 such	 as	 cell	 wall	 synthesis	 and	 cell	 division,	 DNA	 replication	 and	protein	 translation,	 by	 a	 diverse	 array	 of	molecular	mechanisms.	 Determining	which	 cellular	process	 is	 inhibited	upon	 its	 over-expression	of	 a	novel	 toxin	 is	essential	 as	 it	 not	 only	dictates	 subsequent	 experiments	but	 can	narrow	down	possible	targets.	To	determine	the	cellular	process	targeted	by	S.	Typhimurium	VapC,	 the	Gerdes	 lab	used	radiolabelled	 isotopes	of	methionine,	 thymidine	and	uracil	 to	monitor	 rates	of	protein	 synthesis,	DNA	synthesis	and	RNA	synthesis,	respectively	(Winther	&	Gerdes,	2009).	Using	this	method,	I	determined	that	T6	and	 T8	 were	 both	 affecting	 protein	 synthesis	 and	 T6	 was	 also	 affecting	 DNA	synthesis.		
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Over-production	of	T8	led	to	a	rapid	and	specific	inhibition	in	methionine	incorporation,	showing	that	T8	inhibits	protein	synthesis	(Figure	4.1).	There	was	a	reduction	in	the	levels	of	thymidine	incorporation,	however,	this	occurred	after	30	minutes	 of	T8	production	 and	 as	 such	was	most	 likely	 a	 knock	on	 effect	 of	protein	 synthesis	 inhibition.	No	 decrease	 in	 incorporation	 of	 any	 radiolabelled	isotope	 was	 apparent	 upon	 over-expression	 of	 t6,	 when	 the	 values	 were	normalised	to	those	observed	5	minutes	after	induction	(Figure	4.2.1).	However,	there	was	a	stark	difference	between	the	initial	 levels	of	incorporation	for	both	methionine	and	thymidine	suggesting	that	 the	effect	of	T6	occurred	before	this	initial	time	point	(Figure	4.2.3).	From	these	results	it	is	impossible	to	determine	which	 process	 is	 the	 primary	 target	 of	 T6.	 The	 observation	 that	 inhibition	 of	protein	synthesis	upon	over-expression	of	t8	results	in	a	subsequent	decrease	in	the	 rate	 of	 DNA	 synthesis	 (Figure	 4.1.1B),	 suggests	 that	 this	 could	 also	 be	 the	case	 for	T6.	However,	as	 there	 is	 little	amino	acid	sequence	similarity	between	the	two	toxins	 it	 is	possible	that	they	have	different	target(s)	(Figure	4.3.1).	To	better	observe	 the	effects	of	T6,	we	could	 re-clone	 the	 toxin	gene	 into	another	vector	that	would	allow	for	stricter	regulation	of	expression.	Similarly,	addition	of	glucose	 to	 the	medium	could	allow	 for	reduced	expression	of	 the	 toxin	gene	from	the	pNDM220	vector	as	glucose	is	known	to	inhibit	derepression	of	the	Plac	promoter	 (Novy	 &	 Morris,	 2001).	 Another	 caveat	 to	 the	 method	 used	 in	 this	thesis	is	that	the	bacteria	were	incubated	in	rich	medium	throughout	the	entirety	of	 the	 experiment.	 This	 would	 supply	 the	 bacteria	 with	 a	 pool	 of	 un-labelled	isotopes	during	the	stage	in	which	bacteria	were	being	pulsed	with	radiolabelled	isotopes.	These	experiments	should	be	repeated	growing	the	bacteria	in	minimal	media	and	pulsing	in	a	medium	where	the	sole	isotope	pool	is	radiolabelled.		
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Using	purified	T8,	I	aimed	to	further	narrow	down	the	mechanism	of	T8-mediated	 inhibition	 of	 protein	 synthesis	 by	 recapitulating	 this	 experiment	 in	
vitro,	 using	 a	 cell	 free	 expression	 assay	 (Figure	5.6.3).	 These	 assays	 use	E.	coli	transcription	 and	 translation	 machineries	 to	 produce	 proteins	 in	 vitro.	 The	production	of	the	DHFR	protein,	from	the	positive	control	plasmid	supplied	with	the	 kit,	 was	 used	 to	 confirm	 that	 expression	 had	 occurred.	 In	 this	 simplified	assay,	addition	of	either	T8	or	Ac-CoA	individually	had	no	effect	the	production	of	the	control	protein	(Figure	5.6.3).	However,	when	both	were	added	there	was	a	complete	inhibition	of	expression,	suggesting	that	T8	inhibits	protein	synthesis	in	 an	 Ac-CoA	 dependent	manner.	When	 supplementing	 T8	with	 [14C]Ac-CoA	 it	was	possible	to	track	the	transfer	of	the	radiolabelled	acetyl	moiety.	In	doing	so	I	observed	the	appearance	of	a	band	on	the	autoradiograph	corresponding	to	the	acetylation	 of	 a	 component	 of	 the	 cell	 free	 expression	 kit	 that	migrated	 at	 an	apparent	molecular	weight	of	less	than	10	kDa	(Figure	5.6.3,	left	panel).		Ribosomal	proteins	are	small	positively	charged	proteins	to	allow	binding	of	 the	 negatively	 charged	 rRNA.	 The	 ribosome	 itself	 is	 a	 large	 and	 dynamic	structure	 that	 can	withstand	 the	 deletion	 of	 a	 number	 of	 individual	 ribosomal	genes	without	alteration	in	function	(Shoji	et	al.,	2011).	This	would	suggest	that	a	small	 alteration,	 such	 as	 acetylation,	 to	 a	 small	 component	 of	 the	 ribosome	would	have	 little	effect.	However,	 it	 is	plausible	 that	acetylation	of	a	 ribosomal	protein,	which	neutralises	the	positive	charge	attributed	to	lysine	residues,	could	alter	 the	potential	 of	 the	protein	 and	 result	 in	 drastic	 conformational	 changes,	leading	 to	 change	 in	 function,	 as	 is	 the	 case	 for	 L7/L12	 (Ramagopal	 &	Subramanian,	 1974;	 Pettersson	&	Kurland,	 1980).	No	 ribosomal	 proteins	were	shown	to	 titrate	out	T8s	 toxicity	 in	 the	ASKA	 library	 titration	screen,	however,	
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we	considered	that	association	of	the	ribosome	complex	might	be	necessary	for	interaction	 with	 T8,	 thus	 over-production	 of	 the	 single	 protein	 would	 not	 be	sufficient	 to	 titrate	 out	 toxicity.	 To	 determine	 whether	 any	 T8-dependent	acetylation	 was	 occurring	 I	 extracted	 ribosomal	 proteins,	 with	 an	 apparent	molecular	weight	of	 less	than	10	kDa,	from	cell	 free	expression	assays	that	had	been	 incubated	with	Ac-CoA	with	or	without	T8	 to	 allow	 for	 expression	of	 the	DHFR	protein	or	T8-mediated	inhibition,	respectively,	and	analysed	by	nLC-ESI-MS/MS	 (Figure	 5.7.1).	 Contrary	 to	 the	 toxin-titrating	 conditions	 with	 which	 it	was	 necessary	 to	 purify	 other	 putative	 target	 proteins	 for	mass	 spectrometry,	these	 samples	 are	 taken	 from	 a	 limited	 reaction	where	 complete	 T8-mediated	inhibition	was	observed.	As	such,	it	can	be	surmised	that	the	T8-acetylated:non	acetylated	ratio	of	 the	potential	 target	was	sufficient	 to	 inhibit	 synthesis	of	 the	control	 protein.	 This	 would	 necessitate	 the	 majority	 of	 the	 potential	 target	proteins	 to	 be	 acetylated	 in	 a	 T8-dependent	 manner,	 however,	 no	 differential	acetylation	occurred	in	response	to	exposure	to	T8.	Moreover,	when	incubating	purified	ribosomes	(NEB)	with	T8	and	[14C]Ac-CoA,	no	acetylation	was	detected	(Figure	5.7.2).	Together	these	results	strongly	indicate	that	T8	is	not	acetylating	a	ribosomal	protein.			
6.6	T8	acetylates	free	aatRNA			
pth	 was	 specifically	 selected	 for	 when	 screening	 the	 ASKA	 library	 for	genes	 that,	 when	 over-expressed,	 counteracted	 T8	 toxicity	 (Figure	 5.3).	Furthermore,	 recombinant	 Salmonella	 Pth	 completely	 counteracts	 the	 growth	inhibition	 seen	 in	 bacteria	 over-producing	 T8	 (Figure	 5.4.2).	 Pth	 was	 first	
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identified	 in	 1967	 (Cuzin	 et	 al.,	 1967).	 Genes	 encoding	 Pth	 have	 since	 been	described	in	all	three	kingdoms.	Often	during	translation	ribosomes	stall	(Sin	et	
al.,	2016)	and,	unless	rescued	by	other	factors	such	as	tmRNA,	‘drop	off’	causing	release	 of	 ptRNA.	 Pth	 is	 an	 esterase	 that	 recycles	 ptRNA	 by	 cleaving	 the	 ester	bond	 between	 the	 C-terminal	 of	 the	 peptide	 and	 the	 2’-	 or	 3’-	 hydroxyl	 of	 the	ribose	 at	 the	 end	 of	 the	 tRNA	 (Cuzin	 et	 al.,	 1967).	 Pth	 specifically	 cleaves	N-blocked	 aatRNA,	 with	 the	 rate	 of	 hydrolysis	 increasing	 substantially	 for	substrates	with	 two	 or	more	 peptide	 bonds	 (De	 Groot	 et	al.,	 1969).	 Curiously,	when	 carrying	 out	 the	 titration	 screen	 with	 the	 gDNA	 library	 there	 was	 also	titration	of	T8	by	plasmids	containing	a	fragment	of	the	argD	gene.	However,	full	length,	recombinant	Salmonella	argD	did	not	titrate	T8	toxicity.	It	is	known	that	production	 of	 minigenes	 increases	 the	 rate	 of	 drop	 off	 and	 thus	 results	 in	 an	increase	in	ptRNA	(Tenson	et	al.,	1999;	Cruz-Vera	et	al.,	2004).	Though	it	 is	not	known	whether	an	increase	in	ptRNA	results	in	an	increase	in	the	levels	of	Pth,	it	is	 well	 established	 that	 a	 build	 up	 of	 ptRNA	 is	 highly	 toxic	 to	 bacteria	(Menninger,	 1979)	 as	 it	 results	 in	 tRNA	 starvation	 (Vivanco-Domínguez	 et	 al.,	2006).	 Moreover,	 Pth	 is	 essential	 for	 bacterial	 viability	 further	 evidencing	 the	deleterious	effect	of	ptRNA	build	up.	As	such,	it	is	plausible	that	pth	expression	is	increased	 in	 response	 to	 ptRNA	 accumulation	 so	 as	 to	 swiftly	 negate	 its	 toxic	effect.	 It	 is	 possible	 that	 the	 fragment	 of	 the	argD	 gene	 from	 the	 gDNA	 library	plasmid	acted	as	a	minigene,	 increasing	ribosomal	drop	off	and	ptRNA	release,	thus	leading	to	an	increase	in	the	levels	of	Pth.	This	would	result	in	counteraction	of	T8	upon	expression	of	the	argD	fragment.		Pth	was	 an	 interesting	 potential	 target	 for	 T8,	 as	 its	 inactivation	would	result	 in	 the	swift	and	efficient	halt	 in	protein	synthesis	observed	 in	 the	pulse-
Chapter	six:	Discussion		
	 199	
chase	assay	(Figure	4.1.1).	We	investigated	this	possibility	by	purifying	Pth	from	
Salmonella,	with	or	without	parallel	production	of	T8,	 followed	by	and	analysis	by	 nLC-ESI-MS/MS	 (Figure	 5.5.2).	 No	 differential	 acetylation	 was	 observed.	However,	as	previously	mentioned,	it	was	necessary	to	over-produce	Pth	to	the	extent	that	it	titrated	out	T8	toxicity.	This	will	have	resulted	in	a	dilution	of	the	number	of	acetylated	peptides,	decreasing	the	degree	of	confidence	with	which	an	 acetylation	 event	 could	 be	 attributed.	 To	 corroborate	 this	 finding,	 we	determined	that	there	was	no	acetylation	of	Pth	upon	interaction	with	T8	in	vitro		(Figure	5.6.1).	Furthermore,	abrogation	of	Pth	activity	also	results	in	a	build	up	of	 ptRNA,	 which	 was	 not	 seen	 upon	 over-expression	 of	 t8	 (Figure	 5.5.3),	suggesting	 that	 Pth	 is	 still	 active	 in	 bacteria	 over-expressing	 t8.	 Finally	 we	observed	that	there	were	no	deleterious	effects	on	Pth	activity	upon	incubation	with	T8	(Figure	5.6.2).	As	Pth	is	required	for	viability,	one	could	propose	that	any	acetylation	 by	 T8	 would	 be	 swiftly	 counteracted	 by	 a	 third-party	 detoxifying	protein,	such	as	CobB,	as	extended	inactivity	of	Pth	could	potentially	result	in	cell	death.	 However,	 this	 would	 not	 account	 for	 the	 lack	 of	 in	 vitro	 acetylation.	 A	more	 interesting	 hypothesis	 is	 that	 Pth	 is	 a	 second	 third-party	 detoxifying	protein.	As	Pth	has	only	one	known	substrate,	N-blocked	aaTRNA,	we	postulated	that	this	is	also	T8s	target.	Of	the	type	II	toxins	that	inhibit	translation,	several	have	been	reported	as	targeting	 tRNA.	 These	 include	 Salmonella	 VapC,	 which	 cleaves	 the	 initiator	tRNAfMet	(Winther	&	Gerdes,	2011)	and	M.	tuberculosis	MazF-mt9	that	hydrolyses	a	subset	of	tRNAs	(Schifano	et	al.,	2016).	E.	coli	HipA	interferes	with	acylation	of	tRNAGlu,	 by	 phosphorylating	 glutamyl-tRNA	 synthetase,	 thereby	 inhibiting	 its	
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aminoacylation	activity	(Germain	et	al.,	2013;	Kaspy	et	al.,	2013).	However,	none	to	date	have	been	shown	to	modify	the	tRNA	molecule.		First	we	determined	that	when	separated	by	SDS-PAGE	tRNA	migrates	at	the	same	apparent	 low	molecular	weight	as	the	radiolabelled	band	seen	on	the	autoradiograph	 with	 methylene	 blue	 staining	 and	 northern	 blotting	 analysis	(Figure	 5.7.3A-B).	Hereafter,	 tRNA	was	 extracted	 from	 the	 cell	 free	 expression	reactions	that	had	been	incubated	with	Ac-CoA	with	or	without	T8	to	allow	for	expression	 of	 the	 DHFR	 protein	 or	 T8-mediated	 inhibition,	 respectively,	 and	analysed	 by	 acid-urea	 PAGE	 and	 subsequent	 autoradiography	 (Figure	 5.8.1).	tRNA	extracted	from	the	assay	that	had	been	inhibited	had	an	intense	signal	on	the	autoradiograph,	with	no	such	signal	observed	 in	 the	corresponding	control	sample.	 This	 indicates	 that	 T8	 acetylates	 tRNA	 in	 these	 reactions,	 leading	 to	inhibition	 of	 protein	 production.	 It	 has	 been	 reported	 that	 tRNAs	 can	 be	acetylated	on	nucleosides	of	the	anticodon	at	the	wobble	position,	which	leads	to	an	 increase	 the	 accuracy	 of	 their	 decoding	 activity	 (Ikeuchi	 et	 al.,	 2008).	Additionally,	 it	 is	 well	 established	 that	 blocking	 the	 alpha	 amine	 group	 of	 an	amino	acid	bound	 to	 tRNA	by	chemical	acetylation	results	 in	 translation	arrest	(Cuzin	et	al.,	1967).	At	each	cycle	of	elongation,	a	new	aatRNA	molecule	binds	to	the	 ribosomal	 A	 site	 while	 the	 nascent	 ptRNA	 is	 located	 in	 the	 P	 site.	 The	carboxyl	group	of	the	most	recently	incorporated	amino	acid	in	the	peptide	chain	then	reacts	to	form	a	peptide	bond	with	the	primary	amine	group	of	the	amino	acid	bound	to	the	tRNA	in	the	A	site.	Chemical	acetylation,	blocking	this	primary	amine	 group,	 inhibits	 this	 reaction	 and	 thus	 translation	 (Cuzin	 et	 al.,	 1967).	Together	these	reports	support	our	observations	and	suggest	tRNA	could	be	the	true	target	of	T8.	These	results	did	not	suggest	where	the	acetyl	group	was	being	
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transferred	 or	 how	 inhibition	 occurred	 as	 a	 result,	 whether	 free	 tRNA	 is	acetylated	 or	 whether	 active	 translation	 is	 required	 to	 facilitate	 T8-tRNA	interactions.	We	assessed	this	by	monitoring	the	acetylation	of	tRNA	in	cell	free	expression	assays,	before	and	after	 initiation	of	 translation,	and	confirmed	that	T8	 acetylates	 free	 tRNA	molecules	 in	 the	 absence	 of	 active	 translation	 (Figure	5.8.2).		 These	results	also	correlate	with	the	observations	that	the	T8	dimer	has	positively	 charged	 surface	 areas	 that	 would	 facilitate	 tRNA	 binding	 (Figure	5.9.1A).	Furthermore,	our	results	indicate	that	substitution	of	the	predicted	tRNA	binding	 residues	 decreases	 T8	 toxicity	 (Figure	 5.9.2).	 As	 we	 substituted	 the	positively	charged	residues	for	the	negatively	charged	glutamic	acid	residue,	this	decrease	 is	most	 likely	due	 to	 an	 alteration	 in	 the	 tRNA	binding	 affinity	 of	 the	toxin.	This	allows	us	 to	suggest	a	model	of	T8	and	tRNA	 interaction,	 in	 that	T8	dimerizes	allowing	for	two	tRNA	molecules	to	bind	with	the	amino	acid	charged	to	the	tRNA	locating	in	the	vicinity	of	the	Ac-CoA	binding	site.	This	would	suggest	that	T8	inhibits	translation	in	a	molecular	mechanism	similar	to	that	of	chemical	acetylation	 of	 the	 Nα	 amine	 group	 of	 the	 tRNA	 bound	 amino	 acid.	 We	 took	advantage	of	the	fragility	of	the	ester	bond	between	the	amino	acid	and	the	tRNA	molecule	 to	 test	 this.	 Treating	 the	 aatRNA	 with	 a	 high	 alkali	 buffer	 results	 in	deacylation	of	the	tRNA	molecules	(Cuzin	et	al.,	1967;	Janssen	et	al.,	2012).	Upon	alkali	treatment,	T8	is	unable	to	acetylate	tRNA	(Figure	5.10.2)	indicating	that	it	is	 the	amino	acid	charged	to	 the	 tRNA	that	 is	being	 targeted	by	T8	resulting	 in	acetylation	the	Nα	amine	group	of	aatRNA.	
In	vitro	expression	assays	are	highly	simplified	mixes	that	use	translation	machineries	 purified	 from	 E.	 coli.	 We	 sought	 to	 examine	 whether	 T8	 was	
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acetylating	tRNA	in	Salmonella.	However,	it	is	difficult	to	track	acetylation	in	vivo	and	so	this	proved	highly	challenging.	We	confirmed	that	aatRNA	extracted	from	
Salmonella	was	also	a	substrate	for	T8	(Figure	5.10.1).	Furthermore,	upon	over-expression	of	t8	in	Salmonella	there	was	a	build	up	of	tRNA	compared	to	bacteria	devoid	of	TA8	(Figure	5.10.1,	upper	panel).	 Interestingly,	 this	 increase	 in	 tRNA	did	not	 correlate	with	 an	 increase	 in	 radiolabelled	 signal	 (Figure	5.10.1,	 lower	panel),	indicating	that	tRNA	extracted	from	bacteria	over-producing	T8	in	vivo	is	much	less	susceptible	to	acetylation	by	T8	in	vitro.	 	This	could	be	the	due	to	the	
Nα	amine	group	of	the	aatRNA	extracted	from	these	cells	having	already	being	N-blocked	by	an	acetyl	group	in	vivo,	or	the	result	of	such	T8-mediated	acetylation	of	the	aatRNA	turning	it	into	a	substrate	for	Pth,	resulting	in	the	tRNA	extracted	from	these	cells	being	largely	deacylated.		Nonetheless,	these	results	suggest	that	T8	 interacts	 with	 tRNA	 in	 vivo	 and,	 when	 taken	 in	 concert	 with	 all	 the	 other	evidence	put	forward	in	this	study,	that	this	interaction	results	in	acetylation	of	the	Nα	amine	group	of	aatRNA	and	a	block	in	translation.	However,	our	work	did	not	 determine	 where	 this	 block	 in	 translation	 occurs.	 It	 has	 been	 shown	 that	chemically	 acetylated	 aatRNA	 still	 bind	 EF-Tu	 in	 vitro,	 however,	 the	 GTP	hydrolysis	 of	 EF-Tu	 is	 affected.	 This	 results	 in	 inhibition	 of	 association	 of	 the	tRNA	with	the	ribosomal	A	site	(Campuzano	&	Modolell,	1981).	It	is	possible	that	this	block	occurs	before	the	previously	discussed	defect	of	inhibition	of	peptide	bond	 formation	 and	 that	 EF-Tu	 is	 unable	 to	 dissociate	 from	 the	 ribosome.	However,	 EF-Tu	 over-production	 did	 not	 counteract	 T8	 in	 the	 titration	 screen	(Figure	5.3).		Whether,	T8	acetylates	one	or	multiple	 tRNAs	 is	unaddressed	here.	The	tRNA	modelled	 in	Figure	5.9.1	B	 is	alanine-tRNAAla,	however,	 there	 is	sufficient	
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space	 in	 the	 T8	 active	 site	 to	 accommodate	 larger	 amino	 acid	 structures.	 The	other	 type	 II	 toxins	 that	 interfere	with	 tRNA	do	 so	 in	 a	highly	 specific	manner	with	 potent	 effects.	 HipA	 specifically	 inhibits	 acylation	 of	 glutamyl-tRNA	(Germain	et	al.,	2013;	Kaspy	et	al.,	2013)	and	VapC	specifically	cleaves	initiator	tRNA	(Winther	&	Gerdes,	2011).	Both	of	these	mechanisms	result	in	specific	and	drastic	 inhibition	 of	 translation.	 It	 is	 important	 to	 determine	which	 tRNA(s)	 is	being	targeted	by	T8.				
6.7	 Third-party	 detoxifying	 proteins	 allow	 exit	 from	 the	 T8-
induced	persister	state	It	 is	 well	 described	 that	 type	 II	 antitoxins	 interact	 with	 and	 neutralise	their	 cognate	 toxins	 (Yamaguchi	&	 Inouye,	 2011).	 Furthermore,	 it	 is	 proposed	that	 resumption	 of	 growth	 of	 type	 II	 toxin	 induced	 persisters	 occurs	 upon	replenishment	 of	 the	 antitoxin	 pool,	 thereby	 restoring	 the	 necessary	antitoxin:toxin	 ratio	 needed	 for	 bacterial	 growth	 (Cataudella	 et	 al.,	 2012).	However,	with	a	toxin	that	inhibits	translation,	such	as	T8,	it	is	more	difficult	to	accommodate	 this	 theory.	 The	data	 presented	here	 indicate	 that	 Pth	 is	 able	 to	counteract	 T8	 activity.	 Interestingly,	 though	 aatRNA	 is	 not	 a	 substrate	 for	 Pth,	aatRNA	 that	 has	 been	 N-blocked	 by	 chemical	 acetylation	 is	 recognised	 as	dipeptidyl-tRNA	 and	 so	 is	 hydrolysed	 (Cuzin	 et	 al.,	 1967).	 This	 would	 explain	how	Pth	is	capable	of	counteracting	T8	toxicity	(Figure	5.11).	Indeed,	when	T8-acetylated	aatRNA	was	subsequently	exposed	 to	Pth,	a	substantial	 reduction	 in	the	 radiolabelled	 signal	 was	 observed	 suggesting	 that	 Pth	 is	 hydrolysing	 the	ester	 bound	 between	 the	 acetylated	 amino	 acid	 and	 the	 nucleic	 acid	 (Figure	
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5.12.1).	 Moreover,	 over-production	 of	 Pth	 in	 parallel	 to	 T8	 abolished	 the	 T8-induced	increase	in	persister	formation	(Figure	5.12.2	and	Supplementary	figure	4),	indicating	Pth	is	detoxifying	these	cells.	Similarly,	deletion	of	cobB	results	in	an	 extension	 of	 T8	 toxicity	 (Figure	 4.5.2)	 and	 allowed	 T8	 to	 be	 toxic	 in	exponentially	growing	bacteria	(Figure	4.5.3),	suggesting	that	CobB	could	also	be	involved	in	detoxifying	T8-active	cells.		Though	 the	 exact	 mechanism	 of	 exit	 from	 the	 persister	 state	 is	 still	unknown,	 based	 on	 the	 results	 presented	 here	 I	 can	 propose	 a	 model	 of	detoxification	 of	 a	 T8-induced	 persister	 cell.	 Detoxification	 by	 third-party	proteins,	such	as	Pth	and	CobB,	would	not	require	translation	to	resume	in	order	to	counteract	T8-mediated	inhibition	in	translation,	therefore	circumventing	the	current	 paradox	 surrounding	 exit	 from	 persistence.	 This	 could	 occur	 through	variations	in	the	half-lives	of	the	three	proteins:	should	Pth	or	CobB	outlive	T8,	detoxification	would	occur	upon	the	switch	between	high	T8	 to	high	Pth/CobB	levels.	Likewise,	T8	and	CobB	require	coenzymes,	Ac-CoA	and	NAD+,	to	function.	Differences	 in	 the	 intracellular	 levels	 of	 each	 could	 possibly	 also	 affect	 the	respective	 activity	 of	 the	 enzymes.	 If	 the	 intracellular	 levels	 of	 Ac-CoA	 were	depleted	before	that	of	NAD+,	this	could	result	in	inactivity	of	T8	prior	to	that	of	CobB.	 The	results	presented	in	this	project	show	that	TA6	and	TA8	are	bone	fide	TA	 modules,	 confirming	 data	 reported	 by	 Lobato-Marquez	 and	 colleagues	(Lobato-Márquez	 et	 al.,	 2015).	 Further,	 they	 suggest	 there	may	 be	 interaction	between	the	GNAT	TA	modules	upon	internalisation	by	macrophages.	However,	more	 work	 is	 necessary	 to	 determine	 the	 exact	 interactions	 and	 their	consequences.	Both	T6	and	T8	inhibit	translation	(and	possibly	DNA	replication	
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for	 T6).	 However,	 T6	 activity	 is	 highly	 potent	 though	 short	 lived	 and	 so	more	work	will	be	required	to	examine	which	process	is	the	primary	target.	It	can	be	concluded,	from	the	results,	that	T8	binds	to	form	dimers	and	acetylates	the	Nα	amine	group	of	the	amino	acid	bound	to	tRNA.	This	results	in	N-blocked	aatRNA,	which	are	unable	to	react	to	form	a	peptide	bond	with	the	carboxyl	group	of	the	nascent	peptide	chain,	thus	resulting	in	translation	inhibition.	Finally,	our	work	suggests	that	Salmonella	has	several	proteins	capable	of	counteracting	the	effect	of	T8:	A8,	Pth	and	CobB	together	allowing	for	exit	from	the	persister	state.		
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Supplementary figure 2
Supplementary figure 2: T6 and T8 toxicity was extended when bacteria were grown in M9 minimal 
medium. S. Typhimurium ¨WDDQG¨WDstrains harbouring either the pNDM220 empty vector  (     ) or the 
respective toxin containing plasmid  (     ), were incubated in M9 minimal medium supplemented with IPTG to 
induce gene expression. Induction began at time point 0 and OD600 measured at 30-minute intervals. Data 
represent mean ± SEM (n=3).
Supplementary figure 1
Supplementary figure 1: Growth curves of Salmonella over-producing TA8 monitored by CFU count. S. 
Typhimurium ǻWD harbouring the empty pNDM220 plasmid (control), pNT8 (+T8), or  pNT8 and pBA8 
(+T8+A8) were incubated in LB supplemented with IPTG and arabinose to induce gene expression. Induction 
began at time point 0 and CFU was enumerated at hourly intervals. Data represent the mean ± SEM (n=3). 
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Supplementary figure 3: Generation of S. Typhimurium ¨WD. Genes encoding full length GNAT 
toxin-antitoxin operons were replaced with kanamycin and chloramphenicol resistance cassettes using the 
lambda red recombinase method resulting in S. Typhimurium¨WDFDW¨WDNDQ¨WD. Mutant genotype was 
confirmed using colony PCR and separated by DNA gel electrophoresis.
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Supplementary figure 4: Antibiotic kill curves of bacteria over-producing the TA8 and Pth proteins. Lag 
phase S. Typhimurium ¨WD strains harbouring either the pNDM220 empty vector (    ), the pNT8 plasmid (    ), 
the pNT8 and the pBA8 plasmids (    ), the pNT8 and the pBPth plasmids (   ) or the pBPth plasmid (    ) were 
incubated in M9 minimal medium supplemented with IPTG and arabinose to induce gene expression. After 1 
h of induction bacteria were exposed to 100 µg/ml gentamycin. Bacterial survival calculated as a percentage 
of pre-antibiotic treatment at hourly intervals. Data represent mean ± SEM(n=3).
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Time  -T6  +T6  -T8  +T8
0 0.015 0.014 0.01 0.014
1 0.039 0.021 0.036 0.02
2 0.182 0.035 0.22 0.035
3 0.618 0.107 0.602 0.07
4 0.893 0.466 0.845 0.239
5 1.098 0.826 1.011 0.416
S. Typhimurium ta6 S. Typhimurium ta8
Supplementary table 1
Supplementary table 1: Representative raw data from a lag phase over-expression assay.  OD600 
readings of S. Typhimurium ¨WDDQG¨WDstrains, with our without over-expression of the respective toxins.
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Appendix	1:	Representative	raw	MS/MS	data		
Representative	RAW	MS/MS	data	for	ArtJ	with	T6	over-expression	
Query	 Start	 –	 End	 Observed	 Mr(expt)	 Mr(calc)	 ppm		 M	 Score	 Expect	 Rank	 U	 Peptide	1469	 23	 –	 42	 719.6979	 2156.0719	 2156.0426	 13.6	 0	 46	 5.10E-05	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1470	 23	 –	 42	 719.6985	 2156.0738	 2156.0426	 14.5	 0	 18	 0.02	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1471	 23	 –	 42	 719.6989	 2156.0749	 2156.0426	 15	 0	 28	 0.0023	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1472	 23	 –	 42	 719.6991	 2156.0753	 2156.0426	 15.2	 0	 27	 0.0088	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1473	 23	 –	 42	 719.6997	 2156.0772	 2156.0426	 16	 0	 28	 0.0024	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1474	 23	 –	 42	 719.6998	 2156.0777	 2156.0426	 16.3	 0	 39	 0.00046	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1475	 23	 –	 42	 1079.055	 2156.0955	 2156.0426	 24.6	 0	 72	 1.90E-07	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1476	 23	 –	 42	 1079.0552	 2156.0959	 2156.0426	 24.7	 0	 57	 1.30E-05	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1477	 23	 –	 42	 1079.0553	 2156.096	 2156.0426	 24.8	 0	 74	 1.10E-07	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1478	 23	 –	 42	 1079.056	 2156.0975	 2156.0426	 25.5	 0	 69	 3.40E-07	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1479	 23	 –	 42	 1079.0562	 2156.0978	 2156.0426	 25.6	 0	 88	 6.10E-09	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1480	 23	 –	 42	 1079.0563	 2156.098	 2156.0426	 25.7	 0	 71	 2.10E-07	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1481	 23	 –	 42	 1079.0564	 2156.0982	 2156.0426	 25.8	 0	 58	 3.60E-06	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1482	 23	 –	 42	 1079.0564	 2156.0983	 2156.0426	 25.9	 0	 67	 5.70E-07	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1483	 23	 –	 42	 1079.0567	 2156.0988	 2156.0426	 26.1	 0	 11	 0.095	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1484	 23	 –	 42	 1079.0567	 2156.0989	 2156.0426	 26.1	 0	 88	 5.80E-09	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1485	 23	 –	 42	 1079.0568	 2156.099	 2156.0426	 26.2	 0	 80	 6.00E-08	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1486	 23	 –	 42	 1079.0568	 2156.099	 2156.0426	 26.2	 0	 75	 9.50E-08	 1	 U	 K.INFGVSATYPPFESLDASNK.I	1487	 23	 –	 42	 1079.0574	 2156.1002	 2156.0426	 26.7	 0	 18	 0.02	 1	 U	 K.INFGVSATYPPFESLDASNK.I	562	 43	 –	 56	 768.4217	 1534.8288	 1534.8065	 14.5	 0	 92	 2.30E-09	 1	 		 K.IVGFDIDLATALCK.Q	563	 43	 –	 56	 768.4219	 1534.8292	 1534.8065	 14.8	 0	 92	 2.30E-09	 1	 		 K.IVGFDIDLATALCK.Q	564	 43	 –	 56	 768.422	 1534.8293	 1534.8065	 14.9	 0	 112	 3.50E-11	 1	 		 K.IVGFDIDLATALCK.Q	
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565	 43	 –	 56	 768.422	 1534.8294	 1534.8065	 14.9	 0	 85	 1.20E-08	 1	 		 K.IVGFDIDLATALCK.Q	566	 43	 –	 56	 768.4221	 1534.8296	 1534.8065	 15	 0	 107	 8.90E-11	 1	 		 K.IVGFDIDLATALCK.Q	567	 43	 –	 56	 768.4221	 1534.8297	 1534.8065	 15.1	 0	 95	 1.20E-09	 1	 		 K.IVGFDIDLATALCK.Q	568	 43	 –	 56	 768.4221	 1534.8297	 1534.8065	 15.1	 0	 112	 3.20E-11	 1	 		 K.IVGFDIDLATALCK.Q	569	 43	 –	 56	 768.4222	 1534.8299	 1534.8065	 15.2	 0	 99	 5.10E-10	 1	 		 K.IVGFDIDLATALCK.Q	570	 43	 –	 56	 768.4222	 1534.8299	 1534.8065	 15.3	 0	 102	 3.00E-10	 1	 		 K.IVGFDIDLATALCK.Q	571	 43	 –	 56	 768.4223	 1534.83	 1534.8065	 15.3	 0	 103	 2.40E-10	 1	 		 K.IVGFDIDLATALCK.Q	572	 43	 –	 56	 768.4223	 1534.8301	 1534.8065	 15.3	 0	 88	 5.40E-09	 1	 		 K.IVGFDIDLATALCK.Q	573	 43	 –	 56	 768.4223	 1534.8301	 1534.8065	 15.4	 0	 107	 1.80E-10	 1	 		 K.IVGFDIDLATALCK.Q	574	 43	 –	 56	 768.4225	 1534.8305	 1534.8065	 15.6	 0	 107	 1.10E-10	 1	 		 K.IVGFDIDLATALCK.Q	575	 43	 –	 56	 768.4225	 1534.8305	 1534.8065	 15.6	 0	 96	 1.00E-09	 1	 		 K.IVGFDIDLATALCK.Q	576	 43	 –	 56	 768.4226	 1534.8306	 1534.8065	 15.7	 0	 103	 4.30E-10	 1	 		 K.IVGFDIDLATALCK.Q	577	 43	 –	 56	 768.4226	 1534.8307	 1534.8065	 15.7	 0	 47	 3.50E-05	 1	 		 K.IVGFDIDLATALCK.Q	578	 43	 –	 56	 768.4226	 1534.8307	 1534.8065	 15.8	 0	 112	 3.10E-11	 1	 		 K.IVGFDIDLATALCK.Q	579	 43	 –	 56	 768.4227	 1534.8308	 1534.8065	 15.8	 0	 102	 2.60E-10	 1	 		 K.IVGFDIDLATALCK.Q	580	 43	 –	 56	 768.4228	 1534.831	 1534.8065	 16	 0	 93	 2.10E-09	 1	 		 K.IVGFDIDLATALCK.Q	581	 43	 –	 56	 768.4228	 1534.831	 1534.8065	 16	 0	 112	 3.50E-11	 1	 		 K.IVGFDIDLATALCK.Q	582	 43	 –	 56	 768.4228	 1534.8311	 1534.8065	 16	 0	 103	 2.30E-10	 1	 		 K.IVGFDIDLATALCK.Q	583	 43	 –	 56	 768.423	 1534.8313	 1534.8065	 16.2	 0	 107	 1.10E-10	 1	 		 K.IVGFDIDLATALCK.Q	584	 43	 –	 56	 768.423	 1534.8314	 1534.8065	 16.2	 0	 93	 1.80E-09	 1	 		 K.IVGFDIDLATALCK.Q	585	 43	 –	 56	 768.423	 1534.8315	 1534.8065	 16.3	 0	 88	 5.30E-09	 1	 		 K.IVGFDIDLATALCK.Q	1720	 57	 –	 77	 808.0692	 2421.1859	 2421.1457	 16.6	 0	 20	 0.013	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	1721	 57	 –	 77	 808.0694	 2421.1863	 2421.1457	 16.8	 0	 29	 0.0019	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	1724	 57	 –	 77	 1211.6143	 2421.214	 2421.1457	 28.2	 0	 30	 0.0015	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	1740	 57	 –	 77	 813.4001	 2437.1785	 2437.1406	 15.6	 0	 10	 0.12	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	+	Oxidation	(M)	1741	 57	 –	 77	 813.4006	 2437.1799	 2437.1406	 16.1	 0	 7	 0.22	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	+	
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Oxidation	(M)	1743	 57	 –	 77	 813.4014	 2437.1825	 2437.1406	 17.2	 0	 3	 0.47	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	+	Oxidation	(M)	1744	 57	 –	 77	 813.4016	 2437.1829	 2437.1406	 17.4	 0	 22	 0.0083	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	+	Oxidation	(M)	1747	 57	 –	 77	 813.4021	 2437.1844	 2437.1406	 18	 0	 10	 0.11	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	+	Oxidation	(M)	1748	 57	 –	 77	 813.4022	 2437.1848	 2437.1406	 18.1	 0	 6	 0.28	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	+	Oxidation	(M)	1749	 57	 –	 77	 813.4022	 2437.1849	 2437.1406	 18.2	 0	 21	 0.011	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	+	Oxidation	(M)	705	 57	 –	 77	 813.4053	 2437.194	 2437.1406	 21.9	 0	 8	 0.18	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	+	Oxidation	(M)	1750	 57	 –	 77	 1219.6124	 2437.2102	 2437.1406	 28.5	 0	 30	 0.0017	 1	 		 K.QMQAECTFTNHAFDSLIPALK.F	+	Oxidation	(M)	773	 80	 –	 94	 847.9386	 1693.8627	 1693.8345	 16.6	 1	 85	 3.70E-08	 1	 		 R.KYDAVISGMDITPER.S	774	 80	 –	 94	 847.9394	 1693.8643	 1693.8345	 17.6	 1	 64	 9.70E-07	 1	 		 R.KYDAVISGMDITPER.S	775	 80	 –	 94	 847.9405	 1693.8665	 1693.8345	 18.9	 1	 96	 1.40E-08	 1	 		 R.KYDAVISGMDITPER.S	776	 80	 –	 94	 847.9405	 1693.8665	 1693.8345	 18.9	 1	 85	 1.40E-08	 1	 		 R.KYDAVISGMDITPER.S	777	 80	 –	 94	 847.9415	 1693.8684	 1693.8345	 20	 1	 50	 1.90E-05	 1	 		 R.KYDAVISGMDITPER.S	779	 80	 –	 94	 847.9587	 1693.9028	 1693.8345	 40.3	 1	 4	 0.41	 1	 		 R.KYDAVISGMDITPER.S	803	 80	 –	 94	 570.9536	 1709.8391	 1709.8294	 5.66	 1	 74	 1.30E-07	 1	 		 R.KYDAVISGMDITPER.S	+	Oxidation	(M)	804	 80	 –	 94	 570.9539	 1709.8398	 1709.8294	 6.09	 1	 41	 0.00016	 1	 		 R.KYDAVISGMDITPER.S	+	Oxidation	(M)	805	 80	 –	 94	 570.9539	 1709.8398	 1709.8294	 6.09	 1	 68	 6.80E-07	 1	 		 R.KYDAVISGMDITPER.S	+	Oxidation	(M)	806	 80	 –	 94	 855.9376	 1709.8606	 1709.8294	 18.2	 1	 91	 3.20E-09	 1	 		 R.KYDAVISGMDITPER.S	+	Oxidation	(M)	807	 80	 –	 94	 855.9376	 1709.8606	 1709.8294	 18.2	 1	 85	 1.10E-08	 1	 		 R.KYDAVISGMDITPER.S	+	Oxidation	(M)	808	 80	 –	 94	 855.9387	 1709.8629	 1709.8294	 19.6	 1	 17	 0.037	 1	 		 R.KYDAVISGMDITPER.S	+	Oxidation	
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(M)	809	 80	 –	 94	 855.939	 1709.8634	 1709.8294	 19.9	 1	 62	 1.60E-06	 1	 		 R.KYDAVISGMDITPER.S	+	Oxidation	(M)	867	 80	 –	 94	 868.9422	 1735.8698	 1735.8451	 14.3	 1	 14	 0.047	 1	 		 R.KYDAVISGMDITPER.S	+	Acetyl	(K)	616	 81	 –	 94	 783.8801	 1565.7457	 1565.7395	 3.93	 0	 15	 0.11	 1	 		 K.YDAVISGMDITPER.S	617	 81	 –	 94	 783.8874	 1565.7603	 1565.7395	 13.3	 0	 87	 3.90E-07	 1	 		 K.YDAVISGMDITPER.S	618	 81	 –	 94	 783.8889	 1565.7633	 1565.7395	 15.2	 0	 66	 2.30E-06	 1	 		 K.YDAVISGMDITPER.S	619	 81	 –	 94	 783.8892	 1565.7639	 1565.7395	 15.5	 0	 66	 9.50E-07	 1	 		 K.YDAVISGMDITPER.S	620	 81	 –	 94	 783.8893	 1565.764	 1565.7395	 15.6	 0	 63	 2.00E-06	 1	 		 K.YDAVISGMDITPER.S	621	 81	 –	 94	 783.8896	 1565.7647	 1565.7395	 16.1	 0	 68	 1.00E-06	 1	 		 K.YDAVISGMDITPER.S	622	 81	 –	 94	 783.8896	 1565.7647	 1565.7395	 16.1	 0	 86	 2.30E-08	 1	 		 K.YDAVISGMDITPER.S	624	 81	 –	 94	 783.8899	 1565.7653	 1565.7395	 16.4	 0	 41	 0.00079	 1	 		 K.YDAVISGMDITPER.S	626	 81	 –	 94	 783.8904	 1565.7662	 1565.7395	 17	 0	 46	 6.30E-05	 1	 		 K.YDAVISGMDITPER.S	627	 81	 –	 94	 783.8904	 1565.7663	 1565.7395	 17.1	 0	 50	 5.30E-05	 1	 		 K.YDAVISGMDITPER.S	628	 81	 –	 94	 783.891	 1565.7674	 1565.7395	 17.8	 0	 59	 8.70E-06	 1	 		 K.YDAVISGMDITPER.S	629	 81	 –	 94	 783.8913	 1565.768	 1565.7395	 18.2	 0	 57	 1.60E-05	 1	 		 K.YDAVISGMDITPER.S	646	 81	 –	 94	 791.8863	 1581.7581	 1581.7345	 14.9	 0	 34	 0.00066	 1	 		 K.YDAVISGMDITPER.S	+	Oxidation	(M)	647	 81	 –	 94	 791.8874	 1581.7603	 1581.7345	 16.4	 0	 63	 1.30E-06	 1	 		 K.YDAVISGMDITPER.S	+	Oxidation	(M)	648	 81	 –	 94	 791.8875	 1581.7604	 1581.7345	 16.4	 0	 43	 0.00073	 1	 		 K.YDAVISGMDITPER.S	+	Oxidation	(M)	649	 81	 –	 94	 791.8877	 1581.7609	 1581.7345	 16.7	 0	 57	 4.60E-06	 1	 		 K.YDAVISGMDITPER.S	+	Oxidation	(M)	650	 81	 –	 94	 791.8879	 1581.7613	 1581.7345	 16.9	 0	 42	 0.00011	 1	 		 K.YDAVISGMDITPER.S	+	Oxidation	(M)	651	 81	 –	 94	 791.8883	 1581.762	 1581.7345	 17.4	 0	 85	 5.20E-08	 1	 		 K.YDAVISGMDITPER.S	+	Oxidation	(M)	652	 81	 –	 94	 791.8883	 1581.7621	 1581.7345	 17.4	 0	 91	 1.40E-08	 1	 		 K.YDAVISGMDITPER.S	+	Oxidation	(M)	653	 81	 –	 94	 791.8899	 1581.7653	 1581.7345	 19.5	 0	 59	 1.90E-05	 1	 		 K.YDAVISGMDITPER.S	+	Oxidation	(M)	1529	 95	 –	 114	 1086.1047	 2170.1949	 2170.1422	 24.3	 1	 41	 0.00015	 1	 		 R.SKQVAFSNPYYANSALVIAK.K	1128	 97	 –	 114	 652.6857	 1955.0354	 1955.0152	 10.3	 0	 59	 3.00E-06	 1	 		 K.QVAFSNPYYANSALVIAK.K	1129	 97	 –	 114	 652.6864	 1955.0374	 1955.0152	 11.4	 0	 30	 0.0015	 1	 		 K.QVAFSNPYYANSALVIAK.K	
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1130	 97	 –	 114	 652.687	 1955.039	 1955.0152	 12.2	 0	 34	 0.00065	 1	 		 K.QVAFSNPYYANSALVIAK.K	1131	 97	 –	 114	 978.5361	 1955.0576	 1955.0152	 21.7	 0	 27	 0.0029	 1	 		 K.QVAFSNPYYANSALVIAK.K	1132	 97	 –	 114	 978.5363	 1955.058	 1955.0152	 21.9	 0	 29	 0.0021	 1	 		 K.QVAFSNPYYANSALVIAK.K	1133	 97	 –	 114	 978.5363	 1955.0581	 1955.0152	 21.9	 0	 26	 0.0036	 1	 		 K.QVAFSNPYYANSALVIAK.K	1134	 97	 –	 114	 978.5363	 1955.0581	 1955.0152	 21.9	 0	 32	 0.001	 1	 		 K.QVAFSNPYYANSALVIAK.K	1135	 97	 –	 114	 978.5366	 1955.0586	 1955.0152	 22.2	 0	 37	 0.00031	 1	 		 K.QVAFSNPYYANSALVIAK.K	1137	 97	 –	 114	 978.5369	 1955.0592	 1955.0152	 22.5	 0	 13	 0.058	 1	 		 K.QVAFSNPYYANSALVIAK.K	1138	 97	 –	 114	 978.5369	 1955.0592	 1955.0152	 22.5	 0	 7	 0.24	 1	 		 K.QVAFSNPYYANSALVIAK.K	1139	 97	 –	 114	 978.537	 1955.0595	 1955.0152	 22.6	 0	 41	 0.00013	 1	 		 K.QVAFSNPYYANSALVIAK.K	1140	 97	 –	 114	 978.5371	 1955.0597	 1955.0152	 22.7	 0	 66	 1.20E-06	 1	 		 K.QVAFSNPYYANSALVIAK.K	1141	 97	 –	 114	 978.5371	 1955.0597	 1955.0152	 22.7	 0	 58	 5.80E-06	 1	 		 K.QVAFSNPYYANSALVIAK.K	1142	 97	 –	 114	 978.5372	 1955.0598	 1955.0152	 22.8	 0	 25	 0.005	 1	 		 K.QVAFSNPYYANSALVIAK.K	1143	 97	 –	 114	 978.5374	 1955.0603	 1955.0152	 23	 0	 21	 0.011	 1	 		 K.QVAFSNPYYANSALVIAK.K	1144	 97	 –	 114	 978.5374	 1955.0603	 1955.0152	 23.1	 0	 19	 0.016	 1	 		 K.QVAFSNPYYANSALVIAK.K	1145	 97	 –	 114	 978.5376	 1955.0607	 1955.0152	 23.3	 0	 14	 0.053	 1	 		 K.QVAFSNPYYANSALVIAK.K	1146	 97	 –	 114	 978.5378	 1955.061	 1955.0152	 23.4	 0	 33	 0.00085	 1	 		 K.QVAFSNPYYANSALVIAK.K	301	 116	 –	 125	 616.3172	 1230.6199	 1230.6132	 5.4	 1	 43	 0.00013	 1	 		 K.DTYKTFTDLK.G	40	 120	 –	 127	 455.2531	 908.4917	 908.4967	 -5.56	 1	 39	 0.0025	 1	 		 K.TFTDLKGK.R	466	 128	 –	 139	 457.8975	 1370.6706	 1370.6725	 -1.36	 1	 26	 0.052	 1	 		 K.RIGMENGTTHQK.Y	483	 128	 –	 139	 463.2267	 1386.6581	 1386.6674	 -6.68	 1	 31	 0.0025	 1	 		 K.RIGMENGTTHQK.Y	+	Oxidation	(M)	276	 129	 –	 139	 608.2921	 1214.5696	 1214.5714	 -1.45	 0	 32	 0.00098	 1	 		 R.IGMENGTTHQK.Y	277	 129	 –	 139	 608.2957	 1214.5769	 1214.5714	 4.58	 0	 51	 1.90E-05	 1	 		 R.IGMENGTTHQK.Y	278	 129	 –	 139	 608.2972	 1214.5798	 1214.5714	 6.95	 0	 52	 1.80E-05	 1	 		 R.IGMENGTTHQK.Y	279	 129	 –	 139	 608.3029	 1214.5912	 1214.5714	 16.3	 0	 6	 0.25	 1	 		 R.IGMENGTTHQK.Y	298	 129	 –	 139	 616.2914	 1230.5683	 1230.5663	 1.61	 0	 50	 2.10E-05	 1	 		 R.IGMENGTTHQK.Y	+	Oxidation	(M)	299	 129	 –	 139	 616.2919	 1230.5692	 1230.5663	 2.38	 0	 52	 4.20E-05	 1	 		 R.IGMENGTTHQK.Y	+	Oxidation	(M)	
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300	 129	 –	 139	 616.2923	 1230.5701	 1230.5663	 3.09	 0	 47	 0.00012	 1	 		 R.IGMENGTTHQK.Y	+	Oxidation	(M)	1064	 129	 –	 144	 931.9757	 1861.9369	 1861.8992	 20.3	 1	 13	 0.057	 1	 		 R.IGMENGTTHQKYLQDK.H	1074	 129	 –	 144	 939.9734	 1877.9323	 1877.8942	 20.3	 1	 15	 0.039	 1	 		 R.IGMENGTTHQKYLQDK.H	+	Oxidation	(M)	335	 140	 –	 149	 419.5571	 1255.6496	 1255.6561	 -5.16	 1	 11	 0.094	 1	 		 K.YLQDKHPEVK.T	337	 140	 –	 149	 628.8402	 1255.6658	 1255.6561	 7.76	 1	 5	 0.34	 1	 		 K.YLQDKHPEVK.T	338	 140	 –	 149	 628.8408	 1255.6671	 1255.6561	 8.81	 1	 43	 0.0011	 1	 		 K.YLQDKHPEVK.T	339	 140	 –	 149	 628.8408	 1255.6671	 1255.6561	 8.81	 1	 44	 0.00017	 1	 		 K.YLQDKHPEVK.T	340	 140	 –	 149	 628.8408	 1255.6671	 1255.6561	 8.81	 1	 43	 0.00042	 1	 		 K.YLQDKHPEVK.T	811	 150	 –	 164	 857.4539	 1712.8933	 1712.8621	 18.2	 0	 75	 6.40E-07	 1	 		 K.TVAYDSYQNAIIDLK.N	812	 150	 –	 164	 857.4541	 1712.8937	 1712.8621	 18.4	 0	 80	 3.20E-07	 1	 		 K.TVAYDSYQNAIIDLK.N	813	 150	 –	 164	 857.4543	 1712.894	 1712.8621	 18.6	 0	 77	 3.50E-07	 1	 		 K.TVAYDSYQNAIIDLK.N	814	 150	 –	 164	 857.4543	 1712.8941	 1712.8621	 18.7	 0	 70	 1.80E-06	 1	 		 K.TVAYDSYQNAIIDLK.N	815	 150	 –	 164	 857.4543	 1712.8941	 1712.8621	 18.7	 0	 67	 2.80E-06	 1	 		 K.TVAYDSYQNAIIDLK.N	816	 150	 –	 164	 857.4544	 1712.8942	 1712.8621	 18.8	 0	 66	 2.50E-06	 1	 		 K.TVAYDSYQNAIIDLK.N	817	 150	 –	 164	 857.4545	 1712.8944	 1712.8621	 18.9	 0	 74	 2.00E-07	 1	 		 K.TVAYDSYQNAIIDLK.N	818	 150	 –	 164	 857.4545	 1712.8945	 1712.8621	 18.9	 0	 96	 4.20E-09	 1	 		 K.TVAYDSYQNAIIDLK.N	819	 150	 –	 164	 857.4546	 1712.8946	 1712.8621	 19	 0	 87	 3.20E-08	 1	 		 K.TVAYDSYQNAIIDLK.N	820	 150	 –	 164	 857.4546	 1712.8946	 1712.8621	 19	 0	 64	 4.00E-06	 1	 		 K.TVAYDSYQNAIIDLK.N	821	 150	 –	 164	 857.4547	 1712.8948	 1712.8621	 19.1	 0	 85	 4.50E-08	 1	 		 K.TVAYDSYQNAIIDLK.N	822	 150	 –	 164	 857.4548	 1712.895	 1712.8621	 19.2	 0	 46	 4.40E-05	 1	 		 K.TVAYDSYQNAIIDLK.N	823	 150	 –	 164	 857.4548	 1712.895	 1712.8621	 19.2	 0	 79	 2.20E-07	 1	 		 K.TVAYDSYQNAIIDLK.N	824	 150	 –	 164	 857.4548	 1712.895	 1712.8621	 19.2	 0	 84	 7.10E-08	 1	 		 K.TVAYDSYQNAIIDLK.N	825	 150	 –	 164	 857.4548	 1712.895	 1712.8621	 19.2	 0	 75	 2.20E-07	 1	 		 K.TVAYDSYQNAIIDLK.N	826	 150	 –	 164	 857.4548	 1712.8951	 1712.8621	 19.3	 0	 80	 1.30E-07	 1	 		 K.TVAYDSYQNAIIDLK.N	827	 150	 –	 164	 857.4548	 1712.8951	 1712.8621	 19.3	 0	 67	 9.00E-07	 1	 		 K.TVAYDSYQNAIIDLK.N	828	 150	 –	 164	 857.4549	 1712.8952	 1712.8621	 19.3	 0	 88	 3.90E-08	 1	 		 K.TVAYDSYQNAIIDLK.N	
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829	 150	 –	 164	 857.455	 1712.8954	 1712.8621	 19.5	 0	 40	 0.00019	 1	 		 K.TVAYDSYQNAIIDLK.N	830	 150	 –	 164	 857.4551	 1712.8957	 1712.8621	 19.6	 0	 37	 0.00033	 1	 		 K.TVAYDSYQNAIIDLK.N	831	 150	 –	 164	 857.4551	 1712.8957	 1712.8621	 19.6	 0	 60	 2.50E-06	 1	 		 K.TVAYDSYQNAIIDLK.N	1338	 165	 –	 183	 1045.5625	 2089.1104	 2089.0593	 24.5	 1	 58	 7.10E-06	 1	 		 K.NGRIDGVFGDTAVVNEWLK.T	909	 168	 –	 183	 588.309	 1761.9052	 1761.8938	 6.51	 0	 69	 3.20E-07	 1	 		 R.IDGVFGDTAVVNEWLK.T	910	 168	 –	 183	 881.9708	 1761.9271	 1761.8938	 18.9	 0	 64	 2.80E-06	 1	 		 R.IDGVFGDTAVVNEWLK.T	911	 168	 –	 183	 881.9713	 1761.9281	 1761.8938	 19.5	 0	 90	 3.30E-09	 1	 		 R.IDGVFGDTAVVNEWLK.T	912	 168	 –	 183	 881.9716	 1761.9286	 1761.8938	 19.8	 0	 98	 2.20E-09	 1	 		 R.IDGVFGDTAVVNEWLK.T	913	 168	 –	 183	 881.9716	 1761.9287	 1761.8938	 19.9	 0	 93	 2.20E-09	 1	 		 R.IDGVFGDTAVVNEWLK.T	914	 168	 –	 183	 881.9717	 1761.9288	 1761.8938	 19.9	 0	 102	 2.50E-10	 1	 		 R.IDGVFGDTAVVNEWLK.T	915	 168	 –	 183	 881.9719	 1761.9291	 1761.8938	 20.1	 0	 67	 4.90E-07	 1	 		 R.IDGVFGDTAVVNEWLK.T	916	 168	 –	 183	 881.9719	 1761.9291	 1761.8938	 20.1	 0	 81	 2.30E-08	 1	 		 R.IDGVFGDTAVVNEWLK.T	917	 168	 –	 183	 881.9719	 1761.9292	 1761.8938	 20.1	 0	 48	 3.20E-05	 1	 		 R.IDGVFGDTAVVNEWLK.T	918	 168	 –	 183	 881.9719	 1761.9292	 1761.8938	 20.1	 0	 58	 1.70E-05	 1	 		 R.IDGVFGDTAVVNEWLK.T	919	 168	 –	 183	 881.972	 1761.9295	 1761.8938	 20.3	 0	 32	 0.00098	 1	 		 R.IDGVFGDTAVVNEWLK.T	920	 168	 –	 183	 881.9721	 1761.9296	 1761.8938	 20.4	 0	 90	 3.80E-09	 1	 		 R.IDGVFGDTAVVNEWLK.T	921	 168	 –	 183	 881.9722	 1761.9298	 1761.8938	 20.5	 0	 84	 1.30E-08	 1	 		 R.IDGVFGDTAVVNEWLK.T	922	 168	 –	 183	 881.9723	 1761.9299	 1761.8938	 20.5	 0	 30	 0.0015	 1	 		 R.IDGVFGDTAVVNEWLK.T	923	 168	 –	 183	 881.9723	 1761.9299	 1761.8938	 20.5	 0	 98	 6.20E-10	 1	 		 R.IDGVFGDTAVVNEWLK.T	924	 168	 –	 183	 881.9724	 1761.9303	 1761.8938	 20.7	 0	 98	 2.20E-09	 1	 		 R.IDGVFGDTAVVNEWLK.T	1872	 168	 –	 194	 967.1878	 2898.5416	 2898.4763	 22.5	 1	 76	 7.60E-08	 1	 		 R.IDGVFGDTAVVNEWLKTNPQLGPATEK.V	186	 184	 –	 194	 578.3056	 1154.5967	 1154.5931	 3.09	 0	 53	 3.50E-05	 1	 		 K.TNPQLGPATEK.V	187	 184	 –	 194	 578.3057	 1154.5969	 1154.5931	 3.25	 0	 55	 1.30E-05	 1	 		 K.TNPQLGPATEK.V	188	 184	 –	 194	 578.3065	 1154.5983	 1154.5931	 4.51	 0	 43	 0.00028	 1	 		 K.TNPQLGPATEK.V	189	 184	 –	 194	 578.3069	 1154.5993	 1154.5931	 5.36	 0	 56	 6.70E-06	 1	 		 K.TNPQLGPATEK.V	190	 184	 –	 194	 578.307	 1154.5994	 1154.5931	 5.45	 0	 52	 3.90E-05	 1	 		 K.TNPQLGPATEK.V	
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191	 184	 –	 194	 578.3071	 1154.5996	 1154.5931	 5.64	 0	 48	 8.50E-05	 1	 		 K.TNPQLGPATEK.V	192	 184	 –	 194	 578.3072	 1154.5999	 1154.5931	 5.9	 0	 50	 6.10E-05	 1	 		 K.TNPQLGPATEK.V	193	 184	 –	 194	 578.3073	 1154.6	 1154.5931	 5.91	 0	 42	 0.00022	 1	 		 K.TNPQLGPATEK.V	194	 184	 –	 194	 578.3073	 1154.6	 1154.5931	 5.91	 0	 69	 1.30E-06	 1	 		 K.TNPQLGPATEK.V	195	 184	 –	 194	 578.3073	 1154.6	 1154.5931	 5.91	 0	 65	 2.70E-06	 1	 		 K.TNPQLGPATEK.V	196	 184	 –	 194	 578.3073	 1154.6	 1154.5931	 5.98	 0	 52	 3.00E-05	 1	 		 K.TNPQLGPATEK.V	197	 184	 –	 194	 578.3074	 1154.6003	 1154.5931	 6.19	 0	 35	 0.00057	 1	 		 K.TNPQLGPATEK.V	198	 184	 –	 194	 578.3075	 1154.6004	 1154.5931	 6.29	 0	 57	 2.10E-05	 1	 		 K.TNPQLGPATEK.V	199	 184	 –	 194	 578.3075	 1154.6004	 1154.5931	 6.31	 0	 62	 3.70E-06	 1	 		 K.TNPQLGPATEK.V	200	 184	 –	 194	 578.3075	 1154.6005	 1154.5931	 6.36	 0	 47	 0.00011	 1	 		 K.TNPQLGPATEK.V	201	 184	 –	 194	 578.3076	 1154.6006	 1154.5931	 6.5	 0	 48	 8.30E-05	 1	 		 K.TNPQLGPATEK.V	202	 184	 –	 194	 578.3076	 1154.6007	 1154.5931	 6.55	 0	 42	 0.00048	 1	 		 K.TNPQLGPATEK.V	203	 184	 –	 194	 578.3076	 1154.6007	 1154.5931	 6.55	 0	 34	 0.0019	 1	 		 K.TNPQLGPATEK.V	204	 184	 –	 194	 578.3077	 1154.6008	 1154.5931	 6.62	 0	 24	 0.034	 1	 		 K.TNPQLGPATEK.V	205	 184	 –	 194	 578.3078	 1154.601	 1154.5931	 6.85	 0	 67	 2.50E-06	 1	 		 K.TNPQLGPATEK.V	206	 184	 –	 194	 578.3079	 1154.6012	 1154.5931	 6.97	 0	 50	 7.90E-05	 1	 		 K.TNPQLGPATEK.V	207	 184	 –	 194	 578.3079	 1154.6012	 1154.5931	 7.01	 0	 66	 2.10E-06	 1	 		 K.TNPQLGPATEK.V	208	 184	 –	 194	 578.308	 1154.6015	 1154.5931	 7.28	 0	 40	 0.0005	 1	 		 K.TNPQLGPATEK.V	209	 184	 –	 194	 578.3081	 1154.6016	 1154.5931	 7.32	 0	 40	 0.00053	 1	 		 K.TNPQLGPATEK.V	210	 184	 –	 194	 578.3089	 1154.6033	 1154.5931	 8.82	 0	 49	 0.00016	 1	 		 K.TNPQLGPATEK.V	211	 184	 –	 194	 578.309	 1154.6034	 1154.5931	 8.91	 0	 48	 8.70E-05	 1	 		 K.TNPQLGPATEK.V	1537	 195	 –	 214	 1088.5818	 2175.149	 2175.1437	 2.46	 1	 46	 4.90E-05	 1	 U	 K.VTDPRYFGTGLGIAVRPDNK.A	1538	 195	 –	 214	 1088.5834	 2175.1522	 2175.1437	 3.94	 1	 62	 1.60E-06	 1	 U	 K.VTDPRYFGTGLGIAVRPDNK.A	1539	 195	 –	 214	 1088.5837	 2175.1528	 2175.1437	 4.21	 1	 56	 9.50E-06	 1	 U	 K.VTDPRYFGTGLGIAVRPDNK.A	690	 200	 –	 214	 804.4038	 1606.7931	 1606.8467	 -33.4	 0	 43	 8.70E-05	 1	 U	 R.YFGTGLGIAVRPDNK.A	691	 200	 –	 214	 804.4227	 1606.8308	 1606.8467	 -9.94	 0	 61	 2.00E-06	 1	 U	 R.YFGTGLGIAVRPDNK.A	
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517	 215	 –	 228	 741.4661	 1480.9176	 1480.8976	 13.5	 1	 68	 1.20E-05	 1	 		 K.ALLEKLNNALAAIK.A	47	 220	 –	 228	 464.281	 926.5473	 926.5549	 -8.12	 0	 54	 0.00044	 1	 		 K.LNNALAAIK.A	48	 220	 –	 228	 464.2834	 926.5522	 926.5549	 -2.9	 0	 33	 0.013	 1	 		 K.LNNALAAIK.A	49	 220	 –	 228	 464.2835	 926.5523	 926.5549	 -2.72	 0	 52	 0.0018	 1	 		 K.LNNALAAIK.A	50	 220	 –	 228	 464.2837	 926.5528	 926.5549	 -2.25	 0	 46	 0.0011	 1	 		 K.LNNALAAIK.A	51	 220	 –	 228	 464.284	 926.5534	 926.5549	 -1.6	 0	 44	 0.0021	 1	 		 K.LNNALAAIK.A	52	 220	 –	 228	 464.284	 926.5534	 926.5549	 -1.6	 0	 56	 0.0011	 1	 		 K.LNNALAAIK.A	53	 220	 –	 228	 464.284	 926.5534	 926.5549	 -1.6	 0	 54	 0.00081	 1	 		 K.LNNALAAIK.A	54	 220	 –	 228	 464.284	 926.5535	 926.5549	 -1.45	 0	 55	 0.0005	 1	 		 K.LNNALAAIK.A	55	 220	 –	 228	 464.2841	 926.5536	 926.5549	 -1.41	 0	 40	 0.015	 1	 		 K.LNNALAAIK.A	56	 220	 –	 228	 464.2842	 926.5537	 926.5549	 -1.21	 0	 51	 0.0014	 1	 		 K.LNNALAAIK.A	57	 220	 –	 228	 464.2842	 926.5538	 926.5549	 -1.19	 0	 57	 0.00063	 1	 		 K.LNNALAAIK.A	58	 220	 –	 228	 464.2842	 926.5538	 926.5549	 -1.13	 0	 58	 0.00033	 1	 		 K.LNNALAAIK.A	59	 220	 –	 228	 464.2842	 926.5539	 926.5549	 -1.08	 0	 51	 0.00091	 1	 		 K.LNNALAAIK.A	60	 220	 –	 228	 464.2842	 926.5539	 926.5549	 -1	 0	 50	 0.0024	 1	 		 K.LNNALAAIK.A	61	 220	 –	 228	 464.2844	 926.5542	 926.5549	 -0.74	 0	 52	 0.0018	 1	 		 K.LNNALAAIK.A	62	 220	 –	 228	 464.2844	 926.5542	 926.5549	 -0.69	 0	 50	 0.00084	 1	 		 K.LNNALAAIK.A	63	 220	 –	 228	 464.2844	 926.5542	 926.5549	 -0.69	 0	 50	 0.0024	 1	 		 K.LNNALAAIK.A	64	 220	 –	 228	 464.2844	 926.5543	 926.5549	 -0.63	 0	 62	 0.00025	 1	 		 K.LNNALAAIK.A	65	 220	 –	 228	 464.2845	 926.5544	 926.5549	 -0.54	 0	 56	 0.00032	 1	 		 K.LNNALAAIK.A	66	 220	 –	 228	 464.2847	 926.5548	 926.5549	 -0.09	 0	 61	 0.00032	 1	 		 K.LNNALAAIK.A	67	 220	 –	 228	 464.2929	 926.5712	 926.5549	 17.7	 0	 47	 0.003	 1	 		 K.LNNALAAIK.A	767	 220	 –	 235	 564.3125	 1689.9156	 1689.9049	 6.33	 1	 82	 1.90E-08	 1	 		 K.LNNALAAIKADGTYQK.I					
